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PREFACE
The work which is the subject of this thesis was done
by me at The Clayton Aniline Company Ltd. to which organisation
I have been the sole medical officer for 20 years.
The Company manufactures some heavy chemicals but is 
engaged principally in the manufacture of synthetic dyestuffs 
and pigments and of the intermediate chemicals used in their 
synthesis.
At least 123 men who were engaged in this work are known 
to have developed tumours of the bladder. In a few instances 
the tumours were in the ureter or the pelvis of the kidney and 
these cases are included under the present title.
The thesis is set out in the following order. There
is first a short history and explanation of the origin and
development of the synthetic dyestuffs industry in general and 
of that in the Clayton Aniline Company Ltd. in particular.
The historical background of occupational tumours of the bladder 
is then traced and the incidence of the disease abroad and in 
Britain described. The compounds which have been suspected or 
proved to cause the disease in workmen are considered together 
with the methods of their manufacture and the risks involved.
The industrial, epidemiological and experimental evidence of 
their carcinogenicity or otherwise is evaluated. Their 
metabolism and mode of action is considered. Much of the work
- l i ­
on the metabolism of one of these compounds (benzidine) was 
done under my direction in the Vorks Medical Department.
Against this background my own work on the problem of 
occupational tumours of the bladder is prescribed.
The relevant compounds are discussed; these are the 
carcinogens which have been manufactured at Clayton and certain 
other compounds pertinent to the subject. Of the latter some 
have not been manufactured at Clayton and some are thought not 
to be carcinogenic. The conditions existing from time to time 
and the populations exposed are described.
There follows a detailed description and statistical 
analysis of the incidence of the disease in the Clayton factory.
The difficulties of achieving early diagnosis and the 
relative merits of various screening methods are compared.
Clayton was one of the two factories in which exfoliative 
cytology was first used for the early detection of tumours of 
the urinary tract in workmen at risk. Its original introduction 
into industrial medical practice and the successful development 
of the application of cytodiagnostic methods to the Clayton 
works population is detailed at some length.
The clinical, histological and pathological features of 
the tumours are described and an account is given of the incidence 
of recurrent tumours, treatments and age factors.
The legislation relating to the actual working conditions
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PART I - GENERAL.
ORIGIN AND HISTORY OF CHEMICAL DYESTUFFS
Faraday discovered benzene in 1825 and Hofmann isolated it 
from coal tar in 1845* yet as late as 1847 Berzelius was writing 
in support of the belief that a ’’vital force” was necessary for the 
production of organic compounds. Organic chemistry was then in 
its infancy and synthetic dyes were undreamed of. Compounds which 
are commonplace to-day were unknown or merely of academic interest.
In 1856 aniline was a rare, almost precious, substance and 
toluidine was even rarer. In that year William Henry Perkin, then 
aged only 18, was working in Hofmann’s laboratory in London 
attempting to make quinine from the toluidine derivative allytoluidine 
by oxidizing it with potassium bichromate. The experiment was 
unsuccessful but Perkin tried again this time using impure aniline 
sulphate from which he obtained a dark resinous mass which practi­
cally every other chemist of his time would have thrown away. Perkin, 
however, studied it and discovered it could dye silk a brilliant 
mauve, a shade which at that time was obtainable only from natural 
colour and which had always been very fugitive especially on silk 
usually fading to red within 24 hours. He sent his new dye which 
he c&lled mauveine to Sir R.Pullar of Perth, head of the Scottish 
firm as well-known then as it is now. Pullar liked it and was 
prepared to use it if he could obtain it in sufficiently large 
quantities.
2Perkin thereupon set up a factory at Greenford Green in Essex to 
make mauveine on a commercial scale and he took out his first patent 
in 1856, one hundred and two years ago. This was the start of the 
coal tar or aniline dye industry which was soon to become important 
in many countries.
After numerous experiments, Perkin decided that the reduction 
of nitrobenzene was the best source of aniline. He succeeded in 
devising and setting up plant for its manufacture on the requisite 
scale. The aniline which he obtained and the aniline manufactured 
for the next two generations contained many impurities, the most 
important of which were ortho and paratoluidine. On the relative 
amounts of these depended the colour of the mauveine and that of 
many other products. Mauveine would not dye cotton or wool and this 
limited its application. He turned his attention to this aspect of 
the problem and discovered a method of applying it to these materials 
thereby extending its use enormously. Perkin's mauveine was used
MAUVEINE.
(Chief constituent; 
Viomoiogues are 
also present?)
for dyeing many different textiles and paper and as a pigment until 
the turn of the century when it was superseded by newer dyes.
Some mauveine as made by Perkin is, however, still available and a 
piece of silk dyed by it is attached* (in Vol.il).
Perkin's discovery stimulated research into the subject all
3over Europe. In the same year Natansen in Poland produced a new 
purple dye by heating aniline with ethylene dichloride. This was 
soon to sweep the market. Two years later Hofmann obtained a 
similar product from aniline and carbon tetrachloride. In 1859 
Verguin working with Renard Freres et France of Lyons discovered a 
process using stannic chloride and aniline, and this firm was the 
first to manufacture it industrially. The dyestuff was named 
magenta to commemorate the French victory over the Austrians in the 
battle of Magenta in 1859# The Germans took it up with enthusiasm 
and named it fuchsin, a pretty play on their word for fox (fuchs) 
and the name (Renard) of the French originators. In 1860 Medlock 
devised a method of manufacture using arsenic acid with aniline which 
was widely adopted. In 1869 Coupier of Paris developed a process 
using nitrobenzene which was first successfully carried out on an 
industrial scale by the firm of Meister, Lucius and Bruning at 
Hochst-am-Main. This process superseded the arsenic acid method 
everywhere. As with mauveine tne production of colour depended on 
toluidines being present; it is now known that pure aniline yields 
a quite different substance of the induline type. In 1887 Caro 
developed acid magenta, a trisulphonic acid derivative which greatly 
widened its application and its use in industry.
Picric acid was also used as a dye. A well-known firm of 
Burton brewers (Allsops) was disconcerted by the popularity of a 
rival beer which had an enhanced bitter taste compared with their 
own. They employed a firm of analysts to find the reason for this
4and one of their chemists Peter Griess found that picric acid had 
been added to it. Following this Griess subsequently became head 
chemist at Allsops, where, working in his spare time, he developed 
the diazo reaction which he had discovered previously whilst a 
student at Marburg in 1858, On this reaction depends the synthesis 
of a large class of dyestuffs comprising thousands of azo-dyes which 
are the foundation of the dyestuffs industiy. In this class are 
many colours in which benzidine, alphanaphthylamine and betanaph- 
thylamine are used as components and although these intermediates 
have, or have had, other uses inside and outside the dye industry, 
their large scale manufacture and use has been predominantly for the 
production of azo colours.
Benzidine was first discovered by Zinin, a Russian chemist in 
1853. He showed that azobenzene when treated with ammonium sulphide 
and boiled with sulphuric acid gave the sulphate of a base which he 
called benzidine. This was confirmed by Hofmann in 1862, who 
identified and isolated the intermediate hydrazobenzene which he 
found was easy to convert to benzidine by the action of a mineral 
acid. Finally Fittig showed that the base was 44' diaminodiphenyl. 
An early use of benzidine was in the manufacture of Palatine orange 
(tetranitrodiphenyl) which quickly became obsolete as a dyestuff. 
Following Bottigers major discovery in 1885 of the direct cotton 
dyestuffs many of which,such as Congo Red, are made from benzidine, 
benzidine began to be made in very large quantities and hhis has 
continued to the present day. It was not, however, until 1902
that the first commercial patent for its manufacture was registered 
by Lillienfeld in Berlin, This was an electrolytic reduction of 
4-aminobenzoic acid,
Alphanaphthylamine was discovered also by Zinin eleven years 
previously in 1842. It was first prepared by the ammonium sulphide 
reduction of alphanitronaphthol and subsequently many different 
reducing agents have been used in its manufacture, for example, iron 
and acetic acid in 1854, tin and hydrochloric acid in 1861, zinc and 
hydrochloric acid in 1870, and alcoholic potash in 1877, On the 
industrial scale the reduction of alphanitronaphthalene is still the 
method employed.
Betanaphthylamine was first recorded in Germany by Lieberman 
and Schneiding (1875) who obtained it by the reduction of 1-bromo 
betanitronaphthalene with tin and hydrochloric acid. In 1880 it was 
commercially manufactured in Germany by heating betanaphthol with 
ammonia at 160°C under pressure (D.R.P.14612) a principle substan­
tially similar to that which was used in The Clayton Aniline Company 
in Manchester until its manufacture was abandoned in 1950.
Until about 1876 the British chemical industry was pre-eminent 
in the manufacture of dyestuffs but after that it was increasingly 
outstripped by its German and Swiss competitors until by 1914 Britain 
was virtually dependent on them for dyestuffs and many other chemicals. 
The stimulus and stark necessity of war forced an effort from the 
British industry which rendered it independent of foreign suppliers, 
an economic and strategically vital independence which it has
6maintained ever since.
History of Manufacture in The Clayton Aniline Company Limited.
The Clayton Aniline Co.Ltd. of which I have been medical 
officer for 20 years, was founded in 1875 in Manchester and has 
manufactured aniline from that time. The cases of occupational 
tumours of the bladder which are the subject of this thesis arose 
there. It was one of the few dyestuffs manufacturing companies 
in England which survived the Continental competition and between 
1875 and 1914 it continued to make coal tar chemicals. It 
carried out the refining of coke oven benzole to obtain benzene, 
toluene and naphtha. From these were manufactured nitrobenzene, 
aniline, paranitroaniline and various other nitro and amino 
compounds. It listed about 20 dyes, the principal ones being 
aniline black, nigrosine, primuline and some stilbene colours. 
Primuline was developed at Clayton by A.G.Green, later Professor 
of Colour Chemistry in Leeds.
Some indication of the comparative British and German out­
put during these years can be had from the numbers of patents 
taken out between 1885 and 1900 which were quoted by Green at the 
meeting of the British Association in 1901 s-
7England
Brooke, Simpson and Spiller 
The Clayton Aniline Co.Ltd, 
Levinstein and Co. (later I.C.I
7
31
Dyestuffs Blackley) 19
28
9
2
Read Holliday & Co. 
Claus and Ree 
W.Gr .Thompson
Total British patents 96
Total German patents 948
This accords with an estimate (C.A.C.Quarterly, 1951) that by the 
beginning of the 1914 War about Bjfo of all our supplies of dyestuffs 
for textiles came from Germany.
In 1909 as a result of the English Patent Act of 1907 which 
required the compulsoiy manufacture of products in order to maintain 
patent rights, certain reciprocal arrangements were made with the 
Society of Chemical Industry in Basle ^now Ciba Ltd.) which 
culminated in that organisation eventually purchasing the whole share­
holding of the company and taking over effective control in May 1911.
At the outbreak of the war in 1914 about 200 tons of trinitro­
toluene were being made annually at Clayton for dye manufacture.
This substance was of great importance as an explosive and so its 
production was rapidly expanded to 5000 tons a year. In 1917, 
because of the urban location of the factory, manufacture was dis­
continued for safety reasons. The trinitrotoluene plant was then 
turned over th the manufacture of several compounds which are used 
in the intermediate stages of dyestuffs manufacture. One of these
8was benzidine which was made by the zinc reduction process,
Betanaphthylamine manufacture was begun in 1920 in another 
department and continued until it was given up voluntarily in 1950 
because of the health hazard associated with it. Alphanaphthy- 
lamine was made for a short period from 1926 to 1930. At all 
other times it has been bought from other manufacturers and used on 
a fairly large scale. Magenta was manufactured from 1920 to 1926 
and since then has been bought only at intervals and then on a 
comparatively small scale. Several other substances which have 
been suspected of being carcinogenic have been manufactured or used 
and will be referred to later. All these intermediates have also 
been used in the colour factory in the synthesis of azo-dyes and 
other compounds. There has been a rapid development of the manu­
facture of many other intermediates and of all types of synthetic 
coal tar dyes, particularly azo colours, vat dyes and triphenylme- 
thane colours. Auramine has never been manufactured by this 
company.
Thus ,up to the end of the First World War while the dyestuffs 
and chemical industry had grown to large proportions in Germany, and 
to a somewhat lesser extent in Switzerland, a few companies here in 
Britain had maintained a small steady production in the face of 
their continental competitors. It was not, however, until after 
the First World War that the naphthylamines, benzidine and magenta, 
all compounds subsequently to be indicted as bladder carcinogens, 
were manufactured on a substantial commercial scale in this country.
9As already described The Clayton Aniline Company was among the 
largest British manufacturers*
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HISTORY OF OCCUPATIONAL TUMOURS OF THE BLADDER.
Towards the end of the 19th century skin cancers in chimney 
sweeps and workers in shale oil, tar and similar industries had come 
to be accepted as occupational in origin. The occurrence of lung 
tumours in the Sehneeberg miners at Joachims tall in Bohemia had 
already been reported. No occupational tumours in organs remote 
from the site of contact had been recognised.
At a congress of the German Surgical Society in 1895 Rehn, a 
surgeon in Frankfurt-am-Main which was the centre of an important 
chemical industry, discussed the frequent occurrence of haematuria 
in chemical workers in his practice. He reported among them three 
cases of men who had bladder tumours, two with papilloma and one 
with carcinoma, and mentioned a fourth man who had not been examined 
cystoscopically but who also was presumed, for good reasons, to have 
had a tumour of his bladder. All of these men had worked in the 
fuchsin room in one factoiy, and a total of 45 men at the most were 
known to have worked there during the period when these men had been 
exposed. The three men with bladder tumours, recorded by Rehn, 
had been employed in this shed for 15, 29 and 20 years and had had 
haematuria for 4 years, 1-jjr years and 6 months respectively. Rehn 
concluded that
1. the fumes which develop during the manufacture of fuchsin lead
to disturbances in the urinaiy system,
2) after years of work in the fuchsin industry tumours of the 
bladder may occur as a result of continuous irritation,
5) the injurious effect is mainly due to the inhalation of aniline 
vapour.
Thus early these tumours were attributed to exposure to 
aniline and the name "aniline-cancer” was to stick for many years 
before it was finally accepted that aniline is not a significant 
cause and the misnomer was dropped. Despite the convincing evidence 
of certainly three, and probably four, cases of men with bladder 
tumours in a population of 45 in one workshop some scepticism was 
expressed about their occupational origin. Grandhomme (1896), an 
official of the works previously owned by Meister, Lucius and Bruning, 
the firm which introduced the nitrobenzene process for the manufacture 
of fuchsin about 1869 and which had made it on a large scale since 
then, writing on the sanitary and social aspect of his factoiy, 
expressed strong doubts as to the connection between the occupation 
and the disease. He claimed that in the same room and over the same 
period described by Rehn (i.e. 1883 -'95) 493 operatives had remained 
healthy and that in other factories 4000 operatives had worked on 
similar processes and under similar conditions and no bladder tumours 
had been diagnosed. He agreed that aniline might irritate the 
mucous membrane of the bladder and produce pain and haemorrhage but 
maintained that it had no connection with the production of tumours.
Although one may suspect that Grandhomme was not disinterested and 
that his motives were not altogether altruistic, it is nevertheless 
still accepted that heavy exposure to toluidines and some other 
aromatic amines, many of them not carcinogenic, can cause acute 
haemorrhagic cystitis.
Bachfield in 1898 supported Grandhomme's view when he 
reported 63 cases of poisoning by aniline, toluidine or nitrobenzene 
from a factory in Offenbach. Of these, 16 had dysuria and haema­
turia but no tumours were observed. Later in the same year 
Leiehtenstem (1898) attributed a bladder tumour to naphthylamine. 
This was 18 years after the manufacture of betanaphthylamine was 
begun in Germany and about the same time after the alpha-isomer began 
to be widely used. It is the first mention of naphthylamines as a 
cause of tumour.
In 1904 Rehn made a report of a further 20 cases to the 
Surgical Congress which then asked him to compile material for a 
comprehensive survey of the incidence of tumours of the bladder in 
aniline factories. He investigated the workmen at 18 factories and 
found a total of 38 cases which had arisen in seven of the factories. 
In addition to aniline and fuchsin, benzidine and naphthylamine were 
now identified as significant contacts. Several other authors 
reported other cases from the same area but most of them were 
probably included in Rehn's 1906 report (Wendel, 1900, 3 cases: 
Posner,1904, 1 case: Straus,1904, 1 case: Randesheuse 1904, 2 cases: 
Schedler, 1905, 2 cases: Seyberth, 1907, 5 cases: Labour
1 3
Inspector's Report, 1909, 2 cases: Cesabianco, 1911, 1 case).
The cases hitherto reported had nearly all come from the 
Frankfurt area and those like Grandhomme who were sceptical of 
their occupational source, or were unwilling to admit it, were 
very ready to suggest a geographical origin for them, although 
Sehedler in 1905 had reported two cases from Basle which he 
ascribed to aniline. Any credence which the geographical theory 
had gained was exploded in 1912 when Leuenberger produced 18 cases 
in aniline dye workers in Basle. Adding to them the 41 cases 
previously reported, he reviewed all the existing reports.
He compared the incidence in aniline dye workers with that 
in the general population in Basle. He showed that the incidence 
of deaths from tumour of the bladder had increased from 7 per 
thousand of the average population of the city for the decade 1871 - 
'80 to 20 per thousand for the decade 1901 - '10. Further, during 
1901 - *10 the number of workers in aniline and aromatics in Basle 
was 840; the total male working population was 56,500. During 
this time 6 workers in aniline died of bladder tumour compared with 
12 men in the rest of the male population. From these data he 
calculated that the deaths due to tumour of the bladder among workers 
in aniline dyes were 53 times that of those in the rest of the male 
population.
He also cited figures from the records of the Basle Surgical 
Clinic. During the forty years 1861 - 1900, when the chemical
industry was growing, 15,800 patients were recorded, among whom were 
six cases of tumours of the bladder, none of whom was known to have 
worked with aniline; in the next ten years 1901 - 1910, during which 
the chemical industry had developed, there were 16 cases of bladder 
tumour in 8,650 patients. Of these 16 cases, 12 were aniline workers 
or dyers. Of all tumours treated during this latter ten year period 
7.8$ were bladder tumours. In Vienna where there was no chemical 
industry, bladder tumours constituted 0.39$ of all tumours. In 
Frankfurt where the chemical industry was heavily concentrated they 
comprised 25 - 30$ of all tumours by 1918 (l.L.0. Report, 1921).
By 1913 Schewin (1920) had collected 100 cases which he 
discussed at a conference of factory doctors in Leipzig in that year. 
He had personally seen 38 cases of industrial origin against only one 
of non-industrial origin. The rest of his100 cases had previously 
been reported.
Thus by 1913 Rehn's observation that bladder tumours were an 
occupational disease of aniline workers had been confirmed and had 
come to be accepted by those working in this field in Europe. The 
great bulk of the aniline and synthetic dyestuffs industry was still 
located in Germany and Switzerland and no cases had yet been reported 
from elsewhere. In England, Legge, H.M.Senior Medical Inspector 
of Factories in his Annual Reports for 1912 and 1913, following a 
visit to Frankfurt in 1911, had called attention to the hazard, but 
no cases were reported in England despite the fact that this warning 
must have increased the likelihood of any occupational cases being
15
recognised. The German and Swiss industries, aware of the risk 
and alert to it, made considerable improvements in their methods of 
working. As their industry expanded before and during the First 
World War, new plants were built and re-organisation and amalga­
mations into large combines tended to concentrate the dangerous 
manufactures into fewer factories where, on the whole, working 
conditions were better, populations larger and supervision closer.
At the end of the war, the subject of industrial tumours of 
the bladder was again discussed in Germany by the Congress of 
Factory Doctors in 1920. A Commission of Inquiry composed of 
representatives of doctors, manufacturers, government and workers 
was appointed to study the question. Curschmann, the secretary, 
conducted a survey by circulating a questionnaire and he reported 
later the same year on the results. He revealed that 28 new cases 
had arisen since 1913. In addition to these his report included 
several which had been previously reported, several which were not 
tumours but other “troubles of the bladder” and one which was 
described as a cancer of the kidney. He estimated the total number 
of cases since Rahn's first report todate at 177 but the report of 
an I.L.O. study in 1921 revised his estimate pointing out that 
many cases had been included in more than one report. This I.L.O. 
study gave the number as 87 excluding Nassauers1 (1919) 32 cases, 
as there was doubt whether they had been previously included in 
other reports.
The I.L.O. report summed up the position in Germany and
16
Switzerland up to 1920 and made recommendations for industrial and 
medical prophylactic measures. The report recommended the keeping 
of detailed records; it listed many compounds which were suspected 
by various authors as causative agents. Aniline was the substance 
most often named, although the report concluded, among other things 
that it was not possible to determine the substance capable of 
engendering tumours; that one could go no further than to 
incriminate the amine compounds, particularly benzidine and betanaph- 
thylamine. This was the first time such emphasis had been placed on 
■these two compounds which were later to figure so largely in this 
problem.
By the end of the 1914-18 war, the dyestuffs industry through­
out the world had, to a large extent, been redeveloped and manufacture 
in the allied countries had increased to a level comparable with the 
crippled German output. The problem of bladder cancer in these 
countries outside Germany and Switzerland was forgotten, if it had 
ever been seriously believed or heard of, and a complete repetition 
of the German and Swiss experience was set in motion in Great 
Britain, Italy, France and the United States of America.
Great Britain.
In Great Britain, Ross (1918) writing on occupational cancer 
of the bladder stated that although the aniline dye industry was not 
of a large size the Chief Inspector of Factories ’’refers to a series 
of 14 cases of villous growth of the bladder in a works where the
17
men concerned are engaged in handling aniline dyes”. I have not 
been able to trace any published or private reports of these cases* 
Hueper (1954-) and several other writers have, presumably on the 
strength of this paper, mistakenly credited Ross as being the first 
to discover or describe the existence of occupational bladder tumours 
in Britain* Henry, Kennaway and Kennaway (l93l) found some barely 
conclusive evidence from an examination of death certificates that 
there was a higher incidence of deaths from tumours of the bladder 
and prostate in workers in coal gas, pitch and tar than in the 
general population* They also found 61 fatal cases of cancer of the 
bladder in chemical workers and dyers but could not obtain reasonably 
accurate figures of the population at risk* Bridge, H.M.Senior 
Medical Inspector of Factories in his Annual Report in 1926 recorded 
12 chemical workers who had died from the disease in the preceding 
four years*
Wignall (1929) the appointed surgeon to the British Dyestuffs 
Corporation (later Imperial Chemical Industries Ltd.) delivered a 
paper on the “Incidence of Disease of Bladder in Workers in Certain 
Chemicals’1 to the Section of Occupational Diseases of the 97th 
Annual Meeting of the British Medical Association in Manchester*
This is the first report from a factory doctor in England of an 
incidence of occupational tumours of the bladder in a defined 
industrial population. His paper in many ways is reminiscent of 
Rehnfs although he does not mention him. Like Rehn, he describes
a high incidence of cyanosis from methaemoglobinaemia among his 
workmen, and of gross haematuria from the cystitis induced by 
some aromatic amines. He then describes in some detail 14 cases 
of tumour, papillomata and carcinomata, of the bladder arising in 
his factory, 7 of whom had worked in alphanaphthylamine, 3 in 
colour manufacture, 2 in benzidine and the others in other inter­
mediates. A further 8 men whose illness had arisen before 1910 
might have had tumours due to alphanaphthylamine but his information 
on these cases is not complete.
Betanaphthylamine is not mentioned but his successor in the 
factory, Goldblatt (1956), states that Wignall had at that time no 
reason to suspect that benzidine and betanaphthylamine, which were 
extensively used in the factory were able to lead to bladder tumours. 
Macalpine (1929) the urologist who treated Wignall's cases, published 
a detailed surgical description of 7 of them. Apart from another 
reference by Bridge in 1936 no further cases were published in 
England until two years after the last war (Goldblatt 1947). Mttller 
(l95l) remarked that little interest in these diseases had been 
shown in England during the Second World War. This was completely 
unjustified as reports from Goldblatt (1947 and 1949a) and myself 
(Scott 1952) unquestionably showed.
In 1949 Goldblatt reviewed his experience during the period 
1934-47 from two British chemical factories manufacturing inter­
mediates, dyestuffs, and many other compounds. In his series there 
were 99 cases of workmen who developed bladder tumours of whom 59
19
had died, and "as to causative agents, alphanaphthylamine, 
betanaphthylamine and benzidine were manifestly involved1*. He 
also attributed 3 cases of papilloma to aniline, but retracts this 
in a more recent publication (1956) and agrees that later rigorous 
studies by other investigators appear to rule aniline out completely. 
These three cases mentioned by Goldblatt are of interest in that 
they are the only inculpation of aniline as a causative agent in 
post-war England. No other observers appear to have had reason to 
suspect it. (Scott, 1952, 1953, 1954, Williams 1958).
Goldblatt's papeisevince the enormous interest, care and 
work which he had maintained in this problem in his factories during 
the war years. Data were carefully recorded throughout; regular 
examination of all workers at risk and routine urine tests were 
maintained; continuous medical supervision of workers and of the 
working environment was carried out and the investigation and treat­
ment of suspected and established cases of tumour were vigorously 
pursued. It is an index of the care he directed to this problem 
that the average daily excretion of aromatic amine in the urine of 
alphanaphthylamine workers was estimated during the difficult war 
years of 1942, 1943 and 1944.
In a paper read to the International Congress of Industrial 
Medicine at Lisbon in 1951 I presented a further 66 cases from 
another factory3" in England (Scott 1952). These cases were attri­
buted to benzidine, alphanaphthylamine, betanaphthylamine and 
various combinations of these. In addition to thh usual medical
x The Clayton Aniline Co.Ltd.
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and statistical details I gave the history of the manufacture of 
benzidine and betanaphthylamine in this factory with diagrammatic 
illustrations of each. Prom these histories it can be seen that 
many improvements in plant and process working were instituted and 
that some of the most important of these were introduced during the 
war years of 1939-45 thus further demonstrating the efforts made in 
England during the war to improve conditions and lessen risk. 
Goldblatt's papers were published four years and two years respect­
ively before Miller’s statement that little interest had been shown 
in England during the war and my own paper was delivered to the 
International Congress in the same year as Miller made this state­
ment.
Germany 1920 - 1958.
Meantime in Germany there was a succession of reports of 
cases from 1920 onwards from Oppenheimer (1920, 1926 a & b, 1927) 
who suggested in 1920 that not only operatives but also people living 
in the vicinity of the works might develop the disease, Bauer (1926), 
Ullman (1926 & 1933), Brezina (1929), Simon (1929, 1930 a,b,c, 1932), 
Sebening (1930) and Sieben (l93l). Buttner (1931) found that the 
German literature had reported on 300 cases by that time - not a 
surprising figure in view of the size of their industry and the time 
which tumours had had to develop.
In 1940 Gross reported on 85 cases which had occurred in a 
Ludwigshaven factory. He attributed 36 to betanaphthylamine, 3 to
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■benzidine base, 13 to mixed exposures and he gave aniline as the 
cause in 33 cases. He is reported to have confirmed the aniline 
cases when examined by the Allied Commission in 1945 (B.I.O.S.
Final Report No.784 , 24) although he then qualified it by saying 
that very few men in comparison with the number of workers exposed 
to aniline had been affected. On raising this important point 
with him since then, I have received a personal communication in 
which he refutes his 1940 view entirely. He writes (14.11.57) 
”both betanaphthylamine and aniline seem to be extremely dangerous, 
I have not said or written so. This opinion concerns betanaphthy­
lamine only and, as we know now, benzidine too, but never aniline”.
Since then at a meeting of the bladder cancer working group 
of the Deutsche Forschungsgemeinschaft held in Bad Godesburg in 
November 1957 which I attended, the most recent German totals of 
cases were reported. Badische Aniline at Ludwigshaven now have 
191 known cases, Beyers at Leverkusen have 132, Hochst at Greisheim 
23 Bayers at Offenbach 22. These figures have been collected 
since a similar meeting held in 1954 had re-stimulated interest in 
the problem in Germany. Except for these two meetings in 1954 
and 1957 no further reports have emerged from Germany since the 
last war. The proceedings of the 1957 meeting will be circulated 
privately among the 20 attending members but it is unlikely that 
they will be published.
Switzerland 1920 - 1958.
In Switzerland, Miller who had succeeded Leuenberger as 
urologist in Basle, supplemented his predecessor's cases in 1933 
by a collection of 54 further cases of bladder tumour and followed 
this by several subsequent publications (1933, 1934, 1936, 1940, 
1945, 1949) culminating in his outstanding treatise of 1951, the 
most comprehensive review of the subject which had so far been 
written. He added a further group of 85 cases bringing his total 
up to 139. (Miller gives his total number as 161 but 22 cases 
were of haemorrhagic cystitis without tumour). He considers 
aniline to be decidedly dangerous and incriminates it in 22 cases, 
benzidine in 36, betanaphthylamine in 37, various combinations of 
these in 8 and other substances several times. His colleagues 
Uebelin and Pletscher (1954), the medical officers of the factory 
where the majority of his cases originated, in describing 100 cases 
from their factory, most of them undoubtedly in Millers series, 
modified this view. They saMthat the effects of aniline were 
formerly held to be the principal cause of bladder tumours in 
dyestuff workers but to-day this opinion is doubted, and it is 
probable that benzidine and betanaphthylamine are primarily respon­
sible. In their works 300 workmen were directly exposed to these 
two compounds and of their cases they attribute 20 to benzidine,
25 to betanaphthylamine, 20 to a mixed exposure of these two and 
the remainder to mixed exposure of one or the other of them with
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other amines. No tumours arose among 500 workmen in contact with 
aniline alone or with aniline together with other amines.
United States of America
If the U.S.A. had appeared fortunate or provident in having 
had no industrial bladder tumours, any complacency which might have 
been felt there must have been dispelled in 1934 when 27 cases were 
reported by Gehrmann. The first case had arisen in 1931 - about 
16 years after manufacture of coal tar dyes in America had begin 
to assume the proportions of an important industry. Further cases 
quickly followed and by 1934 it was deemed expedient to hold a 
"Symposium on Aniline Tumors of the Bladder" at which papers were 
presented on the incidence (Gehrmann), the etiology (Ferguson), 
the chemical and industrial aspects (Gehrmann), the pathology (Gay), 
the incidence, diagnosis and results (Anderson) and the treatment 
(Washburn). Except for two alphanaphthylamine workers all the men 
had been exposed to either betanaphthylamine or benzidine, or both, 
and only two had not been exposed to betanaphthylamine; no tumours 
were found in aniline workers. Routine cystoscopy of all workers, 
which will be discussed later, had already been applied and 
recommendations for safe working methods were put forward. Three 
years later Evans (1937) reported 83 cases which included those of 
Gehrmann, and he blamed naphthylamines, benzidine and "other nitro 
and amido compounds" as causative agents, but again aniline was 
specifically excluded from the list of suspected carcinogens.
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In a communication to the IXth International Congress of 
Industrial Health in 1948 Gehrmann,Foulger and Fleming (1949) were 
convinced that aniline did not induce bladder tumour, a conviction 
that has not been disproved and, in fact, has since been universally 
agreed. As betanaphthylamine was the only compound able to producd 
tumours experimentally and as every case of tumour they had met with 
had had exposure to it at some time, they refused to accept benzidine 
in the role of a bladder carcinogen until an incidence of tumours, 
higher than that in the general population occurred in benzidine 
workers who had had no contact with betanaphthylamine or, although 
he did not specifically say so, presumably until tumours were induced 
in experimental animals with it.
Both these requisites were soon to be satisfied. I reported 
a new series of cases in England, amongst whom were 23 benzidine 
workers, from a total working population since 1918 of 198 men who 
had never had contact with betanaphthylamine or any other known or 
suspected carcinogen (Scott 1952). Meantime, tumours had been 
induced with benzidine in experimental animals by Spitz, Maguigan 
and Dobriner (1950). Maguigan (1950) also recorded nearly 200 
cases of industrial bladder tumour which had appeared in America up 
to the time of his writing - a figure which is not surprising when 
one considers the size of the post-war American industry and the 
fact that 85 cases had already arisen in the six years between 1931 
and 1937.
Italy
The experience in the other countries in Europe which had 
not started manufacturing dyestuffs on a large scale until the 
First World War was remarkably similar to that in England and 
America. In Italy the first bladder tumour in a dyewoiker to 
be attributed to his occupation occurred in 1931 - the same year 
as the first American case. This first Italian case was one of 
11 reported by Di Maio, a Milanese urologist, in 1937. In 1948 
in London at the IXth International Congress he presented a 
further report. His results are summarised in Table I*
TABLE I
Italian cases in 1947 (Di Maio)
Department
Benzidine Betanaph­
thylamine
Alphanaph-
thylamine
Aniline
No. employed 213 40 30 619
No.with tumours 22 9 2 1
In addition he lists 68 cases with ’’congestive” lesions of 
the bladder which he believed to be precancerous and of which 8 
subsequently became cancerous. At the same Congress, Barsotti
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and, Vigliani (1949) described. 33 cases of tumour and 58 of 
’•congestive lesion” from benzidine, betanaphthylamine and alpha- 
naphthylamine but they found none due to aniline. Their cases 
undoubtedly overlapped Di Maio’s and were probably mostly included 
in his series. Bellesini (194-9) described a factory manufacturing 
benzidine by the zinc reduction process for a total period of 15 
years where none of the 54 workmen had developed tumours. Goldblatt 
(1956) later reveals from his personal knowledge, that subsequent 
cystoscopy of these men revealed five tumours at the first sitting. 
France:
In France there had been no reports of any occupational 
tumour of the bladder up to 1947. As late as 1941 Hugeuin said 
that occupational bladder cancer, so widely known in America, was 
practically unknown in France. Miller (l95l) remarks that the 
Congress of the French Society of Urologists had bladder papilloma 
as its subject in 1946 but chemical aetiology was not discussed.
In view of the incidence in other countries and the similar manu­
facturing conditions existing in France it was too much to hope 
that none had arisen up to that time and it was not surprising when, 
in 1947, Billiard Duchesne disclosed 17 cases from the Rouen and 
Le Havre area. At the International Congress of Industrial Health 
in London in the following year he was able to report a total of 
34 known cases in France which had arisen since 1937 (Billiard 
Duschesne 1949). These included the cases previously published by
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Desoille, Hochfeld and Aboulker (1948) by Douiller (1949),
Delinotte Amaud and Chatain (1949) and Aboulker, Gaultier,
Benguigi and Smagghe (1949). Again his experience agrees with 
that of most other post war observers that the tumours are due to 
contact with benzidine and the naphthylamines.
Other Countries.
Occupational bladder tumours in aniline dye workers are 
not a monopoly of the Western world. Rosenbaum and Gottlieb as 
early as 1926 reported 13 cases in a population of 9000 operatives 
in Russia and cases had occurred in Japan (Wagazio and Kimosita 
1940) by the beginning of the Second World War.
Survey by Association of British Chemical Manufacturers.
Thus,by the early 1950's there existed a large body of 
opinion, supported by a great weight of epidemiological evidence, 
which agreed on the occupational nature of bladder tumours in 
dyestuffs operatives and which indicted certain compounds as causal 
agents. The original cases were attributed to aniline or to 
fuchsin (magenta) or to a combination of them and some years later 
benzidine, alphanaphthylamine and betanaphthylamine emerged as the 
most likely responsible compounds. Aniline was given a clear bill 
by most observers. |*uchsin was not mentioned in the later reports. 
It must be remembered, however, that as the century advanced its 
manufacture declined compared with that of the other suspected 
agents and in later years it has been made only on a comparatively 
small scale. Neverthless five cases have recently arisen in a
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small factory in England (Ashworth, personal communication, 
shortly to be published) and these will be considered later.
Two major surveys have been described, one by Rehn who 
reported in 1906 and one by Curschmann who reported in 1920.
The results of these surveys went a long way towards confirm­
ing the industrial nature of these tumours and indicating the 
agents causing them. A third survey, this time on a major 
national scale, was inaugurated in Great Britain in 1947 when 
the Association of British Chemical Manufacturers (A.B.C.M.) 
decided to conduct and finance a major research project on 
industrial Hpapilloma of the bladder”, as it had come to be 
known, in England* This intentional euphemism had come to be 
used because of the fearful sound of the word cancer to English 
ears and in order not to encourage cancerphobia by its use.
The A.B.C.M. among other measures appointed a ’’Scientific 
Committee”, under the chairmanship of Professor Alexander Haddow, 
to guide research work into the cause, consider diagnostic methods 
and examine preventive techniques. A sub-committee was formed, 
under the chairmanship of Mr N.Strafford,to provide accurate 
methods for the analysis of suspected compounds under industrial 
conditions. The Scientific Committee was disbanded in 1954 and 
succeeded by a smaller permanent one, the Papilloma Committee 
under the chairmanship of Mr J.D.Rose and having as its two medi­
cal members Dr.M.H.C.Williams and myself.
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In 1948 Dr.R.A.M.Case was appointed to a research fellow­
ship created by the A.B.C.M. at the Chester Beatty Institute, to 
conduct an investigation, in the first place by an extensive field 
survey, to establish whether aniline, benzidine, beta or alphanaph- 
thylamine are implicated and what factors affect production of 
tumours of the bladder in workmen in the industry.
Case and his co-workers obtained from the relevant member 
firms of the A.B.C.M. a register of names of men who had had any 
contact of over six month's duration with the named compounds 
(the "Nominal Roll") and a list of all men then known by the firms 
to have developed bladder tumour. They also obtained from the 
records of hospitals in the appropriate areas the names of men 
who had been treated for bladder tumour in the neighbourhood of 
the relevant factories and, from the Registrar General, the names 
of all males dying between 1921 and 1949 whose death certificates 
mentioned bladder tumour. Coroners records and death certificates 
which mentioned the chemical industry as the occupation of the 
deceased were also used.
By the beginning of 1952 they (Case, Hosker, McDonald and 
Pearson 1954) had found 455 cases of bladder tumour from the 
British chemical industry 444 of which had occurred after 1921; of 
these 444 men there were 341 whose names were on the nominal roll 
of men who had worked in contact with the described substances 
in the factories of the member firms. This group of 341 from a 
nominal roll of 4,622 was examined statistically in detail.
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Of these 341 men, 298 (87.4$) had had contact with benzidine, 
betanaphthylamine or alphanaphthylamine or some combination of 
these and 32 (9.4$) were not known to have had such contact.
Case and his co-workers found that the overall risk of dying of 
a bladder tumour, if 9n the nominal roll was 30 times greater 
than that-of the general population - a statistical finding 
remarkably similar to the figure of 33 times reached by Leuenberger 
forty years earlier by much cruder methods.
They also found that betanaphthylamine was the most potent 
agent and that the relative potency was in the ratio of beta­
naphthylamine 5s mixed exposure 2.7: benzidine 1.7; alphanaph­
thylamine Is • The chance of a workman in betanaphthylamine 
developing a bladder tumour was 61 times greater than that in the 
general population, that of a benzidine worker 19 times greater 
and that of an alphanaphthylamine worker 16 times greater. Their 
statistical proof of the industrial carcinogenicity of betanaph­
thylamine, benzidine, and alphnaphthylamine was overwhelming.
They found no statistical evidence to suggest that aniline 
had caused occupational bladder tumours in the British chemical 
industry between 1910 and 1952 (Case and Pearson 1954) but the 
manufacture of magenta and auramine ’’appears to have a definite 
occupational hazard of causing tumour of the urinary bladder” but 
”it should not be assumed that the finished products are necessarily 
dangerous”. This again confirmed the earlier observations made 
by Rehn in 1895 that fuchsin manufacture was dangerous. Case
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and Hosker (1954) have estimated statistically the number of 
cases which may be expected to arise in the future from people 
already exposed. Case (1955) set out a method by which it is 
possible for a firm in Britain to estimate the number of deaths 
that might arise by the non-occupational risk in a given popula­
tion. A comparison of this with the actual number might usefully 
detect unsuspected dangers. Case and Lea (1955) have since set 
out a simpler method which can be more generally applied to other 
forms of cancer as well.
The results of the A.B.C.M. study were given to the Factory 
Department of the Ministry of Labour and to the Ministry of 
Pensions and National Insurance, and in 1955 papilloma of the 
bladder was prescribed in Great Britain as an industrial disease 
in chemical workers under certain conditions. A pamphlet setting 
out the nature of the study, the results, the knowledge available 
and the means of prevention was issued to management and workers 
throughout the industry, by the A.B.C.M. (A.B.C.M.1955). Mean­
time the analytical sub-committee had completed its work and it 
subsequently published analytical methods for determining 
benzidine and betanaphthylamine (Butt oc Strafford, 1956). Diag­
nostic techniques had been studied and appraised in two of the 
member companies, in The Clayton Aniline Co.Ltd. by myself and 
in The Imperial Chemical Industries Ltd. by Drs.Crabbe, Cresdee 
and Williams. The results were published in 1952 and 1956 
(Crabbe, 1952, Crabbe, Cresdee, Scott and Williams 1956).
Dr .Williams and I were invited by the A.B.C.M. to draw up 
a Mcode of industrial practice11 to cover the manufacture and use 
of known and suspected carcinogens. Our recommendations for 
safe working were accepted in toto by the Association and were 
circulated to the member firms in 1953. They were published in 
1957 (Scott and Williams 1957). They have since been circulated 
in extenso by the International Labour Office in English and 
French to its member countries.
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RELEVANT COMPOUNDS 
In considering the compounds which have been suspected or 
proved to be capable of causing occupational tumours in workmen, 
the history of the manufacture of each one will be described and 
special reference will be made to their manufacture at The Clayton 
Aniline Co.Ltd. The experimental evidence relating to their 
carcinogenicity will be reviewed and an assessment of their potency 
will be made.
Fuchsin (Magenta).
Fuchsin was the first of the triphenylmethane group of dyes 
to be manufactured commercially. In Rehn's time it was made by 
oxidising crude aniline with nitrobenzene in the presence of ferric 
chloride. As with Perkin’s mauveine the shade of fuchsin produced 
depended on the purity of the aniline used and the most important 
factor was its relative content of toluidines and xylidines all of 
which have a higher boiling point than aniline.
n ii
n h2 © n h2 ©
PARAROSANILINE HYDROCHLORIDE. ROSA N IL IN E HYDROCHLORIDE.
Hence by using crude aniline of varying boiling points a dye 
ranging from red to blue could be produced at will. As early as
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1864 it had been shown that pure aniline did not produce fuchsin. 
The formulation of the dye depended on the CH3 group in the 
toluidine producing the central carbon atom which is necessary for 
the triphenylmethane structure. The fuchsin at this time was a
mixture of salts of Hrosaniline,f. 
NH2 n h 2 n h 2
CH-
NH2  Nh^
^ N r CH3 X ^ CH3
CH-
A N IL IN E . ORTHOTOLUIDINE. PARATOLUIDINE. METAXYLIDINE. PARAXYLIDINE. 
B.P I80°C. B .R200°C . B.R 200°C. B .P 2 I2°C . B.R 2I5°C.
It was later found to be possible to produce the desired colour 
with accuracy by using pure aniline and the exact proportion of 
toluidines or xylidines required.
Several other amines were also present in the aniline of 
the last century. Walpole, Williams and Roberts (1952) pointed 
out that Hofmann (1862) had identified a new amine, xenylamine 
(4aminodiphenyl) in the distillation residues of aniline and that 
Jackson (1875) had isolated methylated xenylamines and naphthy- 
1 amines from the aniline of his time. The original benzene, 
therefore, must have contained not only toluenes and xylenes but 
also naphthalene and diphenyl which were also nitrated and reduced 
when aniline was made. For the past 40 or more years, and since 
the 1914 war in England, fuchsin has hedn made by condensing ortho 
toluidine with formaldehyde to form ditolyl
CH-.
HoN
CH-
H->N.
+  H CHO
CH3
X \ - NH2
ORTHO TO LUID INE D IT O L Y L  BASE.
The ditolyl base is filtered and dried and is then reacted with 
ortho toluidine hydrochloride using nitrotoluene as an oxidizing 
agent, to give ’♦magenta1' of a slightly different formula from 
the original dye but which is a more stable and constant product*
The statistical evidence of Case and his co-workers &as confirmed 
the original observations of the danger to workmen who have been 
engaged in the manufacture of magenta. The original writers' 
opinions that aniline was the carcinogenic agent were based on 
reasonably adequate evidence at that time. The suggestion of 
Walpole, and his co-workers, that these early tumours were due to 
impurities in the aniline, supported by their experimental results 
(to be discussed later) makes it still valid, especially when one 
considers the heavy exposure which must have been commonplace*
The fact that since 1910 when pure or purer aniline was used in 
Germany no tumours have been attributed to it supports their 
proposition. Neverthless, Case and Pearson's magenta cases all 
arose in association with the more modem magenta process in 
which aniline is replaced by ortho-toluidine. Ashworth's five 
cases were from a factory making magenta from orthotoluidine where 
no other suspected carcinogens have been used.
H2Nv/ \
C l 0
n h 2
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It has been suggested that the toluidine is the offending 
agent but there is no firm evidence to support or contradict this. 
Animal experiment has so far been negative (Williams 1958) but it 
must be remembered that experiments have not yet been on a suffi­
ciently extensive scale to be regarded as conclusive. Haematuria 
from acute cystitis is a common symptom in men exposed to tolui- 
dines. It is described by Rehn and many subsequent writers - 
several cases will be reported later in this work - but it is not 
accepted as a necessary precursor of tumour (Goldblatt, Scott, 
Williams). Bleeding usually occurs when exposure has been heavy 
and may be taken as some index of the conditions existing. Where 
haematuria has been common, it can be presumed that the exposure 
has been heavy not only to toluidine but to the other amines 
present at the same time. More positive evidence than exists at 
present would be required before it could definitely be concluded 
that toluidines are causative agents. Similarly, in the absence 
of conclusive proof, such as animal experiments might afford, it 
is impossible to make any informed judgement as to the role of the 
magenta itself.
As Scott and Williams (1957) stated "it is not possible to 
say at this moment whether the cause of the magenta tumours in 
England is due to intermediates, to impurities in the magenta 
process or to the final product itself."
Magenta was made at the Clayton Aniline Co. from 1920 to
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1926 by the formaldehyde - ortho toluidine process. Its 
manufacture was discontinued in January 1926 and from then until 
1938 small quantities were bought for the preparation of acid 
magenta. The total number of men known to have worked on 
magenta manufacture is 19. As luck would have it, after its 
manufacture ceased 4 of these men were engaged in making pyrogen 
sulphur melt colours some of which involved the use of benzidine. 
There were, therefore, 15 men who had been exposed to magenta 
and not to benzidine and 4 of those have so far developed tumours. 
At the same time 2 of these men who have been exposed to both 
benzidine and magenta have also contracted the disease.
Aniline.
Aniline is manufactured by the reduction of nitrobenzene 
by iron filings in the presence of hydrochloric acid. The iron 
is oxidised to ferric oxide and the aniline is distilled off and 
purified by a series of distillations and condensations.
n o 2  n h 2
+  2 Fe ------- ►
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N IT R O B E N ZE N E . A N IL IN E .
Animal experiments with aniline have failed to yield any 
convincing proof of its carcinogenicity. Hartwell (l95l) lists 
17 series of experiments in rabbits, rats and mice. Roffo (l93l) 
using resin pearls impregnated with the chemical reported 3 
bladder papillomata in rats but he obtained similar results in his
control animals and this experiment can be discounted as evidence* 
Namazki and Sato (1937) claim to have induced papillomata in 12 of 
37 rabbits by introducing 1% solution into the bladder but their 
experiment is not convincing and solutions of 5f° and 10tfo yielded 
negative results. No tumours of the bladder were reported by the 
other workers. Goldblatt (1957) says that aniline has not been 
found to be tumour-inducing in any experimental animal. Beremblum 
and Bonser (1937) and Gerhman, Foulger and Fleming (1949) have also 
failed to induce tumours in carefully set up and controlled experi­
ments.
Walpole, Williams and Roberts suspected that the alleged 
carcinogenicity of the aniline of last century wad due to the 
naphthylamines and aminodiphenyls it contained and they tested 
both 4 aminodiphenyl and 3*2' dimethyl 4 aminodiphenyl on rats 
(1952) and the former on dogs (1954).
 CH3   CH3
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4 A M IN O D IP H E N Y L . 3 = 2 ' D IM E T H Y L  4  AMINODIPHENYL.
Both compounds were found to be highly carcinogenic, the former 
more effective as a bladder carcinogen in the dog than either 
benzidine or 2acetylaminefluorene and at least as potent as 
betanaphthylamine. They suggested that the compounds were meta­
bolised to orthohydroxyamines and that on this orthohydroxylation 
depends their carcinogencity, a suggestion which was to be
extended and developed later.
The inference that those aminodiphenyls and naphthylamines 
present in the early aniline were dmfficient to account for the 
tumours which had been attributed to it was not accepted by Walpole, 
Williams and Roberts in their first paper. They did not believe that 
the small quantities present could have accounted fully for the early 
tumours especially as the greater part of these impurities was left 
in the distillation residues so that even less significant amounts 
would have been present in the distillate. In their second paper in 
1954 however, they modify this view and remark that this amine 
(4aminodiphenyl) might have been partly responsible for "aniline 
cancers of the bladder in Germany before 1920". This revised view 
seems more reasonable because although the dose and time necessary to 
induce a tumour in man is not known, it is highly probable that quite 
small doses for a short time may be sufficient eventually to do so.
Hamilton (1921) suggested that arsenic might be the responsible 
agent. Her contention was based on two facts; first that fuchsin 
was originally made by the arsenic acid method (but not since about 
1870 l), and secondly that arsenic was present as an impurity not only 
in the iron and zinc used for the reduction of nitro benzene to aniline 
or benzidine but also in the sulphuric acid and in the metal of the 
vessels used in the process. Small amounts of arsine were often 
liberated and as late as the time at which she was writing, haemolysis 
from it was frequently observed in workmen.
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Kennaway (1925) finally dispelled this hypothesis* Apart 
from the increasingly conclusive proof pointing to other substances 
he cited his own 38 consecutive cases of arsenical tumour in none 
of which had there been any bladder tumours. He knew of only, one 
case in the literature of a person exposed to any of the other 
cancer-producing materials (i.e. not aromatic amines) developing 
cancer of the bladder and that was an inoperable tumour in a tar 
worker who had previously undergone operation for warts*
Gross's personal communication to me, quoted earlier, is 
perhaps enlightening in that it suggests that aniline was blamed 
in a generic sense when the actual agents which were responsible 
were benzidine, betanaphthylamine and some other amines. Nassauer 
(1919) claimed that the "irritating substance" was always aniline 
and so dangerous did he consider it that he allowed only three 
months employment at a time in the benzidine department where JUJiline 
was liberated as an impurity in the process at that time. This 
practice must have increased the numbers at risk to an enormous 
extent in a plant where exposure must have been heavy. Hamilton 
likewise stated that it was said (although she does not state who 
said it, it was, in fact, Nassauer) that in the making of benzidine 
there may be more actual exposure to aniline vapour than in the 
manufacture of aniline itself and she inferred that the aniline 
vapour rather than the benzidine was the danger.
Since the early 1930's , however, all observers have agreed
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that there is no evidence to suggest that aniline is the acfive 
carcinogen in cases that have arisen in their generation and this 
certainly coincides with the time since reasonably pure aniline 
has been manufactured.
It is, therefore, suggested that while some, and possibly 
many, of the so-called aniline tumours in the earlier years were 
due to carcinogenic impurities in the aniline, many of the others 
were loesely ascribed to aniline when in fact another compound such 
as benzidine or betanaphthylamine was being worked. It must be 
borne in mind that cases arising in Britain from exposure to 
magenta after the First World War remain to be accounted for and it 
cannot be taken as certain that all of the early German fuchsin 
cases were due to impure aniline.
Under modem conditions of manufacture of aniline, which 
takes place in an enclosed system, exposure to the vapour or liquid 
and absorption of it either through the skin or by inhalation is 
so low as to be practically negligible. Williams (1957) suggested 
the possibility that aniline is a very weak carcinogen and that the 
advent of modem conditions lowered absorption to levels below 'those 
capable of producing tumours. British experience does not support 
this view. No cases of aniline tumours are known to have arisen 
in England despite three quarters of a century's experience of 
manufacture during the first 50 years of which conditions of con­
stant and heavy exposure must have prevailed*
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It has been manufactured in The Clayton Aniline Company 
since 1875 and up to the 1920's conditions are admitted to have 
been bad by modem standards. They were improved between the 
wars but it was not until 1940 that a completely enclosed modem 
plant was constructed. Certainly exposure must have been heavy 
even in the first 20 years of this century and until 1940 it was 
more than we would consider safe to-day. Records are good for 
the past 40 years and some go back to 1900. Since 1920 there 
has been a working population of 78 men who have worked on this 
plant (men with less than six months service are excluded). 
Turnover has been so low that there have only been two new workers 
on this plant, one processman and one crane man, since it was 
described by me in 1952. The majority of these 76 men have very 
long periods of employment - up to 45 years - most of it under the 
more primitive conditions of the earlier years. No tumours have 
arisen among these aniline manufacturers nor could any tumours be 
attributed to aniline in any other part of the factory.
The experience at Clayton, therefore, accords with the view 
that aniline is not carcinogenic in man under industrial conditions 
even in the earliest days of its manufacture.
Benzidine (4:4' diaminodiphenyl). Its Homolgues and Derivatives.
Benzidine and its derivatives, the most important of which 
are tolidine, dichlorbenzidine and dianisidine are used largely 
for the manufacture of azo dyes.
BENZIDINE. TOL I DINE.
D IC H LO R B E N ZID IN E . D IA N IS ID IN E .
This process depends on the diazotization by nitrous acid
of an aromatic amine which produces the ”azo” linkage, i.e. two
nitrogen atoms united by a double bond. The molecule is highly
reactive at this point and will unite or ’’couple” with, for example,
an amine* Many of the resultant compounds are colours.
Benzidine manufacture began to assume large proportions about
1880 when the azo dye Congo Red was first made on a commercial scale.
AZO AZO
NH5  L IN K
SO3 H SO3 H SO3 H
NAPHTHIO NIC  ACID. C O N G O  R E D .
It was quickly followed by many similar dyes using benzidine, alpha- 
naphthylamine, betanaphthylamine and many other aromatic amines for 
diazotisation and a great variety of aromatics and aromatic amines 
as coupling agents. There is virtually no limit to the changes 
which can be rung and many thousands of azo colours have been listed. 
Many of them have stood the test of time by virtue of their shade, 
their affinity for certain materials, their brilliance, their fast­
ness to light, sweat, washing and their many other properties*
Benzidine is also used in the manufacture of certain other types 
of colours.
In the manufacture of benzidine, nitrobenzene is reduced in 
an alkaline medium, (it will be recalled that reduction of nitro­
benzene in an acid medium results in the formation of aniline).
The reduction is affected either by zinc or iron and caustic soda, 
by sodium amalgam or by electrolytic means. The nitrobenzene is 
reduced through azobenzene to hydroazobenzene - some factories,for 
example, one I visited in Germany, start with azobenzene which is 
made in another plant. The hydrazobenzene is then converted by 
the addition of hydrochloric acid to benzidine.
REDUCED
HYDROAZOBENZENE. BENZ1 D I N E .
( The arrows indicate the conversion mechanism.)
Diehlorbenzidine, tolidine and dianisidine are made similarly from 
chlomitrobenzene, nitrotoluene and nitroanisole.
Benzidine manufacture (Fig.l) was started in The Clayton 
Aniline Company in 1918 following preliminary experimentation and 
trials in 1917.
HISTORY OF BENZIDINE MANUFACTURE
1918-50
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It has always been made by the zinc reduction process. A solvent 
was introduced into the process in order to keep the reduction 
reaction smooth. Orthodichlorbenzene was used for this purpose 
until 1926 when it was replaced by paraffin oil. In this process 
the hydroazobenzene is formed as granules and these are filtered 
out and re-charged in the next stage. In 1947 this method gave 
way to the use of solvent naphtha, which dissolves the hydrazo- 
benzene and keeps it in solution until the conversion by hydro­
chloric acid. Benzidine dihydrochloride is thereby formed and
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precipitates out. It is redissolved by adding water and heating. 
The aqueous solution of the amine is separated from the upper 
solvent layer by running off and the benzidine dihydrochloride is 
then salted out.
Benzidine was first produced as the sulphate which was then 
converted to the base and until 1944 either the sulphate or base or 
both have been made. From 1944 to 1951 the hydrochloride was 
manufactured.
Open vacuum filters were used until 1929 when they were 
replaced for technical reasons by a large filter press. Contact 
was heavy at this stage. It could not be reduced to the level 
thought desirable, and so in 1944 specially designed covered vacuum 
filters were substituted. (It is of interest to note that in 
November 1957 filter presses were seen in a German factory making 
benzidine). Some exhaust ventilation was installed in 1938 and 
this was added to and improved from time to time since then.
In 1951 a completely new plant was opened. In this the 
manufacture of benzidine and its derivatives is now carried on 
separately from other manufactures. Benzidine is not isolated; 
it is tetrazotised in the usual way with nitrous acid and the 
resulting tetragonium dichloride now containing virtually no 
benzidine and still in the enclosed system, is conveyed by pipeline 
to the colour factory several hundred yards away. It is then
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distributed to the azo dye manufacturing vessels without leaving 
the enclosed system.
By 1949 the danger to workers in benzidine of contracting 
bladder tumours had been agreed by observers in all countries 
except for those in America whose doubts were resolved soon after­
wards. The epidemiological evidence of its carcinogenicity to 
workers was incontrovertible, the danger existing both in its 
manufacture and in its use. It had been held that all stages of 
the manufacturing process were hazardous as men engaged in the 
reduction to hydrazobenzene were apparently affected equally with 
those doing the conversion to benzidine and its separation. Other 
men engaged on other processes in the same building were also 
affected and the whole operation was regarded as dangerous until 
Barsotti and Vigliani (1949) described a factory where hydrazo­
benzene was made in one building and conveyed to another factory
%
for conversion to benzidine. No tumours had occurred among the 
men making hydrazobenzene - the exposure times are not given - 
but tumours had arisen in some of the benzidine men. No tumours 
have so far been induced in experimental animals with hydrazo­
benzene (Hartwell, 1951)• Scott and Williams (1957) believe that 
the hazard exists after the conversion of hydrazobenzene to 
benzidine.
The accepted industrial carcinogenicity of benzidine to 
workmen had naturally led to many experiments being made on animals
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but until 1950 all had negative results. As early as 1920 Jaffe 
sensibly suggested that negative results should be published so 
that other workers would not repeat fruitless experiments. Bierich 
(1922), Kennaway (1924), Berenblum and Bonser (1937), Yoshildi et 
al (l94l), Gehrmann, Foulger and Fleming (1949) all reported 
animal experiments with benzidine in which no tumours were induced. 
The last named used dogs and continued their experiments for five 
years.
In 1950, Spitz, Maguigan and Dobriner published a report of 
the successful induction of tumours in rats and dogs by the 
administration of benzidine. A high proportion, 1C$ of about 
500, of the rats developed tumours of a sebaceous gland adjacent 
to the external auditory meatus and adenocarcinomata of the colon, 
but not bladder tumours; of 11 dogs, seven pn benzidine and four 
on benzidine sulphate, seven survived and three of these were 
eventually reported to have developed papillomata and carcinomata 
of the bladder after periods up to 10 years. The rat tumours 
were similar in type and distribution to those occurring with 
2acetylaminofluorene in that they were found in the liver, colon 
and auditoiy sebaceous gland* A much smaller proportion (4*3$ 
of 105) of rats who received orthololidine contracted tumours.
The doses given were high and administration was prolonged - 
the dosage to the rats was of the order of 15 mg. per week of 
benzidine injected over periods averaging 2 years. The explanation
49
of the failure of previous experimenters to induce tumours may 
lie in inadequate dosage given for insufficient periods, or to 
their using unsuitable species. For example, Beremblum and 
Bonser in 1937 used rats and rabbits - the latter species has 
since proved to be relatively insusceptible to induced bladder 
tumours - and they gave much lower doses. In one series of 8 
rabbits who survived, the experiment was continued for 4 years but 
in another series of 29 rats it was discontinued after 76 weeks.
Thus the carcinogenicity of benzidine was placed beyond any 
doubt by the epidemiological evidence and animal experiments. The 
results of Spitz and her co-workers have been confirmed several 
times since and many compounds related to aminodiphenyl and diamino- 
diphenyl (benzidine) have proved carcinogenic in animals (Walpole, 
Williams and Roberts 1954* Miller, Sandin, Miller and Rusch 1956).
Certain hofiiologues and derivatives of benzidine, of which 
orthotolidine, dichlorbenzidine and dianisidine are the most 
important are used for similar purposes to those of benzidine.
No population of workmen is known which has been exposed to these 
homologues without also having been exposed to benzidine itself.
Most factories which manufacture benzidine make the homologues as 
well, but one at Grenoble in France makes benzidine only and some 
cases of tumour have arisen there (Williams, personal communication). 
The homologues have hitherto been less in demand than benzidine 
and, therefore, have been made on a much smaller scale so that
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exposure to them has been less, both in amount and in total time 
than it has to benzidine#
Orthotolidine was found by Spitz to be a weaker carcinogen 
than benzidine but so far no animal experiments have been published 
in which tumours have been induced by dichlorbenzidine or dianisidine. 
Animal experiments now in progress support the view that the two 
latter compounds are much less active even than orthotolidine,
(Walpole and Williams, personal communication) and it is thought that 
these conclusions can be held also to apply to man (Scott and Williams 
1957).
It is, however, anticipated that the demand for some of these 
materials will increase rapidly for the making of certain paints and 
pigments so that the scale of their production may come to rival that 
of benzidine. Meantime, one must reserve judgement on the carcino­
genicity of these homologues and, if large amounts of them are to 
be handled, they should, as Scott and Williams recommend, be treated 
industrially in a similar fashion to benzidine itself. 
Beta-naohthvlamine (2 Naphthylamine).
The manufacture of betanaphthylamine has been carried out by 
the same fundamental principle since its inception as a commercial 
product about 1880 until it was given up in 1950. It was made by 
the action of ammonium sulphite and ammonia on betanaphthol 
(2hydraxynaphthalene) in autoclaves under pressure at 150°C. This 
is known as Buchererb reaction.
5 i
BETANAPHTHOL.
+ NH3 
+(nh4)2 so3
BETANAPHTHYL AMINE
When the reaction was completed the be tanaphthylamine was 
isolated by being filtered off, dried and distilled. It was then 
allowed to solidify and either broken into lumps or more finely 
prepared by flaking it or grinding it to a powder.
Be tanaphthylamine is a whitish powder or a dull grey red 
flaked product depending on its purity and its physical state.
It is apparently a harmless substance and acute toxic effects 
do not occur readily. MfcLLler has described titee men who developed 
acute haemorrhagic cystitis as a result of massive exposure to it, 
but no such effects have been recorded at Clayton at least in the 
last 25 years of its manufacture. It is non-irritant and has not 
caused dermatitis in the workmen.
Manufacture of betanaphthylamine started at The Clayton 
Aniline Co. in 1920, and F ig .2 is a diagramatic representation of 
its history in the firm.
HISTORY OF £  NAPHTHYLAMINE MANUFACTURE 1920 -  1950.
OPEN TR A Y S : BROKEN BY HAND : GROUND.
1920 ” 1930 ” M M J 411940 ** m  1950
N O R M A L  W ORKING STRENGTH 5 5  
TO TA L NUMBER EXPOSED 129. 
NUMBER OF C ASE S SOLELY ON Bn. 15.
MANUFACTURE CEASED 1950.
F I G .  2 .
The first stag© of the process, the heating of betanaphthol with 
amTwom'nm sulphite and ammonia has been virtually the same through­
out, The second stage, that of separation of the amine from the 
liquors in the autoclave has been progressively improved. For 
the first 13 years until 1933 the charge was filtered in open 
filters and dried in large stoves which the workmen had to enter. 
It was purified by being distilled in another building, (where for 
many years benzidine was also distilled) and the molten amine was 
run on to shallow trays to cool and solidify. When solid it was 
broken up by hand into small pieces and finally ground in a mill
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to a fine powder* In 1933 stoving, setting in trays, breaking up 
by hand and grinding were omitted* The distilled product was 
"flaked” by being run on to a drum revolving against a knife edge. 
It solidified on the surface of the drum and was scraped off in 
flakes. In 1938 more enclosure of the process was attained by 
keeping the reacted charge in the closed vessels and washing out 
the other products from them; the betanaphthylamine was then 
dried in these vessels and piped molten to the still where it was 
distilled and then flaked as before. By 1947 further improvements 
which had been impossible during the war were applied to keep 
exposure to a minimum* The flaker was enclosed and elaborate 
improved exhaust ventilation applied to it; distillation was 
omitted to minimise vaporization.
Finally, in 1950 the manufacture and use of betanaphthylamine 
in this Company was abandoned because of the danger associated with 
it. Other organisations followed this lead and by 1952 it had 
been stopped everywhere in Great Britain. Sulphonation of beta- 
naphthol followed by amidation is now the method used for preparing 
the sulphonic acids in the synthesis of the dyestuffs for which 
betanaphthylamine was previously used as an intermediate.
s o 3 h s o 3h
SULPHONATION AMIDATION
NH2
BETANAPHTHOL. OX Y TO B IA S  ACID. TOBIAS ACID.
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The total number of men who had had over six months* 
employment in the autoclave shed was 129 and the normal working 
strength was 55* An average of two men were employed in the 
stillhouse.
A rough estimation of the hazard existing during these 
periods is indicated in the diagram. Conditions in the first 
13 years of manufacture were bad and exposure must have been 
heavy. There must have been heavy skin and atmospheric 
contamination in the stoving, handling and breaking up of the 
amine and the workmen's clothing, hair and skin became powdered 
with it in the grinding. Some dust must have been inhaled and 
swallowed. Melting and distillation under the conditions 
prevailing must have resulted in a high .vapour content in the 
atmosphere and a correspondingly high intake by inhalation. The 
woiking place was heavily contaminated with dust and the risk of 
absorption even when the process was not running must have 
remained high. The vapour and the dust constituted a danger to 
men working in adjacent processes and in neighbouring sheds.
In view of the German and Swiss experience even before 1920 
it may seem strange that the hazard was not recognised in England 
earlier. Yet itmust be remembered that the same lack of 
realization, or lack of action, ruled in America, Prance, Italy 
and even in experienced Germany and Switzerland for long after 
the First War. It is only fair to say that the Swiss gave up
its manufacture in 1938 and that Britain would have abandoned it 
much earlier than 1950 but for the war. It is still manufactured 
in the U.S.A., in Ttaly and in Czechoslovakia. One German 
factory is known to buy it from the last source (Communication to 
meeting of Cancer Commission. Deutsche Forschungagemeinschaft, 
November 1957)*
There has long been a remarkable agreement among all reporters 
about the carcinogenicity of betanaphthylamine. It was the first 
of the compounds suspected of causing occupational tumours of the 
bladder to be proved capable of inducing tumours in experimental 
animals. Many attempts had been made to induce tumours in animals 
with it before success was achieved. Schar (1930) claimed to have 
induced bladder papillomata in one rabbit in a series of six who had 
been exposed for over two years to the inhalation of betanaphthylamine 
vapour in air but his interpretation of the histology is suspect and 
his experiment is not convincing. Perlmann and Staehler (1932) 
described bladder tumours in 6 of 31 rabbits receiving daily 
injections of it. Berenblum and Bonzer (1937) failed to confirm 
either of these results despite heavy dosage over long periods in 
a large series of rabbits and rats. All their results were 
negative.
A preliminary paper in 1937 from Hueper and Wolfe followed 
by a full report from Hueper, Wiley and Wolfe (1938) described the 
successful induction of tumours, papillomata and carcinomata, in
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female dogs after subcutaneous and oral dosage for two to three 
years* They had also used rabbits and failed to induce tumours 
in them* The dog was later to prove to be the most suitable 
species of animal for this work. The tumours in the dogs were 
similar to those seen in dye-workers in that they continued to grow 
and to recur after cessation of the treatment and in one dog the 
tumour arose several months after administration ceased. In 
several of their dogs they observed lesions which they considered 
to be pretumourous and which were similar in description to those 
described by Di Maio in dye-workers. Their results have been 
confirmed by other workers, notably Bonser (1943) who virtually 
excluded impurities as the cause by inducing tumours in dogs with 
a highly purified compound in similar dosage over five years.
Case and Pearson (1954) nevertheless maintained that impurities in 
the betanaphthylamine might possibly still be the cause as they had 
isolated small amounts of the carcinogen 3s4s5 dibenzcarbazole 
from the so-called pure compound.
Later work on the metabolism of betanaphthylamine and other 
amines in animals and in man sheds a great deal of light on the 
way in which they act and supports the view that the carcinogenicity 
of betanaphthylamine does not depend on impurities in it. This
will be discussed in the chapter on the mode of action.
There is undoubtedly overwhelming evidence that betanaphthy—
lamine is a highly active carcinogen not only to laboratory animals
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but to man under industrial conditions of manufacture and use, 
so much so that its manufacture has been given up in Britain solely 
because of the danger associated with it,
Alphanaphthylamine. (lnaphthylamine).
Alphanaphthylamine is used in industry for similar purposes 
to those for which betanaphthylamine is used, that is for the 
manufacture of azo dyes, condensation colours and for certain 
rubber processess. It is manufactured by the nitration of 
naphthalene to alpha-nitro-naphthalene and its subsequent reduction. 
When naphthalene is nitrated the product consists of about 90 - 96$ 
of alpha-nitro-naphthalene and about 10 - 4$ of beta-nitro-naphthalene 
so that subsequent reduction and isolation yields the corresponding 
proportions of alphanaphthylamine and betanaphthylamine.
n o 2
REDUCED
+  h n o 3
ALPHANITRONAPHTHALENE. A LP H A N A P H T H Y L A M IN E .
REDUCED
BETANITRONAPHTHALENE. BETANAPHTHYLAMINE.
Under present day conditions of manufacture the beta-isomer content 
can usually be kept down to about 4$ .
Alphanaphthylamine is also used for the manufacture of 
alphanaphthol by hydrolysis.
5 8
NH2 OH
HYDROLYSIS
ALPHANAPHTHYLAMINE. ALPHANAPHTHOL
This is in contrast to betanaphthylamine which is made from 
betanaphthol prepared more directly from naphthalene. Sulphonated 
naphthylaminesare used widely in the colour industry and among 
the most widely used are naphthionic acid and sodium naphthionate 
which result from the simple sulphonation usually by sulphuric acid 
of alphanaphthylamine under controlled conditions.
S 0 3 H S 0 3N«
N AP H TH IO N IC  A C ID . SODIUM N A P H T H IO N A T E .
This sulphonation is •’preferential1 to the alpha-isomer. Virtually 
only the alphanaphthylamine is sulphonated in this process with 
the result that most of the betanaphthylamine content is left 
unreacted so that when the naphthionic acid is isolated the residue
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contains a much higher proportion of betanaphthylamine than the 
original compound - often as high as 30$.
Alphanaphthylamine was manufactured in The Clayton Aniline 
Co., by the method described, for only four years, from 1926 to 
1930. The usual number of men employed on this process was three 
and a total of four men in all were engaged on it for over six 
months. None of these has so far developed bladder tumour. Both 
before 1926 and after 1930 it has been bought from other manufacturers 
and used in large quantities for the large scale manufacture of 
alphanaphthol, sodium naphthionate and a wide range of azo dyes ahd 
other colours. The total number of men engaged in work involving 
its use in these respects is 88 and 4 of them have so far developed 
tumours.
The carcinogenicity of alphanaphthylamine has not been so 
readily accepted and agreed upon as that of betanaphthylamine 
despite the number of cases which have been attributed to it in 
many countries (Table 2)«
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TABLE 22
No. of cases attributed to alphanaphthvlaminft 
from literature.
Year Author Country of origin No. of cases
1929 Wignall England 7 (+8 doubtful)
1957 Evans U.S.A. 20
1948 Gehrmann et al U.S.A. 2
1948 Di Maio Italy 2
1948 Barsotti Italy 2
1948 Duchesne Prance 2
1948 Goldblatt England 11
1952 Scott England 1 ( now 4 )
1954 Case et al England 28
The 28 cases found by Case et al in England almost certainly 
include those of Wignall and G-oldblatt and the one of mine. Di 
Maio's and Barsotti*s are probably the same two cases. Hence a 
total of 56 reported cases is estimated but, apart from Mllerb in 
1951, no reports have been published from America or Europe during 
the last ten years and many more cases may have arisen from these 
sources in the meantime.
While there can be no doubt that ’’technical*1 (i.e. commercial)
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alphanaphthylamine is dangerous under industrial conditions of 
manufacture and use,it is not universally agreed whether it is a 
carcinogen per se or only by virtue of its beta-isomer content.
No experimental tumours have so far been induced by it in animals. 
Schar (1930) claimed to have induced papillomata in two rabbits 
with it but one must agree with Beremblum (1932) that the histo­
logical appearances in the photomicrographs are not convincing and 
that they fail to support the findings described in the text. His 
experiments have not been confirmed.
I suggested that the tumours which arise in alphanaphthylamine 
users more heavily exposed to the residues in naphthionic acid 
manufacture might be due to their high be tanaphthylamine content 
(Scott 1953)* I advised that one must reserve judgement about the 
carcinogenicity of pure alphanaphthylamine itself as it is not used 
in the industry but that one must treat its manufacture and use with 
the same care and respect that must be accorded to betanaphthylamine 
and benzidine.
Since then the evidence on which alphanapthylamine may be 
considered to be carcinogenic per se has accumulated. In 1954 
the A.B.C.M. survey (Case et al) revealed 28 cases of bladder tumour 
in workers in alphanaphthylamine (apart from other cases in workers 
exposed to it in combination with other amines such as betanaphthy­
lamine and benzidine), 20 of whom had been engaged in its manufacture 
and 8 in its use. The average latent period from beginning of
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exposure to onset of tumour was 22 years, (S.D. 6 years) and this 
was significantly different from that of betanaphthylamine which 
was 16 years (S.D.6). Case concluded therefore, that the 
betanaphthylamine content of the alphanaphthylamine may not be the 
sole active agent (unless it is assumed without evidence that 
alphanaphthylamine exerts a delaying action on the rate of develop­
ment of betanaphthylamine tumours) and that alphanaphthylamine 
itself is capable of causing tumours in man. The longer develop­
ment may account for the delay in alphanaphthylamine becoming 
accepted as a carcinogen in the industiy and for the small number 
of cases reported in the earlier literature.
Although no tumours have been induced in experimental animals 
with alphanaphthylamine, one of its metabolites 1 amino 2 naphthol 
has been found to induce tumours in five mice out of six when 
implanted into the bladder (Clayson, 1953). Thi§ is also one of 
the metabolites which are excreted in the urine in man.
It is, therefore, difficult to escape the conclusion that 
alphanaphthylamine is carcinogenic to man. Even if it were not 
itself a carcinogen it is never found in industry without at least 
4 of betanaphthylamine in it and in some processes this figure 
rises to 3($> in the residues. The carcinogenicity of betanaph­
thylamine is not in doubt. One must consider alphanaphthylamine, 
therefore, as it is found in industry (”technical alphanaphthylamine”) 
and there can be no doubt epidemiologically and theoretically of
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the risk attached to it. No refuge should be sought on the 
grounds that it takes longer to act and is less potent than either 
betanaphthylamine or benzidine. Scott and Williams (1957) 
recommend a standard of precautionary measures in its manufacture 
and use as high as that recommended for benzidine.
A u ra m in e .
Case et al (1954) found evidence that the manufacture of 
auramine may cause tumour of the bladder in workmen engaged in its 
manufacture. There was a statistically significant excess in the 
number of deaths certified as being due to bladder tumour among 
them. The age at onset and at death tended also to be lower than 
in the general population.
Auramine has been manufactured and used since 1884 for the 
colouring of paper and some textiles. Dimethylaniline and 
formaldehyde are reacted to produce Michler's base (tetramethyl 
diaminodiphenyl methane) which is converted to auramine by heating 
it with sulphur and ammonium chloride in the presence of ammonia.
c h 3 CH^ C H %
N
c *  NH2 ©2 +  HCHO  ► CH2
N
Ci ©
C H 3 CH3
DIMETHYLANILINE MICHLER'S BASE
(METHANE BASEj
CH3 CH3 
A U R A M IN E  .
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No tumours from auramine had been reported before Case, but Mttller 
has described two cases, which he attributed to dimethylaniline 
in men making auramine from it. No other cases of tumour from it 
seem to have appeared before 1954 and Scott and Williams raised 
the point that the tumours in Case's series may have been due to 
other chemicals handled in the auramine shed. They advised 
further examination of this possibility but no further evidence has 
come to light.
Another possible explanation is now suggested. In a paper 
by Kehrmann, Roy and Ramm (1922) it is pointed out that Michlers 
base can be oxidised by lead dioxide and sulphuric acid to tetra 
methyl benzidine, a potent carcinogen (Walpole and Williams (1958).
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M IC H L ER ’S HYDROL. N:N'TETRAMETHYLBEN2IDINE.
( m a i n  p r o d u c t )  ( b y - p r o d u c t ,)
So far there is no evidence that such impurities have been present
CH,
A
CH,
M IC H L ER ’ S BASE.
in auramine or at any stage of its manufacture at any time in 
Britain or the Continent. No work on its metabolism is known to 
have been done but it is possible that tetramethylbenzidine is 
fomed in the body.
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Auramine has never been manufactured at The Clayton 
Aniline Co# but dimethylaniline'and Michler's base, hydrol 
ketone have been made for 25 years# The normal working comple­
ment is 2 men and a total of 20 men have been exposed in all.
No tumours attributable to these have arisen#
Xenylamine (4amidodiphejqyl)
Unlike most of the intermediates implicated as industrial 
bladder carcinogens, xenylamine manufacture was not started on 
an industrial scale until 1938 when it was first made in the U.S.A. 
for use as a rubber antioxidant. The method was the familiar 
one of nitration (of diphenyl) and subsquent reduction.
NITRATION REDUCTION
D IP H E N Y L . 4 :  N IT R O D IP H E N Y L .  4 :  A M ID O D IP H E N Y L  .
( x e n y l a m i n e )
Some 2nitro and hence 2aminodiphenyl are found at the same time.
In 1952 Walpole, Williams and Roberts published the first 
proof of its carcinogenicity. They induced tumours with it in 
rats and in 1954 confirmed this by using dogs. They pointed out 
that it may be capable of causing bladder tumours in man.
In 1955 Melick, Sscue, Naryka, Mezera and Wheeler confirmed 
Walpole and his colleagues’ prognostication when they reported 19 
cases among 171 men who had been engaged in its manufacture and
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iise, that is to say that within 20 years of starting its 
manufacture 12$  of the men exposed to it had developed bladder 
tumours. Its manufacture was forthwith stopped in the U.S.A. 
Scott and Williams recommended that it should not be started in 
Britain and in fact it has never been made in this country. 
Diphenylamine „
Diphenylamine like many of the other intermediates 
considered has been made since about 1880, at first in Germany 
and later all over the world. It is made by the reaction of 
aniline or aniline hydrochloride under high temperature and 
pressure.
2
A N IL IN E .  D I P H E N Y L A M I N E .
A small amount, usually about .025$, of 4aminodiphenyl 
is also formed in some processes (Stagg and Reed, 1957) and is 
likely to be present in the finished product, while as much as 
1$ may be present in the residues. The manufacture of dipheny­
lamine has increased rapidly in amount during the last 15 years 
for rubber anitoxidants and insecticides such as phenothiazine 
and it is still increasing. More men are likely to be exposed 
to it for more continuous periods. Mttller attributed two tumours
to it in 1933, but no other reports of its carcinogenicity have 
been published*
It has been manufactured at The Clayton Aniline Co* since 
1921. Until about 10 years ago the old method of condensation 
of aniline with its hydrochloride was used; since 1948 it has 
been made by condensing aniline using phosphorous trichloride as 
a catalyst in high pressure autoclaves. Amounts of 4aminodiphenyl 
of the order of 0.005 and 0.01$ have been identified in this 
process and of 0.2$ in the residues since Stagg and Redd's method 
of determining it was applied early in 1957. No tumpurs have 
arisen which could be attributed to it. Careful watch is being 
kept on what may ultimately prove to be a dangerous manufacture 
and working conditions are carefully safeguarded.
Other Compounds.
SSveral other compounds which are made and used in the 
dye industry must be considered. It has never been suggested that 
either alphanaphthol or betanaphthol, neither of which are amines, 
are carcinogenic and there has been no evidence to indicate that 
they are likely to be so. As alphanaphthol is made from 
alphanaphthylamine it must be ensured that the final product is 
free of amine. Phenylalphanaphthylamine and ethylalpha- 
naphthylamine have not been shown to be, and are not believed to 
be, dangerous except when made from alphanaphthylamine, the 
handling of which may constitute a danger. They can be made 
safely from alphanaphthol.
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Phenylb etanaphthylamine is sometimes thought to be 
carcinogenic because of its name but there is no evidence to 
suggest that it is dangerous and it is not considered to be an 
industrial carcinogen (Scott and Williams). It was made at 
Clayton from 1932 to 1942, from betanaphthol and aniline, on a 
fairly large scale and no tumours have been attributed to it 
among the men who were engaged on its manufacture and use.
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THEORIES OF CAUSATION AND METABOLISM
Theories of the cause of bladder carcinoma have been largely 
influenced by the general conception of the aetiology of cancer 
accepted at the time and by the existing state of knowledge.
Bayle (1833) first suggested a possible cause in a gouty diathesis 
accompanied by urinary calculus; Waldeyer (1873) suggested an 
epithelial origin and Lubarsch (l90l) distinguished tumours arising 
from embiyonal rests from the far more numerous ones of different 
origin. The knowledge that bilharziasis was directly related 
to a type of bladder tumour strengthened Rehn's contention that in 
his cases the tumours were due to inflammation and irritation 
caused by earlier cystitis and calculi,
Rehn in his first paper quoted Engelhardt as showing that 
aniline is excreted in the urine as a conjugate of paraaminophenol. 
Adler (1907) showed that 3 3' dihydroxybenzidine was found in the
OH
PARAAMINOPHENOL. 3 = 3 '  D IH Y D R O X Y B E N Z ID IN E .
urine of animals given benzidine. Engel (1920) confirmed these 
experiments but was unable to find anything then known to be
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carcinogenic i& the urine although Oppenheimer (1920) had 
suggested that it was a metabolite of benzidine or aniline which 
was specially active on the bladder epithelium. Schar (1930) and 
Perlmann and Staehler (1932) who claimed to have induced tumours 
in animals with alphanaphthylamine and betanaphthylamine were 
likewise unable to demonstrate a carcinogenic agent in the urine.
Tumours were eventually induced in animals with betanaphthy­
lamine by 1937 by Hueper and his co-workers, with benzidine by 1950 
by Spitz and her co-workers and with 4aminodiphenyl by 1952 by 
Walpole, Williams and Roberts. These three are the only compounds 
imputed to be causes of occupational bladder tumours in man, which 
have been confirmed as carcinogens by experiments on animals. In 
most of the experimental animals, tumours have been induced by them 
in many organs, but the dog is the only animal in which bladder 
tumours have appeared readily or early. In men exposed to these 
compounds under industrial conditions careful investigation has 
failed to reveal an incidence of tumours in organs, other than the 
bladder and renal pelvis, higher than that in the general population. 
Man and the dog are the only known animal s who have this high 
susceptibility of the bladder to tumours induced by aromatic 
amines. Why do man and the dog react differently in this respect 
from other species and why should the bladder be attacked?
Bonser and her co-workers (l95l) suggested and investigated 
three possible reasons for this species difference in response,
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(l) that it might be because of a difference in metabolism from 
other species, or (2) that metabolite(s) may be at maximum 
concentration in the urine, or (3) because in man and the dog the 
urine is acid.
They conducted a series of experiments in an attempt to 
determine these several points. First they reconfirmed the high 
susceptibility of the dog to betanaphthylamine by inducing bladder 
tumours in six animals out of six in under four years. In three 
of the dogs the urine was kept alkaline by the administration of 
sodium bicarbonate and no difference in tumour induction compared 
with the other three was observed. This was regarded as sufficient 
evidence to dispose of the third theory - that the pH of the urine 
was important*
Using larger numbers of different animals, rats (25) mice 
(49) and the same number of rabbits (6), they found that tumours 
of the bladder could be induced only occasionally and after a long 
time in rats and rabbits and not at all in mice although the mice 
readily developed benign and malignant hepatornate.
Previously Engel (1920), Wiley (l938) and Manson and Young 
(1950) had shown that 2amino 1 napthol was a metabolite of beta­
naphthylamine in man, dogs and rats respectively.
OH
2 AMINO I N A P H TH O L .
Clayson (1950) had developed a method for estimating 2amino—
1 naphthol conjugates and this enabled Bonser and her colleagues 
to study species differences in the mode of urinary excretion of 
the metabolite after administration of various doses of beta- 
naphthylamine • They found that there was an approximate 
correlation between the relative susceptibility to induced bladder 
tumours in the dog, mouse, rat and rabbit and the amount of 
2amino 1 naphthol conjugates they excrete after dosage with beta­
naphthylamine. In the dog the concentration of 2amino 1 naphthol 
conjugates in the urine was about 200 times that in the blood plasma* 
They concluded that not only was there a species difference in 
metabolism of betanaphthylamine in the dog but there was also a 
maximal concentration of the metabolite in the urine*
The presumption that this metabolite was the active carcinogen 
was attractive, and they tested this theory on three mice using a 
method devised by one of them (jull, 195l) which consisted of 
implanting 2amino 1 naphthol in wax pellets into the bladder* One 
developed a papilloma, one a carcinoma and one metaplasia and 
hyperplasia ’’amounting almost to a papilloma”* Further experiments 
(Bonser, Clayson, Jull and Fyrah 1952) on a larger scale confirmed
these results* This time betanaphthylamine was also trested by
r
implanting it in mice bladders and no tumours were induced by it* 
Sarcomata at the site of injection of 2amino 1 naphthol confirmed 
that it is a local carcinogen whereas no local tumours could be 
induced at the site of injection with betanaphthylamine in mice,
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rats or rabbits* In 1954 Bonser and her co-workers described 
a method of introducing carcinogens in oil into the bladders of 
dogs by catheter, a technique which may facilitate further experi­
ments in this species and render comparison with other species 
easier.
It seems reasonable at this stage to conclude that this 
metabolite, 2amino 1 naphthol, is the active, or one of the active, 
substances in the production of bladder tumours in man and the dog. 
It is not the only metabolite nor is it suggested that it is 
necessarily the only carcinogenic metabolite of betanaphthylamine 
but the fact that it is formed in higher percentages from beta­
naphthylamine in these species and concentrated so highly in the 
urine must be a determining factor in the localisation of the 
initial disease to the bladder.
The position with benzidine is similar in many ways.
Baker (1950 and 1955)»working in my laboratory, isolated 353* 
dihydroxybenzidine from the urine of men working on benzidine and 
induced tumours in the bladder and livers of mice with it. He 
fed it to rats and induced tumours including ear gland tumours, 
similar to those reported by Spitz and her co-workers with benzidine. 
The tumours appeared in a shorter time than those induced by
benzidine itself. Three of the rats developed bladder tumours.
This suggested that a similar mechanism (i.e. by an active meta­
bolite) was operating in the case of benzidine to that of 
2acetylaminofluorene (Bielschowsky 1944) and betanaphthylamine.
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Clayson and Bradshaw (1955) identified 3hydroxybenzidine as a 
minor metabolite in dogs but did not report finding the 3:3* 
compound* Mller, Sandin and Miller and Busch (l956) investi­
gating 4 acetylaminodiphenyl, N:N diacetylbenzidine and eighteen 
related compounds did not find 3hydroxybenzidine or its acetyl 
derivative to be carcinogenic in rats, but they fed them for only 
8 and 10 months respectively and terminated their experiments 
after 13 months* Bonser and her co-workers1 rat experiments 
with 2amino 1 naphthol were sustained for twice as long*
Walpole, Williams and Roberts in their 1952 paper, which 
described the successful induction of tumours in rats with 4amino 
diphenyl and 3:2' dimethyl 4aminodiphenyl, suggested that in 
each case the effective carcinogen is an orthohydroxyamine formed 
in the body by metabolic hydroxylation.
ORTHOHYDROXY 4 AMINO DIPHENYL. ORTHOHYDROXY 3:2' DIMETHYL 4  A.D.P.
They further postulated that the higher activity of the 3s2* 
dimethyl homologue is due to the preferential direction of the 
hydroxy group into a position ortho to the amino group under the 
influences of the 3 methyl group, so that there is formed a large 
amount of the ,forthohydroxyM metabolite, which they presumed to
OH
OH
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be the active one* Again, in 38 rats which developed tumours 
out of a group of 46, only one had a bladder tumour but in their 
next experiments (1954) on two dogs both had developed advanced 
bladder tumours 2} years after the start of dosing. This again 
confirms the ’’species difference” of the dog’s susceptibility to 
induced bladder tumours. They suggested a working rule that if 
a compound does not produce tumours at the site of injection then 
it is not a direct or local carcinogen and that if tumours are 
produced in organs remote from the site of administration then the 
carcinogen must be a metabolite.
Clayson (1953) propounded a similar hypothesis and further 
developed the theory that hydroxylation in the position ortho to 
the amino group renders certain aromatic amines carcinogenic. He 
illustrated his hypothesis by comparing large numbers of published 
experiments and pointed out that this route of conversion is 
facilitated if the position para to the amino group is blocked as 
it is in benzidine and betanaphthylamine. The experimental testing 
of his hypothesis requires proof of the carcinogenicity of the 
ortho hydroxy amines and Dr.Bonser's department of which he is a 
member, has set up experiments on mice using the wax pellet implant 
technique, with 1 amino 2 naphthol, 3 amino 4 hydroxydiphenyl,
3 amino 2 naphthol, 1 amino 2 naphthol 4 sulphnmic acid,
3:3* dihydroxybenzidine and orthoaminophenol.
I AMINO 2 NAPHTHOL. 3 AMINO 4 HYDROXY DIPHENYL.
s o 3h
3 A M IN O  2 NAPHTH O L. I AMINO 2 NAPHTHOL 4  SULPHONIC ACID.
OH
^ ^ N H
3:3' DIHY PROXY B E N Z ID IN E . ORTHO AM 1NO PHENO L.
Clayson states that 1 amino 2naphthol a metabolite of alpha- 
naphthylamine has already induced tumours in five mice out of six 
in experiments in his department, but no results regarding the 
other compounds have been published.
Walpole, Williams and Roberts extended their theory to 
include compounds with a single ring such as orthotoluidine.
Clayson could not agree with them. There is no published evidence 
that amines with only a single ring are active and he considers 
that the hypothesis should be confined to compounds with more 
than one ring. Walpole and Williams (1958) pertinently point out 
that orthotoluidine has never been tested on the dog and they now 
have experiments in progress o
Before one could accept the proposition that single ring 
compounds can be carcinogenic one would require either incon­
trovertible evidence of industrial tumours in workers exposed 
only to them, or proof of their carcinogenicity in experimental 
animals. This does not mean that in the absence of such proof 
one should relax the stringency of the precautions applied in 
industrial practice.
Why the bladder should be especially singled out for attack 
in man would appear, therefore, to be determined by the formation 
of a metabolite, which is a local carcinogen and its being 
excreted in sufficient concentration in the urine to exercise an 
effect on the epithelium of the urinary tract. Ferguson (1934) 
held that the agent circulated in the blood and exercised its 
harmful effect in the terminal capillaries of the bladder mucosa.
He believed that in this way the whole of the bladder was affected 
and that recurrences arose because of this and not from implants 
or seedlings.
Hueper (1938) was able to identify betanaphthylamine in 
the liver, kidneys and bladder wall of mice one or two hours after 
it was injected but none was found in the bladder epithelium.
Tn a second series injected with betanaphthylamine three times at 
four day intervals none of these organs showed any betanaphthylamine
7 8
after the third day following the last injection, although traces 
of it persisted in the urine longer than in the parenchymatous 
organs* These observations indicate that when the organism is 
floodsdwith the compound betanaphthylamine may be deposited in the 
organs as an acute toxic effect but Hueper held ,fthe main and 
probably only contact of the epithelum with the carcinogenic agent 
takes place on the mucosal surface”.
Many other writers from Oppenheimer and Engel (1920) up to 
the present day have also preferred the theory that prolonged 
contact of the bladder epithelium with urine containing the harmful 
agent causes the change. This seems a more reasonable view and 
would account for the bladder being the site of the tumours in 
man and dogs. Many people (e.g. Hueper, Gay 1935) have cited, 
in support of this, the location of the bladder tumours in these 
species - in man around the ureteral openings and the trigone and 
in the dog on the anterior and lateral surfaces of the bladder — 
and have suggested that because of the posture adopted by each the 
urine is more in contact with these areas. This postulation has 
been widely upheld but it is difficult to accept it when one 
reflects that the bladder is only potentially a hollow viscus and 
that when part full it contains virtually no air or gas and the 
whole surface of the wall, as the bladder is contrasted down, must 
be in contact with the urine. Gay in 1937,when he described a 
larger series than he had in 1934,took the view that the distri­
bution of the lesions did not support the theory of a urogenous
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origin, as the majority of the lesions in his oases were 
situated above the level of the ureteric orifices. On these 
grounds he then supported the haematogenous theory.
The contention that a urine borne carcinogen is the active 
agent has been further strengthened by more recent work. Scott 
and Boyd (1953) fed betanaphthylamine to three groups of dogs; 
in the first group with normal bladders all kinds of bladder tumours 
resulted; in the second group the ureter of one kidney was implanted 
into the sigmoid and tumours arose in the bladder but not in the 
colon of these animals; in the third group both ureters were 
diverted the sigmoid and no tumours were found in either the 
bladder or the colon but in some of these animals there were tumours 
in the ureters and metaplastic changes in the pelvis of the kidneys* 
McDonald and Lund (1954) separated pouches off the bladder of dogs 
so that the urine could not get in contact with the mucosa in them 
and fed the animals betanaphthylamine. Tumours developed in the 
bladder but none appeared in the pouches. M&Donald and Thorson 
(1956) placed fragments of papilloma from other dogs fed betanaph­
thylamine in similar pouches in another series of dogs on normal 
diet and several of these became implanted and grew in the mucosa 
of the pouch. All these experiments suggest that while the 
carcinogen reaches the bladder in the urine rather than by the 
blood stream there is also a susceptibility of the urinaiy tract 
epithelium to react to it and that the Hreceptiveness,f of the 
bladder epithelium may also be an important factor in the
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initiation of the tumours.
Boyland, Wallace and Wallace (1955) think that the tumours 
are due to an excess of the enzyme glucuronidase in the urine which 
liberates a free animophenol from the excreted metabolite. They 
found a high glucuronidase content in the urine of men who had 
bladder tumours and also in those who had been treated and were 
free of tumours. They have suggested that this enzyme might be 
inhibited by the administration of saccharolactone especially in 
the event of accidental massive exposure. The problem in industry, 
however, is one of long term exposure possibly to very small doses. 
The threshold of the dose is unknown and may be very low. Prolonged 
exposures over 15 - 20 years are more important than accidental 
contamination and it is not proposed to use saccharolactone. 
Prevention must lie in directions other than the administration of 
uncertain long term antidotes.
To sum up, it would require a great deal more evidence than 
exists at present to support the view that the activity of the 
carcinogen in the bladder depends on its reaching it by way of the 
blood stream. The conclusion that it reaches the epithelium of 
the urinary tract by being conveyed there in the urine and that it 
acts upon it directly is inescapable*
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PART II
"OCCUPATIONAL TUMOURS OF THE BLADDER ARISING AT 
THE CLAYTON ANILINE FACTORY"
ANALYSIS OF RESULTS
Introduction.
In 1950 a works register (the "nominal roll") was compiled 
recording the names and working histories of all men who were known 
to have been engaged for more than six months in the manufacture of 
or use of aniline, alphanaphthylamine, betanaphthylamine, benzidine, 
and magenta. Men with less than six months employment were omitted 
partly because it was difficult to get details of some of those who 
had worked for very short periods and partly because, in the absence 
of any known experience to the contrary, six months exposure was 
regarded as a reasonable minimum time necessary to initiate a bladder 
tumour in industrial conditions. The nominal, roll is brought up to 
date annually but aniline is now omitted as it has not been shown to 
be carcinogenic*
By the end of 1957, when the list was closed for the purpose 
of this analysis, the names of 667 men (excluding the aniline workers) 
were on the roll. At the same time 125 men were known to have 
developed tumours of the bladder. A system of checking the names 
of men whose death certificates mentioned tumours of the bladder or 
chemical work, set up in the Factory Department by courtesy of H.M. 
Senior Medical Inspector has helped to ensure that men who develop 
tumours after leaving the factory are traced. The normal expected 
number of cases in similar members in the general population would 
not exceed three cases in thirty years*
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Of the 123 men who developed tumours, 87 were engaged in 
that section of the works where carcinogens were manufactured, 28 
in processes entailing their use and 8 were ancillary workers —
2 chemists, 2 fitters, a weighman, a transport worker and a man 
who worked as a boiler fireman for 28 years following three months 
exposure to betanaphthylamine.
It is obviously impossible to determine which individuals 
in a working population will develop tumours. Individual 
predisposition has been suggested as an explanation of the fact 
that they appear in some workmen whilst others placed in apparently 
similar circumstances escape. Gross (1958) suggests that chemical 
and other types of carcinogen merely activate latent oncogenic 
viruses. If this is true, then he contends that those who 
develop cancer represent only a small fraction of those actually 
carrying the seeds of the disease. In industrial practice, 
however, many other factors are operating. Some are impossible 
to measure; conditions in the factory have varied from time to 
time and have progressively improved during the past twenty years; 
dirty workers will absorb a higher dose than clean workers.
Familial tendencies are impossible to estimate; two pairs of 
brothers (cases 11 and 12, and 65 and 86) contracted the disease 
but each had worked on the same job as his brother,and other 
workmen on it also developed tumours of the bladder. The pre­
disposing influence of good or poor general health and intercurrent
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disease is also impossible to assess but I have already emphasized 
(1954) that good health and strong physique have no relation to a 
man’s resistance to carcinogens.
There are, however, several measurable factors which may 
influence the incidence of tumours. These include the duration of 
exposure to the dangerous chemical, the time which has elapsed 
since first entry into the dangerous occupation, the type of work 
upon which the men have actually been engaged, and the compound 
handled.
Incidence
In the present series the overall incidence of tumours is 
18.4$. This crude figure is of little value on its own. For 
instance, roughly one half of all the men have entered the industry 
within the last 12 years and would be unlikely to have developed 
tumours as yet.
The incidence among the total population at risk according 
to length of exposure is given in Table 3. It rises with the 
duration of the exposure until it is 71$ for men who have been 
exposed for more than 30 years.
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TABLE 5
Incidence by Length of Exposure
Total Years of Exposure
0-10 11-20 21-30 31+ Total
Population at risk 429 139 75 24 667
No, of cases 26 51 29 17 123
Incidence per cent 6 37 39 (71) 18.4
More information is required in order to be able to assess 
the extent of the hazard to which certain groups of men are exposed. 
It appears probable that not only the actual duration of exposure but 
also the period of time which has elapsed since first entering the 
hazardous occupation influences the incidence (Table 4)•
TABLE 4.
Incidence by Bate of Entry
Date of Entry
After
1951
1947-
1951
1942-
1946
1937-
1941
1932-
1936
1927-
1931
1922-
1926
Before
1922
No,at risk 157 97 63 110 80 62 59 39
No,of cases - 1 2 9 16 28 46 21
Incidence 
per cent - 1 3 8 20 45 7© 54
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It is impossible in the present series however to be able 
to distinguish a difference in these two factor’s which in any event 
are very closely correlated.
In order to assess the effect of the type of work, the men 
who were exposed to benzidine have been grouped in three categories, 
those who were directly engaged in the manufacturing processes, 
those who worked in the same building but were not directly concerned 
with the manufacture ("services menM)and those who used the chemical 
for the synthesis of dyestuffs in an entirely separate building 
(MusersH). The incidence of tumours in these three groups is shown 
in Table 5*
TABLE 5.
Manufacturers. Services Men and 
Users. Exposed to Benzidine.
Date of Entry
Job. Before
1927
1927-
1936
1937-
1957
Total
Manufacturers
(142)
Pop.at risk 
No.of cases
20
13
13
8
109
4
142
25
Incidence 
per cent. (65) (62) 4 18
Services
(149)
Pop.at risk 17 56 76 149
No.of cases 1 3 3 7
Incidence 
per cent (6) 5 4 5
Users Pop.at risk 21
30 33 86
(86) No.of cases 10 4 1 15
Incidence 
per cent. (48) (13) (3) 17
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Although, the numbers who started work more than 20 years 
ago, that is before 1937» are somewhat small, there is a very highly 
significant difference between the experiences of the manufacturers 
and the service men. Twenty-one of the 33 men in the former group 
have developed tumours, compared with 4 of the 73 service men.
The users have an incidence between these other groups, 14 tumour 
cases out of 51 men at risk. These findings indicate that there 
has been a greatly increased hazard for men directly engaged in 
manufacture and, to a lesser extent, in handling the chemical 
compared with men working in less close proximity. This is 
obviously of great importance in the prevention and control of the 
hazard.
The incidence according to age at entry and length of 
exposure in the three categories of workers with benzidine is shown 
in Table 6. Again the numbers are small but there is no evidence 
to suggest that older men entering the industry get a higher 
incidence of tumours than their younger colleagues. This is of 
the greatest importance in the selection of workers and will be 
referred to later.
In the case of the men who have worked solely with benzidine, 
al phfinqph-fchylamitia and magenta it has been possible to allocate 
accurately the compounds to which they have been exposed. The 
numbers involved with the last two compounds are too small for 
fruitful analysis.
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TABLE 6.
Incidence by age at entiy. Length of 
exposure - Benzidine workers.
Type of 
Work.
No. of 
Men with
Length of Exposure (Years)
Under 11
Age at entry
Under
31
31 & 
over
11-20
Age at entry
Under
31
31 & 
over
21 -
Age at entry
Under
31
31 & 
over
Total
Under 
31
31 & 
over
Manufac­
turers.
Pop.at risk 
No.of cases
20
1
86
5
10
7
14
6
11
5
41
13
101
12
Services Pop.at risk 
No. of cases
30
1
59
1
29
1
20
2
66
3
83
4
Users Pop.at risk 
No.of cases
18
2
17
3
16
1
19
6
45
9
41
6
It has not been possible to allocate with the same accuracy the 
men who worked in betanaphthylamine manufacture. Many of them were 
called upon to distil benzidine and use alphanaphthylamine in their 
section of the factory so that, while a proportion of them have worked 
exclusively on betanaphthylamine, many have had mixed exposures. It 
is not easy to trace the history of every man on this plant and 
attempts to do so cause a great deal of alarm, but when a man develops
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a tumour a complete history is obtained and checked against his 
own account*
For this reason the incidence of tumours in the betanaphthy­
lamine men cannot be given accurately nor can the potency of 
betanaphthylamine be compared with the other compounds at the 
present stage. This aspect of the problem, however, has already 
been well covered (Case et al) and the greater potency of 
betanaphthylamine as a carcinogen is generally accepted.
Discussion of Incidence.
Apart from any possible individual predisposition or 
personal factor in actual working, the incidence has been influenced 
by the date of entry into the industry, the length of exposure, the 
type of work done and the type of compound worked. One cannot 
easily separate these factors as more than one, and often all of 
them, have been operating at the same time.
Although it is impossible to forecast which men will develop 
tumours it would be useful to know the final total yield of cases 
which can be expected. Case and his co-workers estimated by an 
elaborate statistical method that eventually, when all the workers 
on their nominal roll will have died, 2($ will have died of the 
disease.
The groups of workers described by Gross, by Hueper and 
by Goldblatt all had a crude incidence varying from 50 - 10C$> at
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the time of their writing and it can be presumed that their 
death rates would be higher than 20$. Mttllerfe workmen already- 
had a 33$ incidence in 1951 and they may well have an ultimate 
death rate higher than one in five. Williams (1958) has 
reported that 94$ of 78 men who had worked for five years or more 
distilling benzidine and betanaphthylamine under poor conditions 
had developed tumours 30 years after starting.
One cannot compare these results with each other or with 
the present series as the groups are comprised differently and 
it is not known precisely which workers have been included. 
Williams' analysis is based on men with five or more years 
exposure under bad conditions whereas Case's figures were derived 
from men with over six months' exposure who were employed by a 
number of firms many of whom made or used only small amounts of 
carcinogens sporadically.
My results come from a factory where the carcinogens have 
been made and used on a large scale all the time; there is no 
doubt that in the earlier years exposure must have been heavy 
although it has decreased progressively over the last 20 years as 
conditions have improved. Already 18.4$ of the men on the nominal 
roll are known to have developed tumours and there may be others 
who have not yet been traced. There is no evidence that the 
annual yield is tending to drop and tumours have already been seen 
among the men who started within the last 20 years. It is only 
within the last ten years that conditions have been brought up to
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the standard now considered satisfaetoxy so that it is unlikely 
that the full effects of improvements in conditions will he felt 
for another decade at least•
Latent and Exposure Periods.
Industrial bladder tumours arise after a long latent period 
between entiy into the industry and onset of the tumour. This 
latent period is not necessarily the same as the period of 
exposure as many men leave the industry and subsequently develop 
tumours. In those who remain in the industry until the tumour 
appears the period of latency and of exposure is, of course, the 
same.
The range of the latent period is wide but there has been 
a surprisingly constant average throughout the sixty three years 
since the hazard was first described. In 1927 Oppenheimer's 
cases had a range of 1 - 45 years with an average of 18 years.
Mller in 1936 described the range as 2 - 28 with an average of 
18; GrOldblatt in 1947 gave the range of 4 - 48, average 19* Ih 
1952 describing the earlier cases now included in this analysis 
I found the range at that time was 4 - 3 3  years and the average 
16 years. Many other writers have had similar averages 
(Anderson 13 years, Buttner (l93l) 17 years, Heuschen (1937) 17 
years, Hueper 11 - 15 years). Hueper (1950) analysed 277 cases 
from the European literature and summarized the percentage 
incidence according to years of latency (Table 7) and Evans (1937) 
tabulated his 83 American cases similarly with a similar result*
4
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TABLE 7
Latent Periods in Years (Hueper 1950).
Latent Period 
in years 1 - 5 -10 -15 -20 -25 -50 -55 -40
No. of cases 52 49 69 74 28 15 6 6
Percentage 11.5 17.7 24.9 26.4 10.1 4.7 2.2 2.2
In the present series the latent periods ranged from 4 to 41 
years, the average was 20.4, and the most frequent period was between 
15 and 19 years (Table 8 and 9). Five men developed tumours 35 or 
more years after starting in the dangerous work.
TABLE 8.
Latent Periods in Years (Present Series)
Latent Period 0 - 4 5 - 9 10-14 15-19 20-24 25-29 30- Total
No. of cases 2 9 25 55 21 15 18 123
Percentage of 
total cases 1.6 7.5 18.7 28.5 17.1 12.2 14.6 100
Most writers have given average latent periods for their 
collected cases as a whole but a few have attempted to analyse them 
according to the chemical involved. Beremblum (1932) pointed out 
that the average latent period varied according to the department and 
that in fuchsin workers it was 24 years but in benzidine workers
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only 12 years. In Mttller1s series the range of the latent period 
was given for various carcinogens but not the average.
Case and his co-workers (1954) in their statistical analysis 
of the collected cases in Britain found that the mean latent period, 
or induction period as they called it, for betanaphthylamine and 
benzidine was the same, (16 years S.D. 5 and 6 years) and that it 
did not differ significantly from that due to mixed exposures,
(18 years S.D.7). There was, however, a significant difference in 
that of alphanaphthylamine which was 22 years (S.D.6). They 
considered that this longer latent period was a characteristic of 
alphanaphthylamine and a proof that it was carcinogenic per se and 
not only on account of its betanaphthylamine impurity.
In the present series there were no statistically signifi­
cant differences between the average latent periods for the various 
compounds although the 4 cases exposed to alphanaphthylamine had 
very short latent periods (18, 16, 14 and 14 years) in marked 
contrast to the experience of Case and his colleagues (Table 9).
The range of the average latent period is remarkably 
constant whether the initial tumour be papillomatous, carcinoma­
tous or multiple and the malignant tumours do not develop more 
quickly than the benign.
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TABLE 9
Mean Latent Period in relation to 
Compound used.
Compound No. of Mean Latent Period
Men with in Years
tumours. Papilloma Carcinoma Total
Ben. 48 18.2 21.25 19.2
An. 4 (16.0) (14.5) (15.3)
Bn. 23 21.1 18.45 19.8
Other 11 25.4 23.7 24.9
Mix. 37 22.15 20.9 21.6
Total 123 20.45 20.4 20.4
Variations in the latent period may be due to a variety of 
possible causes, and it has not been possible to determine the most 
important. The nature of the carcinogen is not necessarily the 
only factor. The intensity £?r length of exposure may also be 
important. Hueper (1950) showed that in experimental dogs dosed 
regularly with 250 mgms. of betanaphthylamine bladder tumours 
appeared in ly - 3 years but if dosage was stopped after six months 
the first tumours did not appear until after 5 years. Case and 
his colleagues failed to confirm that intensity of length of 
exposure influenced the latent period. Williams (1958) suggests
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this was because of the relatively small number of men who 
developed tumours following short exposures or to the wide 
variations of the degree of exposure in the different factories 
from which their material was drawn.
Wide variations in the exposure period have also been 
observed. Mtlller (l95l) states that over the whole of the tumour 
material seen at Basle the exposure varies from 3 months to 36 
years but he gives no further details of the man whose exposure 
was so short. Koelsch (1935) contended that only six months 
exposure to betanaphthylamine was sufficient to induce a tumour 
ultimately but he did not cite any cases in support of this theory. 
Goldblatt (1949 b) described one case of a man who developed a 
small papilloma after three months in the industry. This he 
regarded as non-occupational without giving any reason for this 
assumption. Many exact reports of exposure (and latent) periods 
of one year are available, e.g. Hueper (1938), Oppenheimer, Evans, 
etc. and short exposures of several months must be regarded as 
dangerous. I have taken six months as the qualifying period for 
registration on my nominal roll.
Equally interesting and important is the length of time 
which may elapse between the cessation of work with carcinogens 
and the onset of tumour. In 1954 I gave details of eight workmen 
who developed bladder tumours on an average 7 years (l-13 years) 
after leaving the work. Their average latent period was 15 years - 
little different from that of those men who stayed on and developed
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the disease* This is different from Hueper's finding in animals 
that early cessation of dosgge lengthened the induction period*
This suggestion is confirmed in the present larger series* Twenty- 
five men who left the industry have now developed tumours at some 
time after their exposure to the hazard had ceased. There is 
little difference between the latent periods for these men (mean 
21*5 years) and those of the other 98 men (20.1 years) despite the 
fact that the first group had an average exposure of only 9*9 years 
whilst in the second group it was 20.1 years. Table 10 shows 
that 10 of the 25 men who had left the industiy had actually had 
less than five years exposure although their latent periods ranged 
from 5 to 34 years.
TABLE 10
Length of exposure and latent periods of 25 men 
who left the industry before onset of tumour.
Length of 
exposure 
(years)
Latent Period (years)
Total0-4 5-9 10-14 15-19 20-24 25-29 30-
0-4 1 2 2 1 2 2 10
5- 2 1 1 1 5
10- 1 1 2 4
15 - 1 1 2
20- 1 1 2
25 - 1 1
30 and over 1 1
Total 1 — 5 5 5 8 3 25
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These figures stress the fact that removal from contact 
after short exposures does not eliminate the prospect of develop­
ing a tumour and does not necessarily postpone its onset. These 
points are of great importance in prevention because replacing men 
on this work after short periods of exposure would certainly 
increase the numbers at risk and might well increase the ultimate 
yield of tumours.
Fifteen of these 25 men who developed tumours after leaving 
the industry have so far survived for periods up to 16 years, 8 
of them for more than 5 years. Of the 10 who died, 1 survived 13 
years before dying of arteriosclerosis at the age of 77; the other 
9 all died from tumours of the bladder within 7 years, 6 of them 
under 5 years after the onset of tumour. It follows, therefore, 
that removal from exposure does not mitigate the severity of the 
disease if it arises subsequently.
Perhaps the most sinister and disquieting observation 
arising from the study of these 25 men is the time which elapsed 
between their leaving the industry and the onset of the disease. 
This averaged 11.7 years but 4 men had been out of the industry for 
over 20 years, and 1 of them (Case No.59), who had worked for only 
1 year and 7 months in betanaphthylamine manufacture, developed a 
carcinoma of the bladder 29 years after leaving the industry during 
all of which time he had worked as a railway porter. It is feared 
that other men with similar histories may not have been traced and 
many may well have forgotten the names of the chemicals and some
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even the name of the firm with which they were associated for 
such a short time so long before.
The first 66 cases in this series were described by me in 
1952 and the average latent period for these at that time was 
16 years (range 4-35 )• The lengthening of this by over 4 years 
to its present average of 20.4 years (range 4-41) is not 
statistically significant. The average latent period in my 1952 
series was longer in users (21 years) than in manufacturers (l6 
years) and there was a suggestion that mixed exposures tended on 
the whole to induce tumours earlier but neither of these findings 
are confirmed in this larger series. The average latent period 
for the magenta workers who developed tumours tended to be longer 
but their number is too few for one to draw any conclusions or 
make any comparison with other writers.
The duration or nature of the exposure has never been found 
to have any influence on the type of tumour. Benign and malignant 
tumours and all gradations between them appear apparently 
indiscriminately and independently of these factors. In 1952 I 
noted tbatmen who had tumours following exposure to more than one 
compound had a higher proportion of carcinomata than those whose 
exposure had been to only one carcinogen. This is no longer the 
case as the numbers of papillomata (15) and carcinomata (l6) in 
the mixed exposure group is virtually equal (Table 23)* Earlier 
diagnosis may be responsible for this in that a greater number of 
tumours are detected before demonstrably malignant changes are 
manifest.
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AGE FACTORS
The average age at onset of chimney sweeps who developed 
scrotal cancer prior to 1853 was between 30 and 40 years (Curling, 
1853)* These men had started work when they were 4 - 1 0  years 
old. By the end of the century the effects of the law forbidding 
boys to start work as sweeps until they were sixteen were seen 
when the average age at onset had risen to 40 - 50 years (Butlin, 
1892. By 1935 the average age was 61.9 years but by this time 
improvements in hygiene may well have had a beneficial effect as 
great as raising the age at entiy (Henry, 1937).
I have always insisted that the age at onset of occupational 
bladder tumours is directly related to the age of entiy into the 
industry which entails exposure to carcinogens (Scott, 1952, 1953* 
1954). I also showed that the average age at death from such 
tumours is similarly related to the age of entry.
Curschman in 1920 and Beremblum (1932) had already indicated 
that the onset of the tumours did not depend on the age of the 
workers. Hueper in his 1938 treatise noted a shift towards the 
younger age groups in his own and Evans1 series of occupational 
bladder tumours compared with those of unknown aetiology, and in 
1952 agreed that Mthe manifestation age of environmental and 
occupational tumpurs is directly related to the age at onset of 
the carcinogenic exposureM. In Goldblatt's 1949 series 33f° of 
the 93 cases were diagnosed before the men reached the age of 
45 and the mean age at onset was 50.55. Case and his co—'workers
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(1954) confirmed this tendency when they found that the mean age 
(40.5) at onset of bladder tumours in 137 chemical workers was 20 
years earlier than that in 750 men who had bladder tumours of 
unknown origin. They also found a similar difference, 15 years, 
in the most frequent age at death from bladder tumours in chemical 
workers (50 to 55 year's) compared with other males. Stocks (1950) 
took records of cases of cancer of the bladder and ureter from 275 
hospitals in England and Wales in 1945 and found that the average 
age of all cases at first attendance was 62.5 years and at death 
66.3 years. From the Registrar General's figures for 1947 the 
average age at death of 1,417 males who died of neoplqsms of the 
bladder* ureter and urethra was 67.5 years.
Case and his colleagues showed that the earlier age at death 
from occupational bladder tumours was due neither to a shorter 
survival time from the onset of the disease nor a selectively 
greater susceptibility to the disease in young men, and they 
confirmed that it was dependent on the age at first exposure to 
risk. i had already 1^952) emphasized the shortened expectation 
of life of men who are exposed to bladder carcinogens before the 
age of 30 and the importance of this in the control of the disease 
in industry.
In the present series the average age at onset of tumour 
is 49.7 years (Table 11). This confirms my earlier results and 
is in accord with the experience of other writers. The majority 
(75, i.e. 61$) of the 123 men who have so far developed bladder
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tumours entered the industry before they reached the age of 30,
TABLE 11
123 Cases of Bladder Tumour by Age at Entry.
Age at entry
Total
under 31 31-40 Over 40
No. of cases 75 35 13 123
Mean age at onset 46.9 52.9 50.7 49.7
Mean latent period 19*8 19.6 16.5 20.4
TABLE 12 
55 Fatal Cases by age at Entry.
Age at entry
Total
Under 31 31-40 Over 40
No. of cases 27 18 10 55
Mean age at onset 43.7 54.2 61.5 50.4
Mean age at death 49.6 57.4 66.1 53.7
Thirteen (11$) started after they were 40. Pig.3 shows the ages
at onset in five year groups. The average age at onset in the men
who have subsequently died is given in Table 12 and the ages at
death in five year groups are shown in Fig. 4. Of those who started
under the age of 30 and later died of bladder tumour the average 
age at onset was 43*7 years, whereas of those who entered the 
industry when they were over 40 and later died of tumour the average 
age at onset was 61.5 years.
AGE AT ONSET. AGE AT DEATH
The ages at death are of the greatest importance. Whereas 
the mean age at death for those who entered the industry before 
they were 30 was 49.6 years, it was 66,1 years for thosd entering 
over 40 which approximates to the age at death for non-occupational 
tumours. It was figures such as these which led me in 1950 to 
exclude men under the age of 30 from starting work where carcino­
gens are manufactured and eventually to insist that only men over 
40 should be engaged. This was to exclude younger entrants who 
would have their lives shortened should they develop tumours 
despite modem precautions.
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It will also be noted from Fig, 3 that the age at which the
tumours appeared tend to be much younger than that for non-
occupational tumours appearing on the average about 15 years
earlier than in Stock’s series. This shift to the younger age
groups at onset of a tumour may be used as an indication that a
hazard is operating in cases where thejemay be doubt as to the
occupational origin (Case et al 1954). It will be noted from
♦
Table 11 that the average latent period (16.5 years) for men 
starting over the age of 40 is shorter than that for men (19.8) 
who started before the age of 30. Despite this, it must be 
remembered that there is no evidence to suggest that the incidence 
of occupational bladder tumours is higher in older men entering 
the industry (Table 6).
Another fact which is apparent is the considerably worse 
prognosis for the older men. There were 10 fatal cases among 
13 who started over the age of 40 compared with 27 fatal cases 
amongst the 75 in the youngest age group.
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DIAGNOSIS
Introduction.
Occupational tumours of the urinary bladder once established 
differ little in their clinical features from those arising in the 
general population. There is, however, one important practical 
difference in that they usually arise in men who are known to have 
been at risk. Consequently such men can be kept under supervision 
so that the tumours may be detected at as early a stage as possible. 
It cannot be in doubt that, apart possibly from the degree of 
malignancy, the most important single factor in the effectiveness 
of treatment is the stage of a tumour when it is first discovered.
Tumours appearing in the general population are usually 
heralded by symptoms such as haematuria, dysuria, frequency of 
micturition or pain, and these symptoms may not supervene until the 
tumour has grown to a considerable size, become fungating, infiltra­
ted into surrounding tissues, or even formed metastases. In 
Riches (1958) series of over 500 patients with tumours of the 
bladder haematuria was present in 97$ of them when first seen. 
Routine clinical examination is unlikely to detect the symptomless 
tumours at an early stage and it has never seriously been advocated 
as a useful measure in this respect. Whilst mass screening of 
the general population for the detection of bladder tumours by any 
known methods will be shown to be impracticable on account of the 
difficulties of applying it, and would be unrewarding because of
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the comparative rarity of non—occupational vesical tumours, 
nevertheless the high incidence of such tumours in groups of 
chemical workers not only justifies the application of mass 
screening methods to them but renders it imperative if all 
possible care is to be afforded the workers at risk.
In this section the various methods which have been used 
to screen industrial populations at risk for the early detection 
of tumours of the bladder are described. Regular periodic 
cystoscopy of exposed workers and the routine examination of the 
urine for microhaematuria are evaluated as screening techniques. 
The history of the application of cytodiagnosis to the 
urine of workmen is given* Its introduction and development at 
Clayton are described. The successful results in new cases, and 
the disappointing results in old cases, are analysed and compared 
with those obtained by other writers. Reasons are given for the 
striking differences in these results. A comparison of the old 
techniques with a modified Papaniculaou technique and an 
evaluation of their merits is made.
Screening Methods.
In 1920 Oppenheimer recommended regular microscopical 
examination of the urine for red blood cells and Nassauer suggested 
that pus cells might have some significance. This was taken up 
by the Genaans (Cross), the Swiss (Mttller) and, in the earliest 
days, by the Americans (Anderson). It was adopted in Britain
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from 1934 onwards (Crabbe, Cresdee, Scott and Williams 1956) and 
was the method of screening relied upon in this country until the 
introduction of cytodiagnostic techniques in 1951 • Workers in
many other countries relied upon the routine cystoscopy of all 
their workers at regular intervals usually of a year.
Routine Cystoscopy
In America, when the first bladder tumours arose in men in 
the Wilmington works in 1931, routine cystoscopy of all exposed 
workmen at regular intervals was introduced and it was even extended 
to the pre-employment examinations of new recruits. In the 22 
months between December 1931 and October 1933, 532 men from that 
factory were cystoscoped and 25 of them were found to have tumours 
of the bladder (Gehrmann 1934). By 1937 (Evans 1937) 2,868 cystos­
copies had been performed and 83 cases of tumour detected. These
examinations are said to have been done annually and the rate of 
yield of tumours is interesting s- 49 men were found to have tumours 
when being cystoscoped for the first time, 16 at the second cystos­
copy, 15 at the third and one each on the fourth, fifth and sixth 
occasion. The quickly diminishing number of tumours found after 
the first three annual cystoscopies suggests that a pool of 
undiagnosed tumours was awaiting the investigators when they started. 
As the years went on the number of examinations with a normal result 
must surely seriously discourage a workman from submitting himself 
to an uncomfortable surgical procedure.
Mttller relates how the Americans at a conference with him
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and his colleagues in 1934 convinced the Swiss that they should 
apply routine periodic cystoscopy to their workmen at risk, and 
in 1937 he introduced it for contacts with benzidine, beta- 
naphthylamine and other dangerous substances. In the five years 
before 1937 using the wet smear technique for occult haematuria 
he had performed 152 cystoscopies and detected 15 tumours, whereas 
in the fifteen years after 1937 doing annual cystoscopy of all men 
at risk, he performed 968 cystoscopies and detected 35 tumours. 
Between 1947 and 1950 he did 499 cystoscopies and found 22 tumours. 
This means that before routine cystoscopy was introduced he was 
doing an average of 50 cystoscopies per annum, in the first 10 
years after its inception he averaged 42 per annum and for the last 
4 years precedding his report he averaged 125* From these figures
f"
it can be inferred tha, unless the total number of the employees 
was as low as 125, annual cystoscopy has not been applied even to 
the majority of the men at risk even during the period of greatest 
activity in 1947-50.
Wolfe ^1937) details the difficulties he encountered in 
America in applying routine endoscopic examination to all workmen. 
The time lost following the examination, the attribution of 
extraneous complaints to it, labour unrest, the opposition caused 
by preliminary treatments,such as meatotomy, all engendered many 
persistent refusals to be examined or treated. In the face of 
this discouragement he persevered and apparently was able to 
maintain a reasonably wide cover. He describes 984 original and
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repeat cystoscopic examinations in one plant, of which 329 were 
done in 22^ working days - the imagination boggles at the effects 
such a heroic procedure would have had on a population of British 
workmen. Despite the obvious difficulties, the reports of 
Gehrmann and his colleagues in 1949 showed that the Americans were 
still continuing to apply annual cystescopy as a method of control 
in their factories, and it has not been given up so far as is known. 
It is, however, extremely doubtful if all workers submit to it 
regularly. (Sundry personal communications, Williams, Case, etc.)
In Italy annual cystoscopy had been adopted before 1937 
(Di Maio) and was still being advocated with enthusiasm at the 
International Congress in London in 1948 by Barsotti and Vigliani 
(1949) whose figures do not, however, convince one that they were 
entirely successful in getting their workmen to submit. Only 13 
of 106 men engaged in benzidine utilisation and only 9 of 36 men 
in one group of benzidine reduction workers were cystoscoped. They 
were more successful with their betanaphthylamine men of whom 33 out 
of 40 were examined. Workers were not obliged, but were advised, 
to submit periodically to cystoscopy at the works surgery and they 
say that in many of these workmen cystoscopy could be repeated 
several times. One must infer that the others declined to submit 
themselves for repeat examinations. They also cystoscoped workers 
attending other kinds of work for "control purposes" but they do 
not specify any further details of these examinations.
The French practice seems to have been less unanimous#
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Billiard—Duchesne (1949) advocated systematic cystoscopy of i 
workers# He applied it in two factories and found six tumours 
in 55 workmen# In other factories which he mentions it does not 
appear to have been accepted# Alboulker, Gaultier, Benguign and 
Smagghe (1949) used the wet smear technique for occult haematuria 
but they did not apply routine cystoscopy to all their workers.
In Great Britain routine cystoscopy has never been applied 
to working populations. Although Goldblatt in 1947 advocated 
that it should be performed on all exposed men before starting 
work and .at least once a year thereafter, he never applied it to 
his own werkers. In 1949, he declared that the attitude of 
workers in Britain towards cystoscopy was far from favourable, 
an understatement such as one does not usually get from him. There 
are other more valid objections and drawbacks to its regular use. 
(Scott,1953; Crabbe, Cresdee, Scott and Williams, 1956)* It is 
often an uncomfortable procedure and undesirable sequelae can 
occur so that its application might lead to refusal to undergo it 
at the very time when it has become most necessary; many men 
might leave after one or two cystoscopies rather than continue in 
employment where they had to undergo it, and their replacement 
would increase the numbers at risk; a tumour could arise and 
become inoperable in less than a year after a negative result had 
led to a false sense of security; it would be impossible or 
impracticable to extend regular cystoscopy to all those workers 
whose exposure has been relatively slight but who may have a
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remote chance of developing bladder tumours, for example labora­
tory workers and men who have worked in areas adjacent to the 
dangerous ones* In addition to these practical disadvantages 
all investigators in Britain are agreed that periodic cystoscopy 
would not be accepted by British workmen, either as part of the 
pre-employment examination or as a rdgular routine thereafter, 
and it has never been introduced in this country. This does not, 
of course, apply to the follow-up and re-examination of men who 
have developed tumours.
Haematuria
As routine periodic cystoscopy was not considered to be an 
acceptable and efficient means of screening in great Britain some 
other method of deciding when cystoscopy should be done had to be 
applied. until the end of 195u the examination of wet smears of 
urinary deposits was the only other useful method available and 
was the one depended upon in this country. It was introduced into 
The Clayton Aniline Company in 1936 and was the chief screening 
method used there until cytodiagnosis was started in 1951* As 
urine can be collected and examined without discomfort or difficulty 
the test was extended to all workers in the factory and to those 
members of the staff who had even the most remote contact with 
carcinogens. It is still done at monthly intervals and there have 
never been any objections or refusals. It has been part of the 
factory routine for many years.
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Wet Smear Technique.
The exact technique is described in Appendix A. The 
presence of large numbers or the persistence of small numbers of 
red blood cells in the urine of a man who has had a “sufficient” 
exposure to carcinogens was almost invariably regarded as an 
indication for cystoscopy (Scott 1954) but as haematuria is not 
specific for bladder tumours many other factors had to be consid- 
ered. haematuria, occult or gross, can be occasioned by many 
causes other than tumour, for example, infection, trauma, calculi 
and divers other bladder, prostatic and renal diseases* Acute 
haemorrhagic cystitis is a common manifestation of the absorption 
of certain chemicals such as the toluidines and 5 chi or 2 toluidine 
which are often made and used in dyestuffs factories (Goldblatt 
1949, Scott 1953). Red blood cells are also found in the urine 
of some apparently healthy individuals.
Red blood cells had been observed in the urine of a disturb­
ingly large proportion (8$) of recently employed men on their first 
routine test after starting. There was no apparent cause for this 
and none of them had been exposed to the amines which cause haemorr­
hagic cystitis. These cases raised difficulties in assessing the 
results of the tests. It was impossible to be certain if the men 
were heal tty and the microhaematuria transient or of no significance. 
The urine of the new recruits was, therefore, examined from 1948 
onwards so as to eliminate any men who had microhaematuria before 
they started. It was hoped in this way to avoid periodical
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confusion in the appraisal of urine tests in the future.
During the period of three years - 1948 to 1950 - approxi­
mately 2000 men (1,926) between the ages of 20 and 55 years were 
examined prior to engagement in the factory but not specifically 
for work carrying a risk of tumour of the bladder. Apart from 
those rejected because of various disabilities, 142 (7.4$) were 
rejected because of some abnormality of the urinary system (Table 
15).
TABLE 13.
Pre-emplovment Examinations 1948 - 50.
Total no. examined 1,926 IOC#
Total no# accepted 1,738 90.2#
Rejected for all causes 188 9.8#
Rejected on Mgeneral grounds” 46 2.4#
Rejected for urinary abnormality 142 7.4#
The urinary abnormalities for which these 142 men were 
rejected fell into three groups - albuminuria without red blood cells, 
a history of urinary disease and the presence of microscopic haematuria 
of undetermined origin (Table 14)*
TABLE 14.
142 men re.iected because of urinary abnormality
Albumen without R.B.C*s 17
History of urinary disease 5
Red blood Cells in Urine 120
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The presence of albumen alone did not necessarily entail 
rejection. If it was postural or present only in small amounts 
and there was no evidence of any disability it was not disquali­
fying but no man with albuminuria was allocated to a hazard plant. 
When it was severe, or if accompanied by other factors such as 
cardiovascular or renal impairment it caused rejection in 17 cases. 
Of the five men who had a history of genito-urinary disease four 
had had a nephrectomy and one an operation for renal calculus. One 
man had a history of a previous attack of visible haematuria of 
unknown cause and when examined had many blood cells in his urine; 
he is included in the next group.
The largest number of men rejected (6.2$) were those who 
had a Significant" amount of blood in the urine. (more than 6 - 8  
R.B.C's per low power field on microscopy of centrifuged urine 
deposit) in the absence of any detected disease or disability.
As the pre-employment examinations were strictly for the 
placing of male applicants for employment a certain degree of 
selection had already been exercised by the personnel department 
before the men were submitted for medical examination and the 
obviously unfit and undesirable had been eliminated. The circum­
stances and the need for a prompt assessment precluded the use of 
any elaborate laboratory methods such as Addis counts of cells in 
the urine, nor was it possible to do further investigations on the 
men rejected except in a few cases. All of them were advised to 
consult their own doctoiswho were informed of the reason for
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rejection. Only three men are known to have had further investi­
gation, including cystoscopy, and in each it failed to reveal any 
lesion.
The possibility that many of these cases were due to infection 
is discounted by the fact that no acute gonorrheal infections were 
found in the series nor were there any men with a sufficiently large 
number of leucocytes in the urine to be described as pyuria.
The presence of the blood cells was not related to any parti­
cular age group. Fig. 5 shows the percentage of applicants in each
age group against the percentage of men with blood in the urine in 
each age group, and the proportion is constant. It was not possible 
to assess any dietetic influence but the men were all more or less 
in the same working class social group.
 'A OF NEW STARTERS IN AGE GROUPS -1 .9 2 6  MEN ° 100 X
 % OF REJECTIONS DUE TO R .B .C ’s. IN AGE GROUPS-
III REJECT 10NS= 100%
25
20
16-20 21-25 26-30 31-35 36-40 41-45 46-50 51-55 56-60 61-65 66-70
AGE
F I G .  5 .
^  '
There is the possibility that different men may excrete 
blood cells at different times* Table 15 shows that the percent­
age of men in 1950 who had occult blood in the urine on their first 
routine test after starting work was much lower than it was in 
1947 before applicants with occult blood were rejected*
TABLE 15.
Men with microhaematuria on first urine test after starting.
Total new starters 
in plants
Show blood on 
first urine 
test after 
starting*
%
1947 No.pre-employment 
R.B.C.test 202 16 8.0
1950 Clear at pre­
employment R.B.C«test 337 4 1.2
These results suggest that at least a proportion of the rejected 
men would have continued to show blood in their urine*
No similar healthy population which has not been exposed to 
chemicals was available for comparison and enquiries failed to 
elicit any other similar survey of healthy men or new entrants — 
even in the atomic industry.
No reason, therefore, was found to explain the micro— 
haematuria in these men and it was presumed that they were healthy 
but this was largely speculation until the publication of Green,
01 Shaughnessy and Hendricks 1.1956) six years later strengthened 
the opinion that the majority of the rejects had no serious
115
uro-genital lesions. These writers described the results of 
the urological investigation of 500 patients referred to them 
because of the presence of symptomless microhaematuria which hqfl 
been detected incidentally in the course of examination for 
complaints unconnected with the genito-urinary system* Of these 
patients nearly 8Q$> were over 40 years of age and more than half 
were over 50 so that one could reasonably expect a higher incidence 
of disease among them than in The Clayton Aniline group with its 
higher proportion of younger people. Nevertheless, they found 
that only 1($> of these people had "moderate to great" lesions of 
the genito-urinary tract, and only 2$ had tumours; half of the 
remaining tyjfo had an "insignificant" lesion which required little 
or no treatment and in the other half no lesion whatsoever was 
found. The incidence of significant lesions was not greater in 
thosd who had the higher degrees of microhaematuria. There was 
no indication in the urinary examination ^which did not include 
the study of exfoliated cells) which patients were likely to have 
a detectable lesion and which were not.
It is, therefore, reasonable to conclude that at least a 
very large proportion of the men rejected for employment at Clayton 
on account of microhaematuria were healthy. But where bladder 
carcinogens are contacted the presence of blood cells in the urine 
must always be regarded as a possible sign of bladder tumour. These 
men were rejected lest they should continue to pass blood in their 
urine gnf) difficulty should arise in the assessment of their wet
smears in the future and to eliminate those who might have urinary 
tract disease or a predisposition to it.
Haemorrhagic chemical cystitis.
The occurrence of acute haemorrhagic cystitis in workers in 
certain amines has been recognised since last century# It was 
described by Kehn and many other of his contemporaries and most of 
them attributed it to aniline and toluidines. Mttller (l95l) refers 
to two instances in young men after two days of heavy exposure to 
betanaphthylamine, Goldblatt (1947, 1949b) cites benzidine and 
chlor-aniline as causes and Melick and his co-workers (1955) found 
it in woikers in 4 amino diphenyl. Aniline has not been reported 
as a cause during the last thirty years# By far the most active 
of the commonly used chemicals in this respect are the toluidines 
and 5 chior 2 toluidine. Goldblatt (l949b) thinks the other two 
isomers of chi or toluidine may be inactive. Currie (1933) gives 
details of 11 cases of haematuria from cystitis arising in woikers 
manufacturing 5 chi or 2 toluidine; in one group of 13 woikers 
there were 9 men who developed haematuria. All the men had 
sufficiently heavy exposure to induce some degree of cyanosis from 
methaemoglobinaemia as well. Both the haematuria and the cyanosis 
cleared up rapidly on removal from exposure. These acute attacks 
of cystitis are not thought to be precursors of tumours and it is 
not suggested that 5 chlor 2 toluidine is carcinogenic (Goldblatt 
1949, Scott 1954, Williams 1959, etc.). Truhaut (1952) goes so far 
as to state that it should be absolutely struck off the list of
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substances causing bladder cancer.
Manufacture of 5 chi or 2 toluidine hydrochloride been 
carried out at Clayton since 1929* One man operated the process 
for many years until 1953* He has never complained of haematuria 
or had blood cells in his urinary deposit on regular monthly tests. 
Since then another experienced man has replaced him he also bqg 
had no complaint or signs of cystitis.
In the manufacturing process the temperature does not exceed 
100°C. and the final material is kept in a wet paste as far as 
demands permit so that vapour and dust are not great. From time 
to time a dry product is required and the amine has to be dried on 
trays in a large stove so that the risk from volatilization and 
dusting is increased.
The compound has been used in another part of the same 
building, being condensed with other compounds of low toxicity 
to form an intermediate of the Ciba-naphthol series. Three to 
four men at a time have been engaged on this job which normally 
operates for one or ttto periods of three to four weeks each year. 
The condensation is done at high temperature so that there is a 
potential vapour risk. All the men have their urines examined 
daily while they are on this work. If blood cells are found in 
the urine of any man he is taken off immediately. Despite this, 
and despite the most stringent precautions which are taken on the 
plant, three cases of gross haematuria arose during the past three 
years 1954 - 57.
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The following summary of the three cases, none of whom
became eyanosed, illustrates several points which arose*
Case No.M* 50031 (Age 5l). Started March 1954* In.
May 1954 had worked 3 days on Ciba naphthol. No 
blood cells had been seen in his urine which was 
examined daily. On the evening of the third day 
whilst at home he started passing blood painlessly*
He was sent into hospital by his own doctor. Cyst­
oscopy revealed dense congestion and inflammation of 
the bladder mucosa (’’haemorrhagic cystitis”). This 
cleared up in three days and he was well on discharge. 
There was no recurrence of blood in his urine up to 
his leaving the company on 14.1.55.
Case No.J. 50002 (Age 24). Started October 1955*
On 17th October, 1956, after working a week on Ciba- 
naphthol, his daily urine test revealed 6-8 red blood 
cells per low power field. His job was immediately 
changed so that contact with 5 chlor 2 toluidines 
was eliminated. Next day he had a moderate degree 
of visible haematuria which lasted one day* Micro­
haematuria gradually decreased and took 10 days to 
disappear entirely. He is still employed and has 
had no further symptoms or signs of urinary trouble*
Case No.B* 50016 (Age 52) * Started 14.1.57. On 
28*5.57 he was engaged in cleaning out stoves which 
had contained 5 chlor 2 toluidine. That evening he 
suddenly developed severe dysuria and frequency* The 
urine was blood stained. His symptoms cleared up in 
two days, but he had another slight attack on the 
fourth day. The microhaematuria gradually subsided 
a/nfl by June 3rd his urine contained no blood. Stained 
smears of exfoliated cells showed normal (Class i) cells 
throughout* His urine has been clear on subsequent 
examination.
Other similar cases have been recorded in earlier years 
and all have cleared in a few days under simple treatment; fort- 
unately none has developed clot retention*
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Thus the significance of occult blood in the urine of 
workers in a chemical factozy can be very difficult to assess, 
and a single sample can be misleading. If there is micro­
haematuria in a specimen from a man with a histoiy of recent 
contact with certain amines, further examination after removal 
from exposure may be necessary. The persistence of small 
number of blood cells or the sudden appearance of large numbers 
has usually been regarded as an indication for cystoscopy but 
such signs are in no way specific for tumour even in men with 
histories of long and heavy exposure to carcinogens. Bach case 
had to be considered individually, taking into account the 
history of exposure to carcinogens,before deciding if cystoscopy 
should be advised, bearing in mind the importance of keeping the 
number of negative cystoscopies as low as possible in order to 
avoid the risk of refusal in the future.
Nevertheless, although the application of the wet smear 
technique had disadvantages and short-comings many presymptomatic 
diagnoses have been achieved by this method. The average number 
of men employed during the past 15 years has been about 1,800 and 
approximately 22,000 wet smears have been examined from them each 
year. During the eleven years from 1940 - 1950, 40 men whose 
urine was being examined regularly by the wet smear test, developed 
tumours. In 16 of these men there was no indication whatsoever 
that a tumour was present until blood cells were observed on 
microscopy of their urine. In 12 cases small numbers of blood
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cells considered to be insufficient in quantity to warrant 
advising cystoscopy, were present. In 12 men symptoms or gross 
haematuria were the first indications of bladder trouble. The 
wet smear technique,therefore, was unsatisfactory in detecting 
the presence of tumour in 24 men out of 40.
CYTODIAGNOSIS.
The disadvantages of depending on the detection of micro— 
haematuria or on regular routine cystoscopy for the early 
diagnosis of tumours of the bladder kept one on the alert for any 
other means of screening the workmen. Fragments of tumour and 
tumour cells were sometimes identified on routine examination of 
unstained wet smears of urinary deposit from men known to have 
tumours. This was not a new observation as desquamated cells 
were said to have been seen in the urine as early as 1864 (Sanders). 
It was not, however, until the introduction of differential 
staining by Erlich in 1891 that the accurate assessment of such 
cells became possible. In 1903, Albarren and Imbert suggested a 
search for neoplastic cells in the urine in cases of inexplicable 
haematuria. Stennius (1924) and Heiburg (1926) tried to assess 
the malignancy of cells in urine by measurements of the cells and 
of their nuclei. Parmenter (1925) thought the urine could usefully 
be examined for tumour cells as well as blood cells before cystos­
copy.
Papanicolaou, following the successful application of his 
technique of exfoliative cytology to the diagnosis of cancer of 
the cervix uteri (Papanicolaou and Traut 1943) extended it to the 
urine (Papanicolaou and Marshall 1945, Papanicolaou, 1947). He 
reported his findings from cytological studies of the urine in 
240 hospital patients. Of these, 76 had tumours (55 of bladder,
12 of kidney, 1 of renal pelvis, 8 of prostate) and tumour cells
were found in the urines of 43 ( 57$). A further 21 were 
suspicious or doubtful, 7 were slightly suspicious and 5 were 
negative. There were also two false positive findings.
Schmidlapp and Marshall (1948) treated 333 patients whose smears 
had been classified by Papanicolaou. Despite an encouraging 
number of true positive results they reported that the technique 
was not dependable in the detection of benign tumours - they had 
36 patients with histologically benign papillomata in 27 of whom 
the smear was negative and in 8 of whom it was suspicious. Chute 
and Williams (1948) applied the technique to the urine of 168 
hospital patients with encouraging results in malignant neoplasms 
(55$ true positive in 59 patients with tumours and 12$ false 
positive results in the others) but their results in cases of 
benign papilloma were not dependable. Possible reasons for this 
are discussed later. Although in 1950 Cromwell and Papanicolaou 
(1952) had suggested the screening of dyewoikers at risk by this 
method it has not yet been extensively applied in America. Within 
the past few months it is being introduced there by Melicow for 
the screening of 4 amino diphenyl workers on the advice and under 
the guidance of British industrial physicians (sundry personal 
communications and correspondence).
In 1951 the stained smear method of Papanicolaou was 
introduced into three British factories (Crabbe 1952} Crabbe, 
Cresdee, Scptt and Williams, 1956) one of which was The Clayton 
Aniline Company. It has been used in this fastory as the principal
method of control screening of workers since then. The other 
two factories belonged to Imperial Chemical Industries Ltd. and 
Drs.Crabbe, Cresdee and Williams were their medical officers.
In the 1956 paper the joint results obtained by pramining -y^ e 
urine of some 1800 workers and the cystoscopic findings amongst 
91 men are reported. Of these I contributed approximately 1500 
men who were on routine test and 44 of the 91 men who were cystos- 
coped. Since the joint paper was written further cases of 
bladder tumour have been diagnosed by cytodiagnosis and confirmed 
by cystosoopy.in The Clayton Aniline Company's factoiy and my 
cpmplete results are now described and discussed.
When the technique was introduced at Clayton in January 1951, 
wet smears were being done at monthly intervals on all workers and 
this has been continued. At first if any wet smears showed 
epithelial cells or blood cells a stained smear was made by 
Papanicolaou's method and examined. One also examined stained 
smears from all workers at least annually and at more frequent 
intervals from those men at high risk due to long or heavy exposure 
to carcinogens. The two latter types of survey were done for the 
first four years, but it was found that a great deal of time and 
energy was wasted on preparing smears, many of which were acellular 
when examined. Furthermore, it seemed desirable that a more 
frequent check should be maintained on those workers at high risk.
If the urines of all the men were to be fully processed each month 
it would have necessitated doing something of the order of 1500
stained smears eveiy month, a number which was administratively 
and economically impossible. Therefore, from 1955 stained smears 
were prepared only from those urines with cells in the wet smear. 
Much time previously wasted in preparing and examining acellular 
material has thereby been saved. With experience, variations in 
cell structure were noted in the wet smear and were confirmed on 
examining a stained smear. In this way It was found that cells 
which were atypical or abnormal could be distinguished on the wet 
smear. Stained smears were thereafter prepared for further 
examination and classification only from urines containing abnormal 
or atypical cells and from those containing blood cells.
With the adoption of this procedure, which was finally worked 
out and applied by the beginning of 1955, an average of 100 stained 
smears require to be prepared and examined each month from the 1500 
or so men who are on monthly urine test.
Phase Contrast Microscopy
The fact that atypical and abnormal epithelial cells could 
be distinguished from normal cells in wet smears of urinary deposit 
under the microscope using conventional illuminants suggested that 
if phase contrast microscopy were applied it might be possible to 
make a direct reading. This would eliminate the time spent in 
preparing and examining stained smears.
In order to test this hypothesis 1,000 urine deposits were 
examined using phase contrast microscopy. It was found that the 
classification of the cells present corresponded in all cases to
that made by the same reader on the same urine stained by the 
Papanicolaou technique. It was concluded that direct readings 
by phase contrast microscopy can readily be made on unstained wet 
smears. The re—training of a technician or technologist used to 
examining stained material would not be difficult. The advantage 
expected of phase contrast microscopy was the saving of the time 
spent in preparing and staining smears. In fact little time was 
saved as a fresh specimen had to be prepared for each urine so 
that it could be examined under a high power objective using a 
cover slip. A batch of 20 Papanicolaou smears can be stained and 
mounted in about 30 minutes.
The great disadvantage of phase contrast microscopy was 
found to be the absence of a permanent preparation. This is 
essential for (a) the confirmatory examination by the medical officer 
of a technician's findings, (b) the re-examination of suspicious 
smears and their comparison with subsequent specimens, (c) reference 
back in the case of readings which subsequently appear to be false 
and (d) teaching and demonstration purposes. These considerations 
outweighed the apparent advantages and it was decided to discard 
phase contrast microscopy and to concentrate on increasing the 
efficiency of the stained smear technique.
Stained Smear Technique.
The original technique (Crabbe 1952) consisted essentially 
of fixing the urine with an equal volume of 95$ ethanol and centri­
fuging 40 mis. of it. Smears were made by spreading a small amount
of the deposit on a slide and placing it in a fixative solution.
It is then stained, connterstained and mounted. The technique 
is described in detail in Appendix A. While it is preferable to 
use fresh urine (Sarvaya, Saudin and de Almeida, 1954, state that 
it should be processed within one hour) it has been found that 
unfixed urine will keep several hours and fixed urine as long as 
96 hours at room temperature.
Most urines examined from symptomless, healthy workmen are 
crystal clear and yfrjLd little deposit and few cells. As there is 
a marked increase in the exfoliation of bladder epithelium after 
exercise (Hyman, Solomon and Silberblatt, 1956) urine is collected 
from men at work, when they are active, in order to get the maximum 
possible number of cells in the specimen. The collection of clear 
urine in two pots appeared unnecessary and during a trial period 
of two months in 1955 smears were prepared from each pot and from 
a mixture of the two specimens. There was rarely any difference 
in the smear whichever specimen was used and since then one pot 
specimens have been collected. Occasionally when there is a heavy 
cellular deposit a two pot specimen may be required.
In industrial practice most of the urines yield little 
cellular deposit. The addition of the 95$ abohol often precipi­
tated a heavy deposit of amorphous debris and also halved the 
possible cellular yield in the final deposits. It was found after 
a series of trials that the ommxssion of alcohol for fixation did 
hot affect the cells if they were processed within four hours of
micturition and alcohol fixation was therefore discarded*
The smears made from many of the urines showed so few 
cells that a great deal of time had to he spent in searching for 
them. Some method of concentrating more cells into a smaller 
area was sought. Deden (1954) used 400 ml. of urine, allowed it 
to settle for six hours and centrifuged the deposit. This is 
cumbersome and is impracticable in mass screening. Rofe (1955) 
concentrated the cells by differential centrifugation. A 
modification of his method was eventually developed and is the one 
now used. Fig.6 shows a random smear prepared after ordinal 
centrifugation of clear urine and Fig.7 shows a smear from the 
same specimen after special concentration. It will be s^en that 
many more cells are available in each field for examination.
Deden (1954) found that staining by haematoxylin and eosii^ 
was as reliable as Papanicolaou8s stains. A series of smears ■ '1 
stained by each method confirmed Deden’s opinion. It was found*  ^
however, that examining H & E stains for long periods was much more 
tiring to the eyes than the Papanicolaou stains and the latter
are preferred and used.
Variations in staining were troublesome until trials showed 
that standardization of the pH of the urine and of the stains gave 
uniform results. Leishman’s stain was also tried in order to get 
more delicate nuclear staining but was abandoned because all 
attempts to stain smears in batches with it resulted in uneven and 
unsatisfactory staining. ,
Th® us® of a tissue processor for staining was also tried 
as it was thought that automatic staining might save time fly>d 
standardize results. Against controls stained by hand there was 
some distortion of the cytoplasm and the nuceli were poorly 
defined. This was probably due chiefly to the time taken (75 secs 
to change over from one bath to another so that the smears tended 
to dry out, and partly to the limited number of operations possible 
Automatic staining has, therefore, not been introduced. In any 
case the time that vmight have been saved by its use is small
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compared to that required to examine the slides.
The technique of preparation and staining of the smears 
which was finally adopted is detailed in Appendix A.
Classification of smears.
Papanicolaou (1954) described and depicted in his Atlas the 
criteria of malignancy. His classification of smears is as 
follows
Class I. Absence of atypical or abnormal cells.
Class II Atypical cytology but no evidence of malignancy.
Class III Cytology suggestive of, but ns>t conclusive for
malignancy.
Class IV Cytology strongly suggestive of malignancy.
Class V Cytology conclusive for malignancy.
Crabbe, Cresdee, Scott and Williams emphasize that the 
interpretation of the smears is difficult and requires a thorough 
knowledge not only of the criteria of malignancy but also of the 
numerous variations from normal due to non-neoplastic conditions.
We stress that it takes many months of instruction and practice 
to train a technician to make a reliable assessment of exfoliated 
cells.
As Papanicolaou points out, exfoliated cells differ greatly 
in appearance from corresponding cells in tissue section. No 
single criterion is sufficient to establish conclusively the 
presence of malignancy and he bases his classifications on struct­
ural modifications of cells and their nuclei, and changes in the 
inter-relationships of cells as evidenced in cell clusters and 
tissue fragments. Crabbe (1999) includes as the main criteria 
enlargement and prominence of the nucleus with an alteration in 
the amount and pattern of chromatin, marked irregularity in nuclear 
shape and abnormality in size, and he notes that mitotic figures, 
though uncommon, are sometimes seen; the cells may be large and 
bizarre in shape and phagocytosis of other cells by malignant ones 
is common. Figs. 8 and 9 show malignant cells illustrating many 
of these criteria in smears from the urine of men under routine 
test.
As a practical working method in screening the Clayton 
workers, Class I and II have been regarded as negative, Class III 
as suspicious and Class IV and V as positive. A positive result 
is regarded as an indication for investigation (including cystos­
copy of the genito-urinary tract Suspicious smears are regarded 
as positive if blood is also present or if exposure to carcinogens 
is deemed to have been significant but otherwise the examination
is repeated until a definite appraisal can be made. Many of 
the case histories illustrate the application of these principles.
Results of cytodiagnosis 
The results cover the seven year period 1951 - 58.
Special reference will be made to the last three years when the 
improvements in cytodiagnostic technique and interpretation had 
been fully developed.
Approximately 1500 men were examined regularly when new 
starters and leavers are taken into account. Table 16 shows the 
number of hourly paid male employees on the tests. A number of 
the staff were also examined.
TABLE 16 
Men on routine urine tests
Total at 
Jan.lst
(A)
Rew Starters 
during year
(B)
Leavers during 
year
<o)
Overall
Total
(A + B )
1951 1472 627 498 2099
1952 1601 81 778 1682
1953 904 534 240 1438
1954 1198 392 294 1590
1955 1296 282 248 1578
1956 1330 10U 261 1430
1957 1169 212 179 1381
1958 1202
The results are divided into two main groups, first those 
men who had never previously had bladder tumour and secondly,
those who had developed, and been treated for, tumours and who 
were under regular follow-up review. The results in these two 
groups are so strikingly different that they are described and 
discussed separately.
Cytodiagnoaia in men with no previous tumour.
In the first group 55 men were cystoscoped because of the 
findings in the routine urine tests or because of the onset of' 
symptoms and 35 new cases of bladder tumour were discovered.
Ihe results are summarized in Sable 17.
Smear results compared with cystoscopic findings in 55 men
Tumour Present No tumour found
True
Pos.
Prob.
True
False
Neg.
Total False
Pos.
True
Neg.
Total
Symptoms 
and/or R.B.C's 10 2 3 15 1 15 16
If©. « »• 17 3 - 20 2 2* 4
Total 27 5 3 35 3 17 20
* cystoscoped at own request
There were 27 men with positive Papanicolaou smears in whom 
tumours were found on first cystoscopy (true positives). Of these 
10 had symptoms or a degree of micro haematuria sufficient in 
themselves to be an indication for cystoscopy; the other 17 had 
not at any time had symptoms or blood cells in the unne or any 
indication, other than the stained smear, that a tumour was present
Five other men with positive smears, but in whom no tumour was 
found when they were first cystoscoped, were found to have tumours 
on re-examination at varying intervals up to 18 months later and 
are regarded as probably true positives. Three men who had 
negative smears were investigated because of sudden haematuria in 
one, and the persistence of red blood cells in the urine of two, 
and they were found to have bladder tumours (false negatives).
No tumour has been found in 20 men who have been cystoscoped 
for various reasons. Three examinations were made on men whose 
smears were considered to be positive (false positives) and 17 on 
men whose smears were negative (true negatives), 15 because they 
had symptoms or occult haematuria and two at the men's own request 
for an examination to allay their fears.
Discussion of results.
Of 35 men whose stained smears were positive 27 (77$) were 
found to have bladder tumours on first cystoscopy. When the 5 
“probably true positives'* are included this figure becomes 32 (91$) •
Men who hqd negative Papanicolaou and negative wet smears 
were presumed to be clear of tumours in the absence of symptoms and 
they were not investigated further. During the period under 
review all the tumours which were found were at an early stage of 
development when first seen. This supports the view that no 
tumour remained undetected until it was at a late stage. In the 
three cases in which a tumour was found associated with a negative 
stained smear, two of the men had increasing microhaematuria which
prompted, further examination hut the other had only ftw 
insignificant number of blood cells in the urine before a sudden 
haematuria supervened. In each case the Papanicolaou smss** was 
positive after initial out-patient cystoscopy and before the 
were admitted to hospital for treatment, so that the detection of 
the tumour by stained smear examination would probably not have 
been long delayed had the other reasons for initiating investi­
gations not arisen.
The ability to distinguish normal cells on the unstained 
wet smear leads one to the conclusion that urines which are 
classed as normal in this way are rightly regarded as negative 
for tumour. During the last 3-year period 1955-57 approximately 
40,000 urines were examined by this method and 2,544 were selected 
for staining and further examination. Deducting 820 smears from 
men with new tumours or established tumours which had previously 
been treated there were therefore 1724 true negative stained smears 
and approximately 39»000 true negative smear examinations in all. 
During this period the presence of only one bladder tumour has 
been revealed other than by routine urine examination (Case No.4l) 
and it is reasonable to presume that this is the only false 
negative result, using the two techniques, in about 39,000 examin­
ations.
Both tests have been applied throughout. Table 18 shows 
the results of the application of the wet smear technique for 
microhaematuria and Table 19 those of the Papanicolaou technique
since the latter was introduced in 1951.
TABLE 18 
Vet Snear Results.
Cystoscopy Red Blood cells or symptoms Total
Present 
(Positive )
Absent 
( Negative )
Tumour present 15 20 35
No tumour present 16 4 20
Total 31 24 55
TABLE 19 
Papanicolaou Smear Results.
Cystoscopy Papanicolaou Test Total
Positive Negative
Tumour Present 32 3 35
No Tumour Present 3 17 20
Total 35 20 55
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These data emphasize the great superiority of the 
Papanicolaou technique over the wet smear technique for the 
detection of blood cells. With the latter there were 20 (36.4$) 
false negative results whereas with the Papanicolaou technique 
there were only 3 (5.5#). Moreover there were 16 (29#) false 
positive results with the wet smear and only 3 (5.5#) with the 
Papanicolaou smear.
The improvements in the technique and the experience gained 
in the interpretation and classification of the smears would be 
expected to improve the results. Table 20 shows the results for 
the past three years 1955 - 57 during which 21 new cases of bladder 
tumour have arisen in men still at work and under supervision.
TABLE 20
Tumours arising in the past 3 years.
Papanicolaou smear
True Pos. False Pos. False Neg. Total
Blood cells and/ 
or symptoms 1 0 1 2
No blood cells 
or symptoms 19 0 0 19
No. of men with 
tumours 20 0 1
_
21
There were during this period 19 men (90#) with symptom-
less tumours which were detected by the Papanicolaou before there 
was any other indication whatsoever of their presence.
False positive results.
There were eight men whose smears were positive but in whom
no tumour was found when they were first investigated. Five of
these men were found to have tumours on subsequent urological
investigation at intervals varying from five to 18 months later and
they have been tabulated as Hprobably tiue positives". The
following case is representative
Case No.122. This man was aged 56 when the tumour was 
found in 1954. He had worked on magenta manufacture 
for 3 years 1922 - 25 and had used benzidine in small 
amounts for 19 years 1930 - 49* In January 1954 a wet 
smear of his urine contained a few red blood cells and a 
Papanicolaou smear revealed "many malignant cells and 
clusters - Class V - positively malignant". Cystoscopy 
was done on 25*1.54 but no tumour was seen in the bladder; 
intravenous pyelography revealed no abnormality. Ex­
foliated malignant cells continued to be present in the 
urine and he was re-investigated four months later. On 
25.5*54 cystoscopy showed widespread papillomatosis of 
the bladder which proved on biopsy to be papillary 
carcinoma.
Von Ham™ and Menzies (1953) found malignant cells in vaginal 
smears from laboratory animals seme time before experimentally 
induced carcinomata of the cervix uteri could be identified* and 
it seems reasonable to presume that cells with malignant character­
istics were exfoliated from early foci of tumour formation which 
were too small to be demonstrable by the most careful investigation. 
Melicow and Hollowell (1952) described 30 cases of carcinoma in 
situ from the Squier Urological Clinic in New York. Among these
were 17 in the bladder epithelium while two involved the ureter 
and one the renal pelvis.
it is possible that the appearance of malignant cells in 
one case in this series in which no cause haa been found may 
prove to have a similar explanation
Case No. F.M. 53055? Born 10.10.02. He worked in 
a process using benzidine for 20 years 1931 - 51.
A carcinoma of the colon was successfully removed by 
right hemicolectomy in 1954. In March 1956 cells 
with characteristics suggestive of malignancy (Class 
P'j were observed in his urine. On 21.8.57 he 
complained of severe lower chest and abdominal pain 
radiating to the left arm and was admitted to the 
Manchester Royal Infirmary as an emergency on 21.8.57. 
Investigations and liver function tests confirmed a 
diagnosis of acute pancreatitis. He was discharged 
from hospital on 27.9.57. He was cystoscoped as an 
out-patient on 19.10.58 and no bladder tumour was 
found. Smears up to 17.3.58 have been Class I. He 
is being kept under observation.
It remains to be seen if this man will eventually develop 
a tumour. Roland and Marshall VI957) held that unexplained 
positive smears should be followed up indefinitely. Crabbe, 
Cresdee, Scott and Williams had four men ^the above case is not 
one of them) who had repeatedly shown malignant cells in their 
smears over periods of up to two years but in none of them had 
a tumour been found. Two of these men were from The Clayton 
Aniline Co .Ltd. and are included in the present series (Case 
Nos. 47 and 127). Both of them have since been found to have 
tumours on follow-up cystoscopy and are now included in the
"probably true positive" group*
Une of two men in the series who developed the initial
tumour in the renal pelvis had malignant cells in his urine for
a year before a diagnosis of tumour was confirmed* These was
a gradual progression of the classification from normal to
frankly malignant over a few months and this has been observed
in many of the cases*
Case No.127 H.C.: B o m  9.6.05* This man worked 
on or near the benzidine manufacturing unit for 
13 years 1939 - 52. Stained smears of his urine 
were classified as I or II until 1st November 1955.
A reading of Class II - III was made on that day and 
again on 30th November and 3rd January 1956. On 
the 2nd February 1956 it was Class III - IV and on 
the 2nd March Class XV. Three further smears during 
the same week were Class IV. Some blood cells were 
also present then. Fig. 10 is a photomicrograph of 
the smear on 2nd March. In view of these findings 
he was cystoscoped on 26th March 1956. No tumour 
was present in the bladder. Straight x-ray of the 
urinary tract showed no abnormality and an intravenous 
pyelogram revealed good excretion and no abnormality 
of the renal or pelvic outlines.
He continued to exfoliate Class IV or V cells 
and he was admitted to Salford Royal Hospital on 
22.12.56. Cystoscopy again revealed an apparently 
normal bladder. On retrograde pyelography the 
appearances were suggestive of tumour at the right 
pelvi-ureteric Junction and this was confirmed on an 
intravenous pyelogram.
On 15.1.57 right nephrectomy and ureterectomy 
was performed by Mr D.S .Poole-Wilson and a papillo­
carcinoma of the renal pelvis was found. Section 
showed this to be invasive. Smears were Class I 
after his operation.
He subsequently developed bilateral pulmonary 
tuberculosis of which he died on 18.12.57. At post­
mortem examination his bladder, left kidney and renal 
pelvis were clear of tumour,
Papanicolaou ^1954) stated that there was evidence that 
exfoliation appears early in tumours of the pelvis of the kidney.
He cites two cases in which the diagnosis was made by the 
examination of ureteral urine and was confirmed by nephrectomy 
performed on the strength of the urinaiy findings. Owing to 
the limitations of diagnostic methods the detection of renal 
pelvic and ureteral tumours at as early a stage as those in the 
bladder is difficult and it is likely that exfoliation does not 
necessarily take place earlier from these tumours than from 
bladder tumours but that it occurs before the growth is suffi­
ciently advanced to be demonstrable by other methods. For this 
reason it is probable that renal pelvic tumours will give rise 
to positive readings on urinary smears before they can be 
demonstrated by conventional methods.
Two of the men whose smears were classified as positive 
were investigated and were found to have symptomless renal 
calculi. Ferguson U949) held that certain non-neoplastic 
conditions can produce cells almost identical to malignant cells. 
Papanicolaou in his Atlas pointed out that renal calculi may 
cause the appearance of atypical transitional cells which are 
mostly small or ium sized and that their differentiation from 
malignant cells is at times difficult. The smears from each 
case showed clusters of cells which were not unlike those from a 
benign papilloma. There was, however, ample cytoplasm between 
the nuclei the cell membranes and the outline of the clusters 
was smooth and well-defined; there were some erythrocytes and 
leucocytes in each case. Fig.ll is a photomicrograph ^Case No.
59028) shewing these several points. It was thought that one 
could in the future recognise these appearances as typical of 
the presence of renal calculi and differentiate them from those 
of benign papilloma. Smears from two patients in Salford 
Royal Hospital who were known to have renal calculus were made 
and this impression was strengthened. Fig.12 shows a photo­
micrograph from a smear of one of these patient ‘ s urine a^d the 
same characteristics are evident. This can be compared with 
Figs. 13 and 14 which are from benign papillomata.
Crabbe (1959) feels it is far worse to miss detecting a 
tumour until it becomes inoperable than for a man to undergo 
what he describes as a "negative cystoscopy" and that, therefore, 
false positive results are far less undesirable than false 
negatives. No one could seriously refute this statement. Deden 
(1954) looking at the same point from another aspect is of the 
opinion that if one aims to be so cautious as to exclude any 
false positive the result would presumably be to get too low a 
number of correct positive findings and thus reduce the clinical 
value of the procedure. These views are merely speculative.
The point has already been made that in approximately 40,000 
examinations in the last three years, only one case arose which 
was not first detected by the smear technique. In all other 
cases a positive smear gave an indication that a tumour was 
present and in a few apparently false positive cases it proceeded 
the appearance of the tumour by some months. Furthermore, in
only one case does a false positive smear remain unftxpifl,ir>o^ 1 
False negative results.
Three men (Case Nos. 22, 23 and 4l) whose Papanicolaou
smears were negative were found to have tumours when cystoscoped.
Two were investigated because o f the presence o f significant
numbers of red blood cells in the wet smear and one (No.4l)because
of the sudden onset of haematuria. Thus if both techniques are
taken into account there was only one false negative.
Case No.41: Bora 12.1.07. This man had been 
engaged in the manufacture of beta-naphthylamine 
for 23 years, 1927 - 50. Wet and stained smears 
examined at monthly intervals had been consistently 
negative, the latter was Class I on every examina­
tion except for a Class II reading on 14.10.55*
The last urine test previous to the onset of symptoms 
was on 16.1.56 and it was again negative. On 
18.2*56 he had a sudden attack of haematuria. Cystos­
copy on 24*2.56 revealed a tiny benign papilloma 
which was destroyed by diathermy. Biopsy confirmed 
that the tumour was a benign papilloma.
In each of these three cases the clinical appearances were 
those of a benign papilloma and this was confirmed by biopsy in 
two of them. In the other case (No.22) the biopsy material 
showed oedematous bladder wall only. Soon afterwards this man 
passed large numbers of cells with the characteristics of 
malignancy and he has continued to do so. He is discussed more 
fully in the consideration of established cases (page 149).
C ra b b e , C re s d e e , S c o tt and W illia m s  had a  fa ls e  n e g a tiv e  
f in d in g  in  a  man w ith  a  s o lid  ty p e  o f carcinom a co vered  w ith  
s lo u g h  and c a lc a re o u s  d e p o s it w h ich  presum ably s e a le d  o f f  any
cells which might have exfoliated. No advanced or solid 
carcinomata occurred in the present series and the three false 
negative Papanicolaou findings were all associated with tiny 
benign papillomata*
Benign Papillomata.
Papanicolaou in his discussion of the criteria of 
malignancy states that Class V is the only conclusive group aT14 
that a varying degree of error in interpretation is to be 
expected in each of the other four groups. Many authors (Chute 
and Williams, 1943, Schmidlapp and Marshall 1950, McDonald 1954, 
Deden 1954) stress the difficulty of detecting benign papillomata 
because the cells exfoliated from them would not be expected to 
show the usual criteria of malignancy and would be similar to the 
normal. In fact Dean (1948) and Leadbetter (1955) maintained 
that they showed no recognisable difference from normal cells. 
Osborn (1953) thought that even fragments of tissue voided in the 
urine from benign papilloma showed little cellular variation from 
each other or from the normal, but three years later (1956) he 
said that cytology of the urinary tract was of the greatest value 
in diagnosing both benign and malignant tumours and that the cells 
from each are easily distinguished from the other.
Crabbe, Cresdee, Scptt and Williams (1956) reported 56 new 
cases of bladder tumour. Among these were 29 casds of clinically 
benign papilloma which had been detected by the appearance of 
positive smears and of which 15 were confirmed on biopsy. In
three cases clumps of cells which were considered to be benign 
papilloma cells were seen and in each the presence of a benign 
papilloma was confiimed on cystoscopy. My co-workers and I 
were convinced that, contrary to many opinions, it is possible 
to detect a significant proportion of benign papillomata by the 
stained smear technique. My own experience since then 
strengthened me in this conviction.
The reading and interpretation of large numbers of smears 
have resulted in a greatly improved perception of the character­
istics of cells exfoliated from benign papillomata and malignant 
neoplasms. The results still show that while both types of 
tumour may exfoliate cells with malignant characteristics, some 
benign papillomata will exfoliate cells, which while not having 
the criteria of malignancy have specific characteristics by which 
they can be classified as having originated from benign papilloma. 
Figs. 15 and 16 show two examples of such smears. They are from 
Cases No.51 and 66 respectively. The cells are clustered in 
groups, are fairly small but have a high nuclear cytoplasmic 
ratio and there is nuclear hyperchromasia; there is little 
variation in the size or shape of individual cells within the 
clusters. Occasionally a small piece of tissue is identified 
as having been shed from a benign papilloma and Fig. 17 shows such
a particle from Case No.38.
x h e re  w ere  3 2  men in  whom th e  o n set o f a  tum our was 
a s s o c ia te d  w ith  a  p o s it iv e  P a p a n ic o la o u  sm ear (T a b le  21).
table 21
32 men with tumours whose Paranlnnl ami 
smears were positive
Papilloma Carcinoma Total
Class IV or 7 16 10 26
Papilloma cells 6 0 6
Total 22 10 32
In 6 the smear contained cells typical of benign papilloma 
and in 26 the smears were classed 17 or V, in fact, the appear­
ances were suggestive of or conclusive for malignancy* Of these 
32 men, 10 had clinical carcinomatous lesions all confirmed by 
biopsy and 22 had clinically benignpapillomata of which 14 were 
confirmed by biopsy* The latter include the 6 cases (Bos* 20,
33, 40, 46, 51, 66) in which only clumps of benign papilloma cells 
were seen.
Thus, 16 men out of the 22 with benign papillomata had 
apparently malignant cells in the urine* It is difficult to 
explain this finding in such a high proportion of men with benign 
tumours, unless malignant changes are already taking place in 
these tumours* If this is so then one would expect a higher 
eventual incidence of malignancy over all the period than there 
actually is.
The degree of innocence or malignancy of the simple 
histologically benign papilloma is a very controversial point 
(Crabbe 1959). Some (e.g.Demming 1950) regard it as benign 
throughout, others le.g. Marshall 1956) take the easier way of 
regarding it as being in a distinct class by itself and many 
(Ash 1940, Wakeley and Craves 1958) regard the papilloma as a 
potential source of cancer. Wakeley and Graves held that 
"some benign growths will remain benign, some will become malig­
nant soon and some will have malignancy thrust upon themN 
(the last from super-added irritant). Dukes(1947, 1952) held 
that some benign neoplasms contain a focus of carcinoma which 
is not invasive and Macalpine (1947) thought that a urinary 
papilloma may be benign in one part and malignant in another.
The one very important conclusion that can be drawn with 
certainty from the results in this series is that it is possible 
to detect benign papillomata by cytodiagnostic techniques but 
it has not been found possible to predict the nature of the tumour 
from the appearance of the exfoliated cells except in the small 
number of men in whose urine benign papilloma cells could be 
identified. If, as some claim, normal looking cells are, in 
fact, exfoliated from a benign papilloma and are not identifiable 
in the urine tb«»n it could be expected that the degree of malig- 
nancy of the tumour would be very low. Such a false negative 
reading would not be so serious as it would be in the case of 
a malignant tumour or one potentially malignant. The more
nalignant a tumour is the more readily does it exfoliate in the 
early stages (Chute and Williams 1948, Booth 195# in print) and 
the more likely it is to be detected.
Contrary to the many opinions expressed previously, it has 
been found that the cytodiagnostic technique is capable of 
detecting a significant proportion, and probably most, of the 
benign papillomata. Many of the opinions to the contrary were 
expressed in the early days of its application and were founded 
on the results in various series of hospital patients in whom new 
untreated tumours and advanced or previously treated tumours were 
indiscriminately mixed.
Cytodiagnoais in the follow-up of old cases.
The high liability to recurrence makes it essential that 
regular review of all those who have bladder tumours should be 
maintained for the rest of their lives. The possibility that 
examination of smears could be substituted at least in sane 
measure for cystoscopic examinations was naturally attractive 
and it was hoped that it would prove dependable in this respect. 
The results (Table 22) have utterly dashed this hope.
The table shows the results for the 2^ year period up to 
Januaiy, 1958. This period is chosen because the improvements 
in technique had been established by then and the readings are 
likely to be more accurate than in the earlier days of its use. 
Despite this it is obvious that the results are quite inconsis­
tent and that no dependence can be placed on them.
TABLE 22
Results of 150 review cystoscopi^g and 
smears of* 47 men who Lave had tumours.
Smear
Results
Cystoscopy
Negative 
(No tumour 
found).
Suspicious Positive
(Tumour
Present)
Total
negative 46 4 19 69
Suspicious 10 1 0 11
Positive 19 2 29 50
Total 75 7 48 130
Marshall and Whitmore (1956), because they had a "moderate 
number" of patients who had positive smears for some time before 
cystoscopic observation could detect a recurrence, concluded that 
the Papanicolaou smear technique had become a useful adjuvant to 
follow up examinations. This would only hold good if a large 
proportion of recurrences were detected and if one could be reason­
able certain of the absence of recurrences in those with negative 
smears. It is disappointing that, in the present series, in 19 
instances patients with negative smears had recurrent tumours on 
cystoscopy and only in 46 instances out of 69 (66.6$) was a 
negative smear completely vindicated on cystoscopy. In fact,
there are only 76 agreements (46+29+1) between the smear and 
the cystoscopy results in 130 cases, that is to say, in almost 
half of them they did not correspond.
Melicow (1952) found nests of malignant cells in sections 
of grossly normal areas from cystectomized bladders which had 
had tumours. He suggested these might be carcinoma in situ and 
that they were foci from which fresh neoplasms would spring.
It is possible that malignant cells may be exfoliated from simi­
lar nests in the bladder of workmen who have been treated for 
tumours and have no demonstrable recurrence.
While one cannot, therefore, agree with Marshall and 
Whitmore that smear control is of much value in follow-up it 
might be expected that individuals with consistently negative 
smears would have a better prognosis than those with positive 
smears. Here again the facts are inconsistent and disappoint­
ing. Only 9 men among the 47 old cases have had consistently 
negative smears during the 2? year period. Each has been 
cystoscoped two to four times and only four have been clear of 
recurrent tumour throughout; three have had one recurrence, 
one has had a recurrence on two occasions and one on three 
occasions. All the recurrences have been clinically benign 
papillomata. In several other instances the agreement between 
the smears and cystoscopic findings has been highly inconsistent, 
for example, one man (Case No.40) had one recurrence following 
two successive positive smears, six months later there was
another recurrence following two auccesive negative swears and 
since then no recurrence has been found following consistently 
positive sowars.
The appearance of positive smears in treated cases haa 
accompanied or heralded the onset of recurrent tumour in only a 
third of those cases in which they were seen. Remembering that 
positive snwars were observed in same of the new cases up to 18 
months before a tumour could be demonstrated by other methods it 
is probable that recurrence will eventually be found in a proport­
ion of the others. There are 19 such cases (Table 22) and the 
following Case !o.22) is given as an example :
Case Iq.22. ¥.L. Boro 20.12.12. This man was 
a benzidine user for 17 years from 1951 until 1948 
after which he continued to work as foreman in the 
same department.
In May 1952 he had numerous erythrocytes in 
his urine. A stained smear was negative. 'Cystos­
copy revealed a small clinically benign-1 ooking 
papilloma of the bladder but biopsy showed ©edematous 
bladder wall only and no evidence of tumour* He is 
'One 'Of the three false negatives described in. the 
Papanicolaou smear findings in the new cases.
On 16.3.55 M s  smear was Class III - If and 
it has been either Class III or Class IT on every 
monthly occasion until 18.9.56 when a reading of Class 
T was made. On 10.2*58 and 15.5.58 it was again 
Class T. A photomicrograph of a smear from this man 
is shown m  Fig. 18 and many criteria of malignancy can 
be seen.
No recurrences have so far been detected on 
investigation at intervals of three to six months since 
1952; the most recent was in August 1958. Cystoscopy 
and retrograde and intravenous pyelography have failed 
to reveal the presence of a tumour and one can onGLy 
wonder what the prognosis will be.
Discussion and evaluation of cytoch'ftpnng-fci r> t^^hnique.
The difference in the results and in the dependability of 
the test in old and new cases is striking. Equally striking is 
the difference between my series of initial tumours and those 
described by other observers (Papanicolaou, Schmidlapp and Marshall, 
Chute and Williams, Deden, Marshall and Whitmore, etc.) many of 
whose results have been widely quoted as evidence that the tech­
nique had only a moderate value in diagnosis. Careful appraisal 
of their results suggests that in none of these studies was any 
differentiation made between new cases and those with advanced or 
previously treated tumours.
Papanicolaou in his 1947 paper does not state if his patients 
were new cases or had previously had tumours, but he describes 
them as "recent cases"; 8 of his 19 men with "suspicious" smears 
had tumours on investigation and 8 had none (one was "doubtful") - 
a finding rather similar in some ways to those in my series of 
treated cases.
Chute and Williams* 1948 report has been quoted as a 
reflection of the value of the technique by many writers (Crabbe, 
1952, Poole Wilson, 1953, Crabbe, Cresdee, Scott and Williams, 1956) 
but Chute Williams themselves state that they realise their 
observations were not controlled as closely and accurately as 
possible. All their smears were from hospital patients and they 
only 3 case® diagnosed, by the smear® which were previously 
unsuspected or unknown to have tumours. They were so highly
selective in thent  material that i "doubtful* (i.e. «a»«pirn m a ) 
smears ware excluded and all those patients in whom a definite 
diagnosis of some disease could mot be made were discarded.
So selective were they in fact, that they had 338 specimens from 
256 patients and reported only on 194 smears from 168 patients. 
Bost patients bad only one specimen examined and they thought 
that repeated examination would have resulted in a higher per­
centage of positive results - 45$ of their negative readings 
proved to be false. Furthermore, that many of their patients 
previously had tumours might be inferred from their cases of 
prostatic cancer with positive smears of whom half had already 
been on stilboestral treatment.
Schmidlapp and Marshall in 1948 reported on 333 of 
Papanicolaou's cases and they included " a large percentage" of 
patients with genito-urinaxy neoplasms. The high proportion 
of correct results they give in their table refers to malignant 
tumours only. No differentiation was made between new cases 
and those with advanced or previously treated tumours. The 
apparent anomaly of many of their results, e.g. 27 false negative 
smears in 36 patients with beniga papillomata, is similar to 
that of ny series of old cases and in the light of ay experience 
it is suggested that it would probably not have arisen in new 
cases. On these figures has been based the assumption by many 
writers that the technique is undependable in cases of benign 
papillomata.
Deden in. his 1954 thesis did not describe or evaluate 
his old and new cases separately. He had hospital patients only, 
most of than with advanced inoperable disease and few in which 
the diagnosis of tumour was unsuspected or even in doubt. The 
urines he collected were so "dirty" and thick with blood, pus 
and debris that he had to devise a tedious and time consuming 
method of separating the exfoliated cells out of the deposit.
The application of cytodiagnosis to patients with advanced 
recurrent disease accompanied by haematuria or pyuria has not, 
therefore, been succesful. The presence of blood or pus cells 
in large numbers obscures the exfoliated cells and limits the 
degree to which they can be concentrated in the smear. In the 
industrial population exfoliation of malignant cells has been 
detected at a vexy early stage before blood or pus appear in any 
quantity, and a reliable reading has been made more easily. The 
confusion arising from the inclusion of old or advanced cases is 
eliminated.
In no other series reported except that of Crabbe, Cresdee, 
Scott Miliiaas, have the results of new and old cases been 
separated so that, with this exception, one cannot ccm^are the 
results of any other series with the present one.
Cytodiagnosis as a screening technique.
The results during the past seven years have proved that 
cytodiagaostic techniques can successfully be used to screen an 
industrial population especially if both wet and stained smears
are used in conjunction* The most important advantages which 
have been gained from their use are the detection of tumours at 
a very early stage of development, the ease and convenience of 
the examination compared with routine cystoscopy so far as the 
workman is concerned, the frequency with which the examinations 
can be made and the large number of people with minimal exposures 
to carcinogens to whom they can be extended.
Pool e-Wilson (1953), only two years after cytodiagnosis 
was started on the workmen he examined urologically, noted that 
occupational bladder tumours tended to be seen at an earlier stage 
than those in the general population. He is now certain that 
the bladder tumours seen in workers referred to him are all at 
a much earlier stage than is usual in hospital practice i (personal 
communication). The size of tumour seen is usually about 4-8 mm. 
high.
Had routine cystoscopy been applied to the Clayton workmen 
even annually it would have required something of the order of 
5000 cystoscopies in the seven years to cover all the workmen 
at greatest risk, if there had been no refusals, compared with 
the 55 which in fact were done (excluding the follow up examin­
ations of men who had had tumours before).
The fact that early diagnosis was achieved in all the 
cases detected and that, with one exception, no tumours appear to 
have been missed using both tests makes reasonable the conclusion 
that cytodiagnostic techniques offer over-riding advantages in
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screening industrial workers who have been exposed to bladder 
carcinogens.
The possibility of using such methods to screen the 
general population in cancer detection programmes has been widely 
canvassed, especially in the U.S.A.#since Papanicolaou first 
suggested in 1945 that it might be useful in this sphere as well 
as in the detection of carcinoma of the cervix uteri. The 
total number of new tumours which have arisen in the Clayton work­
men over the past three years has been 21, an average of 7 per 
year in approximately 2000 men, i.e. an incidence of 3.5 per 
thousand per year. Since the incidence in the chemical industry 
is 34 times greater than in the general population one would expect 
about 1 per ten thousand per year in the latter. The detection 
of the 21 new cases of tumour involved nearly 40,000 urine 
examinations and the chemical workers were examined monthly so that 
it is liMy that in a similar number of examinations of the general 
population no new cases of tumour, or only one, would be disclosed. 
It appears, therefore, that examinations of the general public 
could not be made at sufficiently frequent intervals to make 
application of the technique valid and that the incidence of bladder 
tumour in the general population is too low to make the work worth 
while.
On the other hand cytodiagnosis must be regarded as the 
method of choice and as being indispensable in the screening of 
industrial workers where a hazard of bladder tumour is known or 
suspected to be operating.
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CLINICAL FEATURES 
The tumours in the workmen, once established, had no 
distinguishing features from those which arise in the general 
population. Papillomata and carcinomata occurred without any 
apparent correlation to any particular substance or job,
(Table 23) except that the comparatively small proportion of 
malignant tumours in the benzidine workers is possibly statis­
tically significant (P <5$).
TABLE 23
Malignant and Benign Tumours 
according to compound worked.
Papilloma Carcinoma Multiple Total
Benzidine 50 15 3 48
Alphanaphthylamine 1 2 1 4
Betanaphthylamine 12 11 0 23
Other 8 3 0 11
Mixed 15 16 6 37
Total 66 47 10 123
The tumours were classified according to the biopsy findings or, 
if there were none, the clinical appearances. This division,
assumed to facilitate the analysis, is admittedly arbitrary but 
it avoids the dilemma of having to choose between the contra­
dictory clinical, histological and cytological appearances which 
occur in some cases. Broadly, the tumours described as papillo­
mata fall into Stage I of the classification described by Melicow 
(1955) and those described as carcinomata fall into Stage II,
III or IV.
Poole-Wilson (1953) thought there was a tendency to greater 
multiplicity of tumours in those of occupational origin, although 
it was not marked. Winsbury White, Henderson and Wilkins (1950) 
hold that tumours appearing initially as frank carcinomata are 
commonly solitary. Wakeley and Graves (1958) make the point 
that the multiplicity of tumours and the co-existence of papillo­
mata and carcinomata are due to the multifocal neoplastic change 
and the presence of different phases of this change simultan­
eously or at different times. Mllller had 10 cases of multiple 
primary tumour in his 1951 series of 143 men with confirmed 
tumours - In three cases one of the growths was in the renal 
pelvis. Anderson reported 10 men who had multiple tumours in 
the bladder in 23 men in his series. There were also, curiously 
enough, exactly 10 men in the present series of 123 with multiple 
tumours on first examination and all were benign papillomata. 
Multiple recurrent tumours were seen more frequently on follow- 
up examination and are recorded simply as a recurrence.
In my first 66 cases in this series, reported in 1952,
exactly 50$ of the tumours were malignant and now the incidence 
of malignant tumours has fallen to 42$. Table 24 compares the 
percentage incidence of malignant and benign tumours in four 
earlier series and the present one.
TABLE 24
Ratio of Malignant and Benign Tumours.
No.of cases Malianant Benign
$
MtLLler 1949 111 71 29
Goldblatt 1949 75 64 36
Barsotti & Vigliani 1952 34 79 21
Scott 1952 66 50 50
Scott 1958 123 42 58
While it might be thought that improved working conditions 
may be held to have some influence in the reduction of the proport­
ion of malignant tumours it has been shown that the type of com­
pound and the nature of the job have no relation to the malignancy 
of the tumour. Some other factor must be operating. It is 
suggested that the explanation lies in the fact that owing to the 
improved diagnostic methods introduced in 1951 many tumours are 
now seen at an earlier stage and before malignant changes have 
begun.
Tumours of the renal pelvis.
Epithelial tumours of the renal pelvis and ureter are
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comparatively rare. Riches, Griffiths and Thackray (l95l) 
estimated that they constituted only 3$ of all renal tumours. 
laches tl9S8i had 43 in his series of 500 cases. Maealpiae 
^1947) described four cases in dyeworkers all of whom H«d 
previously had bladder tumours. Moore (194-2) found only 60 
cases in the literature Goldblatt (1949) had two cases of renal 
pelvic tumours co-existing with or following occupational tumours 
of the bladder. Leuenberger (1912) and Sebening (1930) each had 
one case in which the tumour was in the renal pelvis only.
Among the 123 cases of tumour at Clayton there were 15 men 
who developed tumours of the renal pelvis, 13 following earlier 
bladder tumours. There were two men (Case Nos.60 and 127) in 
whom a renal pelvic tumour was the first manifestation of the 
disease (Case No.127 is discussed at length in the chapter on 
Diagnosis). The increase in the number of these tumours in 
recent years is probably due to the longer survival, resulting 
from earlier diagnosis and improved treatment, affording more 
time for renal tumours to develop before death supervenes. 
Epithelial hyperplasia.
Congestive lesions which were said to be the precursors 
of occupational bladder tumours were described by Gay (1954) said 
1957) and at some length by M  Maio (1949). They have not 
been observed as a specific feature in my cases and it has not 
been possible to recognise pre-neoplastic congestive lesions. 
Poole-lfilson (1953), the urologist who examined and treated the
I 59
majority of these cases since 1945, stated that, while the mucosa 
over the area of tumour formation may be red or congested, he 
has not observed an abnormal incidence of vesical congestion or 
epithelial hyperplasia as a precursor of occupational tumours.
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TREATMENT
A close appreciation of the treatment and its results 
been maintained and a short account of them is given in this 
section. The treatments given total more than 123 because there 
were cases in which more than one type of treatment was applied. 
For example, when endoscopic diathermy was followed at a later 
or recurrent stage by radon seed implant or other radiation, both 
treatments are included. The therapeutic measures adopted at 
Salford Royal Hospital and The Christie Hospital and Holt Radium 
institute, Manchester, where the majority of the men were treated 
have been according to the principles laid down for spontaneous 
tumours. (Poole-Wilson 1956, Gibson 1956, Millea 1956).
Diathermy. Benign pedunculated villous papillomata have, where 
possible, been treated by endoscopic fulguration. Recurrent 
tumours of this type have been kept under control as far as 
possible by this means. In all, 65 of the workmen had initial 
tumours treated by per-urethral diathermy. Of these 22 have had 
no recurrences, 31 up to three recurrences, 6 between 4 and 8 
recurrences, and 6 have had more than 9 recurrences.
Radon Seed Implant. Localised malignant tumours which were not 
too deeply invasive were treated with fulguration and radon seed 
implantation through a suprapubic cystostomy. Nineteen men were 
treated in this way and only 2 have had more than 4 recurrences. 
Irradiation. Tumours which have not been controlled by simple 
fulguration and carcinomata which were not amenable to treatment 
by other means were treated by deep x-rays or, as in 2 cases of
multiple superficial tumours, by intracavity irradiation. Eight­
een men were thus treated by radiation. These include men in 
whom recurrent tumours of a malignant nature necessitated deep 
x-ray therapy and there were some advanced cases. 
Nenhroursterectoffly. When operable, tumours of the renal pelvis 
and ureter were treated by nephroureterectomy. This operation 
was performed on 11 men, 2 of whom have survived over 10 years. 
Three others, all of whom have been operated on within the last 
2 years, survive. Six have died, all within 3 years of the 
operation, one of pulmonary tuberculosis 11 months afterwards, 
and the others as a result of their tumours. In 2 men the 
tumours were inoperable and in 2 men they were discovered post 
mortem. In a further 2 men nephrectomy was performed for uni­
lateral pyelonephritis.
Total cystectomy. As the whole of the bladder mucosa may be 
assumed to be potentiated by the carcinogenic mechanism total 
cystectomy has been advocated by many writers. Riches (1959) 
holds that it should not be left to be undertaken as a last 
resort for extensive or multiple papillary tumours. On the other 
hand Jacobs and Barr Stirling (1952) described the poor results 
from ureterovesical anastomosis in 476 patients with malignant 
bladder disease, of whom 75$ were dead within a year, and from 
total cystectomy in 705 patients, of whom 54$ were dead within 
a year. Only 2.2$ survived the first operation for 5 years or 
more and only 20.4$ the second. In the first group are included
many on whan cystectomy had been planned but who died of the 
preliminary operation. Winsbury White 11953) writes of the 
rearguard action some surgeons continue to fight in the losing 
battle to support cystectomy and Jacobs \1954) is impressed by 
the futility of the operation as a curative procedure for the 
advanced case. Poole-Wilson (1953) strikes a more hopeful note 
when he points out that it has, in practice, proved to be largely 
unnecessary. He writes, somewhat naively, that it has been 
found to be extremely unpopular with the workmen. In fact it 
is now almost invariably refused by our workmen all of whom have 
seen, or heard of, the physical, social and psychological effects 
of it on some of their mates. it is advised with the greatest 
reluctance and only when other measures offer no hope of a cure 
(Scott, 1953). As a result it has been done only in those 
patients in whom the prognosis is already poor. Five men have 
had the operation and all have died (Case Nos. 74, 82 , 87, 96,
121). The longest survivor lived in discomfort and depression 
for 20 months (Case No.87^. Three were dead within three 
months of ureter transplantation and before cystectomy could be 
done. The fifth died while still in hospital two months after 
the cystectomy. When a cystectomy is proposed or performed an 
one of the workmen the effect on the morale of the men who have 
tumours,and on those who know they may develop them, is disastrous 
and, in the Clayton experience at any rate, even more depressing 
than the death of one of the sufferers. Two men to whom the
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operation was advised steadfastly declined to have it done 
although they were well aware of the consequences of their 
refusal* Both died in a few months from infiltrating carcinoma 
(Cases No.34 and 109).
Partial cystectomy. Seven men were treated by partial cystec­
tomy, for solitary papilloma in six cases and for a malignant 
tumour in one case (No. 65). The latter died of a perforated 
peptic ulcer seven months later and the genito-urinary tract was 
free of tumours at post mortem.
Others. In one man, (Case No.84) who was thought to have died 
of Paget's disease a large papilloma nearly filling the bladder 
was found on post mortem examination. Only one man (Case No.7l) 
resolutely refused any kind of treatment from the beginning and 
he died in 1939 of an infiltrating carcinoma of the bladder and 
spinal metastases.
The numbers treated by each type of therapy were relatively 
small. There was considerable overlapping of treatment in many 
cases, some having,for example, radon seed implants for malignant 
recurrences soon after endoscopic fulguration. The men were 
not all treated by the same urologist nor did they attend the 
same hospital. It is not possible, therefore, to attempt to assess 
the relative value of each, or any, type of treatment in any grade 
of tumour and, with the exception of total cystectomy, no attempt 
has been made to do so.
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RECURRENCES
All observers are agreed that the recurrence rate in 
occupational tumours of the bladder is W a k e l e y G r a v e s
(1958) have suggested that recurrences even of simple papillomata 
are more frequent in spontaneous cases than they were usually 
thought to be. Comparative figures are not available but there 
can be no doubt about the high recurrence rate in dyeworkers who 
have developed the disease.
Of the 103 men who survived their initial tumour, 70 have 
already had at least one recurrence (Table 25)• Six men - four 
of whom are still alive, two in good health - have had more than 
8 recurrences. Only 6 men survived more than 10 years from the 
onset of their tumour without a recurrence.
TABLE 25
Recurrence rate in men who survived initial tumour.
Time elapsed since 
onset of first tumour
Pop, * 
at risk
Ken who have had a recurrence
0.10
H
recur. Total
1 2+ No. #age
Over 20 years 1 - 1 1
At least 10 years 29 5 18 23
* •* 6 * 52 15 29 44 85#
M H 4 M 65 20 32 52 80#
It M 2 M 89 33 36 69 77#
Under 2 years
(Cumulative Total) 103 33 37 70 68#
* 20 men who died as a result of their initial tumour 
are not included.
Table 26 shows the relative incidence of recurrences 
among men exposed to different compounds. There is no evidence 
of any correlation between the chemical involved and the 
frequency of recurrence.
TABLE 26
Recurrences according to compounfl.
Compound Period since onset first tumour
0 - 4  years 5 vears and over
Pop.* No. of Recur. Pop.* No. of Recur.
Bz. 18 7 24 22
Bn. 4 3 14 11
Mixed 14 10 16 10
Other * 8 3 5 4
* 20 men who died as a result of their initial tumour
are not included.
e Includes alphanaphthylamine.
The recurrences have not always been the same as the 
original tumour; while they have frequently been so, Table 27 
shows that in 20 cases they were different from the original tumour, 
some papillomata recurring after carcinomata dnd some carcinomata 
succeeding benign tumours.
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SABLE 27
Cases in which recurrence id different 
from original tumour
C O M P O U N D
Bz. An. Bn. Mix. Others Total
No. of cases . 9 0 1 9 1 20
Mean latent period 
(Years) 15 - 34 18 31 18
167
DEATHS
So far 55 of the men who have had tumours of the bladder 
have died, 43 as a direct result of the tumour and 12 from other 
causes* Six of the 12 died of cancer in other sites (3 in the 
lung, one each in the liver, pancreas and oesophagus)* The ages
of the men at death and its implications have already been 
discussed (page 98 ).
The mean latent period in the men who have died from tumour 
was 18.9 years and of those who survive 21*2. The difference is 
not significant and it is possible to infer that those tumours which 
take shorter times to develop are not necessarily the most fatal 
and that those which incubate slowly are not necessarily of low 
malignancy once they are established*
Of the 10 men who developed tumours before 1937 only one 
(Case No.58) is still alive; 21 men have survived 10 years or 
longer after onset of their tumour, but 29 died within the first 
5 years after it was detected, 12 of them in the first year (Table 28).
TABLE 28
Survival Time After Onset of Tumour.
Time since onset tumour Living Dead
Tumour Other
Under 1 year 2 12 2
1 - 4  years 28 17 1
5 - 9 years 17 10 5
10 - 19 years 20 4 4
20 and over 1 — —
T O T A L 68 43 12
There is no evidence that the type of compound has any effect on 
the death rate*
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LEGAL POSITION
The Factories Acts and the more specialised section of them, 
the Chemical Works Regulations (1922) impose certain standards on 
all chemical works. The manufacture of the nitro amido 
derivatives of benzene or its homologues is specially included in 
a section of the Regulations but no special regulations have been 
laid down concerning the carcinogenic aromatic amines* This is 
only of legal interest, in fact, the precautions applied by those 
manufacturing and using these carcinogens are much more rigid than 
are required for the nitro and amido derivatives of benzene*
By 1938 papilloma of the bladder had come to be recognised 
as a hazard of the dyestuffs industry and tentative discussions 
were held between interested parties to examine the possibility of 
its being scheduled as an industrial disease under the Workmen's 
Compensation Acts* It was generally agreed that this could not 
be conveniently accomplished* There were three main difficulties, 
all of which were successfully overcome fifteen years later; the 
evidence was hardly enough in quantity, or exactness; it was 
deemed impossible to formulate a satisfactory definition of the 
disease or of the nature of the work to which it was to be related; 
the diagnosis had to be confirmed by cystoscopic examination and 
it was not practicable for this to be done by the doctor certifying 
the disease for official purposes*
It may seem to-day that these objections could easily have 
been surmounted and it is possible that they would have been over­
come had the climate of opinion at that time been more ready to
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make public the knowledge that the disease was industrial * It
is doubtful if the employers were altruistic enough to risk "the 
adverse effect on the industry generally and on recruitment of 
labour in particular that the publicity of scheduling the disease 
would have caused*
A suitable and reasonably fair compromise was reached*
An undertaking was given by the Association of British Chemical 
Manufacturers to H.M.Senior Medical Inspector of Factories, Dr. 
J.C.Bridge, representing the Home Office of which the Factory 
Department was then a part* It stated that "in the event of 
absence from work for the purpose of examination or treatment, 
illness or death directly due to papilloma attributable to 
exposure to betanaphthylamine or benzidine whilst not binding 
themselves to pay any specific scale of wages, grants or lump­
sum compensation (the members of the A.B.C.M.) undertook to deal 
with such cases very sympathectically with the sincere intention 
that the men concerned should not suffer as compared with similar 
cases dealt with under the Workmen’s Compensation Act”* The 
agreement continued to be observed by the member firms after the 
introduction of the national Health Service and National Insurance 
(industrial Injuries) Act in 194-8*
By 1952 the survey which the A.B.C.M. initiated in 1947 
haft provided sufficient evidence of the incidence and extent of 
thedisease in industry to allow representation to be made by the 
employers to the Minister of Pensions and National Insurance that
170
it should be prescribed as an industrial disease. Reasonably 
vide definitions of the disease the occupation were 
recommended to the Minister but he vould not agree to include 
papilloma of the pelvis of the kidney or ureter in the definition 
of the disease nor would he include work in the homologues of 
benzidine in the definition of the occupation. This was on the 
grounds that all the recorded tumours of the ureter or renal 
pelvis in the industry had been accompanied, or preceded, by 
bladder tumours and no cases of industrial tumour resulting exclu­
sively from exposure to the homologues of benzidine had been 
recorded. Apparently the Minister did not want at that stage to 
widen the scope of the prescription more than was necessary. The 
previous difficulty of diagnosis for the purpose of certification 
was easily overcome, it being agreed that a urologist's or an 
industrial medical officer's certificate vould be accepted without 
its entailing a special ad hoc cystoscopic examination. Finally, 
on the 1st December, 1955 "papilloma of the bladder" was prescribed 
as an industrial disease under the National Insurance (industrial 
Injuries Act (ref.) with the exact wording as follows :
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Description of disease 
or injury
Nature of occupation
39* Primary neoplasm 
of the epithelial 
lining of the 
urinary bladder 
(Papilloma of the 
bladder)
Anv occupation involving -
(a) work in a building in which 
any of the following sub­
stances is produced for 
commercial purposes :-
(i) alpha-naphthylamine, 
beta-naphthylamine or 
benzidine or any of their 
salts;
(ii) auramine or magenta;
(b) the use or handling of any 
of the substances mentioned 
in sub-paragraph (l) of 
paragraph (a), or work in a 
process in which any such 
substance is used or handled 
or is liberated;
(c) the maintenance or cleaning 
of any plant or machinery 
used in any such process as 
is mentioned in paragraph 
(b), or the cleaning of 
clothing used in any such 
building as is mentioned in 
paragraph (a) if such cloth­
ing is cleaned within the 
works of which the building 
forms a part or in a laundry 
maintained and used solely
in connection with such works.
By 1957 two cases of initial tumour of the renal pelvis had 
arisen at Clayton (Case Nos#60 and. 127) and another case of 
papilloma of the ureter without previous or concomitant bladder 
tumours b«d been reported to the Papilloma Committee from another 
factory* In collaboration with Dr. M.H.C.Williams, I drew up 
evidence which was submitted to the Minister and to the Industrial
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Injuries Joint Advisozy Council with the recommendation that the 
definition of the disease should be extended to cover tumours of 
the ureter and renal pelvis. At the same time we pointed out that 
there was a great increase in the use of certain of the homologues 
of benzidine which had previously been used on a scale too small to 
yield an incidence of tumours exclusively attributable to them.
We expressed our concern at the possibility that men might in the 
future develop tumours from these substances when benzidine was 
not associated with them and, by the terms of the definition, they 
would be excluded from benefit. The Advisory Council accepted 
our recommendations and made the appropriate representation to the 
Ministry with the result that on 7th July, 1958 the prescription 
of the disease was amended to read as follows:
Description of disease 
or injury
Nature of occupation
59. Primary neoplasm of the 
epithelial lining of 
the urinary bladder 
(Papilloma of the 
bladder), or of the 
epithelial lining of 
the renal pelvis or of 
the epithelial lining 
of the ureter.
Any occupation involving :
(a) Work in a building in which any 
of the following substances is 
produced for commercial purposes.—
(i) alpha-naphthylamine or beta- 
naphthylamine;
(ii) diphenyl substituted by at 
least one nitro or primary 
amino group or by at least 
one nitro and primary amino 
group;
(iii) any of the substances men­
tioned in sub-paragraph (ii) 
above if further ring substi­
tuted by halogeno, methyl or 
methoxy groups, but not by 
other groups;
(iv) the salts of any of the sub­
stances mentioned in sub- 
paragraphs (i) to (iii) above;
(v) auramine or magenta;
(b) the use or handling of any of the 
substances mentioned in sub—para­
graphs (i) to (iv) of paragraph 
(a), or work in a process in which 
any such substance is used or 
handled or is liberated;
(c) the maintenance or cleaning of 
any plant or machinery used in 
any such process as is mentioned 
in paragraph (b), or the cleaning 
of clothing used in any such 
building as is mentioned in para­
graph (a) if such clothing is 
cleaned within the works of which 
the building forms a part or in
a laundry maintained and used 
solely in connection with such 
works.
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The effect of this is that tolidine, dianisidine, dichlorben- 
zidine and certain other compounds such as xenylamine are now 
included in the definition of the occupation, while many other 
amino and nitro compounds not suspected of carcinogenicity are 
still excluded.
No further enactments or regulations have been promulgated 
in this country regarding occupational bladder tumours. In 
France, Italy and Switzerland naphthylamines and benzidine are 
included in the schedules of occupational diseases. So far as 
is known there are no specific regulations in the United States 
of America. Nothing is known of the legal position in the 
other countries, Japan, Czechoslovakia and Russia, where these 
compounds are manufactured.
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PRETENTION AND CONTROL
The measures which have been adopted for the prevention 
and control of the hazard will not be described in great detail. 
They have been the subject of a recent publication of which I 
was co-author and which is appended in Volume II (Scott and 
Williams 1957)* In this a comprehensive description of pre­
ventive measures is given. Only certain principles and the 
broad outline of the prevention programme will be considered 
here.
In the preventive field the simplest and most effective 
solution to the problem of industrial cancer in general and of 
industrial bladder cancer in particular is the complete prohibi­
tion of the dangerous compounds and processes. At first sight 
this would appear to be an attractive and easy solution to the 
doctor in industry, to the industrial administrator and to the 
legislator. The numbers of men affected by bladder cancer in 
the dyestuffs industry and the gravity of the disease leave no 
room for doubt that, unless safe measures can be adopted, pro­
hibition would have to be insisted upon by the medical advisers 
to the industry.
The high potency of betanaphthylamine had become evident 
at Clayton during the war and it was later confirmed by the 
results of the A.B.C.M. field survey in 1954. By 1950 it had 
been decided at Clayton that it was impossible to devise and
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operate safe pJLant in which it could be manufactured at an 
economic cost* Its manufacture and use was, therefore, given 
up by the Company in 1950, and the alternative methods described 
on page 53 were put into operation. The capital cost of 
installing the alternative process was high (of the order of 
£90,000 in 1950) and the running cost is many times that of the 
process in which the amine was used*
No alternatives are available for alphanaphthylamine or 
for benzidine and its homologues in the dyestuffs industry. A 
ban on the use of these compounds would,therefore, appear to be 
the rational consequence. Two factors of great importance 
however must be considered. First, these compounds are essential 
for a very large range of colours for wool, cotton, paper and 
many other fabrics. If prohibition were to be imposed it would 
result in grave damage not only to the chemical industry but to 
the textile, paint, rubber and many other industries as well.
The loss of these chemicals would cause widespread unemployment 
and have serious adverse effects on our export trade and economy 
generally* I have recently discussed the moral and material 
justifications for continuing many highly dangerous manufactures 
and processes which are essential to maintain our modern standards 
of living (Scott 1959). The hazards associated with many 
dangerous or lethal materials are accepted when proper pre­
cautions are attached to their use. The second factor is that 
the potency of alphanaphthylamine, benzidine and its homologues
is of a considerably lower order than that of betanaphthylamine. 
This has been shown not only in the A.B.C.M. field survey but 
in animal experiments. In view of these considerations the 
manufacture and use of benzidine and its homologues has continued 
but a high standard of safe working practice is imposed.
At first the methods of prevention followed the usual 
lines. The diagram of the history of benzidine in Fig.l and of 
betanaphthylamine in Fig. 2 show some which were applied up to 
1950. I have described (Scott, 1953, 1954) the medical super­
vision of men on these processes and how by 1950 the high morbi­
dity and early mortality stimulated the intensification of efforts 
to make the processes safe. The old benzidine plant was scrapped 
and in 1950 a specially designed new building with modem plant 
was completed. In- this benzidine and its homologues are made in 
a totally enclosed system so as to avoid contact between the 
operators and the chemicals as completely as possible. This was 
in production by 1951* Fig.19 is a photograph of the old plant 
and Fig.20 shows one of the new benzidine units. It is enclosed 
and draughted and it can readily be seen that the risk of contact 
with the materials used and produced is infinitely less than it 
was in the older plant.
Except for one foreman, a completely new force of men was 
employed «nd trained, none of whom had previously woxked in
^nd an of whom were over 40 years old. Thus if tumours 
should arise, they will not arise in young men. It would also
be possible to attribute them to work on this plant and not 
to previous contacts with chemicals*
Alphanaphthylamine is bought from another company and its 
use is confined to nne part of the colour factory under strict 
sonditions and to a limited number of men. Magenta has not been 
manufactured since 1926.
By 1950 the dangers associated with the carcinogenic amines 
were widely known and appreciated by the manufacturers but some 
users, especially those whose turnover was small, were thought to 
be still handling these substances in an unsafe manner. The 
progress made in the A.B.C.M. investigations was such that it was 
felt by its Papilloma Committee that the information gained should 
be utilized to attain the safest possible methods of working 
throughout industry*
Dr.M.H.C.Williams and myself, as the medical members of the 
Papilloma Committee, were therefore invited by the A.B.C.M. in 
1952 to draw up a "code of industrial practice to cover the 
manufacture and use of known or suspected bladder carcinogensM.
In 1953 our recommendations were presented to the Association and 
accepted. They were circulated to all member firms with the 
advice that they should be implemented and so far as is known 
this has been done. The Committee decided that this information 
should not be restricted to the member firms or even to the 
British industry and a summarized version was published in 1957.
In the code of practice we cover many fundamental
industrial principles to be observed in order to avoid contact 
between the operator and the carcinogen. We make specific 
recommendations regarding the design and material construction 
of buildings, plant and machinery. We advise on general venti­
lation and local draughting. Old plants which cannot be 
rendered safe should be scrapped and replaced by plant conform­
ing to the principles laid down. General methods of handling, 
separation, purifying, packaging and transporting of carcinogens 
are given. Detailed consideration is made of some twenty 
compounds known or suspected to be carcinogenic and methods for 
their manufacture and handling are advised. The danger to sub­
sequent users in the factory or after sale is emphasized and the 
measures which should be taken to eliminate it are described.
The absolute ban on betanaphthylamine is repeated.
Personal protective measures are recommended in detail in 
order to give an added margin of safety should the plant and 
process design fail to prove adequate against accidental failure 
or contamination. Working clothing, baths, protective clothing 
and breathing apparatus are discussed. Selection of workers with 
particular regard to age and previous history is important.
Hours of woik, overtime, and the limitation of the numbers of men 
to be exposed are discussed. Adequate records are essential and 
should be kept in detail in respect of men and of plant operations. 
Analyses for the detection and determination of amounts of 
carcinogens in the atmosphere, on clothing and on plants provide
a check on conditions. Estimations of amines in the rie» 
provide an index of possible absorption.
The Code recommends that where there is a hazard of 
bladder tumours a medical officer should be employed - part time 
or full time depending on the amount of work involved - in order 
to ensure adequate supervision of the health of workers and of 
the plant hygiene. This work includes the screening of workers 
to achieve early diagnosis of tumours by cytodiagnostic and other 
examinations, co-operation with the family doctor and the urolo­
gist in the investigation and treatment of workmen and in the 
re-habilitation to work of those who develop the disease.
Before accepting the invitation to write the Code, both 
of us obtained an undertaking from our respective managements 
that we had complete freedom to draw up its provisions regardless 
of what the practice in our own works might be. It was also 
agreed that each company would conform to whatever recommendations 
were laid down. As was to be expected, little alteration had, 
in the event, to be made in the practice of either company, both 
of which had already instituted elaborate precautions. The 
working practice at Clayton now conforms to that laid down in the 
Code.
It is obviously too soon yet to be sure of the final success 
of the measures which have been adopted. All that can be done 
is to give certain results up to date. Since the new benzidine 
plant was started in 1951 ninety—one men have worked for more than
six months in it but only nine have been continuously engaged for 
5 years or more. None of them has developed a tumour. The 
atmosphere is sampled continuously by two apparatus, one of which 
is moved from point to point throughout the building; the other 
is sited beside the benzidine conversion vessel where the highest 
readings might be expected. Twenty-four hour samples of air are 
analysed and the readings which have been obtained have always 
been virtually ’’background11 (0.1 - 0.05 micrograms of benzidine 
per cubic metre of air) except in isolated instances when main­
tenance operations or accidental breakdown have given rise to 
higher readings. Any reading above 0.5 micrograms per metre is 
taken as an indication that some failure of the precautions has 
arisen and steps are taken to remedy it. Analyses of the urine 
of the men for amines, done as a spot check at irregular intervals, 
have so far shown negative results in the men in the new plant.
Elsewhere in the factory, the provisions of the Code are 
likewise implemented. It may be some measure of the success of 
banning betanaphthylamine on the one hand and of intensifying the 
precautions with other compounds on the other, that the average 
latent period is now 4 years longer than it was in 1951.
This figure is too tenuous for statistical proof to be 
significant and final judgement must be reserved for many years.
It lias been seen that the incidence is very significantly lower 
in service men than it is in manufacturers in the same building 
who are in closer proximity, so that even crude measures which
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reduce the exposure could be expected to lead to an improvement. 
It may, therefore, not be too much to hope that the fine control 
now exercised in the prevention of this industrial disease will 
be successful.
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THE HUMAN ASPECT
The medical officer in a comparatively small company the 
size of The Clayton Aniline Co.Ltd., is fortunately in 
closer personal contact with the workmen than would be the case 
in a company employing many thousands of men. I have known for 
many years every man who has contracted the disease while still 
at work in the company. In the same way the members of the 
higher management have had an intimate and personal knowledge of 
their workmen. It is not surprising, therefore, that a high 
degree of confidence and good faith exists between all grades of 
men and management.
I have always advocated (1952, 1955» 1954; Scott and 
Williams 1957) that it is not possible to justify the concealment 
of a risk such as cancer of the bladder from men exposed to it 
and this policy has been accepted and freely applied at Clayton,
I am quite certain that as a result of complete frankness better 
co-operation has been achieved with the workmen and a higher 
degree of confidence has been engendered in their minds. A full 
explanation of the hazard and of the importance of his meticulous 
observance of the precautions is given by me to every workman who 
has to work in the manufacture or use of carcinogens, so that he 
nan understand what he must do to protect himself. Work on these 
processes is entirely voluntary and any man is taken off them 
and transferred to other work without penality if he so desires.
A
It is some indication of the confidence and good faith existing 
that this is seldom requested. A few men asked to he 
transferred when they have recovered from tumours but only e
i
has done so on the grounds that he was afraid he might get one.
He was the deputy to the 'benzidine1 man in the colour factory 
and had only twice been called upon to stand in for him because 
of illness.
In the 20 years I have been at Clayton the attitude of the 
men to this hazard has been a constant source of wonderment to 
me» The quiet acceptance of the possibility of contracting 
tumours in those who have been exposed under the bad working 
conditions of earlier years may smack of fatalism but the attitude 
of other men who accepted the risk and continued to accept it from 
choice was, in some ways, gladiatorial. Even though preventive 
measures have been progressively improved there can be little 
doubt that it has taken a rare kind of courage or an unusual atti­
tude of mind to enable men to carry on in this work, especially 
in the years of full employment.
In the first years when conditions were bad no danger was 
apprehended. From the later 1950's until 1951 danger money was 
claimed paid. This payment must have encouraged men to accept 
the risk and the institution of precautions at the same time may 
have conferred some degree of reassurance. That the earliest 
attempts at prevention failed is now proved by the tumours which 
have arisen in men subsequently exposed. Although the present
prophylactic measures in force are thought to be effective, final 
proof must await the absence of tumours in a whole generation.
I have condemned (1953, 1957) the payment of danger money to make 
up for unsafe plant and dangerous environment. The men and their 
unions have accepted this principle and danger money has not been 
paid at Clayton to men working on the new benzidine plant. This 
has not apparently affected their morale or their willingness to 
undertake the work. The shorter hours of work, the cleanness of 
the job and the opportunity to start a hew career at the age of 
40 may account for the popularity of this work.
Certain payments are made to those who suffer from the 
disease. Since 1938 ex-gratia payments in addition to the usual 
insurance benefits have been made to men who are off work because 
of tumours of the bladder. When the disease was prescribed 
under the Industrial Injuries Acts in 1953, these payments were 
continued and now a flat rate of £5 per week is paid. On retire­
ment at 65 a special pension is paid to all men who have had 
tumours of the bladder. A pension is paid to the widow of every 
m«n who had such a tumour irrespective of whether he died 
from it or from any other cause either before or after retirement* 
The same financial benefits are extended to those men who develop 
tumours after leaving the company and to those who leave the 
company after they have developed tumours. An average of 10 men 
at a time throughout the year receive the weekly ex—gratia pay­
ments for absence from work; some are off only a few days for
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review cystoscopies but one or two have continuous absences 
of several years#
While many men who had industrial tumours must have gone 
untraced in the past, it is probable that few, if any, which 
arise nowadays are not ultimately disclosed# The prospect of 
payments has undoubtedly helped in tracing men who develop tumours 
after leaving the company's service for woik elsewhere# The local 
hospitals and many of the general practitioners know the circum­
stances and advise men who have previously been employed with us 
to report back to the company when they find they are suffering 
from tumours of the bladder# H.M.Senior Medical Inspector of 
Factories maintains for the industry a register of names of men, 
supplied by the firms concerned, who have had contact with the 
prescribed bladder carcinogens# All death certificates mention­
ing chemical work or bladder tumours are checked against it#
When a workman is known or suspected to have a tumour of 
the bladder arrangements are made with his doctor to refer him to 
a urologist for the necessary investigation and treatment# Close 
contact with the men's family doctors is maintained meticulously 
and their co-operation has been unfailing. There are advantages 
in having all the cases investigated and trdated by the same 
urologist who thereby gaina valuable experience of the aetiology 
fttifl course of industrial tumours# Mr J• B.Macalpine, until he 
retired in 1945, and his successor Mr D#S.Poole Wilson, consulting 
urologists to the Salford Royal Hospital and the Christie Hospital
and Holt Radium Institute Manchester have treated the majority 
of the Clayton men. In 1951 a special monthly cystoscopic clinic 
for the Clayton dyeworkers was started at the former hospital and 
there the workmen are investigated and reviewed. When treatment 
is necessary it is done through the usual National Health channels.
The majority of the men who develop tumours can return to 
work after treatment. Where possible they have been encouraged 
to go back to their old jobs, so as to minimize any suggestion of 
invalidism. It might be argued that these men should not return 
to the same job but in fact the recurrence rate has not been 
apparently increased in those who do,and under present day condi­
tions there is little likelihood of dangerous absorption. In 
practice the psychological effect of being able to return to full 
productive work is a major factor in assisting many sufferers to 
lead a normal social and working life. Unfortunately, these 
tumours, by their very nature, develop in the longer serving 
employees and recurrences are common so that the effects of age 
and ill-health combine to reduce the number of men who can do the 
work in which they were previously engaged. Of 50 men who have 
had tumours,and are still employed in the company, only 14 are 
now back at their old jobs or on similar plant work; of the 
remainder, 3 have been promoted to staff jobs (two foremen, one 
clerk) and 33 are doing sheltered work as messengers, gatemen, 
laboratory cleaners and the like. One of the last group (case 
No.25) although fully recovered was unwilling to return to work
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with any kind of chemicals and alternative work was arranged for 
him on this account.
Several of the men who developed tumours after leaving 
the company had worked for many years in their next job and have 
been content to remain in that employment, for example one man 
(Case No.59) has worked for 29 years with British Railways. They 
are encouraged to keep in touch and I see them at regular inter­
vals, usually at the time of their review examinations. Others 
have not had the same security in their subsequent jobs and six 
men have been re-employed by the company in order to afford them 
sheltered work and security of tenure with the added advantages 
of closer supervision of their health.
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THE FUTURE
Many more men have still to develop tumours before the 
final yield in the present generation is complete. Already 123 
cases have been fully recorded; many may still be untraced 
some may be untraceable. There can be no doubt that tumours 
have yet to appear in a proportion of the men who were exposed 
when conditions were worse than would be accepted now and when 
betanaphthylamine was still being made and used. Until a whole 
generation has been unaffected there can be no absolute certainty 
that the rigid precautions in force today are effective. All 
that can be stated is that none of the men who started after 
1950 has so far developed a tumour.
A careful watch is being kept on the incidence of the 
disease locally and nationally. The various interested bodies 
centralise their information through the Papilloma Committee of 
the industry. The records maintained at the Factory Department 
will provide starting material for subsequent field surveys and 
will make collation of information for them easier. It is 
intended that another survey will be conducted on a national scale 
in about 10 years time. By then it may be possible to include 
other industries in addition to the chemical and rubber trades.
Carcinogenic amines such as benzidine have been used in
the paper industry for making security paper to make writing on
bank cheques indelible9 in medical laboratories for testing for
occult blood and in chemical laboratories for spraying chromato­
graphs. In the textile industry alone the use of benzidine and
naphthy1 amines in indii*ect dyeing and in textile printing 
been extensive and in many instances no precautions have been 
taken.
Some concern has recently been expressed (Lancet 1958) 
at the possibility of carcinogens being present in foodstuffs 
colours. Certainly benzene-azonaphthol was until recently one 
of the permitted foodstuffs colours on the American list. This 
compound, when metabolized, would be likely to break through the 
azo linkage, into aniline and betanaphthylamine. Fortunately, 
so far as is known no such potentially dangerous colour has been 
used in food in Britain.
On the experimental side many new developments and lines 
of research are already foreshadowed. Walpole and Williams 
(1958) have recently published, as a guide to chemists who may 
contemplate their use, a summary of the results of new experi­
ments on many diphenyl and stilbene compounds and the effects 
on their potency of ring substitution on their amino derivatives. 
Bonser, Clayson and Jull (1958) have similarly dealt with many 
chemicals, chiefly orthohydroxyamines and aromatic amines of 
two three ring types. Their methods of testing for carcino­
genicity by implantation in the mouse bladder is claimed by them 
to be the most important advance in the last decade. It must 
be borne in mind, however, that the metabolism of a compound 
has to be worked out before Valid conclusions as to its carcino­
genicity to can be drawn from implantation experiments in
the mouse*
Radiochemical techniques will facilitate the study of the 
distribution of compounds in the body and of their excretion. 
Already Goldblatt (1958) and his colleagues (1954 and 1956) have 
used labelled betanaphthylamine for excretion studies in various 
animals. Boyland (1958) again suggests the prospect of prophy­
lactic treatment of workers by administering saccharolactone as 
a routine. While one would agree with him that, if it works, 
it might be used in cases of accidental contamination to inhibit 
the formation of the carcinogenic metabolite in the urine, one 
can hardly accept the prospect of dosing men for all their working 
life as a practical proposition. Safe plant design and good 
working practice can obviate contact between operator and 
carcinogen and it is wrong to depend on anything else as a routine. 
Nevertheless the future may hold some hope that further develop­
ments may enhance and facilitate this line of attack when there is
accidental failure of the industrial precautions.
In the future many new compounds will be introduced into 
the dye-stuffs industry. It will not be possible to forecast 
the carcinogenic potency of them all nor will it be possible to
test them all on animals. Many years may elapse before their
danger to workmen becomes apparent. Other compounds already 
manufactured on a scale too small to have revealed them as dan­
gerous may come to be in greater demand and extension of their 
manufacture may eventually reveal unsuspected carcinogenicity.
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New methods of manufacture and new processes may result in 
the formation of carcinogens as by-products or impurities*
The workman will in the future, as in the past, be unable 
to protect himself against these insidious dangers to his health 
and his life. The application of many diverse technical skills 
and professional disciplines will still be required to safeguard 
him. As has been shown in this thesis, a great fund of 
technological and medical knowledge exists and its application 
can almost certainly protect workers against the known hazards 
of today. As research advances and as new products and new 
dangers are introduced the lessons of the past must not again be 
forgotten. In the future research into combating these dangers 
and preventing new outbreaks of disease must be promoted and 
pursued as vigorously as the search for new and better products, 
so that an industry which brings so much colour and brightness 
into the lives of mankind does not darken and destroy the lives 
of those who work in it.
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Perk-i n’s Mauveine.
This silk is dyed with mauveine actually made 
by W.H. Perkin. I am indebted to the Dept. 
oj* Colour Chem istry, University o£ Leeds 
Jor the dyesfu-ff.
CASE HISTORIES
The case history of each of the 123 men in the series 
is given in this section, set out in the following order:
i) Date of birth, of entering and leaving the industry, 
of onset of tumour, and of death: age on entering the 
industry, at onset.of tumour and at death: exposure 
and latent periods. The date oh which the diagnosis 
was first confirmed is usually taken as the date of 
onset. The ages and the exposure and latent periods 
are calculated to the nearest six .months.
ii) Working history. The type of work done, the exposure to 
carcinogens or suspected carcinogens and its duration, 
are described briefly.
i'ii) History of onset. Special reference is made to the 
appearance of symptoms and to the results of routine 
screening tests if they were in operation at the time.
iv) The hospital attended and the urologist or consultant
surgeon. In some cases more than one hospital or surgeon 
is mentioned. Many men were referred from other hospitals 
to The Christie Hospital and Holt Radium Institute, 
Manchester, for radiation treatment. It is referred to 
in the case histories as Christie Hospital.
v) Diagnosis, course and treatment. The clinical appearance 
of the tumour, the histological classification when 
available, and the treatment are stated. The dates on 
which recurrences were diagnosed, and the type of recurrent 
tumours and their treatment are tabulated. Most of the 
men had follow-up cystoscopic examinations at regular 
intervals. Examinations on which no abnormality was 
detected are not recorded unless the result is of special 
interest.
vi) Progress. The progress of each case to the end of 195& is 
summarised. The degree of recovery and the subsequent 
employment are described. Causes of death and findings on 
post mortem examination, when available, are given. Points 
of special interest and items of additional information are 
included.
The cases are presented in order of their serial numbers.
It was found to be impracticable and confusing to present them 
in any other order.
Four men (Case Nos. 92, 94> aad 101) to whom numbers 
had been allocated were discarded from the series; two because 
they were eventually found not to have tumours of the urinary 
tract and two (who had died after leaving the Company) because 
the history of tumour of the bladder was doubtful. For this 
reason the serial numbers of the 123 cases go up to No.127*
Cases are referred to in the text by their serial numbers 
and a cross reference to the page number is given in the case 
histories which are mentioned.
CASE No.l (J.A.)
Date of Births 4.11.97• Age at Entry: 30 years
Date of Entry: 20.12.27* Age at Onset: 49 years
Date of Onset: 3.12.46. Latent Period: 19 years
Working History:
1927 - 46 Worked in the building in which betanaphthylamine 
was manufactured. For the first five years, 1927- 
19319 be did general work on the plant including 
the distillation of betanaphthylamine and the 
powdering of the distilled product.
From 1931 until 1946 he was employed on the filter- 
pressing of various naphthylamine sulphonic acids 
as well as the manufacture of betanaphthylamine.
History of Onsets
In late November 1946 he had sudden haematuria. He had had 
no previous symptoms or signs of bladder trouble and routine 
urine tests had been negative for blood cells.
Hospitals Salford Eoyal Hospital. Surgeon: Mr. J. B. Macalpin<
later Mr.D.S.Poole-Wilsoi
Diagnosis, Course and Treatment:
3.12.46. Papilloma P U diathermy
19. 3.51. H ” ”
Progress:
Cystoscopic examinations have been made at regular intervals. 
He is now examined annually. The most recent occasion was in 
May 195$ when the bladder was clear of tumour.
He continued at his old job until 1950 when he was transferred 
to messenger work. For the last three years he has been an 
attendant in the works garage.
CASE No.2 (J.B.)
Date of Birth: 20.11.98. Age at Entry: 41 years
Date of Entry: 27. 3.40. Age at Onset: 46 years
Date of Onset: 15. 1.45* Latent Period: 5 years
Working History:
1940 - 44 Worked as a general labourer on the manufacture of 
amino salicylic acid, amino p-cresol, diamino- 
diphenylamine sulphate, ortho-amino-phenol and 
nitro-aminophenol. Dianisidine was manufactured in 
the shed in which he worked and benzidine in the 
next shed.
He was employed as a coal-bagger for 20 years before 
entering the industry and had never worked in 
chemicals previously.
History of Onset:
On 31st December 1944 he experienced a scalding sensation on
passing urine and two days later he passed blood in his urine.
Routine urine tests for blood had been negative.
Hospital: Christie Hospital, Surgeon: Mr.D.S.Poole-Wilson.
Manchester.
Diagnosis, Course and Treatment:
11. 2*45- Carcinoma. Deep X-ray therapy
9.11.49. Left pyelonephrosis. Left nephrectomy
He was off work for several months and then returned to his 
usual job. Regular review examinations have been made.
In November 1949 he had a left nephrectomy for pyelonephrosis 
and stones. There was no evidence of tumour on microscopical 
examination.
After recovering from this operation he was taken off plant 
work and put on painting. In April 1950 > following an operation 
for umbilical hernia, he was transferred to sheltered work in 
the Locker Room where he is still employed.
In 1953 he developed a urethral stricture due to instrumental 
trauma. This was dilated at increasingly frequent intervals 
until June 195$ when a first stage Swinney operation for its 
excision was performed. The second stage was completed on
ll.ll.58. and he is now making an apparently good recovery.
No recurrences of tumour have been seen since the original 
lesion 13 years ago.
CASE No.3 (L.C.)
Date of Birth: 29* 5*00. Age at Entry: 21 years
Date of Entry: 19*10.21. Age at Onset: 40 years
Date of Onset: 29*11*40. Latent Period: 19 years
Working History:
1921 - 40 Engaged in the manufacture of benzidine azo colours.
For fourteen years, 1926-1940, was handling benzidine 
daily.
History of Onset:
In November 1940 red blood cells were found in the urine on 
routine test at the factory. There were no symptoms or other 
signs of bladder trouble.
Hospital: Salford Hoyal Hospital. Surgeon: Mr. J. B. Macalpine.
later Mr.D.S.Poole—Wilson*
Diagnosis, Course and Treatment:
29*11*40. Papilloma P U diathermy
24* 8.42. 11 " M
19. 9*47*
29*11*57* " "
Progress:
Regular cystoscopic examinations have been made since 1940.
His general health has been good all the time. For 10 years, 
from 1947 until 1957 he had no recurrence.
He has continued at work but has not been employed on plant 
work since 1947 when he was transferred to the canteen.
CASE liro,4 (J«C.)
Date of Birth: 30#12*03*
Date of Entry: 16# 1*36*
Date of Onset: 24*12*47•
Age at Entry: 32 years
Age at Onset: 44 years
Latent Period.: 12 years
Working History:
1936 - 47 Worked as a process man in the sulphonation of
betanaphthylamine to which he was exposed during 
the whole of this period#
History of Onset:
On 25*11*47 he had sudden haematuria. There were no previous 
symptoms. Routine examinations of his urine for blood cells 
had been negative.
Hospital: Salford Royal Hospital# Surgeon: Mr#D#S#Poole-Wilson# 
Diagnosis, Course and Treatment:
24*12#47* Papilloma P U diathermy
21. 8.52. *• " "
Progress:
Regular review cystoscopic examinations have been made# The 
recurrence in 1952 was a tiny area of raised mucosa and it was 
uncertain if fronds were present. He is now reviewed annually.
He has continued work as a process man and is still doing a 
full job# His general health is good#
L
CASE Ho.5 (A*H.) j
Age at Entry: 23 years !
Age at Onset: 34 years
Latent Period: 11 years
Working History:
1928 - 39 Worked on the manufacture of 'betanaphthylamine#
History of Onset:
Began with haematuria of sudden onset. Routine test of urine 
four months previously had shown no blood cells# In late 1939 
the tests were perforce being done at irregular intervals.
Hospital: Salford Royal Hospital. Surgeon: Mr* J# B. Macalpine.l
later Mr.D.S.Poole-Wilson#i
Diagnosis, Course and Treatment:
21*11*39* Carcinoma 
28*11*52* Papilloma 
9* 7*56* Papillomatosis of 
left renal pelvis 
and ureter.
Progress:
He had a severe radiation reaction and was off work until 
October 1941* He then worked as a bath attendant in the Locker 
Room until 1950 when he was transferred to the Labour Department 
as a clerk, a position he still holds#
Apart from a small recurrence in 1952 he enjoyed good health 
until January 1956 when he had an attack of haematuria. On 
cystoscopy there was an area of roughness in the old tumour area 
which was apparently where one of the gold seeds had extruded. 
This was thought to account for the bleeding.
On review examination on 9*7*56* the left ureteric orifice was 
patulous and several fronds of tumour could be seen coming down 
from it. Further investigations indicated a non-functioning 
left Sidney. The right kidney appeared normal. On August 7th 
a left nephroureterectoray was performed# There was 
papillomatosis of the pelvis and lower end of the ureter which 
on section proved to be benign#
He made a good recovery and returned to work three months after 
the operation. At his last review cystoscopy on 24*11*5^* the 
bladder was clear.
Gold seed implant 9*1*40* 
P IT diathermy 
H ephrouret erectomy
Date of Birth: 23* 7*05*
Date of Entry: 26* 3*28.
Date of Onset: 21*11.39*
CASE Ho. 6 (H.J.)
Date of Births 10.12.96* Age at Entry: 26 years
Date of Entry: 30. 3.25* Age at Onset: 41 years
Date of Onset: 9* 2.40. Latent Period: 15 years
Working History:
1925 - 27 Worked on sulphonations in primuline factory.
1927 - 36 Worked on the distillation of diamines and the
stoving of paranitraniline. During this time was 
engaged in the department where "betanaphthylamine 
was manufactured.
1936 - 40 Worked on the distillation of betanaphthylamine
and on the purification of Tobias acid.
History of Onset:
In February 1940 he was referred to Salford Royal Hospital 
because of copious haematuria.
Hospital: Salford Royal Hospital. Surgeon! Mr. J. B. Macalpine.
later Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
9# 2.40. Carcinoma Biopsy - malignant.
11. 4*40. Gold seed implant. Open
(operation.
11. 1.44* Papilloma P U diathermy
4. 3.45*
15.10.46. " M "
1.11*46. Clot retention Suprapubic cysotomy
Progress:
On initial cystoscopy there was seen an irregular raised area 
high up on the right lateral wall. On biopsy this proved to 
be malignant.
After the operation there was a prolonged radiation reaction and 
he was off work for a year. He did not return to plant work.
He was employed as a Locker Room attendant for ten years. He 
was then transferred to the Works Police and for the past two 
years has been in charge of the car park.
His recurrences have been small benign papilloma which were 
gasily fulgurated. Two misfortunes have beset him. He was 
operated on for clot retention in 1946. In 1951 ke developed a 
urethral stricture due, presumably, to instrumental trauma.
This has to be dilated every two months. Despite this he is 
uncomplaining and unfailingly cheerful. His general health is 
excellent.
Date of Births 28.8*03* Age at Entry: 28 years
Date of Entry: 13*4.31* Age at Onset: 46 years
Date of Onset: 31*3*49* Latent Period: 18 years
Working History:
1931 - 49 Snployed almost exclusively on the manufacture of 
naphthionate of soda. (The crude naphthionic acid 
contained alphanaphthylamine which was extracted 
from the salt with toluene.)
History of Onset:
In March 1949 there were moderate numbers of red blood cells in 
the urine on three consecutive routine tests. He had had no 
symptoms or other signs of bladder trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatments
9. 4*49* Papilloma
8.11.49* ”
14* 9.51.
12.11.51. "
28. 1.52. 11
8. 7*52. "
30.12.52. "
2. 9.53.
8. 7.54.
20.12.54. '*
16. 9.55.
5* 3.56.
15* 2.57. "
Progress:
Since 1949 he has been employed as a messenger but has been off 
work frequently because of the recurrences. This case is of 
interest as frequent benign recurrences have been kept under 
control by per-urethral diathermy. He has had no recurrence 
now for nearly two years.
In August 1957j on a routine M.M.R of his chest, a large 
glandular shadow was seen at the right hilum. He was admitted 
to Park Hospital, Davyhulme. On thoracotomy enlarged glands 
were found at the right hilum, interlobar fissure and along the 
trachea. Biopsy of one gland showed Hodgkins* disease. He was 
transferred to the Christie Hospital where he had X—ray 
treatment. In May 1958 there was some regression of the X-ray 
appearances. His general condition has improved but he has not 
yet recovered sufficiently to return to work.
P U diathermy
11 i t
11 i t
*1 i t
I f tt
I t t i
f t i f
M it
tt t i
i t tt
t t it
« t i
t i tt
CASE Ho.8 (E.M.)
Date of Birth: 
Date of Entry: 
Date of Onset:
Working History: 
1936 - 39
11.12.00. 
20.10.36. 
3. 6.43.
Age at Entry: 
Age at Onset: 
Latent Period:
36 years 
42 years 
7 years
Worked as a general labourer, mainly trucking raw 
materials in building where betanaphthylamine was 
made.
1939 - 43 Manufacture of Tobias acid and Bronner acid (2:6
naphthylamine sulphonic acid). At that time these 
were made on the same unit as betanaphthylamine and 
he also helped with its manufacture.
History of Onset:
He had haematuria in May 1943* He had had no previous symptoms 
and routine urine tests at the factory for blood cells had been 
negative.
Hospital: Salford Royal Hospital,
Diagnosis, Course and Treatment:
3. 6*43* Papilloma 
10. 5.48.
9. 5.50.
13. 2.51.
16. 5.52.
25. 4.55.
22.11.55.
18. 3.57.
27. 6.57.
10. 9.57.
Surgeon: Mr. J. B. Macalpine. 
later Mr.D.S.Poole-Wilson*
P U diathermy
Papillomatosis 
left renal pelvis.
Left nephroureterectomy
Progress:
After treatment for papilloma in 1943 he returned to plant work 
for five years but since 1948 he has been employed on sheltered 
work as a messenger and bath attendant. He has had many periods 
off work because of the recurrences and cystoscopic reviews. In 
July 1957 he began to complain of vague but persistent pain in 
the left loin. Investigation indicated a tumour of the left 
kidney and a nephroureterectomy was performed on 10.9*57.
Benign papillomatosis of the kidney and ureter was present and 
was confirmed on microscopy.
His general condition has been poor since the operation and he 
has not yet returned to work.
Date of Birth: 2.10,01, Age at Entry: 30 years
Date of Entry: 6. 7*31* Age at Onset: 47 years
Date of Onset: 13*11.48* Latent Period: 17 years
Working History:
1931 - 48 Worked as a processman on the manufacture of 
hetanaphthylamine•
History of Onset:
In November 1948 appreciable numbers of red blood cells were 
found in the urine on routine test* He had had no symptoms 
or other signs of bladder trouble*
Hospital: Salford Royal Hospital* Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
13.11*48. Papilloma 
15*12.50.. M
13. 2*51. "
27. 4.51. "
18* 9.51.
20. 2.52. *'
27*10*52* ?Solid tumour
17* 3*53* Papilloma
28. 9.53.
21* 1*55
10. 7*56. "
1. 6.58. »
Progress:
This man had six recurrences within two years between December 
1950 and October 1952* It is interesting to note that the 
frequency of recurrences has abated and that he had none for 
two years from July 1956 until June 1958*
He was taken off plant work after 195^ and transferred to 
sheltered work in the Locker Room as a bath attendant. For 
the past four years he has been greenkeeper of the Works bowling 
green. His general health is now excellent.
P U diathermy
m r»
f t  t t
i t  t t
i t  t t
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Biopsy - no malignancy.
(P U diathermy. 
P U diathermy
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CASE Ho.10 (j.S.)
Date of Births 
Date of Entrys 
Date of Onsets
Working History:
30.5.06. 
2.3.26• 
29.6.44.
Age at Entry: 
Age at Onset: 
Latent Period:
20 years 
38 years 
18 years
1926 - 31 Drying hetanaphthylamine and H.Acid in stoves.
1931 - 33 Manufacture of 1:8 naphthylamine sulphonic acid.
1933 - 35 Manufacture of alphanaphthylamine sulphate.
1935 “ 44 Manufacture of hetanaphthylamine.
History of Onset:
He was referred to hospital by his own doctor on account of 
symptoms of acute cystitis and haematuria. Routine urine tests 
for R.B.Cs. at the factory had been negative.
Hospital: Salford Royal Hospital.
Diagnosis, Course and Treatment:
29. 6.44. Papilloma 
23. 1.47.
17.11.48.
15. 1.49.
3. 2.51.
13. 7.51.
21. 8.52.
3. 2.53.
Surgeon: Mr. J. B. Macalpine. 
later Mr.D.S.Poole-Wilson.
P U diathermy
»t
4.10.54.
Progress:
Papillomatosis 
left renal pelvis. 
Papilloma (bladder)
Hephrouret erectomy 
(biopsy - benign papilloma) 
P U diathermy
He has had regular cystoscopic examinations since 1944* For the 
first nine years recurrences were frequent. They were kept 
under control by repeated diathermy but some anxiety was felt 
that this might cease to be effective.
Prom August 1952 onwards he had frequent attacks of haematuria. 
Ho tumours were seen in the bladder on cystoscopy on 27*10.52. 
and X-rays and intravenous pyelography were negative. On 
28.1,53j when he was again investigated, retrograde pyelography 
showed a gross filling defect of the calices of the left kidney. 
It was excised and papillomatosis of the renal pelvis was 
present. It was confirmed on section.
Seeding from the tumour of the renal pelvis to the bladder is a 
possible explanation of the many recurrences before the kidney 
was removed in 1953 especially as there has been only one 
recurrence since then.
He was off work for a year after the nephroureterectomy. Since 
early 1954 he was worked regularly in sheltered jobs as a gate- 
man and a laboratory messenger.
Date of Birth: 8.5*01.
Date of Entry: 1.8.20.
Date of Onset: 18.1.48.
Age at Entry: 19 years
Age at Onset: 47 years
Latent Period: 27 years
Working History:
1920 - 48 Worked in the betanaphthylamine manufacturing
department. After a few months as a general 
labourer he worked as a processman on the manufacture 
of 1:8 and 1:5 betanaphthylamine sulphonic acids.
He was also called upon to stove benzidine base from 
time to time during the two years 1928 to 1930.
History of Onset:
Investigation was done on account of the appearance of R.B.Cs. 
in his urine during routine monthly tests. He had had no 
symptoms or other signs suggestive of bladder trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole—Wilson.
Diagnosis, Course and Treatment:
18.1.48. Papilloma P U diathermy
21.4.58. " " "
Progress:
Regular cystoscopic reviews were carried out at intervals at 
first of three months, gradually extending to one year between 
1948 and April 1958. In 1953 he was found to have a urethral 
stricture probably due to instrumental trauma. This is dilated 
from time to time.
He is one of the few who survived over 10 years without a 
recurrence.
He continued at work as a process man until 1956 when he was 
transferred to work in a laboratory. He is still working and 
keeps in good health.
He is a brother of Case Ho.12.
This case is referred to on page 82
CASE Ho.12 (T.S.)
Date of Birth: 16.1.16.
Date of Entry: 4*9*39*
Date of Onset: 28.1.49*
Age at Entry: 23 years
Age at Onset: 33 years
Latent Period: 9 years
Working History:
1939 - 49 Worked on the manufacture of benzidine and,
for two years 1943-45? also on the manufacture 
of tolidine.
History of Onset:
Increasing numbers of red blood cells were seen in the urine 
on routine tests from October 1948 to January 1949. He had 
had no symptoms or other signs of bladder trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
28.1.49. Papilloma P U diathermy
2.5.56. " " «
Progress:
Regular cystoscopic, examinations have been made. The most 
recent was on 24*11*58* He continued at his work as a 
processman in the same department until it was closed in 
1952. He was then transferred to another department where 
acetanilide is made.
His general health is good.
He is a brother of Case Ho.11.
This case is referred to on page 82
CASE Ho.13 (R.S.)
Date of Birth: 3*4*15*
Date of Entry: 8.2.34-
Date of Onset: 30.4*49*
Age at Entry: 19 years
Age at Onset: 34 years
Latent Period: 15 years
Working History:
1934 - 42 Worked as labourer in the Ice Plant. This involved 
taking ice into the Colour Factory where benzidine 
was used.
1942 - 45 Worked in Colour Factory as a processman.
1945 - 49 Worked in Ice Plant.
History of Onset:
In April 1949 he complained of dysuria and frequency of 
micturition. The urine was faintly blood-stained.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
30.4*49* Papilloma P U diathermy
Progress:
He has been reviewed at regular intervals and cystoscopy is now 
done every twelve months.
This case is of interest in that he has had no recurrence in 
nearly ten years.
He is still working in the Ice Plant on his usual job which is 
a fairly heavy one.
CASE Ho.14 (H.W.)
Date of Births 13.9.96. Age at Entry: 31 years
Date of Entry: 1.7.27. Age at Onset: 50 years
Date of Onsets 6*4*46. Latent Period: 19 years
Working History:
1927 - 34 Worked on the manufacture of an intermediate made 
from alphanaphthylamine and metanilic acid.
1934 - 36 Left Company*s employment.
1936 - 39 Labourer in the Engineering Department.
1939 - 41 Left Company*s employment.
1941 - 46 Worked on the vacuum distillation of 
b et anapht hylamine•
History of Onsets
In March 1946 routine examination at the factory revealed red 
blood cells. He had had no symptoms or other signs.
Hospitals Christie Hospital, Surgeon: Mr.D.S.Poole-Wilson.
Manchester.
Diagnosis, Course and Treatment:
23* 4*46* Carcinoma Open operation.
Gold seed implant.
18. 2.48. Papilloma P U diathermy
5* 5*48. it 11 11
2O.i2.48. ” " »
Progress:
On cystoscopy there was a solid tumour of the bladder. He was 
transferred to Christie Hospital for treatment.
This case is interesting in that after three recurrences within 
a year the bladder has been clear for ten years. Regular 
cystoscopic examinations have been made since 1946. In 1953 
he developed a severe stricture of the urethra due to 
instrumental trauma. In 1955 it was impossible to dilate the 
stricture sufficiently to allow the cystoscope to pass and a 
two stage Swinney operation was completed in December 1956.
He has not worked since 1948 because of chronic bronchitis and 
dyspnoea and is usually confined to the house except in fine 
weather.
CASE No.15 (F.C.)
Date of Birth: 31®3*00, Age at Entry: 34 years
Date of Entry: 12*5*34* Age at Onset: 48 years
Date of Onset: 10.5®48* Latent Period: 14 years
Working History:
1934 * 48 Worked as a process worker on the manufacture of azo 
colours some of which involved the handling of 
benzidine base.
History of Onset:
On 10,11,47 he consulted me with a history of slight haematuria 
of two weeks duration. Routine urine tests for blood cells had 
previously been negative. On cystoscopy by Mr, Pool e-Wilson no 
definite tumpur was seen in the bladder but there was a "mossy" 
area above the right ureteric orifice. It was decided to review 
him in six months. On re-examination on 10,5*48* there were 
three tiny papillomata in the area previously noted.
Hospital: Salford Royal Hospital, Surgeon: Mr,D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
10.5*48. Papillomata P U diathesrmy
28,4*52. " M ««
24.2.53. Carcinoma Open operation.
(biopsy - malignant) Gold seed implant.
Progress:
He continued work as a processman until 1953 when a malignant 
recurrence was found. He was off work for just over a year 
after his radon seed treatment. Since then he has been 
employed in a laboratory as a cleaner and messenger.
Regular cystoscopic review continues at six monthly intervals. 
His general health is good.
CASE No.16 (j.S.)
Date of Birth: 12.8*97* Age at Entry: 34 years
Date of Entry: 15.1.32. Age at Onset: 52 years
Date of Onset: 1.9.49. Lat ent Period: 17 years
Working History:
1932 - 49 This man is a millwright. He has worked as a plant 
fitter in all sections of the Intermediates 
Department, in particular on the betanaphthylamine 
plant. He also did alterations to the benzidine 
plant during the time it was being changed over to 
the solvent process.
History of Onset:
For about two weeks in September 1949 be complained of 
suprapubic discomfort and had occasional terminal haematuria. 
Routine urine tests had previously been negative.
Hospital: Salford Royal Hospital, Surgeon: Mr,D,S.Poole-Wilson* j
Diagnosis, Course and Treatment:
1,9,49* Papilloma P U diathermy
Progress:
There have been no recurrences and review cystoscopies have 
now been extended to yearly intervals.
After treatment he resumed his usual work. His health has 
since been good.
In 1951 he was promoted to foreman, a position he still holds.
CASE Ho.17 (C.I.)
Date of Birth: 17• 4*03. Age at Entry: 23 years
Date of Entry: 28.4.26. Age at Onset: 47 years
Date of Onset: 29*8.50. Latent Period: 24 years
Working History:
1926 - 32 Worked on the milling of a wide variety of finished 
dyestuffs.
1932 - 50 Worked as a processman on the manufacture of azo
colours, using benzidine almost continuously during 
the whole of this period and, in addition, from 1940 
alphanaphthylamine at infrequent intervals.
History of Onset:
On IO.8.5O. he noticed some burning and scalding when he passed 
urine. Hext morning it was blood stained. Routine tests had 
been negative for blood cells.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
30. 8.5O. Papilloma P U diathermy
9* 3*51*
15. 8.51* " 1 "
5.11.51 • 1 " "
Progress:
Apart from the short absences occasioned by recurrences he 
continued work as a processman until 1956 when he was 
transferred to a laboratory as a cleaner and messenger.
He is now examined annually and the bladder was clear of tumour 
in May 1958. His general health is good.
CASE No.18 (R.M.)
Date of Births 21.4*04* Age at Entry: 20 years
Date of Entry: 4*3*24* Age at Onsets 47 years
Date of Onset: 20.2.51* Latent Periods 27 years
Working History:
1924 - 32 Worked on the manufacture of azo colours which
entailed the continuous use of alphanaphthylamine. 
1932 - 34 Worked on manufacture of azo colours using Benzidine. 
1934 — 51 Worked on shift doing general work in the same azo 
colour factory hut not employed directly with 
benzidine or alphanaphthylamine.
History of Onsets
In March 1942 he was referred to Salford Royal Hospital because 
of the persistence of small numbers of red blood cells in his 
urine which were first observed on routine test.
On investigation the bladder was clear of tumour but there was 
a rough oxalate stone in the left renal pelvis. This was 
removed at operation and he made a good recovery.
His urine remained clear of blood or other abnormal constituents 
and he had no complaints until 1951* He consulted me on 5*2.51* 
complaining of severe spasmodic pain along the urethra which had 
been present intermittently for three days. There was no 
history suggestive of recent colic or bladder stone. He was 
referred to Salford Royal Hospital for investigation. Ho
evidence of calculus was found but there was a small papilloma
near the right ureteric orifice.
Hospitals
Salford Royal Hospital.
Diagnosis, Course and Treatments
20.2*51* Papilloma
9*7*53* "Suspicious area"
(biopsy - no growth)
12.8.57* Papilloma
Progress:
He has continued on his usual shift work and is in good health. 
He is reviewed regularly.
Surgeons
1942 - Mr. J. B. Macalpine. 
1951 - Mr. D. S. Poole-Wilson.
P U diathermy
II II
II II
CASE No.19 (C.G.)
Date of Births 21* 12*12. Age at Entry: 25 years
Date of Entry: 6. 1.36. Age at Onset: 40 years
Date of Onset: 28. 1.52. Latent Period: 16 years
Working History:
1936 - 38 Worked for the first three months as a general 
labourer in the betanaphthylamine shed* Then 
employed in another building on non-carcinogenie 
intermediates.
1938 - 39 Worked a year and nine months on the manufacture
of betanaphthylamine.
1939 - 42 Served in H.M.Forces.
1942 - 43 Worked on the manufacture of betanaphthylamine.
1943 - 45 Recalled to H.M.Forces.
1945 - 50 Worked on the manufacture of betanaphthylamine.
1950 - 52 Worked on the manufacture of Tobias Acid.
History of Onset:
In  January 1952 a few red blood ce lls  were noted on routine 
urine te s t; in  a stained smear there were many Class IT  ce lls  
and some clusters of ce lls  suggestive o f benign papilloma. He 
had no symptoms or other signs of bladder trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson*
Christie, Manchester.
Diagnosis, Course and Treatment:
28.I.52. Papillomata and 
? carcinoma.
5.3*52. Papilloma
17.1.58. «
Progress:
On 28.1.52 two groups of benign papillomata were seen one above 
and behind the right ureteric orifice and one behind the left 
ureteric orifice. Below the latter the mucosa became piled up 
and gave the impression of a flat invasive tumour extending over 
an area of two centimetres in diameter. There was a small 
benign papilloma in the vault of the bladder. He was 
transferred to the Christie Hospital for biopsy and intra-cavity 
radiation.
Five weeks later, on March 5th, the same urologist (Mr. D. S.
Poole-Wilson) again examined him. The indurated area which was 
thought to be a carcinoma had completely disappeared. The 
papillomata were diathermized. He has had only one recurrence 
and that was six years later.
He is in good health and still works as a process man on Tobias 
acid production.
Transferred to Christie 
Hospital.
P U diathermy
II II
Date of Birth: 13*3.08.
Date of Entry: 2.1*47*
Date of Leaving: 1.2*48.
Date of Onset: 28.1.52.
Age at Entry: 39 years
Age at Onset: 44 years
Exposure Period: 1 year
Latent Period: 5 years
Working History:
1947 — 48 Worked one month on dichlorpyrazolone and twelve
months on paranitrotoluol sulphonic acid in the 
building in which naphthionic acid was manufactured 
but had no direct exposure to alphanaphthylamine.
This case is exceptional in that there was no 
significant exposure to any known carcinogen and his 
employment was of very short duration. There is no 
history of other employment in the chemical industry 
or in any industry where he would be likely to come 
in contact with carcinogens.
History of Onset:
In December 1951 be applied for re-employment. On examination 
many red blood cells were found in his urine; in a stained 
smear clusters of cells suggestive of benign papilloma were 
seen. On the 8th January 1952 > while awaiting further 
investigation, he had slight haematuria.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
28. 1.52. Papilloma P U diathermy
20. 6.52. " . . . .
16. 9.52. M .. ..
27.10.52. " " »
20. I.53. ” « "
26. 8.53. " «
29* 3.54* ” "
30. 8.54. 11 . . . .
15* 3*55* " 11 "
27. 2.56. " " "
5* 2,57*
ll.ll.57. " ” "
Progress:
He has had many recurrences but has been free of recurrent 
tumour for a year. He is now examined at intervals of six 
months. He was re-employed by the Company in December 195* 
on sheltered work as a messenger and has naturally lost a 
great deal of time but he is now in good general health and 
is working.
This case is referred to on page 144
CASE Ho.21 (F.L.)
Date of Birth: 22* 9*05* Age at Entry: 22 years
Date of Entry: 17.10.27* Age at Onset: 46 years
Date of Onset: 29. 2.52. Latent Period: 24 years
Working History:
1927 - 36 Process worker on the manufacture of azo dyes using 
benzidine sulphate.
1936 - 41 Worked on the manufacture of benzidine disulphonic 
acid.
1941 - 52 Worked on various intermediates in the building next 
to that in which benzidine was manufactured.
History of Onset:
On 19.2.52. a stained smear was prepared from his routine urine 
test. It showed Class IV cells. There were no blood cells and 
he had had no symptoms or other signs of bladder trouble.
Hospital: Christie Hospital,
Manchester.
Diagnosis, Course and Treatment:
29.2.52. Carcinoma.
(biopsy - malignant)
21.1.58. Infiltrating recurrence,
(biopsy - malignant)
Progress:
Surgeon:
Mr. D. S. Poole-Wilson.
Open operation. 
Gold seed implant. 
Inoperable
Regular review cystoscopic examinations have been made. On
1.4.57. the bladder was seen to be clear of tumour. He 
developed pain and haematuria about seven months later. On
21.1.58. a large infiltrating epidermoid carcinoma was present 
at the base of the bladder. Total cystectomy, even if it were 
to be considered, was impracticable.
He is still alive (December 1958) but is suffering the misery 
of inoperable cancer of the bladder and requires constant 
sedation.
CASE Ho.22 (W.L.)
Date of Birth: 20.12.12. Age at Entry: 18 years
Date of Entry: 1. 5*31* Age at Onset: 39 years
Date of Onset: 26. 5«52. Latent Period: 21 years
Working History:
1931 - 42 Processman in the manufacture of azo colours using | 
benzidine and alphanaphthylamine.
1942 - 48 Benzidine weighing and distribution.
1948 Appointed foreman in the azo colour department.
History of Onset:
On routine urine tests at the factory in March, April and early 
May 1952 there were numerous red blood cells in the deposit, 
there were no abnormal cells in the stained smears during this 
period. A cystoscopic examination was arranged for May 26th 
but oh the 21st he had slight visible haematuria.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
26.5.52. Papilloma P U diathermy
(biopsy - negative)
28.4.58. Papilloma ” "
Progress:
On cystoscopy a thin fringe of papillomatous growth was present 
near the right ureteric orifice.
Follow-up review cystoscopies have been carried out regularly.
In the later months of 1956 large numbers of Class V cells were 
persistently present in his urine. These were very similar in 
appearance to those seen in Case Ho.26 before a papillary 
carcinoma of the renal pelvis was foiind. Ib.ll investigation of 
the urinary tract as an in-patient in December 1956 failed to 
reveal any lesion. On cystoscopy on several occasions since, 
the last in August 1958? the bladder has been clear of tumour.
The classifications of stained smears of his urine now range 
from I to V and are quite inconsistent* These findings are fully 
discussed in the text.
He has continued his work as a foreman and keeps in good general 
health.
This case is referred to on pages 141 and 149
CASE Ho.23 (T.B.)
Date of Birth: 14.10.13. Age at Entry: 18 years
Date of Entry: 14*12.31* Age at Onset: 39 years
Date of Onset: 27*10.52. Latent Period: 21 years
Working History:
1931 - 34 Employed in the Colour Factory transporting ice in 
harrows.
1934 - 52 Worked on the manufacture of a number of azo colours 
which involved the use of benzidine. Until 1949 it 
was charged by him but after 1949 all benzidine was 
charged by the "benzidine man".
History of Onset:
In September and October 1952 routine tests of the urine 
revealed the presence of large numbers of red blood cells. 
Stained smears in March, April and October had been "negative" 
(Class I). He had no symptoms or other signs of bladder 
trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson*
Diagnosis, Course and Treatment:
27*10.52. Papilloma P U diathermy
(biopsy - benign)
27. 1.58. Papilloma " "
Progress:
Cystoscopic examinations have been made at regular intervals; 
the last was in March 1958.
His general health is good and he is still working at his 
usual job.
This case is referred to on page 141
CASE No*24 (F.B.)
Bate of Birth: 16*3.13* Age at Entry: 33 years
Bate of Entry: 22.8.46. Age at Onset: 40 years
Bate of Onset: 26.1.53* Latent Period: 6 years
Working History:
1946 - 52 Worked on the manufacture of benzidine.
1952 — 53 Worked on other intermediates after benzidine 
manufacture was transferred to a new building 
in July 1952.
History of Onset:
Routine urine test showed a fairly large number of red blood 
cells in the deposit in October 1952 and again in Becember. In 
November the urine was clear. A stained smear on 15*10.52. was 
“suspicious" (Class III) but on 10.12.52. it was "negative", 
there being only a few atypical cells and many normal squamous 
and transitional cells present. In view of the mierohaematuria, 
the exposure history, and the suspicious smear he was 
investigated.
Hospital: Salford Royal Hospital. Surgeon: Mr.B.S.Poole-Wilson. 
Christie Hospital.
Biagnosis, Course and Treatment:
24*7*53* Papilloma
5*7*54*
29*7*57* Carcinoma
Progress:
On review cystoscopy on 29*7*57* a flat invasive tumour about 
1*5 cms. in diameter on the right postero lateral wall of the 
bladder was seen. A second smaller nodule about .75 cms. in 
diameter was present in the vault. He had a radical course of 
X-ray treatment at the Christie Hospital and made a good 
recovery. In May 195$ the bladder was clear of tumour. At his 
next review in September there was a recurrence of the larger 
tumour and on examination of biopsy material carcinomatous 
invasion was seen in the deeper layers.
He has continued at work except for a period of four months 
following X-ray treatment in 1957• He is still in good general 
health despite the malignant recurrence but he has not worked 
since May 1958* The urologist does not consider this a suitable 
case for total cystectomy.
P U diathermy
it «t
Transferred to Christie  
Hospital.
Beep X-ray therapy.
CASE No.25 (S.H.)
Date of Births 26. 9*00. Age at Entry: 31 years
Date of Entry: 13* 4*31* Age at Onset: 53 years
Date of Onset: 26.10.53* Latent Period: 21 years
Working History:
1931 - 47 Worked on the manufacture of alphanaphthol from 
alphanaphthylamine.
1947 - 51 Promoted to chargehand. In this capacity he also
came into contact with hetanaphthylamine manufacture 
until it was given up in 1950.
History of Onset:
On a routine test on 24*9.53* there were Class IV cells in 
the urine and large numbers of erythrocytes. The results of 
previous tests had been negative and he had had no symptoms 
or other signs of bladder trouble.
Hospitals Christie Hospital, Surgeon: Mr.D.S.Poole-Wilson.
Manchester.
Diagnosis, Course and Treatment:
30.11.53# Carcinoma Open operation.
Gold seed implant.
Progress:
The report on the biopsy specimen taken at operation was 
’’doubtful as the tissue was necrotic”. He made a good 
recovery and returned to work in May 1954* He was unwilling 
to go back to any kind of plant work and after doing several 
odd jobs for two years is now employed in the Works Surgery 
as a cleaner and messenger.
Cystoscopic examinations have been made annually, the most 
recent in September 195^* There has been no recurrence so 
far. His general health is good.
This case is referred to on page 187
CASE Ho.26 (A.H.)
Date of Birth: 13. 2.05. Age at Entry: 25 years
Date of Entry: 1.12.31. Age at Onset: 49 years
Date of Onset: 25* 1*54* Latent Period: 22 years
Working History:
1931 - 52 Worked as a processman in the building in which 
benzidine was made. Prom 1937 until 1941 be was 
engaged in its manufacture.
1952 - 54 Worked with many other intermediates not suspected 
of being carcinogenic.
History of Onset:
On routine examination of his urine in January 1954> Class V 
malignant cells were seen in the stained smear. There were no 
blood cells and he had had no previous symptoms or other signs 
of bladder trouble.
Hospital: Salford Royal Hospital.
Diagnosis, Course and Treatment:
25. 1.54. Carcinoma
(section - papillary 
carcinoma)
2.10.56. Carcinoma
left renal pelvis.
(section - epidermoid 
carcinoma)
Progress:
He made a good recovery from his first operation. In October 
1954 he returned to light work of a semi-clerical nature in the 
Milling Department. Ho tumours were seen in the bladder on 
review examinations up to and including January 1956-
In July 1956 he began to have intermittent haematuria. (Stained 
smears were consistently Class IV or V but by this time it was 
known that no dependence could be placed on Papanicolaou smears 
in old cases.) On 21st August on cystoscopy no tumour was seen 
in the bladder but retrograde and intravenous pyelography showed 
evidence of a tumour in the left renal pelvis. Hephro- 
ureterectomy was performed,on 2nd October and the presence of 
a carcinoma in the renal pelvis was confirmed.
He made a good recovery and returned to his sheltered job after 
six months. In July he developed an incisional hernia in the 
nephrectomy scar and he was fitted with a surgical belt. He is 
still working.
At his most recent review in June 195^ no evidence of recurrent 
tumour was found.
Surgeon: Mr.D.S.Poole-Wilson.
Open operation.
Gold seed implant.
Left nephrouret erect omy
CASE Ho.27 (H.T.)
Date of Birth: 13. 1.93.
Date of Entry: 1.11.24.
Date of Onset: 23* 3*54.
Age at Entry: 31 years
Age at Onset: 61 years
Latent Period: 29 years
Working History:
1925 - 39 Worked on the manufacture of azo colours involving 
the use of benzidine and alphanaphthylamine.'
1939 - 47 Worked on the milling of various finished dry colours 
1947 - 54 Worked as a hoist man in the azo colour factory.
History of Onset:
In January 1951 he was referred to the urologist for 
investigation because of the presence of considerable 
numbers of red blood cells in three successive urine tests.
He had no symptoms or other signs of bladder trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
In January 1951 investigation of the urinary tract failed to 
reveal the presence of any tumour but there was a small reddish 
area on the posterior wall of the bladder. About this time the 
Papanicolaou tests began to be used in the factory. They were 
negative in this case until January 1953 when Class IV cells 
were seen. The microhaematuria had persisted on and off all the 
time. Re—investigation for tumour in January 1953 was again 
negative and the small reddish area was unchanged. He was 
listed for re-examination in six months time but was not sent 
for until 1st March 1954*
In March 1954 the area on the posterior wall appeared to have 
increased in size and its appearance was suggestive of tumour 
formation. Biopsy yielded no evidence of papilloma or 
malignancy.
He was re-examined on April 12th and the clinical appearances 
were such that the urologist decided to treat the area as 
malignant. Radon seeds were implanted at open operation. A 
piece taken for section at operation again showed no evidence 
of malignancy.
He continued his usual work on the hoist until 1954 but he had 
a severe radiation reaction and has not worked since. His 
general condition is poor, he is old for his years and his 
bladder is still extremely irritable.
Ho recurrences have been seen at regular cystoscopic 
examinations.
Date of Birth: 11,4.13. Age at Entry: 19 years
Date of Entry: 29*2.32. Age at Onset: 41 years
Date of Onset: 27.5*54* Latent Period: 22 years
Working History:
1932 - 35 Transported intermediates from warehouse to plant.
These included benzidine and alphanaphthylamine 
sulphate.
1935 — 39 Worked on the manufacture of 5“°hlor-orthotoluidine.
1939 — 45 H.M.Forces.
1945 — 54 Worked on the manufacture of azo colours involving
the use of benzidine and alphanaphthylamine. After 
I95O ihe weighing and charging of these substances 
were by the "benzidine man".
History of Onset:
In March and April 1954 a few red blood cells were seen on 
routine urine tests and these persisted on repeated tests. In 
May 1954 a stained smear was Papanicolaou class III. Because 
of the suspicious cells and the blood cells the smear was 
regarded as "positive". He had had no symptoms or other signs 
of bladder trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson. 
later Christie Hospital.
Diagnosis, Course and Treatment:
27.5*54* Papilloma P U diathermy
9*2.55* Carcinoma Open operation.
Gold seed implant.
Progress:
The initial papilloma was just above the right ureteric orifice. 
On review again in January 1955 there was a clinically 
malignant growth on the posterior wall of his bladder but not 
where the original papilloma had been. Section of biopsy 
material did not reveal any tumour growth but the tumour was 
treated by gold seed implant because of the clinical appearances. 
The bladder has remained free of tumour up to his most recent 
review in July 1958.
He resumed his usual job after his first treatment but, since 
the radiation treatment, he has been transferred to clerical 
work.
CASE Ho.29 (J.M.B.)
Date of Birth? 14.7.99.
Date of Entry: 19.1.25.
Date of Leaving: 4*1.39*
Date of Onset: - 6.42.
Age at Entry: 25 years
Age at Onset: 40 years
Exposure Period: 15 years 
Latent Period: 18 years
Working History:
1924 - 39 Engaged in the manufacture of betanaphthylamine,
and the distillation of betanaphthylamine, benzidine, 
tolidine and phenylbetanaphthylamine.
History of Onset and Course:
In 1954? fifteen years after he had left the Company, this man 
reported that he had papilloma of the bladder and asked to be 
re-employed.
He joined the Army in 19399 after leaving the Company earlier 
in the year. In early 1941 be had an attack of haematuria and 
was admitted to a military hospital but no cause was found.
It recurred several times and he was admitted to the Victoria 
Hospital, Glasgow, in June 1942. A papilloma was found in his 
bladder and he was treated by diathermy. He was then discharged 
from H.M.F. In 1944 be had a recurrence and was treated at 
Ancoats Hospital, Manchester5 from there he was transferred to 
Crumpsall Hospital, Manchester, where he has attended since.
He had four recurrences treated by per urethral diathermy 
between then and 1950 but has been clear since then*
He was re-employed by the Company in September 1954 on light 
work as a fitter1s mate, but he has not worked since February 
1957 because of severe intermittent claudication in both legs.
CASE Ho.30 (A.S.)
Date of Birth: 12.1*12. Age at Entry: 27 years
Date of Entry: 22*5.39. Age at Onset: 43 years
Date of Onset: 4*7*55* Latent Period: 16 years
Working History:
1938 - 39 Worked as a scalesman weighing a variety of products
including benzidine and alphanaphthylamine.
1939 - 46 H.M.Forces. Was prisoner of war in Japanese hands
1942-45.
1946 - 48 Worked in the manufacture of azo colours on units 
adjacent to those where benzidine was stoved and 
used.
1948 - 52 Worked in manufacture of a benzidine azo colour and 
acted as stand-in for benzidine distribution man.
1952 - 55 Worked in vat dyes and had no contact with known 
carcinogens.
History of Onset:
On 11.5*559 on. routine urine test, there were Class III cells 
in the stained smear. On 10.6.55* i'be smear was Class IV - V.
He had had no previous symptoms or signs of bladder trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson* 
Christie Hospital.
Diagnosis, Course and Treatment:
18. 8.55* Papilloma Biopsy
(?Carcinoma)
21.10*55. Carcinoma Deep X-ray therapy
15.12.56. Papilloma P U diathermy
Progress:
On cystoscopy in August 1955 there was a lesion on the left side 
of the bladder very suggestive of early superficially 
infiltrating carcinoma. Biopsy material showed an indefinite 
picture- "some superficial inflammation and a projection of 
tissue like a small papilloma which has been burnt". (Ho 
treatment had been given). On October 11th the appearance of 
the bladder was unchanged and further biopsy material still 
showed no definite evidence of tumour growth. The clinical 
appearances were so characteristic of carcinoma that he was 
transferred to the Christie Hospital for a full course of deep 
X-ray therapy.
He made a good recovery and resumed his usual work in February 
1956. Except for one small recurrence in December 1956 he has 
remained in good health since.
CASE Ho.31 (H.P.M.)
Date of Birth: 22.7*98*
Date of Entry: 26*9.12**
Date of Onset: 4*7*55*
Age at Entry: 14 years
Age at Onset: 57 years
Latent Period: 33 years
Working History:
1912 - 22 General labouring with no exposure to known 
carcinogens.
1922 - 24 General work on all products in azo colour factory.
1924 - 48 Worked as a processman in the manufacture of 
benzidine azo colours.
1948 - 53 Worked on azo colours not involving the use of 
known carcinogens.
1953 - 55 Worked on stoves drying finished colours.
History of Onset:
Stained smears of urine on routine test in March 1955 were 
Class II, in April Class III-IV and in May Class IV. Several 
repeat smears were consistently Class IV. He had no symptoms 
or other signs of bladder trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
4.7.55. Papilloma P U diathermy
(biopsy)
Progress:
On cystoscopy a cluster of low growing papillomata were seen 
just below the left ureteric orifice. A biopsy was taken and 
the growth was fulgurated. Microscopy of the biopsy material 
showed papilloma with an area of apparently solid growth with 
mitotic activity and cell irregularity but no evidence of 
invasion.
He has had no recurrence up to his most recent review 
examination in Hovember 1958.
He returned to work on his old job for a year and was then 
transferred to work as a laboratory attendant and messenger.
* For the analysis of this tumour case his starting 
date has been taken as 1922, the year in which he 
was first exposed to carcinogens.
CASE Ho.32 (j.E.B.)
Date of Birth: 6. 8.03*
Date of Entry: 4*12.33•
Date of Onset: 4* 7*55*
Age at Entry: 30 years
Age at Onset: 52 years
Latent Period: 22 years
Working History:
1933 - 39 Worked on the manufacture of benzidine.
1939 - 55 Worked in the same department on other intermediates
History of Onset:
Routine urine tests were negative until May 1955 when a stained 
smear was Class III. A very few red blood cells were present. 
In June the stained smear was Class II but in view of his 
exposure and the urinary findings cystoscopy was advised.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson
Diagnosis, Course and Treatment:
Ho recurrences have been observed up to his last review 
examination in August 1958. He continues work at his usual 
job and is in good health.
4* 7*55* Papilloma
(biopsy - benign 
papilloma)
P U diathermy
Progress:
Date of Birth: 13.8.98* Age at Entry: 20 years
Date of Entry: - 7*15** Age at Onset: 57 years
Date of Onset: 5*9*55* Latent Period: 37 years
Working History:
1918 - 55 Worked with the Transport Department. Hever worked 
in the plants. The transport of aniline and 
benzidine formed a considerable part of his work.
For the first 20 years the benzidine, often as a 
slurry, was transported in casks with open tops or 
sacking over them and there was considerable 
exposure.
* The latent period is calculated from 1918 when 
benzidine manufacture was started.
Previous health: Amputation left leg 3" below
knee — gunshot wound 1917*
History of Onset:
In June 1955 on routine test of his urine a stained smear was 
Class II. In July it was Class III and on August 28th and 
September 1st it was Class V. There were no symptoms or other 
signs of bladder trouble.
Hospital: Christie Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
5*9*55* Papillary carcinoma Deep X-ray therapy
(biopsy - carcinoma)
24*1*58. Papilloma P U diathermy
Progress:
The tumour, which was above the left ureteric orifice, was 
fulgurated. Biopsy showed the presence of transitional cell 
papillary carcinoma. In view of this he was re-admitted in 
December 1955 for a course of deep X-ray therapy and was finally 
discharged from hospital on 7th March 1956. There was a severe 
and prolonged radiation reaction and he did not resume work 
until January 1957*
He has made a very good recovery and has had only one 
recurrence, a benign papilloma. Because of his old leg 
amputation and his long absence from work he was put on 
sheltered work as a gate-man on his return and is still 
working on this job.
CASE Ho. 34 (W.W.)
Date of Birth:
Date of Entry:
Date of Onset:
Date of Death:
Working History:
1920 - 24 Worked on the manufacture of magenta.
1924 — 55 Worked on the manufacture of rhodamine. For a short 
time he had contact with dimethylaniline.
History of Onset:
Routine urine tests were negative until August 1955 when 
stained smears were Class V.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson. 
Diagnosis, Course and Treatment:
5*9.55* Papillary carcinoma.
(biopsy - transitional 
cell carcinoma)
18.3.57* Carcinoma.
(biopsy - carcinoma)
30.9*57* Massive carcinoma.
Progress:
At preliminary cystoscopy there was a small papilloma over the 
right ureteric orifice. A biopsy specimen was taken. Examina­
tion of this showed a poorly differentiated transitional cell 
carcinoma. At open operation on 30.9.55* a gold seed implant 
was carried out.
At review cystoscopy on 21.1.57* a pink grnaular raised area 
at the centre of the gold seed implant area was diathermized 
after a biopsy was taken. Section of the biopsy material 
showed epidermoid carcinoma.
Total cystectomy was advised as the only possible course of 
treatment but he steadfastly declined it.
He died on 28.5.58. At post mortem examination there was a 
large recurrent carcinoma of the bladder infiltrating the 
paravesical tissue and adjacent glands. Ho other secondaries 
were present.
Open operation. Gold seed 
implant (30.9*55)*
Declined total cystectomy.
Inoperable.
7.10.91. Age at Entry: 29 years
11. 3*20. Age at Onset: 64 years
5* 9*55* Age at Death: 66 years
28. 5.58.
This case is referred to on page 163
CASE Ho. 35 (J.M.)
Date of Births 22.12.92. Age at Entry: 30 years
Date of Entry: 1. 3*23. Age at Onset: 63 years
Date of Onset: 5* 9*55* Latent Period: 32 years
Working History:
1923 - 39 Worked on the manufacture of Benzidine azo colours.
1939 ~ 48 Worked on the manufacture of alphanaphthylamine azo 
colours.
1948 - 51 Worked on the manufacture of other azo colours until 
he contracted severe sensitization dermatitis from 
dinitrochlorbenzene and was transferred.
1951 — 55 Analytical department as a sampler.
History of Onset:
On routine urine test on 17.7•55* the stained smear was Class 113^  
on 17.8.55 an-cL 10.9*55 it was Class IV. He had no symptoms or 
other signs of Bladder trouBle.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson. 
Diagnosis, Course and Treatment:
5*9.55. Papilloma P U diathermy
(biopsy - transitional 
cell papilloma)
19.7.56. Papilloma " fl
Progress:
He was three months off work following an operation for 
umbilical hernia in April 1956. Apart from this he continued 
at work until he retired at the age of 65 in December 1957*
His general health is still good and no tumour was found at 
his most recent follow-up review in ingust 1958.
CASE Ho.36 (F.H.)
Date of Birth* 14* 2.12.
Date of Entry* 1. 6.39*
Date of Onsets 24*10.55*
Age at Entry* 27 years
Age at Onset* 43 years
Latent Periods 16 years
Working H istory*
1939 - 51 5*03? first two years, 1939-41> worked on
benzidine manufacture, and thereafter worked on 
a varie ty  of products on the vat next to i t .
1951 - 55 Similar work but no exposure to benzidine.
History o f Onset*
In September 1955 at routine monthly urine test the stained 
smear was Class IV and this was confirmed on a repeat specimen. 
He had no symptoms or other signs of bladder trouble.
Hospital * Salford Royal Hospital. Surgeon* Mr.D.S.Poole—Wilson
Diagnosis, Course and Treatments
24*10.55* Papilloma P U diathermy
20.12.56. ” " »
Progress*
He has continued at work and is  in  good health. At his most 
recent follow-up cystoscopy in  April 1958 the bladder was clear
CASE Ho.37 (J.W.S.)
Date of Births 30. 8.08. Age at Entry: 23 years
Date of Entry: 23*11*31* Age at Onsets 47 years
Date of Onsets 24*10.55* Latent Periods 24 years
Working History:
1931 - 40 Worked on the manufacture of betanaphthylamine.
1940 - 45 Worked on the manufacture of alphanaphthol using
alphanaphthy1amine.
1945 - 51 Worked on the manufacture of betanaphthylamine.
1951 - 55 Worked on the manufacture of other intermediates.
History of Onsets
Routine urine tests were negative until September 1955 when 
stained smears were Class IV. A stained smear in October was 
again Class IV. He had no symptoms or other signs of bladder 
trouble.
Hospitals Salford Royal Hospital. Surgeons Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatments
24*10*55* Papilloma P U diathermy
(biopsy - papilloma)
19* 3*57* Papilloma 
1. 6.58.
Progresss
He returned to work after treatment for his original tumour but 
has been off work since 16*1.57 with emphysema and chronic 
bronchitis.
it 11
i i  i t
CASE Ho.38 (H.T.)
Date of Birth* 30.4*03* Age at Entry* 20 years
Date of Entry* 7*9*23. Age at Onsets 53 years
Date of Onsets 3*1*56* Latent Periods 32 years
Working H istory: !
1923 - 24 Records of this man’s early working history are
sketchy and his own recollection of it is confused.
It is certain that at one period he worked with 
Case Ho.34 on. the manufacture of magenta.
1926 - 39 Worked as a processman on the manufacture of
rhodamine.
1939 - 56 Worked as an electrician’s mate - would he in all
departments of the factory from time to time. |
History of Onset:
On 9*12.55* and the following day he passed a little blood in 
the urine at the end of the stream. He had had no previous 
symptoms. Ho blood cells or abnormal cells had been seen on 
routine urine tests. On 30.9*55* a routine stained smear was 
Class I and on 29*11*55* it was Class II. In a smear from the 
blood stained urine a small piece of tissue was identified as 
benign papilloma (Fig 17).
Hospital: Ancoats Hospital, Manchester. Surgeon: Mr. G. 0. Jelly.' 
Diagnosis, Course and Treatments 1
P U diathermy j.
t
He continues at work as an electrician’s mate and has been in 
good general health since he was treated. At his last 
cystoscopic review in July 1958 the bladder was clear.
3.1.56. Papilloma 
Progresss
This case is referred to on pages 143 and 144
CASE No.39 (G.E.)
Date of Birth: 20.11.09* Age at Entry: 35 years
Date of Entry: 13* 8.46. Age at Onset: 46 years
Date of Onset: 21. 1.56. Latent Period: 11 years
Working History:
1944 -  45 Warehouseman.
1945 “ 50 Worked on the manufacture o f benzidine azo colours. 
1956 -  56 Worked as benzidine d is tribu tion  man weighing and
charging a l l  the benzidine. For the la s t four years 
i t  was in  an enclosed system and there was no direct 
contact.
History of Onset:
In  January 1955 ke complained that he fe l t  burning on 
m ictu rition . Stained smears of urine deposit were Class I .  
There were no blood c e lls . When he was investigated no 
tumour was seen in  the bladder and X-rays and pyelography 
were normal. The burning cleared up in  a few days and he 
had no further symptoms or signs.
Eleven months la te r ,  in  December 1955? Class IV  ce lls  were 
seen in  stained smear on routine test and in  repeat te s ts .
There were no symptoms or other signs at th is  time.
Hospital: Salford Royal Hospital. Surgeons Mr.D.S.Poole-Wilson.
Diagnosis. Course and Treatments
24*1*56. Papilloma P U diathermy
(biopsy p ap illa ry  
carcinoma)
Progress:
The papilloma was tin y  and was fulgurated a fte r  the biopsy 
specimen had been resected. Radiation treatment was not 
considered to be necessary.
At his most recent cystoseopy in  September 1958 the bladder 
was s t i l l  c lear of recurrent tumour.
He continues to work on benzidine distribution.
CASE Ho.40 (W.B.A.)
Date of Births 
Date of Entrys 
Date of Onsets
28.10.99* 
16.12.33. 
23. 1*56.
Working History:
Age at Entry:
Age at Onsets
Latent Period:
34 years
56 years
22 years
1933 - 34 General labourer transporting materials in a
building where benzidine was being manufactured 
but did not handle it.
1934 - 44 Worked on the manufacture of nitrobenzene sulphonic
acid and other non-earcinogenic intermediates.
1944 - 46 Worked on the manufacture of dichlorbenzidine and 
para anisidine. (benzidine and tolidine for six 
weeks only).
1946 - 47 Worked on the manufacture of para anisidine.
1947 - 52 Worked on the manufacture of benzidine, tolidine,
and dichlorbenzidine.
1952 - 56 Worked on the manufacture of other non-carcinogenic 
intermediates.
History of Onsets
Routine urine tests were negative until October and Hovember 
1955 when stained smears were Class III. In December 1955 
and January 1956 the smears were '’positive" and clumps of 
benign papilloma cells were present. There were no other signs 
or symptoms of urinary disease.
Hospital: Salford Royal Hospital. Surgeons Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatments
23*1*56. Papilloma P U diathermy
(biopsy - papilloma)
8.3*56* Papilloma " "
18.9,56. " " "
30.9.58. " " «
Progress:
He has kept on at his usual job as a processman and is in 
good general health*
This case is referred to on pages 144 and 148
CASE No.41 (J.H.M.)
Date of Birth: 12.1.07.
Date of Entry: 6.9.27*
Date of Onset: 27*2.56*
Age at Entry: 20 years
Age at Onset: 49 years
Latent Period: 26 years
Working History:
1927 - 50 Worked on betanaphthylamine manufacture.
1950 - 56 Worked on the manufacture of the sulphonic acids 
of various other intermediates.
History of Onset:
On the 18th January 1956 he had a sudden severe haematuria. 
Routine urine tests had been negative and stained smears had 
been Class I except for a Class II smear on 14*10.55* A 
specimen of urine at routine test two days before the onset 
of the haematuria showed no blood cells and was Class I.
Hospital: Salford Royal Hospital. Surgeon: Mir *D. S. Pool e-Wilson.
Diagnosis, Course and Treatment:
27* 2.56. Papilloma P U diathermy
(biopsy - papilloma)
5* 6.56. Papilloma " w
6.12.56. 1 « ”
Progress:
He has continued at work but has been transferred to a lighter 
job as a messenger and gate man.
His general health is good and the bladder was clear of tumour 
on cystoscopic examination in May 195®*
This case is referred to on pages 133 and 141
CASE No*42 (G.A.)
Date of Birth: 25*10.12.
Date of Entry: 19*10.31#
Date of Leaving: 21# 8*35*
Date o f Onset: 30. 9*56*
Age at Entry: 19 years
Age at Onset: 44 years
Exposure Period: 4 years
Latent Period: 25 years
Working H istory:
1931 -  35 Worked on the manufacture o f various beta­
naphthylamine sulphonic acids and on the 
d is t i l la t io n  o f benzidine, to lid in e  and other 
products* He also assisted at busy times in  
the manufacture o f alphanaphthylamine sulphate*
Before entering the chemical industry he was 
f iv e  years in  engineering* A fter leaving the 
Clayton Aniline Company he worked at another 
firm  fo r 10 years on the manufacture of sulphur 
dioxide and thereafter worked with several 
engineering firm s.
History of Onset:
Twenty-one years a fte r  leaving the Company he was admitted 
to hospital with gross haematuria. There was a history of 
a s im ilar attack four years before which had cleared up in  
24 hours and had given no fu rther trouble.
Hospital: Manchester Royal Infirmary. Surgeon: Mr. R. Newell.
Diagnosis. Course and Treatment:
30*9*56* Papillomata P U diathermy
Progress:
There were three papillomata in  the bladder* His general 
health has remained good and the bladder was clear when he 
was las t reviewed in  October 195$ •
He was re-employed at Clayton when he developed the tumour 
in  1956 and has worked regu larly  since then as a works 
window cleaner.
CASE No.43 (W.P.)
Date of Birth: 28*5*07* Age at Entry: 43 years
Date of Entrys 27*4*50* Age at Onset: 50 years
Date of Onset: 12*1*57* Latent Period: 7 years
Working History:
I  have been unable to trace any s ign ificant exposure in  th is  
case except that he worked in  the factory for seven years 
before developing a tumour. Before that he worked 28 years 
in  a wood saw-mill*
1950 -  53 Worked as a f ilte r -p re s s  cleaner handling ch ie fly  
sulphurised dinitro-oxydiphenylamine, indophenols 
and to lazine .
1953 (February-April) Worked on service team delivering
ice and sa lt to plants.
1953 -  57 Worked in  warehouse handling packaged m aterials.
History of Onset:
He had a sudden attack o f haematuria on 24*11.56 which lasted  
six days. No blood had been seen on routine tests of his 
urine and stained smear results had been consistently Class I  
or Class I I .
Hospital: Salford Eoyal Hospital. Surgeon: Mr.D.S.Poole-Wilson*
Diagnosis, Course and Treatment:
12*1*57* Papilloma P U diathermy
(biopsy -  benign)
19*5*58* Papillomata '* 1
Progress:
He has continued at his work as a warehouseman.
The fu lguration in  May 1958 was fo r recurrent papillomata at 
the in ternal meatus and le f t  la te ra l lobe of the prostate. 
Following th is  he developed a prostatic abscess in  July. I t  
eventually discharged spontaneously. This has now cleared up 
and he is  in  good general health and is  back at work.
This case is  of p articu lar in terest in  that he is  the most 
recently employed worker to develop a tumour o f the bladder. 
Despite the fact that there has been l i t t l e  or no known 
direct exposure to carcinogens he is  accepted as a case of 
occupational tumour because o f his seven years* work in  the 
factory.
CASE Ho. 44 (G.M.)
Date o f B irth : 22.11.97. Age at Entry: 22 years
Date o f Entry: 11. 5*20. Age at Onset: 59 years
Date of Onset: 29. 9 .57. Latent Period: 37 years
Working History:
1920 - 42 Worked on the manufacture of "benzidine.
1942 -  55 Worked on the manufacture of alphanaphthyl amine 
sulphonic acids.
1955 -  57 Worked on the manufacture o f amino benzoic acid, 
dimethylaniline and other products.
History o f Onset:
In  November 1955 ^be stained smear of the urinary deposits 
was Class I I I  on routine te s t. In  December i t  was again 
Class I I I  but in  January 195^ i t  Class V. On th is  
finding cyst ocopy, X-rays and pyelography were done on 
23*1* 56* No tumour was found.
The stained smears continued to be positive and a repeat 
investigation, made in  July 1956y not reveal any
abnormality. He was reviewed again in  A pril 1957 and on 
th is  occasion, f if te e n  months a fte r  the positive smear was 
f i r s t  recorded, there was a papilloma in  the bladder. This 
case is  discussed in  the tex t in  considering "false positive"  
cytodiagnostic resu lts .
Hospital : Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis. Course and Treatment:
29*4* 57* Papilloma P U diathermy
(biopsy -  papilloma 
suspicious o f early  
malignant changes)
Progress:
Ho recurrences have been seen on review cystoscopies. He 
has continued at work but was transferred to a sheltered job 
as a cleaner in  the transport department.
CASE Ho. 45 (H.H.)
Date of Births 1. 2*04* Age at Entry: 29 years
Date of Entry: 9*12.32. Age at Onset: 53 years
Date of Onset: 28. 1.57* Latent Period: 24 years
Working H istory:
1932 -  39 Worked on henzidine manufacture.
1939 -  45 H.M.Forces.
1945 -  52 Worked on henzidine manufacture.
1952 -  55 Worked on the manufacture o f cihanaphthol and
cihanaphthol R.C.T. using 5“cklor*“Orthotoluidine. 
1955 “ 57 Worked on the manufacture o f 5“cklor-orthoto lu id ine.
History o f Onsets
He had one attack of haematuria in  July 1955 which was 
ascribed to exposure to 5-chlor-orthoto lu id ine. This 
cleared rap id ly  and stained smears were Class I  or I I  
u n til December 195^ when a smear was Class I I I .  The next 
month, in  January 1957 > the smear was Class IV . Ho other 
symptoms or signs were evident.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis. Course and Treatments
28.1*57 Papilloma P U diathermy
(biopsy -  f,Trans. ce ll 
papilloma. One suspicious 
area of possible invasion")
28. 4. 58* Papilloma P U diathermy
10*9#58. Papillomata " "
Progress:
He has continued working on process work but has been 
transferred to a job where he will not be exposed to 
carcinogens or to compounds likely to cause cystitis.
His general health is good.
Date of Births 2.4*94*
Date of Entry: 26.2.24-
Date of Onsets 28.1.57*
Age at Entry: 30 years
Age at Onsets 63 years
Latent Periods 33 years
Working Hi story s‘
1924 — 30 Worked on the manufacture of naphthionate of soda !;|
and sulphanilic acid. During this time it is 1
possible that he came into contact with j
betanaphthylamine. j
1930 - 48 Worked on the manufacture of oxy Tobias acid. j
1948 - 57 Worked on the manufacture of naphthionate of soda ;|
which involved the use of alphanaphthylamine. j;
History of Onsets
I
On routine urine tests there was one Class III smear in early j
1955* They were Class I until December 1955 when the smear 
was again Class III. In January 1956 was Class IV and 
clumps of benign papilloma cells were present. He had no '
symptoms or other signs of bladder trouble. j
Hospitals Salford Royal Hospital. Surgeons Mr.D.S.Poole-Wilson.
|
Diagnosis) Course and Treatments
28.1.57* 2 papillomata P U diathermy ■
(biopsy - ulceration
and inflammation) j
Progresss
The biopsy result was indefinite but the clinical appearances 
were indubitable.
He has been clear of recurrences up to and including his most 
recent review in November 1958.
Because of his age he was transferred to light work as a j
laboratory cleaner after his operation. His general health J
is good. j
This case is referred to on page 144
Date of Births 26.8.98.
Date of Entry: 6.9*20.
Date of Onset: 12.3.57*
Age at Entry: 22 years
Age at Onset: 59 years
Latent Period: 37 years
Working History:
1920 - 28 Worked on the manufacture of H.Acid entailing some 
exposure to alphanaphthylamine.
1928 - 33 Worked on the manufacture of azo colours using 
henzidine.
1933 - 35 Office work.
1936 - 57 Canteen and Locker Hoorn foreman.
History of Onset:
On routine urine test on 13*7*55* ‘kke stained smear was 
Class IV. Several repeat smears yielded similar readings.
On cystoscopy, X-ray and pyelography on 5<>9*55 no evidence 
of tumour was found.
The stained smears of the urine continued to he Class IV.
He was again investigated eight months later in May 1956 
and again no evidence of tumour was found.
Class IV cells were still being exfoliated when he was 
re-investigated on 12.3.57* A tiny papilloma was then 
present in the vault of the bladder.
Hospital: Salford Hoyal Hospital. Surgeon: Mr.D.S.Poole-Wilson. 
Diagnosis, Course and Treatment:
12.3*57* Papilloma P U diathermy
Progress:
On cystoscopy in March 1957 an area of red velvety mucosa with 
frond formation was diathermized. Biopsy was attempted but a 
good piece was not obtainable. On review examination three 
months later the area was healed. No further abnormalities 
have been seen and the bladder was clear in April 1958*
He continued to work in the Locker Hoorn until he retired at 
the age of 60 in August 1958. His general health is excellent.
This case is referred to on page 137
CASE No.48 (J*H.)
Date of Birth: 15. 6.00.
Date of Entry: 9*10.29*
Date of Leaving: 10. 5*40.
Date of Onset: 20. 6.46*
Working History:
Age at Entry: 29 years
Age at Onset: 46 years
Exposure Period: 11 years 
Latent Period: 17 years
1929 — 40 Worked in the department where benzidine was made and 
from 1937 to 1940 was engaged in its manufacture.
History of Onset:
In June 1946, six years after leaving the Company*s employment, 
he had painless haematuria and attended hospital. In 1955 
reported to the Company that he was suffering from papilloma of 
the bladder.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
A case report obtained from the hospital in 1955 states that 
four small papillomata were found originally on 20.6*46. and 
small recurrences had been found on several occasions since 
then. He has been followed up closely since he got in touch 
with me in 1955* He had recurrences in August 1957 and in 
June 1958* All the treatments have been by endoscopic diathermy.
Since leaving Clayton he had been continuously employed as a 
concreter. In 1957 he was having difficulty in keeping up with 
such heavy work and he was re-employed by the Company in 
September of that year as a laundry worker - a light job which 
he is still doing.
His general health is good.
CASE No.49 (R*M.)
Date of Birth: 30.4*00.
Date of Entry: 1*9*39*
Date of Onset: 30*9*57*
Age at Entry: 39 years
Age at Onset: 57 years
Latent Period: 18 years
Working History:
1939 - 52 Worked as a general labourer on the manufacture of 
betanaphthylamine. There was some contact with 
alphanapht hylamine•
1952 - 57 Worked as a cleaner in Transport Department.
History of Onset:
Stained smears from routine urine tests were Class III in July 
1957 and Class IV in August and September 1957* He had had no 
symptoms or other signs of bladder trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr. D.S.Poole-Wilson. 
Diagnosis. Course and Treatment:
Three weeks after his diathermy treatment he was found to have 
a mass over the pubis which was thought to be due to 
extravasation of urine. This resolved very slowly and at the 
end of six months had disappeared. He was then symptom free.
In 1952 he was transferred to light sweepingwip duties because 
of chronic bronchitis* His general health is still poor, and 
he has not yet resumed work although the bladder was clear at 
his most recent review in July 1958.
30.9*57* Papilloma
(biopsy - benign)
Progress:
P U diathermy
CASE No.50 (E.C.)
Date of Birth: 3.10.06.
Date of Entry: i9.lo.3i*
Date of Leaving: 12. 7.37.
Date of Onset: 28. 3*50.
Age at Entry: 25 years
Age at Onset: 43 years
Exposure Period: 6 years
Latent Period: 18 years
Working History:
1931 - 37 Worked on the manufacture of betanaphthylamine.
History of Onset:
In March 1950> thirteen years after leaving the Company, he 
was admitted to Christie Hospital, Manchester because of a 
history of three years1 haematuria.
Hospital: Christie Hospital. Surgeon: Mr. Wilson Hey.
Diagnosis and Treatment:
In June 1951 1 was informed of this case by a letter from the 
R.S.O. at the hospital.
At operation on 28.3*50 "a large carcinoma of the bladder was 
excised completely and the bladder closed. At the beginning 
of June 1950 he began a course of X-ray therapy.” The report 
on the excised tumour was “epidermal carcinoma invading the 
bladder wall.”
Progress:
He has made a good recovery apart from one small papillomatous 
recurrence which was fulgurated in September 1955* At the 
most recent review cystoscopy in June 1958 the bladder was 
clear.
When he left the Company in 1937 he removed to Southport and 
took up clerical work. He had difficulty in keeping a job 
because of the time he lost for review examinations and the 
seasonable nature of the work. In view of this he was 
re-employed by the Company in 1957 as a clerk in the Transport 
Office. He is still working there and is in good health.
CASE No. 51 (J.M.)
Date of Birth: 25*11*02. Age at Entry: 21 years
Date of Entry: 23.11.23. Age at Onset: 55 years
Date of Onset: 27* 1.58. Latent Period: 34 years
Working History:
Worked as a scalesman handling and weighing out raw materials 
and intermediate products including tolidine, dianisidine and 
dichlorbenzidine but he has not been engaged on actual process 
work. The shed in which he worked was next to the benzidine 
shed and formed part of the same department.
History of Onset:
Routine urine tests were clear until December 1957 when a 
stained smear was Class III. Two stained smears in January 
1958 were "positive”. The cells were of the type by then 
recognised as having been exfoliated from benign papilloma 
(Fig 15). He had had no symptoms or other signs of bladder 
trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr.D. S.Pool e-Wilson.
Diagnosis. Course and Treatment:
27.1.58. Papilloma P U diathermy
(biopsy - benign)
Progress:
He is still working on his usual job as a scalesman but does 
not handle carcinogens or suspected carcinogens.
This case is referred to on pages 143 and 144
CASE No.52 (H.D.)
Date of Birth: 14*4.94.
Date of Entry: 5,7*39,
Date of Leaving: 19.9.44.
Date of Onset: 19.9.49.
Exposure Period 
Latent Period:
Age at Entry: 
Age at Onset:
45 years 
55 years 
5 years 
10 years
Working History:
1939 - 44 Employed as a "cask man" in intermediates
department, looking after and washing the casks, 
including those used for henzidine.
History of Onset:
He was referred to hospital by his own doctor on account of 
symptoms of bladder trouble. He wrote to the Company soon 
afterwards stating that he was suffering from papilloma of 
the bladder.
Hospital: Ancoats Hospital. Surgeon: Mr. G. 0. Jelly.
Diagnosis. Course and Treatment:
19#9* 49* Papilloma P U diathermy
Progress:
No recurrences have been seen at regular review cystoscopy; 
the most recent review was in September, 1958*
He still has recurrent dermatitis. He has been unable to 
work for the past eight years because of osteoarthritis of 
the spine and chronic bronchitis with dyspnoea.
In 1944 he contracted severe sensitization 
dermatitis and left the Company's employment.
Date of Birth: 31* 7.00.
Date of Entry: 15*11*27*
Date of Onset: 19* 7.44-
Date of Death: 28* 9*58*
Age at Entry: 27 years
Age at Onset: 44 years
Age at Death: 58 years
Latent Period: 17 years
Working History:
1927 - 28 Worked on the manufacture of H.Acid.
1928 - 31 Worked in intermediates department powdering
hetanaphthylamine.
1931 - 44 Worked on the sulphonation of betanaphthylamine.
History:
This man developed symptoms of bladder trouble in 1944 and was 
referred by his own doctor to Manchester Royal Infirmary where 
a papilloma was diagnosed and treated by per-urethral diathermy#
He thereupon left the Company's employment and firmly refused 
all offers of ex gratia payments or advice.
In 1951 a relative who worked at Clayton informed me that he 
had had a recurrence and had diathermy treatment. Attempts 
were again made to get in contact with him and to get his 
consent to have the hospital reports sent to me, but again he 
refused all co-operation.
He died on 28.9*58. and the death was certified as "cancer of 
the bladder". The death occurred after the list was "closed" 
for the analysis of this series of cases and is not included 
in it.
One cannot but respect his spirit of pride and independence 
however financially misguided it may have been. His widow has 
accepted the usual pension which the Company offered.
CASE No.54 (J>M.)
Date of Birth: 27*7*98*
Date of Entry: 1.9*23-
Date of Onset: 26.8.39*
Date of Death: 9*5*58*
Age at Entry: 25 years
Age at Onset: 41 years
Age at Death: 60 years
Latent Period: 16 years
Working History:
1923 - 32 Worked on the manufacture of henzidine.
1932 - 39 Worked on the nitration and isolation of a 
variety of intermediates.
History of Onset:
No exact record.
Diagnosis, Course and Treatment:
26.8.39* Papilloma P U diathermy
23*6*52. Papillomata " " (4 areas)
9*4*57* Carcinoma " "
Progress:
He left the Company in January 1941 when he took over a small 
coal business which he ran until he died.
Regular review examinations were continued. In January 1943» 
having been clear of tumour for nearly four years, four 
papillomatous areas were seen, one of which was possibly 
malignant. The biopsy result was "doubtful"• They were all 
fulgurated and no recurrence was seen until April 19575 when 
there was a small tumour which proved on biopsy to be a 
papillary carcinoma. It was treated by fulguration. When he 
was cystoscoped in October 1957 the bladder was clear.
In early 1958 he had a fall and bruised his ribs. After this 
he gradually deteriorated and by March there was weakness in 
the left arm and leg. By the end of the month there was left 
hemiplegia. He died on May 9th. At post mortem examination 
there were widespread metastatic deposits of papillary 
carcinoma, confirmed histologically.
As he died after the lists were*t>losed" for the analysis of 
this series of cases he is not included in the "deaths".
CASE No.55 (R*C.)
Date of Birth: 28. 8.10.
Date of Entry: 1.12*33*
Date of Leaving: 1.10.37*
Date of Onset: 18. 6«49-
Age at Entry: 23 years
Age at Onset: 39 years
Exposure Period: 4 years
Latent Period: 16 years
Left:
Re-employed: 27* 4*44* 
 I.IO.45.
Working History:
1933 - 37 Worked on the manufacture of betanaphthylamine.
1944 “ 45 Worked in engineering department - no contact 
with chemicals.
History of (faset:
After he had left the Company he was referred by his own doctor, 
in June 19499 to hospital with a history of two attacks of 
haematuria, one four years before and one two days previously.
Hospital: Salford Royal Hospital. Surgeon: Mr*D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
18.6.49* Papilloma P U diatherny
Progress:
The clinical appearances were those of a papillary carcinoma 
but there is no record of a biopsy.
Follow-up cystoscopies were done in May and December 1950 ancl 
the bladder was clear. He failed to attend when he was sent for 
six months later. All efforts to get in touch with him by the 
hospital and by the firm have failed and nothing has been heard 
of him since. Although his present address is unknown he is 
presumably still alive as no death certificate has been reported.
CASE No.56 (R.W.)
Date of Birth: 2.8*01• Age at Entry: 25 years
Date of Entry: 13*7*26. Age at Onset: 43 years
Date of Onset: 26.1.45* Latent Period: 19 years
Working H istory:
1926 -  45 Worked on the manufacture of azo colours which 
entailed the use o f henzidine.
History of Onset:
He started with haematuria in  January, 1945* A few red blood 
c e lls , not considered to be in  su ffic ien t number to warrant 
cystoscopy, had been present in  the urine on routine tests  
some 12 months before, but none had been present in  the more 
recent specimens.
Hospital: C hristie  Hospital. Surgeon: Mr. D. S. Poole-Wilson.
Diagnosis. Course and Treatment:
26.1.45* Carcinoma Open operation.
Gold seed implanted.
Progress:
Section of the tumour showed i t  to be a tran s itio n a l ce ll 
carcinoma.
This man did not return to the Company's employment as he was 
afra id  to return to any kind of chemical work. He was o ff  
work for a year and then took a job as a lavatory attendant at 
a local pleasure garden where he s t i l l  works.
He attended hospital fo r review cystoscopies u n t il  January,
1950 and no recurrences were seen. For the next eight years 
he pers istently  declined to have further examinations. In  
early January, 195$ I  persuaded him to be re-examined. 
Cystoscopy on the 9th  January showed the bladder to be clear 
of tumour. He is  to be reviewed in  January, 1959*
CASE No.57 (D.H.)
Date of Birth: 29.8.96. Age at Entry: 38 years
Date of Entry: 4-2.35. Age at Onset: 52 years
Date of Leaving: IO.4.42. Exposure Period: 7 years
Date of Onset: I6.8.48. Latent Period: 13 years
Working History:
1935 - 42 Worked on the manufacture of benzidine.
History of Onset:
Six years after he left the Company he was referred to hospital 
by his own doctor presumably for symptoms of bladder trouble.
After he had been treated he reported to the Company that he was
suffering from papilloma of the bladder.
Hospital: Christie Hospital. Surgeon: Mr. D. S. Poole-Wilson.
Diagnosis9 Course and Treatment:
16. 8.46. Papilloma 
23. 4.49.
1. 3.50. *'
15.11.50. "
21. 7•51• Carcinoma
Progress:
At review cystoscopy in July 1951 there was a small hard 
ulcerating tumour which was clinically malignant. A week 
later radon seeds were implanted. A biopsy was then taken 
but failed to reveal any carcinoma. The piece taken showed 
largely a necrotic ulcer. Since then there has been no 
recurrence but he had very frequent attacks of cystitis for 
the first four years. The bladder was clear when he was 
last examined in January 1958.
He suffers from chronic bronchitis and has not worked since 
the onset of his carcinoma in 1951*
P U diathermy 
11 »»
11 11
11 I f
Open operation. Gold seed implant.
CASE Ho.58 (W.H.)
Date of Birth: 10. 4«93*
Date of Entry: 13. 5*19*
Date of Onset: 3*11*33*
Age at Entry: 26 years
Age at Onset: 40 years
Latent Period: 14 years
Working History:
1919 - 24 Worked on the manufacture of nigrosine.
1924 - 33 Worked on henzidine azo colours and on stoving 
finished colours.
Diagnosis, Course and Treatment:
This man left the Company’s employment in 1937 and from his 
records it appears that, at that time, it was not realised 
that he had had an occupational tumour of the bladder in 1933*
In 1952 in the course of the A.B.C.M. field survey he was 
traced through the Christie Hospital records. Prom these it 
was learned that he had had haematuria in 1933 and was treated 
at Stockport Infirmary for a papilloma of the bladder by 
suprapubic diathermy.
He apparently remained well until 1951 when haematuria recurred 
and he was treated at the Christie Hospital for ’’multiple 
papillomata*’ by a cobalt radiation source in a balloon.
He has not been seen since then but no record of his death has 
been traced or reported.
This case is referred to on page 167
CASE Ho.59 (R.K.)
Date of Births 14. 2.07. 
Date of Entry: 2.12.25.
Date of Leavings 2# 7*27. 
Date of Onset: - 1.55-
Exposure Period: 1 year 7 months 
Latent Period: 29 years
Age at Entry: 18 years
Age at Onset: 48 years
Working History:
1925 - 27 Worked in a chemical works for only 19 months.
He was engaged in the betanaphthylamine manufacturing 
department at the time when the amine was distilled, 
broken up by hand and ground. There is no precise 
record of the job that he did and his own memory of 
it is not clear, but he remembers it was on the 
stoves. At that time and as a youth of 18 in that 
department, it is likely that he would be employed 
as a stove-boy in the stoves where betanaphthylamine 
was dried as this was the usual job preliminary to 
becoming a process man at 18.
After leaving the Company in 1925 he worked for 29 
years as a railway porter and is still working at 
this job.
History of Onset:
He was referred to hospital by his own doctor because of the 
onset of symptoms of bladder trouble. I first learned of this 
case from the urologist after the operation.
Hospital: Christie Hospital. Surgeons: Dr. Ralston Paterson
Regular cystoscopic examinations have been made. In December
1955 there was still a large sloughing area over the site of the 
tumour on the anterior wall of the bladder near the bladder neck. 
Biopsy of this area showed inflammatory reaction only. In May
1956 only one tiny slough remained and the rest was healed. On 
re-examination in May 1957 healing was found to be complete.
The bladder was clear of tumour in August 1958.
He has continued his usual work with British Railways and his 
general health is good. He comes to see me at the factory 
regularly twice a year.
and Mr. D. S. Poole-Wilson
Diagnosis, Course and Treatment:
Carcinoma of the bladder 
(biopsy - pleomorphic 
carcinoma)
Deep X-ray therapy
This case is referred to on pages 96 and 188
CASE No.60 (J.K.)
Date of Births 22. 4.90.
Date of Entry; 28. 6.28.
Date of Leavings 20. 4.42.
Date of Onsets 13.12.54.
Date of Deaths 10. 9*58*
Age at Entry: 38 years
Age at Onset: 64 years
Age at Deaths 68 years
Exposure Periods 14 years
Latent Periods 26 years
Working History:
1928 - 42 Worked chiefly on the manufacture of rhodamines and
supervised other manufactures in the same shed. He 
was exposed to the following:- rhodamines, fluorescin, 
phthalic anhydride, resorcin, aniline, dimethylaniline, 
methane base, Michler's hydrol, betanaphthol and 
several triphenylmethane colours.
Ho direct contact with any of the recognised 
carcinogens has been traced but in view of his 14 
years in the chemical works in a department next to 
that in which naphthylamines were sulphonated his 
tumour is regarded as occupational.
History and Progresss
After leaving the Company in 1942 he worked as a watchman in an 
engineering works until he retired in 1952.
In December 1954 he had several attacks of painless haematuria 
and was referred by his own doctor to Crumpsall Hospital, 
Manchester. He was admitted for investigation. On intravenous 
pyelography the right kidney was seen to be enlarged and there 
was some hydronephrosis; the left kidney appeared normal. Ho 
abnormality was seen in the bladder on cystoscopy. Retrograde 
pyelography showed the presence of right hydro ureter and 
incomplete filling of the right renal pelvis.
A right nephrectomy was carried out on 25*2.55* There was gross 
papillomatosis of the renal pelvis. Histologically this proved 
to be a transitional cell papilloma; there was no infiltration 
of the wall of the pelvis but cytologically it was regarded as 
malignant.
He made a complete recovery for three years but died from 
metastates in April 195&. His death occurred after the list was 
"closed” for analysis of these cases and he is not included in 
the deaths.
This case is of particular interest as the initial tumour was in 
the renal pelvis and no tumours developed in the bladder.
It was largely on the strength of this case and Case Ho.127 that 
in 1957 the definition of the prescribed disease was enlarged to 
include tumours of the pelvis of the kidney or ureter.
This case is referred to on pages 158 and 171
CASE Ho.61 (F.H.)
Date of Births 27. 3*99*
Date of Entrys 1, 3.26.
Date of Leavings , 1. 8.42.
Date of Onsets 1.11.53*
Age at Entrys 27 years
Age at Onset: 54 years
Exposure Periods 16 years 
Latent Periods 27 years
Working History:
1926 - 42 Worked in the azo colour factory on the manufacture 
of colours which involved the use of benzidine and 
alphanaphthylamine.
History of Onsets
In November 1953* eleven years after leaving the works, he had 
a sudden attack of haematuria.
Hospitals Manchester Royal Infirmary. Surgeons Mr. P. Newell.
Diagnosis, Course and Treatments
Nothing was known of this case at the factory until he reported 
it a year after onset in November 1954 and applied for 
ex-gratia payments.
A report from the surgeon stated that when first seen he had a 
papilliferous neoplasm about 5 cms i*1 diameter in the right 
lateral wall of the bladder. Biopsy showed it to be a 
transitional cell carcinoma. He was treated by radon seed 
implantation.
There have been no recurrences. He continues at his usual 
work as a watchman at an engineering works where he has been 
employed since he left Clayton in 1942.
CASE Uo*62 (T*W*)
Date of Births 20*5*91* Age at Entry: 31 years
Date of Entry: 2*2*22* Age at Onset: 53 years
Date of Onset: 15*6*44* Latent Period: 22 years
Working: History:
1922 - 40 Worked on the manufacture of a variety of sulphonated 
naphthylamines*
1940 - 44 - Worked on manufacture of betanaphthylamine and its 
distillation* Also distilled benzidine during this 
period*
History of Onset:
He had a sudden haematuria in October 1943*
Hospitals Salford Eoyal Hospital* Surgeons Mr*J*B*Macalpine*
Christie Hospital* later Mr.D.S.Poole-Wilson*
Diagnosis* Course and Treatment:
11*11*43* Carcinoma Partial cystectomy
21* 5*48* Papilloma P U diathermy
13* 4*49 “ M M
15* 7*49* Carcinoma Deep X-ray therapy
Progress:
The initial tumour in 1943 was a papillo-carcinoma on section*
Ho biopsy was made of the recurrence in 1949* recurrences 
have been seen since 1949* The most recent review was in 
March 1958*
He returned to work and continued in sheltered employment as 
a gate-man until he retired in 1956 at the age of 65*
He is still alive and well.
This case is of some interest in that two carcinomata in the 
bladder have been successfully treated at an interval of six 
years*
CASE No*63 (E.N.M.)
Date of Birth: 14*8*88*
Date of E n t r y :  16*
Retired: 31*5*48*
Date of Onset: 16*1*57*
Age at Entry: 28 years
Age at Onset: 68 years
Exposure Period: 32 years 
Latent Period: 41 years
Working History:
1916 - 48 Joined the Company as a graduate chemist in 1916*
He set up and developed the benzidine plant and was 
the plant chemist and manager of the department 
until he became General Manager of the Company in 
1946* He retired in 1948.
History of Onset:
Nine years after he retired he had a sudden attack of haematuria 
on 4*1*57* His urine was examined at the factory* It was 
impossible to distinguish any cells other than blood cells until 
a small piece of white tissue the size of a pinhead was picked 
out from the clots* On smearing and staining this it showed 
cells recognisable as having originated from a benign papilloma*
Hospital: Christie Hospital, P.P.H. Surgeon: Mr*D.S.Poole-Wilson*
Diagnosis, Course and Treatment:
16* 1*57* Papilloma
22*10*58. Papilloma
P U diathermy 
Biopsy: "Papillomaj tumour 
of transitional type. Down- 
growth cannot be assessed." 
P U diathermy
Progress:
On review cystoscopy in August 1957 the bladder was clear. He 
has severe osteoarthritis of both hips but otherwise is in good 
health*
This is the longest latent period in the series (41 years).
CASE No*64 (J«B«)
Date of Birth: 13.12.11#
Date of Entry: 28* 7*30*
Date of Leaving: 1.11.40.
Date of Onset: 2. 8*57*
Age at Entry: 18 years
Age at Onset: 45 years
Exposure Period: 10 years 
Latent Period: 27 years
Working History:
193O - 40 Worked on the manufacture of betanaphthylamine. 
1940 - 46 H.M.Forces.
I946 - 57 Worked at Imperial Chemical Industries Ltd. Was 
using benzidine 1946-49*
History of Onset:
I was informed by the Medical Officer at I.C.I.Ltd. that this 
man had developed a papilloma of the bladder.
Hospital: Ancoats Hospital. Surgeon: Mr. J. H. Tasker.
Diagnosis, Course and Treatment:
2.8.57. Papilloma P U diathermy
Progress:
This man still works at I.C.I.Ltd. and in order to obviate 
administrative difficulties he has been admitted to their 
ex-gratia payments scheme and is "followed up" by their 
medical officer who keeps me informed of his progress. There 
can, however, be little doubt that the significant causative 
exposure was the 10 years to betanaphthylamine at Clayton.
Date of Birth: 
Date of Entry: 
Date of Leaving: 
Date of Onset: 
Date of Death:
Working History:
24.6.04. 
12.6.23. 
26.1.27. 
16.9*57. 
19.4.58.
Age at Entry: 19 years
Age at Onset: 53 years
Age at Death: 54 years
Exposure Period: 3 years 6 months
Latent Period: 34 years
1923 - 27 Worked on the manufacture of betanaphthylamine and 
at times handled alphanaphthylamine.
1927 - 57 After leaving the factory he did a number of jobs, 
none of which was in chemical work.
History of Onset:
He was admitted to hospital in September, 1957 with gross 
painless haematuria, thirty years after leaving the factory, 
was informed by the house surgeon that he was an in-patient.
Hospital: Manchester Royal Infirmary. Surgeon: Mr. R. Newell.
Diagnosis and Treatment:
16.9.57. ’'Papilloma"
(section - transitional 
cell carcinoma.)
Progress:
Open operation. Excision 
of tumour.
A large papilloma was found on cystoscopic examination. The 
bladder was subsequently opened, the tumour was excised and its 
base diathermised. No radiation treatment was given. Section 
of the excised tumour showed it to be a transitional cell 
carcinoma. He made a good recovery.
Seven months later he had a perforated peptic ulcer and died of 
enteritis following an operation.
On post mortem examination the bladder and kidneys were found to 
be free of tumour.
As his death occurred after the case list was "closed" for the 
analysis he is not included among the deaths in this series.
His brother (Case No.86) who worked in the same department 
also developed a tumour of the bladder.
This case is referred to on pages 82 and 163
CASE No.66 (S.P.)
Age at Entry: 32 years
Age at Onset: 63 years
Latent Period: 31 years
Working History:
1925 - 31 Worked on the manufacture of hydrochloric acid.
1932 - 54 Worked on the Duron sulphuric acid concentrators as a 
processman until 1951 and thereafter as foreman.
From 1932-40 benzidine was ground in the vicinity of 
the Duron units.
History of Onset:
In July 1954 be complained of dysuria and frequency of 
micturition. The cells in the stained smear of the urinary 
deposit were Class I but there were large numbers of red and 
white blood cells present. He was investigated and on cystoscopy 
no tumour was seen in the bladder but there was basal cystitis.
The symptoms cleared up after a course of urinary antiseptics.
There were no further symptoms or signs until November 1955 when 
a stained smear was Class III. In December and in January 1956 
it was Class IV and there were present many clumps of cells 
recognizable as having originated from a benign papilloma (Fig 16)., 
There were no symptoms or other signs of bladder trouble at this 
time and no blood cells were present in the smears.
i
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson. 
Diagnosis, Course and Treatment:
23.1.56. Papilloma Diathermy
Progress:
He returned to work after treatment and continued until he 
retired at the age of 65 in December 1957* S© is in good health.
Regular cystoscopic examinations are made.
Date of Birth: 15*11.92.
Date of Entry: 6. 1.25-
Date of Onset: 23* 1*56.
This case is referred to on pages 143 and 144
CASE No.67 (T.D.)
Date of Birth: 29* 5*00*
Date of Entry: 19.10.22.
Date of Onset: 14. 7*44*
Age at Entry: 22 years
Age at Onset: 44 years
Latent Period: 22 years
Working History:
1922 - 44 Worked as a processman in the manufacture of azo
colours. Prom 1930 to 1942 he handled benzidine 
and ortho-tolidine daily. At other times he worked 
on various units and handled benzidine sporadically.
Previous Health:
1934 Perforated duodenal ulcer - operation 
1936 Perforated duodenal ulcer - operation 
1938 Recurrent duodenal ulcer - gastroenterostomy.
History of Onset:
Red blood cells were present in his urine on routine test at the 
factory in May 1944. H© bad had no previous symptoms. He was 
referred to Ancoats Hospital, Manchester, at the wish of his own 
doctor.
Hospital: Ancoats Hospital, Manchester. Surgeon: Mr. G. Hughes.
Regular review cystoscopies have been continued since 1944* In 
1952 he developed an incisional hernia in his suprapubic scar. 
This was repaired on 18th April, 1953*
In the early part of 1957 he began to go downhill and in June 
was again admitted to Ancoats Hospital for investigation. X-rays 
of his chest revealed tuberculous infiltration at the right apex. 
Five weeks later this was found to be spreading rapidly. He was 
admitted to Monsall Hospital, Manchester, on 20th July, 1957 and 
was an in-patient until April 1958 on antibiotic treatment. On 
discharge his general condition was very much better and his 
chest lesion had healed satisfactorily.
His general health has been poor for over 20 years. He was at 
work on and off after the onset of his papilloma in 1944* When 
he developed pulmonary tuberculosis in 1957 he was put on 
retirement pension to help him financially. He made a good 
recovery and in September 1958 he applied to be re—instated. An 
©asy job was found for him and he is now working in the Locker 
Room on the issue of clothing.
He has remained free of bladder trouble since 1949 and was last 
cystoscoped on.7th October, 1958*
later Mr.G.O.Jelly
Diagnosis, Course and Treatment
Papilloma Suprapubic cystotomy and excision 
of papilloma.
Suspicious area fulgurated 
per-urethram.
Date of Birth: 28.6.02* Age at Entry: 30 years
Date of Entry:  32. Age at Onset: %  years
Date of Leaving: 4*1*40. Exposure Period: 8 years
Date of Onset: - I.58. Latent Period: 26 years
Working History:
1932 - 40 Worked on the caustic melt autoclaves in the building 
in which betanaphthylamine was manufactured. Was 
also engaged in the sulphonation of alphanaphthylamine 
from time to time.
History of Onset:
In January 1958, 18 years after leaving the Company, he had a
sudden attack of haematuria.
Hospital: Christie Hospital. Surgeon: Mr. D. S. Poole—Wilson. 
Diagnosis, Course and Treatment:
- I.58. Papillomata P U diathermy
Progress:
Several small papillomata were treated by per-urethral diathermy. 
At review examination in June 1958 the bladder was clear of 
tumour.
Since leaving the Company in 1940 he has worked at another firm 
as a storekeeper and is still in the same job. His general 
health is good.
CASE No.69 (A.A.)
Date o f B irth : 
Date of Entry: 
Date of Onset: 
Date of Death:
18*4*82. 
28.6.24* 
31.5*40. 
-  -  45*
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
42 years 
58 years 
63 years 
16 years
Working H istory:
1924 -  40 Worked on the manufacture of benzidine.
History of Onset:
No record.
Hospital: Salford Hoyal Hospital. Surgeon: Mr. J. B. Macalpine. 
Diagnosis* Course and Treatment:
31*5*40 Papilloma P IT diathermy
Progress:
Regular follow-up cystoscopic examinations were made. The 
bladder remained clear of tumour u n til his death in  1945 
from cerebral thrombosis.
CASE No.70 (T.B.)
Date of Birth: 21*11.65#
Date of Entry: 24.11.22.
Date of Onset: ? -  - 30-
Age at Entry: 57 years
Age at Onset: ?66 years
Age at Death: 67 years
Date of Death: 10. 9*31*
Working History:
1922 - 30 Worked on the manufacture of hetanaphthylamine.
History:
This case came to light in the course of the A.B.C.M. field 
survey.
A  coroner*s certificate stated the cause of death as cancer 
of the bladder. It had been confirmed on post mortem 
examination.
CASE No.71 (L.B.)
Date of Birth: 6. 2.92.
Date of Entry: 19. 1.22.
Date of Onset: 11. 5*34*
Date of Deaths - 10.39*
Age at Entry: 30 years
Age at Onset: 42 years
Age at Death: 47 years
Latent Period: 12 years
Working History:
1922 - 37 Worked on the manufacture of betanaphthylamine and
He first attended Ancoats Hospital in 1934 and a copy of the 
hospital report to his doctor has been obtained. At cystoscopy 
there were said to be multiple small haemorrhages in the mucosa 
of the bladder and these were diathermized. No tumour formation 
was seen.
He left the Company*s employment in August 1937*
In a hospital report from Salford Royal Hospital dated 26.8.39* 
it is stated that he was referred to the urologist there in 1937 
on account of haematuria but he never attended. When seen in 
August 1939 there was a large carcinomatous growth at the base 
of the bladder. Total cystectomy was advised but he refused it. 
He also declined any other form of treatment such as implantation 
of radium or deep X-ray therapy.
He died from infiltrating carcinoma and spinal secondaries in 
October 1939*
benzidine.
History:
This case is referred to on page 163
CASE No.72 (j.A.B.)
Date of Birth: 
Date of Entry: 
Date of Onset: 
Date of Death:
2,11.01.
25.10.27. 
9. 3.39.
6.10.43.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
26 years 
37 years 
42 years 
11 years
Working History:
1927 39 Worked on the manufacture of benzidine and tolidine.
History of Onset:
On routine urine test in March 1939 there were large numbers 
of red blood cells in the urinary deposit. He had no symptoms 
or other signs of bladder trouble.
Hospital: Salford Hoyal Hospital. Surgeon: Mr. J. B. Macalpine. 
Diagnosis, Course and Treatment:
9. 3.39.
13.11.42.
1. 2.43.
25. 9.43.
6.10.43.
Progress:
He returned to work on his old job and continued at it, apart 
from the periods when he was under treatment, until his death 
in October 1943. Regular review examinations were made.
In April 1943 a mass was palpable in the left renal area. On 
excretion urography no shadow was seen on the left side. At 
operation on 16.4*43. a left nephrectomy was performed and the 
ureter was excised on 7*5*43* There was a papilliferous growth 
at the upper end of the ureter and nearly the whole of the 
kidney was replaced by neoplasm.
In September he had severe haematuria from a papilloma in the 
bladder which could not be controlled per urethrally.
Suprapubic diathermy was carried out on October 6th. He had 
severe reactionary haemorrhage following the operation and died 
the same day.
This case is fully reported by Macalpine (1947) in his 
description of two cases of papilloma of the renal pelvis in 
dyeworkers.
Papilloma - bladder.
11 11
Papilloma - left 
renal pelvis 
and ureter 
Papilloma - bladder
P U diathermy
11 h
Left nephrectomy, 16.4.43*
11 ureterectomy, 7*5*43.
Fulguration failed.
Open operation. Diathermy. 
Reactionary haemorrhage. 
Died.
Date of Birth: 26»12»76» Age at Entry: 43 years
Date of Entry: 8* 9*19* Age at Onset: 62 years
Date of Onset: 28*11*38. Age at Death: 65 years
Date of Death: 28* 5*42* Latent Period: 19 years
Working History:
1919 — 38 Worked on the distillation of betanaphthylamine, 
Benzidine, tolidine and phenyl hetanaphthylamine.
History of Onset:
There is no exact record of the initial symptoms or signs.
Hospital: Salford Royal Hospital. Surgeon: Mr. J. B. Macalpine*
Diagnosist Course and Treatment:
1.12.3S* Papilloma P U diathermy
1. 3*41* " Suprapubic diathermy
(biopsy - "no malignancy")
Progress:
He returned to his old job and worked until his health began to 
fail in September 1941*
Regular cystoscopic reviews were continued, the last being in 
May 1941*
He died in May 1942 of an ascending urinary tract infection.
On the post mortem examination there were numerous infiltrating 
papillomata in the bladder and advanced bilateral pyelonephritis.
CASE No.74 (J.R.B.)
Date of Birth: - - 95*
Date of Entry: 10.12.25*
Date of Onset: 21. 1.46.
Date of Death: 21* 4*46.
Age at Entry: 30 years
Age at Onset: 51 years
Age at Death: 51 years
Latent Period: 20 years
Working History:
1925 - 31 Worked on the manufacture of benzidine.
1931 - 35 Worked on the manufacture of azo colours but, so far
as can be traced, not on those for which carcinogens
were used.
1935 ~ 46 Worked on the grinding and warehousing of finished
colours.
History of Onset:
Started with a slight haematuria in January 1946. Routine tests 
for blood cells had previously been negative.
Hospital: Salford Royal Hospital. Surgeon: Mr*D.S.Poole-Wilson. 
Diagnosis, Course and Treatment:
21.1.46. Malignant papillomata. Transplantation of ureters. 
Progress:
There were two malignant papillomata on the right side of the 
bladder and some papilloma formation round the bladder neck.
The urologist*s opinion was that no treatment other than 
cystectomy was practicable.
The first stage, ureterosigmoidostomy, was performed two weeks 
later. The patient gradually went downhill and died on 21*4.46. 
of ascending infection of the kidneys and uraemia three months 
after the operation.
This case is referred to on page 162
Date of Birth 
Date of Entry 
Date of Onset 
Date of Death
CASE Ho.75 (E.C.)
8. 1*06. Age at Entry: 18 years
15* 5.24* Age at Onset: 34 years
19. 7*40» Age at Death: 34 years
11*10#40. Latent Period: 16 years
Working History:
1924 - 40 Worked on the manufacture of alphanaphthylamine 
sulphate from alphanaphthylamine*
History of Onset:
Large numbers of red blood cells were present in wet smears 
of urine on a routine test and on a repeat test*
Hospital: Salford Royal Hospital. Surgeon: Mr*J.B.Macalpine.
Diagnosis, Course and Treatment:
19*7*40* Carcinoma Open operation.
(biopsy - malignant) Radon seed implant.
Progress:
In July 1940 there was a solid growth above the left ureteric 
orifice and he was listed for admission* At open operation 
in October radon seeds were inserted. On section the tumour 
was a carcinoma and was more anaplastic than transitional cell 
in type.
He developed a fulminating pneumonia and died two days after 
the operation*
CASE No.76 (G.F.)
Date of Birth: 14*12.96. Age at Entry: 26 years
Date of Entry: 17.11.22. Age at Onset: 42 years
Date of Onset: 1.11.38. Age at Death: 47 years
Date of Death: 29. 5.44. Latent Period: 16 years
Working History:
1922 - 44 Worked on the manufacture of benzidine.
History of Onset:
This man was referred to hospital in October 1938 "because of 
the presence of microscopic blood in the urine" according to 
the records. Routine urine tests had been introduced only a 
short time before and were done about every six months at that 
time.
Hospital: Salford Royal Hospital. Surgeon: Mr. J. B. Macalpine.
Diagnosis, Course and Treatment:
17•11•38. Papilloma P U diathermy
31. 1.44* Carcinoma right kidney.
?Papilloma left renal 
pelvis.
Progress:
On regular follow-up examinations no recurrent tumour was found 
until 31st January 1944*
On that day no neoplasm was seen in the bladder but excretion 
urography showed a non-functioning right kidney and a large left 
kidney the upper calyx of which was dilated and at its junction 
with the pelvis proper there was a filling defect suggestive of 
a tumour in this situation. In view of the non-functioning 
right kidney no steps were taken to explore the left kidney. It 
was decided to review him in six months.
He was re-admitted early on 23rd May 1944 with anuria and he 
died in uraemia six days later.
On post mortem examination there was a large papillocarcinoma of 
the right kidney which had invaded the duodenum and other 
neighbouring organs. In the pelvis of the left kidney there was 
a small sessile papilloma.
This case is reported at length by Macalpine (1947)•
CASE Ho.77 (E.E.H.)
Date of Birth 
Date of Entry 
Date of Onset 
Date of Death
2.10.08. 
8. 3.26.
25.11.40.
15.12.41.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
17 years
32 years
33 years 
15 years
Working History:
1926 - 30 Worked on the manufacture of alphanaphthylamine 
sulphate from alphanaphthylamine.
1930 - 33 Worked on caustic soda powdering.
History of Onset:
There is no precise record of the history of onset in this case 
hut there is a note in the man’s case history dated 25*11.40. to 
the effect that the urine had shown no abnormalities on 
microscopical examination and that there were no physical signs 
on examination. He may have been referred to hospital by his 
own doctor because of symptoms of bladder trouble.
Hospital: Crumpsall Hospital, Manchester. Surgeon: Mr. T. Moore.
later Christie Hospital. Dr. Ralston Paterson.
Diagnosis, Course and Treatment
25.11.40. Papillomata 
25* 1.41. Papillomatosis
Progress:
P U diathermy 
Deep X-ray therapy
In November 1940 several small papillomata were seen and 
fulgurated. Biopsy of portions of these showed benign papilloma. 
He was listed for review in two months.
Two months later there were still one or two papillomata in the 
bladder and several "suspicious"areas. He was referred to the 
Christie Hospital for a course of deep X-ray therapy which was 
completed on February 17th.
He was re-admitted to Crumpsall Hospital early in December and 
died there on the 15th. On post mortem examination there were 
multiple papillomatosis of the bladder, a reeto-vesical fistula 
and bilateral pyelonephrosis.
CASE ffo.79 (J.B.J.)
Date of Births 11.12.76*
Date of Entry: 27*11®23*
Date of Onsets 1. 8.38.
Date of Deaths 16. 7*45.
Age at Entry:
Age at Onsets
Age at Deaths
47 years
62 years
69 years
Latent Periods 15 years
Working History:
1923 - 34 Worked on the manufacture of "benzidine.
1934 - 38 Did odd jobs in various parts of the factory.
1938 - 42 Worked as a locker room attendant.
History of Onsets
There is no record of the exact premonitory symptoms or signs, 
the earlier history is taken from hospital reports.
Hospitals Ancoats, Manchester.
later Salford Royal 
Hospital.
Diagnosis, Course and Treatments
1. 8.38. 
7*12.39* 
14* 8.41. 
11. 6.42.
Papilloma
if
Papillomata
Surgeon s
Mr. J. B. Macalpine.
Suprapubic diathermy (Ancoats) 
P U diathermy (Salford)
it 1
11 ti
Progress:
The recurrences in June 1942 are interesting. There were about 
12 small papillomata scattered over the left lateral wall. They 
were completely cleared by diathermy and did not recur.
He left the Company on 3«9*42. but continued to attend hospital 
for review examinations. There were no recurrences up to the 
time of his death from pneumonia in 1945*
Date of Births 
Date of Entry: 
Date of Onset: 
Date of Deaths
Working History:
20.9.84*
20.2.22.
11.4.40.
23.8.40.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
37 years 
55 years 
55 years 
18 years
1922 - 29 Worked on the manufacture of sulphanilic acid in 
the same building as the distillation of 
betanaphthylamine, benzidine and tolidine was 
carried out.
1929 - 40 Worked on the manufacture of the sulphonic acids 
of a variety of intermediates.
History of Onset:
Microhaematuria was found at routine tests in March 1940 and 
in repeat tests.
Hospital: Salford Royal Hospital. 
Christie Hospital,
Manchester.
Diagnosis and Treatments 
11.4*40. Carcinoma
Surgeons Mr. J. B. Macalpine. 
Dr. Ralston Paterson.
Palliative X-ray
Progress:
At cystoscopy at Salford Royal Hospital on 11.4*40* there was a 
deeply ulcerated carcinoma in the vertex extending under the 
mucosa from the ulcer itself down the anterior wall. The area 
was about the size of half-a-crown.
He was transferred to the Christie Hospital for partial 
cystectomy and gold seed implantation but on admission on
27.6.40. glandular metastases were present. Palliative X-ray 
treatment was given. He died of carcinomatosis two months 
later.
CASE Ho.81 (j.W.L.)
Date of Birth: 29*10.95*
Date of Entry: 6. 7*28.
Date of Onset: 17. 1*48*
Date of Death: 19* 3*48#
Age at Entry: 33 years
Age at Onset: 52 years
Age at Death: 52 years
Latent Period: 20 years
Working History:
1928 - 48 Worked on the manufacture of benzidine.
History of Onsets
In January 1948 was referred to hospital for investigation 
because of the presence of red blood cells on routine and 
repeat urine examinations.
Hospitals Salford Royal Hospital. Surgeons Mr.D.S.Poole—Wilson. 
Diagnosiss
17.1.48. Papilloma P U diathermy
Progress:
On cystoscopy on 17*1*48 there was a small pedunculated 
papilloma on the left lateral wall of the bladder. He was 
admitted two weeks later and it was fulgurated by per urethral 
diathermy.
Soon afterwards his health failed and he died of carcinoma of 
the liver on 19*3*48.
At the post mortem examination (which I attended) the liver 
was grossly enlarged and there were many nodules of carcinoma 
in it. The bladder, renal pelvis and ureters were clear of 
tumour and no primary cancer was found elsewhere. The cancer 
of the liver was thought to be a primary growth, but 
unfortunately a histological report could not be obtained 
as the pathologist lost the sections or did not prepare any.
CASE Wo.82 (F.M.)
Pate of Birth: 17. 8.00. Age at Entry: 29 years
Pate of Entry: 25* 9*29* Age at Onset: 41 years
Pate of Leaving: 11.10.37. Age at Peath: 48 years
Pate of Onset: 30. 1*42* Exposure Period: 8 years
Pate of Deaths 6. 2.49* Latent Period: 12 years
Working History:
1929 - 37 Worked on the manufacture of betanaphthylamine and 
the handling of alphanaphthylamine*
History:
He left the Company in 1937 and nothing more was heard of him 
until it was learned that he died in hospital in February 1949* 
The following history of the course of his illness is taken 
from the Christie Hospital records.
6. 2*42. A history of haematuria three years previously. Was 
well until three months ago.
Cystoscopy: area -JM diameter over left ureter, 
sessile and raised, and very suggestive of malignancy. 
Treatment: open operation and gold seed implant.
16. 3*45* Papilloma on left lateral wall diathermized.
26.11.47* New lesion on vault, definitely neoplastic.
3.12.47* Cystoscopy: tumour in vault confirmed, also an
extra-vesical area of tumour on right lateral wall 
of pelvis.
Operation: bilateral transplantation of ureters.
10. 2.48. Deep X-ray therapy to right side of pelvis.
From this date the patient*s general and local condition 
deteriorated and he died of infiltrating carcinoma on 6.2*49*
There is no record of a post mortem examination.
This case is referred to on page 162
Date of Births 3* 2.83* 
Date of Entry: 19* 1*25*
Date of Onset: 19*11*40*
Date of Death: 15* 1*44*
Age at Entry: 42 years
Age at Onset: 57 years
Age at Death: 61 years
Latent Period: 16 years
Working History:
1925 - 26 Worked on the stoving of various intermediates*
1926 - 44 Worked on the manufacture of "benzidine and tolidine.
History of Onset:
In October and November 1940 there were many red blood cells in 
the urine on routine tests. He had no symptoms or other signs 
of bladder trouble.
Hospital: Salford Royal Hospital. Surgeon: Mr*D.S.Poole-Wilson. 
Diagnosis, Course and Treatment:
19*11*40* Papilloma Diathermy
Progress:
He had regular follow-up cystoscopic examinations^ the last was 
on 26.3*42. when the bladder was clear of tumour.
A few months later he developed a malignant stricture of the 
oesophagus from which he died on 15*1*44*
CASE No.84 (W.H.T.)
Date of Birth: 2.10.90.
Date of Entry: 27*11*22.
Date of Onset: 21.10.47.
Date of Death: 21.10*47.
Age at Entry: 32 years
Age at Onset: 57 years
Age at Death: 57 years
Latent Period: 25 years
Working History:
1922 - 47 Worked on the manufacture of benzidine sulphur 
colours, diphenylamine and primuline. For the 
last 13 years he was foreman of this department.
History:
In August 1947 he was admitted to Stockport Boyal Infirmary 
with a diagnosis of Paget’s disease of bone. His condition 
deteriorated rapidly and he died on 21.10.47*
On post mortem examination there was a large cancerous mass 
nearly filling the bladder. This had not been diagnosed 
during life.
The cause of death was certified as carcinoma of the bladder.
This ease is referred to on page 163
Date of Births 4.11.97. Age at Entry: 23 years
Date of Entry: 17. 3.21. Age at Onsets 40 years
Date of Onset: 11.10.37. Age at Deaths 49 years
Date of Deaths 18.12.46. Lat ent Period: 16 years
Working- History*
1921 - 46 Worked on the manufacture of benzidine.
History of Onset:
Was referred to hospital for investigation and cystoscopy in 
September 1936 because of the presence of red blood cells in 
the urine. The tests were introduced in the factory in that 
year and the microhaematuria was found on the first test of 
this man* s urine.
Hospitals Salford Royal Hospital. 
Christie Hospital.
Diagnosis, Course and Treatments
Surgeon: Mr. J. B. Macalpine 
later Mr.D.S.Poole-Wilson
11.10.37.
29.10.38.
7. 2.39.
15.11.40.
15.12.41. 
20. 8.42. 
19. 3.43.
1.12.46.
Progress:
Carcinoma
Papilloma
Fulguration.
Diathermy
Deep X-ray
(therapy.
Carcinoma - bladder.
" - left kidney.
Regular follow-up examinations were made at intervals of three 
to twelve months. Ho recurrences were seen on cystoscopy 
between March 1943 and April 1946. He returned to his usual 
work after treatment was completed in 1937 and except for 
absences due to recurrences and reviews he continued at work 
until ll.ll.46. On that date he had sudden haematuria and was 
admitted to hospital.
He died on 16.12.46. The post mortem findings were (l) old 
telangiectatic areas in the bladder due to X-ray treatment 
(a) one small area of malignant growth in the bladder (3) a 
large carcinomatous mass in the right kidney possibly primary 
(4) secondary carcinoma left kidney (5) haemorrhages into both 
supra renals.
CASE No.86 (M.Y.)
Date of Births 1* 5*06»
Date of Entry: 12.11.22.
Date of Onset: 24«H*47«
Date of Death: 13.12©47*
Age at Entry: 16 years
Age at Onset: 41 years
Age at Death: 41 years
Latent Period: 25 years
Working History*
1922 - 47 Worked on the manufacture of betanaphthylamine.
History of Onsets
Ho exact record. He was admitted to Ancoats Hospital on 
24th November 1947 with a provisional diagnosis of prostatic 
abscess, having been referred to out patients by his own 
doctor.
Hospital: Ancoats Hospital. Surgeon: Mr. G. 0. Jelly. 
Diagnosis:
24*11.47• Carcinoma of the bladder. Inoperable.
Progress:
After admission the clinical signs were indicative of a 
breaking down carcinoma of the prostate or base of the bladder.
He died in uraemia on 13.12.47.
At post mortem examination - there was a large infiltrating 
papillary carcinoma of the bladder (later confirmed on 
microscopy). There was pyonephrosis of the left kidney and 
the right kidney was necrotic.
He is a brother of Case Ho.65*
This case is referred to on page 82
Date of Birth: 6*3.00.
Date of Entry: 7•3*30.
Date of Onset: 9*6.44*
Date of Death: 7*4*46.
Age at Entry: 30 years
Age at Onset: 44 years
Age at Death: 46 years
Latent Period: 14 years
Working History:
1926 - 39 Worked on the manufacture of a variety of 
naphthylamine sulphonic acids.
1939 - 44 Worked on the distillation of benzidine, tolidine, 
betanaphthylamine and other products.
History of Onset:
In May 1944 many red blood cells were seen in the urinary 
deposit on routine test and on a repeat test.
Hospital: Christie Hospital. Surgeon: Mr. J. M. Macalpine.
Diagnosis and Treatment:
The tumour was a carcinoma originating at the vesical outlet 
and was sessile. It extended back along the trigone for some 
distance towards the left ureteric orifice.
In September 1944 a total cystectomy with transplantation of 
the ureters into the pelvic colon was done.
He survived nearly two years but control was poor and he was 
seldom able to go out. He died in uraemia in April 1946.
9.6*44* Carcinoma T
(section - 
epidermal carcinoma)
otal cystectomy
Progress:
This case is referred to on page 162
CASE Ho .88 (A.W.)
Date of Births 
Date of Entry: 
Date of Onsets 
Date of Death:
Working History: 
1924 - 25
23. 6.89. 
1.10.24* 
16. 3.45* 
26.12.51.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
35 years 
56 years 
62 years 
21 years
Worked on the manufacture of betanaphthylamine 
disulphonic acids. Exposure to betanaphthylamine 
would be heavy during this period.
1925 - 29 Employed in a "non-carcinogic plant” breaking and 
grinding solid caustic soda.
1929 - 40 Manufacture of naphthionate of soda - small
quantities of alphanaphthylamine are present as an 
impurity in the crude naphthionic acid.
1940 - 45 Manufacture of H.Acid.
History of Onset:
On 16th February 1945 began passing blood in his urine. This 
persisted until he had treatment. Routine urine examination 
for blood cells had been negative.
Hospital: Salford Royal Hospital:
Christie Hospital,
Manchester.
Diagnosis, Course and Treatment:
16.3.45.
20.5.46.
Progress:
Papilloma
Carcinoma
Surgeon: Mr.J.B.Macalpine. 
later Mr.D.S.Poole-Wilson.
P IT diathermy 
Deep X-ray therapy
There was a prolonged radiation reaction and he did not work 
after 1946. An ulcerated area persisted for three years; a 
biopsy specimen of this area was taken in May 194& ^ut no 
malignant changes were seen in it.
His last cystoscopy was on I4.ll.5i. recurrent tumour was 
seen but a plaque of debris was diathermized although it was 
not regarded as being tumour formation. On discharge from 
hospital he was in good general condition.
He took ill at home on Christmas Day and died on the 26th 
December 1951* The cause of death was certified by his own 
doctor as carcinoma of the bladder. A post mortem examination 
was not made.
Date of Birth: 5. 1.09.
Date of Entry: 13.12.29*
Date of Onset: - 4*34-
Date of Death: 14* 6*51.
Age at Entry: 21 years
Age at Onset: 25 years
Age at Death: 42 years
Latent Period: 4 years
Working History:
1927 - 30 Worked on the stoving of betanaphthylamine*
1930 - 34 Worked on the manufacture of alphanaphthylamine 
sulphate.
History:
He developed a papilloma of the bladder in April 1934 and was 
treated at Ancoats Hospital by electrocautery. He then left 
the Company and obtained an indoor job as a clerk in the Post 
Office, a situation he held until his death.
In late 1950 k© had haematuria and was admitted to Crumpsall 
Hospital, Manchester, under the care of Mr. D. S. Poole-Wilson. 
He was found to have small multiple papillomata of the bladder 
and these were fulgurated. There was also a large tumour of 
the left kidney. This was removed at operation on 28.12.50.
On section it proved to be a transitional cell epithelioma, 
doubtless derived from the renal pelvis.
He went steadily downhill and died at home on 14th June 1951* 
There was no post mortem examination.
This case is of particular interest because of the early age 
at onset. He is the youngest man in the series to have 
developed a tumour of the bladder.
CASE Ho.90 (R*W*)
Date of Birth: 15* 2.83*
Date of Entry: 6. 3*18.
Date of Onset: ? - - 37*
Date of Death: 12*12*37•
Age at Entry: 35 years
Age at Onset: 7 54 years
Age at Death: 54 years
Latent Period: 19 years
Working History:
1918 - 37 Worked on the manufacture of hetanaphthylamine and 
various naphthylamine sulphonic acids*
This case came to light during the A«B*C*M« survey when his 
death certificate with the cause of death as "cancer of the 
bladder" was noted*
Ho inquest was held* It has not been possible to trace any 
further information about this case from hospitals, relatives 
or workmates*
History
Date of Birth: 28*4*00*
Date of Entry: 8*4*24*
Date of Leaving: 16*4*25*
Date of Onset: - - 37*
Date of Death: 30*6*42*
Age at Entry:
Age at Onset:
Age at Death: 
Exposure Period: 
Latent Period:
24 years 
37 years 
42 years 
1 year 
13 years
Working History:
1924 - 25 
(Clayton
records)
1925
(inquest 
Report)
Worked on the manufacture of H.Acid - would involve 
exposure to alphanaphthylamine and possibly 
b et anaphthylamine•
Worked three months at Levensteins (later I.C.I.Ltd.) 
as a labourer.
History:
This case came to light after he died when enquiries were made 
by the Coroner*s Officer. The history is gained from the 
inquest report. His widow said he had worked at Levensteins 
before the First World War and for three months after he was 
demobilised.
After leaving Clayton in 1925 he had worked as a boot repairer 
until his death in 1942.
He first attended hospital in 1937 and attended several times 
after that. On the last occasion he was in hospital for 10 days 
before he died*
The pathologist who made the post mortem examination gave 
evidence that there was a malignant tumour infiltrating the 
bladder wall and advanced pyelonephrosis of both kidneys with 
abscess formation*
A verdict of death from natural causes was returned by the jury!
Date of Birth: 10*3*84*
Date of Entry: 30*8*20*
Date of Onset: - 5*31*
Date of Death: 4*2*32.
Age at Entry: 36 years
Age at Onset: 47 years
Age at Death: 48 years
Latent Period: 11 years
Working History:
1920 - 31 Worked on the manufacture of betanaphthylamine. 
History:
This is one of the earliest known cases to arise in the 
factory. It came to light when a summary of the inquest 
proceedings was found in an old file in the Labour 
Department. The history is gathered from the report of 
the inquest held 10.2.32.
In May 1931 he complained of gastric trouble, sickness 
and vomiting. He became worse in July and was admitted 
to Crumpsall Hospital, Manchester. He died on 4*2.32.
At post mortem examination there was extensive carcinoma 
of the bladder* The other organs were healthy.
An open verdict was returned.
CASE Wo* 95 (S.H.)
28 years 
39 years 
39 years 
11 years
1927 - 38 Worked on the manufacture of benzidine*
History:
This case came to light when the death certificate was noted 
in the course of the A.B.C.M. field survey#
The death was certified as cancer of the bladder*
Wo details of the medical history can be traced*
Date of Birth: 
Date of Entry: 
Date of Onset: 
Date of Death:
10*1*99. 
25.7.27. 
- - 38.
2.7.38.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
Working History:
Date of Births 
Date of Entry: 
Date of Onsets 
Date of Deaths
Working Historys
5.10.99. 
22. 4.32. 
22. 4*43.
4. 6.52.
Age at Entry: 
Age at Onsets 
Age at Death: 
Latent Periods
32 years 
42 years 
52 years 
11 years
1932 - 35 Worked on the manufacture of chlor-toluidine
sulphonic acid in the Building where benzidine was 
manufactured.
1935 — 43 Worked on the manufacture of benzidine.
History of Onsets
In April 1943 he had slight haematuria of sudden onset. Routine 
microscopy of urine at factory had revealed no R.B.Cs. until 
then.
Hospitals Salford Royal Hospital. Surgeons Mr.D.S.Poole—Wilson.
Diagnosis, Course and Treatments
22.4.43.
17.5.47.
23.2.51.
8.5.51.
4.5.52.
Papilloma
1
Carcinoma 
(biopsy - transitional 
cell carcinoma) 
Recurrence
P IJ diathermy
11 it
Deep X-ray therapy
1st stage total cystectomy 
(uretero-sigmoidostomy)
This man resumed work as a processman after treatment for his 
initial papilloma in 1943 but did not work on benzidine. He 
continued at work until 1951* During this period regular 
cystoscopic review was carried out at intervals of three to six 
months.
In February 1951 an area of recurrent papilloma near the 
internal meatus was treated by diathermy. Three months later in 
this area there was a solid tumour the surface of which was 
necrotic. Biopsy revealed a transitional cell carcinoma. The 
response to deep X-ray therapy was unsuccessful and a two stage 
cystectomy was planned.
Transplantation of the ureters into the sigmoid colon was 
performed in May 1955* Following this operation he deteriorated 
steadily and died in uraemia on 4.6*52.
This case is referred to on page 162
Date of Birth:
Date of Entry:
- - 80. 
 19. *
Age at Entry: 39 years
Age at Onset: 68 years
Age at Death: 68 years
Latent Period: 28 years
Date of Retirement 
Date of Death:
4.7.47. 
 48.
Working History:
* This man worked at Clayton on and off from 1900 hut there are
no records of this early employment. For the analysis of the
tumour cases his starting date has been taken as 1919 > the year 
in which he was first exposed to betanaphthylamine.
* 1919 “ 22 Worked on the sulphonation of betanaphthylamine.
1922 - 26 Left Company.
1926 - 47 Worked on the manufacture of various intermediates
and had intermittent contact with betanaphthylamine.
He retired in 1947 at the age Of 67. Nothing further was heard 
of him, except that he had died in 1948, until, in the course 
of the A.B.C.M. survey his death certificate with cancer of the 
bladder as the cause of death came to light.
History:
CASE Ho.98 (T.E.)
Date of Birth: ---76.
Date of Entry: - - 20. *
Date of Leaving: 15*3*40.
Age at Entry: 36 years
Age at Onset: 66 years
Latent Period: 22 years
Date of Onset: - -.42.
Date of Death: 6.8.42.
Working History:
* Although this man started work at Clayton in 1912, the year 
1920 is taken as the date of entry for the purpose of the 
analysis of the tumour cases, i.e. the year in which the 
manufacture of betanaphthylamine started.
* 1920 - 40 Worked as a pipe fitter in the department in which
betanaphthylamine was manufactured. He maintained 
the plant in which it was made.
He retired in 1940 and nothing further was heard of him until, 
in the course of the A.B.C.M. field survey, his death 
certificate was noted to have as the cause of death - 
"(a) carcinomatosis (b) carcinoma of the bladder.M
History:
CASE Ho.99 (A.G.H.)
Date of Birth: 25*3*01.
Date of Entry: 1.3.24.
Date of Leaving: 1.2*46.
Date of Onset: - 7.50.
Date of Death: 3*9*5®.
Age at Entry: 23 years
Age at Onset: 49 years
Age at Death: 49 years
Exposure Period: 22 years
Latent Period: 26 years
Working History:
1924 - 25 Worked on the stoving of betanaphthylamine.
1925 - 46 Weighman handling benzidine and alphanaphthylamine.
This case came to light through the A.B.C.M. survey when the 
death certificate mentioning carcinoma of the bladder was 
noted. His occupation was given on the certificate as - 
“formerly a fish fryer.11
Enquiries revealed that he had been ill only about six weeks 
before he died.
There was no post mortem examination.
History
CASE No.lOO (C.B.)
Date of Birth: 
Date of Entry: 
Date of Leaving: 
Date of Onset: 
Date of Death:
26.6,78.
10.8.23.
25.3*44.
- - 47.
- - 47.
Age at Entry:
Age at Onset:
Age at Death: 
Exposure Period: 
Latent Period:
45 years 
69 years 
69 years 
21 years 
24 years
Working History:
1923 - 44 Worked on the manufacture of azo colours some of 
which entailed the use of benzidine.
History:
This case was reported to me on 15*5*51* hy the Nuffield 
Department of Occupational Health, University of Manchester, 
to whom enquiries had been made by the widow. The man left 
the Company in 1944* He was admitted to Manchester Royal 
Infirmary three years later and was found to be suffering 
from cancer of the bladder from which he died soon afterwards. 
Ho post mortem examination was made.
Date of Birth: 
Date of Entry: 
Date of Onset: 
Date of Death:
Working History:
25* 5.96. 
7.11.21. 
- 3.52.
28. 6.52.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
25 years 
56 years 
56 years 
30 years
1921 - 24 Worked on the manufacture of magenta.
1924 - 26 Left Company.
1926 - 29 Worked on the manufacture of aniline.
1929 - 52 Worked on the grinding and milling of a large
variety of finished colours and some intermediates 
e.g. paranitraniline and 5-chlor-2-toluidine.
History:
This man was admitted to Ashton Infirmary in March 1952 with 
a provisional diagnosis of enlarged prostate. Routine urine 
tests had been negative.
At operation an inoperable carcinoma of the bladder was found. 
He died on 28th June 1952.
An inquest was held. The pathologist's report was that he 
died of a cancer of the bladder of a type similar to that 
found in people who work in aniline dyes, with secondaries 
in the abdomen and chest. 1 had not been informed that a 
post mortem examination was to be made and was not present 
at it.
CASE Ho.103 (T.D.)
Sate of Birth: 11.11.95- Age at Entry: 24 yeare
Date of Entry: 10. 1.20. at onset: J  1-7.1
Date of Onset: *n a A7 * x -n xu ** years■n x « -n  ,, 110 4#4i* Age at Death: 157 Vears
Date of Death: g r x x -n • j years
o. Latent Period: 27 years
Working History:
Sept 1920 - Jan 1921 Employed in the colour department on the 
stoving of betanaphthylamine and other intermediates 
and finished colours.
1921 - 47 Worked as a boiler fireman exclusively.
History of Onset:
Referred to hospital by his own doctor because of symptoms of 
bladder trouble.
Hospital: Manchester Royal Infirmary. Surgeon: Prof. A. M. Boyd. 
Diagnosis. Course and Treatment:
11.4.47. Papilloma Suprapubic cystotomy and
excision of papilloma
Progress:
Regular follow-up examinations were carried out and no 
recurrences were seen. The last examination was in April 1951*
He continued at work until he developed a primary carcinoma of 
the bronchus in 1952. It was inoperable when found. He died 
of secondaries in the brain on 8.9*52* Ho post mortem 
examination was made.
CASE Ho.104 (G.H.)
Date of Births 
Date of Entrys 
Date of Onsets 
Date of Deaths
Working History:
5.10.86.
5. 9.27* 
21. 9.49.
25.11.52.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Periods
41 years 
63 years 
66 years 
22 years
1927 - 29 Worked on the manufacture of melantherine BH and JH.
1929 - 49 Worked on the manufacture of 5 chlor-2 toluidine in
a plant where benzidine was used extensively for azo
colour manufacture.
History of Onsets
In April 1949 he had slight transient haematuria which was 
attributed to chlortoluidine cystitis. He was moved to other 
work where he did not come in contact with this amine but in 
August he had another attack of haematuria and was referred 
to hospital.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
21*9*49* Papilloma P U diathermy
(biopsy - malignant 
papilloma)
19.4» 51* Papilloma ” 1
Progress:
He returned to sheltered work as a messenger. Regular review 
examinations were made and no recurrences were seen in the 
bladder after 1951*
In late 1952 he developed carcinoma of the head of the pancreas 
which was considered to be a primary growth. He died on 
November 25th. Ho post mortem examination was made.
CASE No.105 (A.H.)
Date of Birth:
Date of Entry:
Date of Onset:
Date of Death:
Working History:
* He started work at Clayton in 1915> "but for the 
analysis of the cases his date of entry is taken 
as 1918, the year in which benzidine manufacture 
was started*
1918 - 50 Worked on manufacture of benzidine and tolidine.
History of Onset:
In February 1950 red blood cells were present in fairly large 
quantities in three successive urine tests; the first was on 
routine examination.
Hospital: Christie Hospital. Surgeon: Mr. D. S. Poole-Wilson.
Diagnosis, Course and Treatment:
7*3*50* Carcinoma Open operation
and gold seed implant
Progress:
At operation on 5*4*50. there was a nodular growth above the 
right ureteric orifice about 3 ems in diameter which appeared 
to be indurated and was drawing up the adjacent bladder mucosa. 
Below this and behind the interureteric bar there was a small 
diverticulum inside which was a papilloma. The diverticulum 
was excised. The nodular tumour was diathermized and implanted 
with radon seeds.
The bladder was clear of visible recurrence when he was reviewed 
in November 1951*
He made a poor recovery from his initial operation and did not 
return to work. In October 1952 there was recurrent infiltrating 
growth in the left pelvic wall. He died in April 1953 of 
secondary carcinomatosis and extensive local growth in the pelvic 
cavity, confirmed on post mortem examination.
25. 3.86. 
18.10.18. (1915)* 
7. 3.50.
16. 4*53*
Age at Entry: 32 years
Age at Onset: 64 years
Age at Death: 67 years
Latent Period: 32 years
CASE No.106 (J.O.)
Date of Births 
Date of Entry: 
Date of Leavings 
Date of Onsets 
Date of Deaths
Working Historys
3. 5.04.
- - 31.
- - 40.
1. 2.51.
13.10.53.
Age at Entry:
Age at Onset:
Age at Deaths 
Exposure Periods 
Latent Periods
27 years 
47 years 
49 years 
9 years 
20 years
1931 - 40 Worked on manufacture of "benzidine, tolidine and 
dianisidine - chiefly on drying the products in 
stoves.
History of Onsets
In January 1951* eleven years after leaving the Company, he was 
referred "by his own doctor to the Christie Hospital because of 
haematuria and dysuria.
Hospitals Christie Hospital. Surgeons Mr. D. S. Poole-Wilson. 
Diagnosis, Course and Treatments
1.2.51. Carcinoma Gold seed implant
Progress:
There was a flat papillomatous tumour above and behind the 
interureteric bar. This was treated by open operation diathermy 
and gold seed implant. On biopsy the tumour was seen to be a 
transitional cell carcinoma.
In the following October the mucosa at the site of the implant 
was still ulcerated but in February and August 1952 and in 
March 1953 the bladder was healed and no tumour was seen.
In June 1953 he developed venous obstruction with oedema of the 
right leg and a pelvic mass was palpable per rectum.
He died of infiltrating carcinoma of the pelvic structures on 
the 13th October 1953.
CASE No>107 (J.M.)
Date of Births 4, 9.94*
Date of Entry: 26. 9*23*
Date of Onsets 21. 8*41*
Date of Deaths 15.12.53.
Age at Entry: 29 years
Age at Onsets 47 years
Age at Deaths 59 years
Latent Periods 18 years
Working Historys
1923 - 26 Worked on the manufacture of benzidine and tolidine. 
1926 - 41 Worked on the manufacture of various other
intermediates, in the shed in which benzidine was 
made.
History of Onsets
In 1942 there was microhaematuria in successive routine urine 
tests.
Hospitals Salford Royal Hospital. Surgeons Mr. J. B. Macalpine. 
Diagnosis, Course and Treatments
21.8.42. Papilloma P U diathermy
Progress:
A "suspicious" mossy area was diathermized in 1949 but no other 
abnormality was seen in the bladder on regular review 
examinations.
He continued at his usual work until he retired because of 
chronic bronchitis at the beginning of 1952.
He died of myocarditis and bronchitis in hospital on 
15th December 1953*
Date of Birth; 31.3.00.
Date of Entry: 9*4.31.
Date pf Onset: 20.1.49*
Date of Death: 11.1«54*
Age at Entry: 31 years
Age at Onset: 49 years
Age at Death: 53 years
Latent Period: 18 years
Working History:
1931 - 39 Worked in the shed in which benzidine was made as 
general labourer with occasional spells on vacuum 
stove (dianisidine, para-amido-phenol base).
1939 - 47 Worked on ice distribution and on vacuum stove.
1947 - 49 Worked on the manufacture of nitro diazo, paranitro- 
orthotoluidine, cresapol, ortho-nitrotoluol sulphonic 
acid, nitrobenzene sulphonic acid, nitrochlortoluene 
sulphonic acid, chlornitraniline, meta-nitro- 
paratoluidine, ortho-nitrophenol sulphonic acid and 
di ni t ro napht halene.
History of Onsets
Referred to hospital for investigation because of symptoms of
bladder trouble. Routine urine tests for blood cells had
previously been negative.
Hospitals Salford Royal Hospital. Surgeons Mr.D.S.Poole-Wilson, 
later Christie Hospital.
Diagnosis, Course and Treatments
20.1.49. Carcinoma Open operation and G.S.I.
3.4*51* Keloid in scar; Excised.
3 stones in bladder. Removed.
26.5*53* Keloid in scar. Excised and irradiated.
Progresss
On section the tumour proved to be an epidermal carcinoma.
He returned to light work in June 1949 as a joiner*s labourer. 
He had regular periodic cystoscopic examinations. The last one 
was on 26.5*53* when the bladder was clear.
In early November 1953 he complained of severe headache and of 
stumbling to the left side when walking. He died at home in 
the following January of secondaries in the brain and lungs.
No post mortem examination was made.
CASE No.109 (C.W.)
Date of Birth 
Date of Entry 
Date of Onset 
Date of Death
25. 4*00, 
9.12.21.
4. 8.38.
17. 8.54.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
22 years 
38 years 
54 years 
17 years
Working History:
1921 - 38 Worked on the manufacture of alphanaphthol and
various naphthylamine sulphonic acids using alpha- 
and betanaphthylamine. Was chargehand from 1928-38.
History of Onset:
Ho record.
Hospital: Manchester Northern,
later Salford Royal Hospital.
Surgeon: Mr. K. H. Watkins,
later Mr.D.S.Poole-Wilson.
Diagnosis. Course and Treatment
5.3.38.
12.1.39.
25.5.41.
15.1.46.
8.7.46.
14.9.4 .^
9*9.50. 
13.1.51. 
- 2.53.
Progress:
Papillomata
Papilloma
Carcinoma
Papilloma
"Suspicious" area 
Carcinoma
P U diathermy (Northern Hospital)
" " (Transferred to
Salford Royal Hospital) 
Open operation. Gold seed implant. 
P U diathermy
The original tumours, which were multiple, were fulgurated in 
two separate sessions at the Northern Hospital.
In May 1941 a nodular sessile tumour was seen on the posterior 
wall of the bladder which, on biopsy, proved to be malignant. 
This was treated by open operation and gold seed implant.
He continued at work. After 1938 his duties were mainly 
supervisory and in 1943 he was promoted to foreman.
He had several recurrences which were successfully fulgurated 
but in January 1952 a mass of low growing nodular carcinoma was 
seen on the anterior wall of the bladder and there was a nodular 
area on the vault. Between these two areas the appearance of 
the mucosa was suggestive of infiltrating carcinoma.
He was advised to have a total cystectomy but calmly declined 
the operation as he had seen two of his mates who had had it.
He was well aware of the consequences of his considered refusal.
He survived an unexpectedly long time before he died of 
infiltrating carcinoma on 17th August 1954* H© never appeared 
to regret his decision.
This case is referred to on page 163
CASE No.110 (A.W.)
Date of Birth: 29* 3*96.
Date of Entry: 17* 3*24*
Date of Leaving: 24*10.34*
Date of Onset: - 8.36.
Date of Death: 30.12.43*
Age at Entry: 28 years
Age at Onset: 40 years
Age at Death: 47 years
Exposure Period: 10 years
Latent Period: 12 years
Working History:
1924 - 34 Worked on the manufacture of betanaphthylamine - 
chiefly engaged on drying it in stoves.
Nothing was heard of this man after he left in 1934 until 1955 
when his widow applied to the Company for a pension because of 
his death from cancer of the bladder 12 years previously.
It was confirmed that he had had a partial cystectomy for 
carcinoma of the bladder at Ancoats Hospital in August 1936 
and that the cause of his death in December 1943 had been 
certified as "cancer of the bladder".
Previously, for a year, 1920-21, and for 2§- months 
in 1922 he had worked in another chemical factory 
(i.C.I.Ltd.) part of the time on the boilers and 
part on the manufacture of aminoazo-toluene.
History:
The short periods of employment at I.C.I. were considered to 
be insignificant and an ex gratia pension was granted.
Date of Birth: 25.12.96.
Date of Entry: 1. 9.20.
Date of Onset: 23* 6*52.
Date of Death: 3* 9*55*
Age at Entry: 24 years
Age at Onset: 56 years
Age at Death: 59 years
Latent Period: 32 years
Working History:
1920 - 50 Worked on the manufacture of betanaphthylamine.
In the earlier years one of his jobs was to break 
up betanaphthylamine in open trays by hand.
195° “ 52 Worked on other products in the same building.
History of Onset:
In April, May and June 1952 stained smears were Class III and 
a moderate number of red blood cells were present in routine 
urine tests.
Hospital: Salford Hoyal Hospital. Surgeon: Mr.D.S.Poole-Wilson. 
Diagnosis, Course and Treatment:
21.7.52. Papilloma P U diathermy
No recurrent tumours were seen in the bladder on regular review 
examinations.
The last cystoscopy was on 25*4*55* four months before his 
death, when the bladder was clear. His general condition 
gradually deteriorated after this and he died at home on 
3.9.55. The signs and symptoms were typical of cerebral 
arterial degeneration. His own doctor certified the cause 
of death as "cancer of the bladder" and this was not disputed. 
No post mortem examination was made.
Date of Births 23.10.98. Age at Entry: 41 years
Date of Entry: 5. 2.40. Age at Onset: 50 years
Date of Onset: 3.11.48. Age at Death: 57 years
Date of Death: I4.ll.55. Latent Period: 9 years
Working History:
1940 - 42 Worked on the manufacture of nitro diazo, 
paranitrochlor "benzol sulphonic acid, and 
similar intermediates, which were made in 
the "benzidine shed.
1942 - 48 Worked on the manufacture of "benzidine.
History of Onset:
Routine urine tests showed small numbers of red blood cells 
persisting for several months from August 1948.
Hospital: Salford Royal Hospital. Surgeons Mr.D.S.Poole—Wilson. 
Diagnosis, Course and Treatment:
13«12.48. Papilloma P U diathermy
24. 2.49. " " "
26. 7*49. " " ”
22. 9.52. " " "
8.12.52. " " "
25. 8.55* Carcinoma of right Inoperable
kidney with metastases.
Progress:
He returned to his usual plant work for two years and was then 
transferred to work as a fitter’s mate.
Cystoscopic examinations were made regularly. After four 
recurrences had been treated the bladder was clear for nearly 
three years after 1952.
In March 1955 &© had slight haematuria. On cystoscopy there 
was considerable prostatic hypertrophy which was thought to 
account for the haematuria. On 5th August 1955 w9-s again 
cystoscoped and the bladder was clear. Barely three weeks 
later a fixed mass was palpable in the right loin and this was 
undoubtedly a carcinoma of the kidney. An attempt was made to 
remove the kidney in October but it was inoperable. A piece 
removed for section showed the presence of "atypical carcinoma"•
He died a few days later on the 14th November 1955*
Date of Birth: 27*9*02.
Date of Entry: 17.9.24.
Date of Onset: 27*2.41.
Date of Death: 20.9.55.
Age at Entry: 22 years
Age at Onset: 35 years
Age at Death: 53 years
Latent Period: 16 years
Working History:
1924 - 27 Worked as a still-man in the diamine factory.
1927 - 36 Worked on the distillation of betanaphthylamine, 
benzidine, tolidine, phenylbetanaphthylamine and 
diphenylamine.
1936 - 41 Weighman in betanaphthylamine department.
History of Onset: v
He had haematuria of sudden onset in February 1941*
Hospital: Salford Royal Hospital. Surgeon: Mr. J. B. Macalpine.
Diagnosis, Course and Treatment:
27.2.41* Carcinoma Partial cystectomy
He returned to his work as a weighman until 1947 when he was 
transferred to the Works Police.
Regular review examinations were made.
This case is of particular interest in that he had no 
recurrences after his initial treatment. He died suddenly 
of coronary thrombosis 14 years later.
Date of Births 1883*
Date of Entry: 1918.
Date of Onset: 1931*
Date of Death: 1931*
Working History:
1918 - 31
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
35 years 
48 years 
48 years 
19 years
Worked on the manufacture of alphanaphthol from 
alphanaphthylamine and on the manufacture of 
Betanaphthylamine. Also distilled Benzidine and 
tolidine.
History of Onset:
It was stated in evidence at the inquest on this man that he 
complained of difficulty in micturition for 6 months Before 
his death.
Hospitals Crumpsall Hospital.
Diagnosis, Course and Treatment:
24»6#31» Inquest report. Carcinoma of the Bladder.
History:
This death occurred several years Before it v/as generally 
recognised in Britain that such tumours of the Bladder were 
occupational. Nevertheless an inquest was held and the 
following history is culled from the notes which were taken 
at the time.
Inquest 24*6.31. He had complained of passing Blood early in 
the year and was admitted to Crumpsall Hospital, Manchester, 
in May 1931*
On post mortem examination there was a tumour in the Bladder 
which was Breaking down and there was inflammation of the 
kidneys. The pathologist stated that there was nothing to 
differentiate Between what was found and a growth produced 
By natural causes.
An open verdict was returned
Date of Birth.: 
Date of Entry: 
Date of Onset: 
Date of Death:
16. 1.01. 
12. 9.26. 
20. 8,39. 
4.12.55*
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
25 years 
39 years 
54 years 
13 years
Working History:
1926 - 39 Worked on the manufacture of benzidine.
History of Onset:
No record.
Hospital: Salford Royal Hospital, 
later Christie Hospital.
Diagnosis, Course and Treatment:
25. 8.39. 
14.11.47.
10. 8.55.
Progress:
Papilloma
Carcinoma
Metastasis
Scapula
Surgeon: Mr. J. B. Macalpine. 
later Mr. D. S. Pool e-Wilson.
P U diathermy 
Deep X-ray
Deep X—ray
Regular review examinations were made until 1943 when he was 
discharged from hospital as he had had no recurrences. He 
continued at work until 1947.
In September 1947 there was marked microhaematuria on successive 
routine urine tests at the factory and he was referred back to 
hospital. On cystoscopy a carcinoma was seen on the right side 
of the bladder and he was transferred to Christie Hospital for 
radiation therapy.
He was admitted there in December 1947 and on re—examination 
several foci of neoplasm were seen in the bladder wall. He was 
treated by a course of deep X—ray therapy. In July 1948 the 
bladder was seen to be clear of tumour and it remained so on 
regular follow-up examinations until the last one in October 
1954 by which time they were being done annually.
In August 1955 a lump appeared over the right scapula. This 
proved on biopsy to be secondary carcinoma. It was treated by 
deep X-ray. Other secondaries appeared in the ribs soon 
afterwards and he died at home on 4th December 1955* post 
mortem examination was made.
CASE No.116 (J.C.)
Date of Birth: 9*10.77.
Date of Entry: 1. 3.16.
Date of Onset: 26. 5*52.
Date of Death: 25*12.55.
Age at Entry: 38 years
Age at Onset: 75 years
Age at Death: 78 years
Latent Period: 36 years
Working History :
1916 - 18 Worked on the manufacture of sulphuric acid.
1918 - 26 Worked on the manufacture of hetanaphthylamine.
1926 - 45 Worked in acid department on the recovery of 
sulphuric acid.
1945 - 52 Worked as a dogger - repairing clogs and 
protective footwear.
History of Onset:
In April 1952 on routine urine tests a stained smear was 
Class IV and there were many red and white blood cells in 
the wet smear.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
26.5.52. Papilloma P U diathermy
11.8.55* Papillomatosis Nephroureterectomy
left kidney.
Progress:
After treatment he continued to work as a dogger until he 
retired in January 1953 at the age of 75* 2e was reviewed 
regularly and no recurrences were seen in the bladder.
In early August 1955 ke had several attacks of haematuria. 
Investigations revealed the presence of a tumour in the left 
renal pelvis. A nephroureterectomy was performed on 1*9*55* 
Papillary carcinoma was confirmed on section.
A few weeks after the operation, on December 8th, he was 
re—admitted with a mass of secondary carcinoma in the 
nephrectomy wound. He died on Christmas Day 1955*
The clinical findings were confirmed on post mortem examination.
CASE No.117 (W.H.S.)
Date of Birth 
Date of Entry 
Date of Onset 
Date of Death
31.10.01. 
27. 5-29. 
24.12.47.
27. 1.56.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
28 years 
46 years 
54 years 
19 years
Working History:
1929
1932
1940
1945
32
45
- 45
- 47
General labourer in yard of benzidine plant.
Worked on the manufacture of benzidine disulphonic 
acid, nitrodiazo N.S., meta-nitroparatoluidine, 
metanilic acid and p-nitro p-anisidine.
Worked on the manufacture of various 
alphanaphthylamine sulphonic acids.
Worked on benzidine manufacture.
History of Onset:
He had haematuria early in December 1947. Prior to this routine 
urine tests had shown a few red blood cells in February 1946 but 
had otherwise been negative.
Hospital: Salford Royal Hospital. 
Diagnosis, Course and Treatment:
Surgeon: Mr .D. S.Pool e-Wilson.
24.12.47. 
15* 5.48. 
10. 7.48.
10.11.48. 
29. 3.51. 
22. 9.53.
Papilloma P U diathermy
it it
Progress:
He returned to work as a processman but was not in contact with 
carcinogens.
Regular cystoscopic review examinations were made.
On 28th November 19559 two years after the last recurrence, he 
had an epileptiform fit and was subsequently admitted to Salford 
Royal Hospital. He was found to have a carcinoma of the lung 
with secondaries in the brain. The neoplasm in the lung was 
considered to be a primary tumour. The bladder was clear of 
tumour on cystoscopy at that time.
He was discharged from hospital and died at home on 27.1*56.
No post mortem examination was made. The cause of death was 
certified as:
I Primary carcinoma of right bronchus 
II Papilloma of the bladder.
Date of Birthj 
Date of Entry: 
Date of Onset: 
Date of Death:
Working History:
1. 8.94. 
25. 9.29. 
12.11.42. 
9* 4.56.
Age at Entry
Age at Onset
Age at Death
35 years
48 years
61 years
Latent Period: 13 years
1929 - 42 Worked on the manufacture of sulphanilic acid and 
the distillation of many chemicals including 
betanaphthylamine, benzidine and alphanaphthylamine.
History of Onset:
In late October 1942 he complained of a dull pain in his 
abdomen and frequency of micturition. On one occasion he had 
seen blood in his urine. Routine urine tests had previously 
been negative.
Hospital: Salford Royal Hospital. Surgeon: Mr.J.B.Macalpine.
later Christie Hospital. later Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
12.11.42.
10.12.43. 
24. 4.44. 
14. 5.45. 
13. 7.45. 
13. 4.46.
Progress:
Papilloma
1
P U diathermy
Pyonephrosis
Carcinoma
(bladder)
Right nephrectomy 
Diathermy and gold seed 
implant
Regular review examinations were made.
In 1945 the right kidney was removed because of pyonephrosis. 
There was no neoplasm on histological examination.
At review in April 1946 a clinically malignant recurrent tumour 
was seen in the bladder above the interureteric bar. He was 
transferred to Christie Hospital and in August a gold seed 
implantation was done. On section the tumour proved to be a 
transitional cell carcinoma.
He had a severe radiation reaction and was off work for six 
months. He returned to light plant duties for four years. He 
had frequent attacks of cystitis and in 1951 wa-s transferred to 
the Works Surgery as a cleaner. In late 1955 k© began to go 
downhill and in October a secondary mass was present behind the 
left clavicle. No tumour was seen in the bladder in April 1955> 
the last occasion on which he was cystoscoped. He died of 
secondary carcinomatosis on 9*4*56*
CASE No.119 (S.T.H.)
Date of Birth: 29* 6.91.
Date of Entry: 11. 9*39.
Date of Onset: 17#12.47*
Date of Death: 5» 7*56*
Age at Entry: 48 years
Age at Onset: 56 years
Age at Death: 65 years
Latent Period: 8 years
Working History:
1939 — 47 Worked on the manufacture of benzidine and tolidine.
History of Onset:
In December 1947 h© had a sudden attack of haematuria. There 
had been no blood cells on routine urine tests until then.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson.
Diagnosis, Course and Treatment:
15* 1.48. Papilloma P U diathermy
4.11.49. " " "
19. 5.50. " " "
5. 8.55. " " "
Progress:
This man developed chronic bronchitis with dyspnoea in the late 
1940's. Because of this he only worked for short periods after 
1948 and he finally ceased work in 1951*
In the beginning of 1956 he began to lose weight rapidly. He 
was admitted to hospital. Investigation showed a filling 
defect in the left renal pelvis and a shadow in the upper lobe 
of the right lung. A diagnosis was made of carcinoma of the 
left renal pelvis with secondary deposit in the lung.
He died on 5th July 1956. On post mortem examination there was 
a large tumour in the upper lobe of the right lung, a mass of 
tumour tissue in the abdomen involving the pancreas and a tumour 
of the left renal pelvis. The histological findings were 
surprising. The lung tumour was a primary oat—celled carcinoma 
and the mass in the abdomen was secondary to it. The renal 
pelvic tumour was a papillocarcinoma.
An inquest was held and the verdict was that death was due to 
"natural causes due to primary carcinoma of the lung."
CASE No.120 (T.R.)
Date of Birth: 17. 7*04*
Date of Entry: 17.11*25#
Date of Leaving: 5* 9.30*
Date of Onset: 1* 6.54*
Date of Death: 25* 1*57-
Age at Entry: 21 years
Age at Onset: 50 years
Age at Death: 52 years
Exposure Period: 5 years
Latent Period: 29 years
Working History:
1925 - 30 Worked on the sulphonation of betanaphthylamine and 
on the milling of benzidine and tolidine.
History of Onset:
In 1954> 24 years after leaving the factory, he had haematuria 
for seven weeks. A year before that there was blood in the 
urine on one occasion only.
Hospital: Ancoats Hospital, 
later Christie Hospital.
Diagnosis, Course and Treatment:
1.6.54- Papilloma
21.9-55- Carcinoma
Progress:
In June 1954 there were two areas of tumour formation in the 
bladder, one apparently benign and the other larger area having 
clinical appearances suggestive of papillocarcinoma. No biopsy 
material was taken. Both areas were fulgurated.
Three months later one small papilloma and three "suspicious" 
areas were fulgurated. Ten months later, in April 19559 the 
bladder was clear.
Surgeon: Mr. G. 0. Jelly,
later Mr. D.S.Pool e-Wilson.
P U diathermy 
Radon seed implant
He was re—employed by the Company on sheltered work as a gateman 
in October 1954 and worked until August 1955- At that time on 
review examination there was a nodular ulcerated neoplasm on the 
posterior wall of the bladder. He was transferred to the 
Christie Hospital where a radon seed implant was carried out on
26.9-55- He had a severe radiation reaction and never worked 
again.
In August 1956 a nodule could be felt over the left external 
iliac vessels. Soon afterwards there were deposits in the 
pelvis and a large mass of glands in the groin.
He died on 25-1*57- On post mortem examination the bladder was 
clear of tumour. There was involvement of the right and left 
superficial inguinal glands extending along the lumbar iliac 
group and secondaries in the brain. Both suprarenals were 
replaced by neoplasm.
CASE No.121 (L.C.)
Date of Births 8. 1.05*
Date of Entry: 19.11.36.
Date of Leaving:. 27 * 5*44-
Date of Onset: — 11*56.
Date of Death: 20. 3-57-
Working History:
1936 - 38 Worked on the manufacture of hetanaphthylamine.
1938 - 44 Worked as a fitter's mate - no direct exposure 
to chemicals.
History of Onset:
Twelve years after leaving the Company he was referred to 
hospital by his own doctor because of a six weeks history 
of frequency of micturition and haematuria.
Hospital: Ancoats Hospital. Surgeon: Mr. G. 0. Jelly.
Diagnosis, Course and Treatments
5-12.56. Carcinoma Total cystectomy
(biopsy - carcinoma)
Progress:
On cystoscopy in December 1956 he was found to have an advanced 
carcinoma of the bladder with very small capacity. A total 
cystectomy was subsequently performed. The sections showed 
carcinoma with little penetration of the muscle wall and no 
secondaries were seen in the lymph nodes examined. Excision 
was thought to be complete.
He developed a urinary fistula through the abdominal wound and 
several abscesses which discharged. He died on 20th March 1957 
three months after the operation. On post mortem examination 
there was a large pyonephrosis on one side and a severely 
infected kidney on the other.
Age at Entry: 32 years
Age at Onset: 52 years
Age at Death: 52 years
Exposure Period: 8 years
Latent Period: 20 years
This case is referred to on page 162
CASE No.l22(A.W.)
Date of Birth: 
Date of Entry: 
Date of Onset: 
Date of Death:
Working History:
14.3.98.
7.3.22.
25.1.54.
13.4.57.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
24 years 
56 years 
59 years 
32 years
1922 - 25 Worked on manufacture of magenta-
1925 - 30 Worked on manufacture of triphenylmethane colours.
I93O - 49 Used benzidine in manufacture of sulphur colours.
1949 — 54 Hypertension. Light work as messenger.
History of Onset:
In January 1954 on routine urine tests stained smears were 
Class V.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole-Wilson, 
later Christie.
Diagnosis, Course and Treatment:
25.1.54.
25.6.54.
17.4.56.
? Papilloma
Malignant papillomatosis, 
(biopsy - papillary 
carcinoma)
Carcinoma
Central source cobalt 
radiation.
Inoperable
Progress:
When he was investigated on 25th January 1954 no tumour was 
seen in the bladder and no evidence of tumour was found 
elsewhere in the urinary tract.
Malignant cells continued to be exfoliated. On 25th June 1954 
there was widespread papillomatosis of the bladder which on 
biopsy proved to be papillary carcinoma. He was transferred 
to the Christie Hospital and treated by intracavity cobalt 
radiation.
In March 1955 He developed pulmonary tuberculosis. After six 
months chemotherapy in a sanatorium he was discharged well.
In April 1956 there was a mass of secondary carcinoma on the 
left side of the bladder invading adjacent structures. He died 
on 13th April 1957 of ascending pyelonephritis and recurrent 
carcinoma of the bladder, confirmed on post mortem examination. 
The tuberculous lesion in the lung was healed.
This case is referred to on page 136
CASE No.123 (G.W.)
Date of Birth: 
Date of Entry: 
Date of Leaving: 
Date of Onset: 
Date of Death:
Working History:
12.1.02.
- 9.35*
- 4.49. 
17.2.54.
3.7.57.
Age at Entry: 
Age at Onset: 
Age at Death: 
Exposure Period: 
Latent Period:
34 years 
52 years 
55 years 
14 years 
19 years
1934 - 35 Worked on the manufacture of benzidine azo colours. 
1936 - 38 Warehouseman weighing benzidine and 
alphanaphthylamin e•
1938 - 39 Warehouse weighman - but no carcinogens.
1939 - 45 H.M.Forces.
1945 — 49 Warehouse weighman - but no carcinogens.
History of Onset:
Five years after leaving the Company he consulted his doctor 
because of haematuria of four months' duration.
Hospital: Ancoats Hospital. Surgeon: Mr. G. 0. Jelly.
Diagnosis, Course and Treatment:
17. 2.54.
30. 4.54.
15.12.54.
Papilloma
1
P U diathermy
16. 3.55.
3.10.55. 
19. 1.56.
4.10.56.
24. 1.57. 
21. 2.57. 
3. 7.57.
Progress:
(on urethral margin) 
Papilloma
1
(on urethral margin)
Papilloma M "
It H II
Carcinoma Prostatectomy and excision of
prostatic urethra*
He was re-employed by the Company in August 1954 as a watchman. 
He was never fit for any but the lightest work, but, apart from 
the necessary absences for treatment he kept at work all the 
time. He was reviewed regularly and had many recurrences.
In July 1957 there was a malignant recurrence at the base of 
the bladder extending into the prostate. This was excised 
together with the prostate. He collapsed and died the same 
day. On post mortem examination death was found to have been 
due to air embolism. There were secondaries in the para aortic 
glands confirmed histologically.
CASE No.123 (G.W,)
Date of Birth: 
Date of Entry: 
Date of Leaving: 
Date of Onset: 
Date of Death:
12.1.02.
- 9.35*
- 4.49. 
17.2.54.
3.7.57.
Age at Entry: 
Age at Onset: 
Age at Death: 
Exposure Period: 
Latent Period:
34 years 
52 years 
55 years 
14 years 
19 years
Working History:
1934 - 35 Worked on the manufacture of benzidine azo colours. 
1936 - 38 Warehouseman weighing benzidine and 
alphanaphthylamin e•
1938 - 39 Warehouse weighman - but no carcinogens.
1939 - 45 H.M.Forces.
1945 ~ 49 Warehouse weighman - but no carcinogens.
History of Onset:
Five years after leaving the Company he consulted his doctor 
because of haematuria of four months* duration.
Hospital: Ancoats Hospital. Surgeon: Mr. G. 0. Jelly.
Papilloma
1
(on urethral margin) 
Papilloma
Diagnosis. Course and Treatment:
17. 2.54.
30. 4.54.
15.12.54.
16. 3.55.
3.10.55.
19. 1.56.
4.10.56.
24. 1.57.
21. 2.57.
3. 7.57.
Progress:
P U diathermy
(on urethral margin)
Papilloma ** H
It II H
Carcinoma Prostatectomy and excision of
prostatic urethra.
He was re-employed by the Company in August 1954 as a watchman. 
He was never fit for any but the lightest work, but, apart from 
the necessary absences for treatment he kept at work all the 
time. He was reviewed regularly and had many recurrences.
In July 1957 there was a malignant recurrence at the base of 
the bladder extending into the prostate. This was excised 
together with the prostate. He collapsed and died the same 
day. On post mortem examination death was found to have been 
due to air embolism. There were secondaries in the para aortic 
glands confirmed histologically.
CASE No.124 (S.P.)
Date of Birth: 7* 8.80.
Date of Entry: 1. 9*15*
Date of Retirement: 31*10.41# 
Date of Onset: 21#10#42*
Date of Death: 12. 8.57*
Age at Entry: 35 years
Age at Onset: 62 years
Age at Death: 77 years
Exposure Period: 26 years
Latent Period: 27 years
Working History:
1915 — 41 Was the chemist in charge of an intermediates 
plant. From 1920 onwards he had close contact 
with the manufacture of betanaphthylamine and 
before that with its development and starting up.
History of Onset:
A year after he retired he had haematuria of gradual onset.
Hospital: Salford Royal Hospital. Surgeon: Mr.J.B.Macalpine.
Diagnosis, Course and Treatment:
19.11.42. Papilloma P U diathermy
7. 1.43. " " “
Progress:
Regular cystoscopic examinations were made. He had no 
further recurrences after February 1943.
He died on 12.8*57• of cerebral arteriosclerosis.
CASE Ho.125 (W.Mcff.)
Date of Birth: 
Date of Entry: 
Date of Onset: 
Date of Death:
Working History:
30. 8.02. 
1.11.16.
13. 7.44.
14. 9.57.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
14 years 
42 years 
55 years 
28 years
1916 - 19
1920
1920 - 44
Laboratory boy. There are no records of the exact 
work he did but his own recollection and that of an 
older chemist is that he worked on the 
betanaphthylamine process when it was being 
developed and piloted in the laboratory.
Left the Company.
Re-employed as a processman on the manufacture of 
toluidines. Had contact with paratoluidine, 
orthotoluidine, chiorparatoluidine and 
mononitrotoluol.
History of Onset:
A few red blood cells were present in a routine urine test in 
1944* Before the next test he had an attack of haematuria.
Hospital: Salford Royal Hospital. Surgeon: Mr.J.B.Macalpine.
later Mr.D. S.Pool e-Wilson.
Diagnosis, Course and Treatment:
13. 7.44. Papilloma
26. 4.45* "
25.10.54.
14.12.55.
Progress:
He continued at his usual work until 1951 when he developed 
auricular fibrillation and was transferred to light work in 
a laboratory.
Regular review examinations were made. He had three tiny benign 
recurrences and it is interesting that there was an interval of 
nine years between the two of them.
He died on 14*9.57. of right heart failure after an illness of 
two months.
P IT diathermy
It «t
II II
II II
CASE No.126 (J.B.)
Date of Birth 
Date of Entry 
Date of Onset 
Date of Death
16. 7.00.
20. 3.24* 
26. 9.55. 
28.11.57.
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
24 years 
55 years 
57 years 
31 years
Working History:
1924 — 26 Worked on the manufacture of magenta.
1926 - 30 Worked on the manufacture of triphenylmethane 
colours.
1930 - 42 Worked on the manufacture of sulphur melt colours 
using benzidine. 4
1942 - 55 Worked on the manufacture of triphenylmethane 
colours.
History of Onset:
Stained smears from routine urine tests were Class III-IV in 
August 1955, Class III in September 1955 &&& Class IV on a 
repeat test. There were no symptoms or other signs of bladder 
trouble.
Hospital: Salford Royal Hospital.
Diagnosis, Course and Treatment:
26. 9.55. Papillomata
(biopsy - papilloma)
26.11.56. Carcinoma
(biopsy - carcinoma)
Progress:
The initial papillomata were two tiny benign growths which were 
well pedunculated and situated above the right ureteric orifice. 
Histologically the section of the biopsy material was benign 
papilloma.
He returned to work after treatment. At review cystoscopy in 
May 1956 the bladder appeared clear.
He was next examined on 26.11.56. A flat nodular invasive 
tumour surrounded the internal meatus and extended up to the 
trigone on the right lateral wall* On biopsy it proved to be a 
transitional papilliferous carcinoma. A course of deep X-ray 
therapy was given.
Response to treatment was poor and he died a year later of 
recurrent carcinoma of the bladder and iliac glands with 
secondaries in the lung. This was confirmed on post mortem 
examination.
Surgeon: Mr.D.S.Poole-Wilson.
P U diathermy 
Deep X-ray
CASE No.127 (H.C.)
Date of Birth: 9* 6.05.
Date of Entry: 29* 8.39- 
Date of Onset: 15* 1*57* 
Date of Death: 18.12#57•
Working History:
Age at Entry: 
Age at Onset: 
Age at Death: 
Latent Period:
34 years
51 years
52 years 
18 years
1939 — 41 Worked on the manufacture of benzidine.
1941 - 50 Worked on the manufacture of other intermediates in 
the same plant in which benzidine was made.
1950 “ 57 Transferred to Locker Room owing to chronic 
bronchitis.
History of Onset:
In March 1956 stained smears from routine urine tests were 
Class IV (Fig 10). Investigations failed to reveal any tumour. 
The stained smears continued to be positive and he was again 
investigated in December 1956. The history of the onset of 
this case is described fully in the text.
Hospital: Salford Royal Hospital. Surgeon: Mr.D.S.Poole—Wilson# 
Diagnosis, Course and Treatment:
15.1.57.
Progress:
Carcinoma of left 
renal pelvis, 
(section - invasive 
papillo carcinoma)
Left nephroureterectomy
For a few months after the operation his progress was moderately 
satisfactory but his chest condition soon began to deteriorate. 
This was attributed to the chronic bronchitis.
He died at home in December 1957> and a post mortem examination 
was ordered by the Coroner. This revealed extensive bilateral 
pulmonary tuberculosis. The bladder and remaining kidney and 
ureter were clear of tumour.
This case is of special interest for two reasons:-
I The exfoliation of malignant cells in the urine for 
eighteen months before a tumour of the renal pelvis 
was diagnosed by conventional means.
II The fact that the initial tumour was in the renal 
pelvis and there was no tumour in the bladder. It 
was largely on the strength of this case and Case 
No.60 that tumours of the renal pelvis or ureter 
were added to -the definition of the prescribed 
disease in 1957*
This case is referred to on pages 137 > 13®> 158 and 171
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APPENDIX A
Techniques for Routine Urine Testing
Wet smear
The men attend at the works surgery and pass urine into two 
jars, the first of which is discarded to exclude cells from the 
urethra and prepuce.
10 - 15 ml. of urine from each specimen is poured into 15 ml. 
conical tubes and 16 are centrifuged together at 2,000 r.p.m. 
for 10 minutes. The supernatant fluid is decanted into 6fl x 
test tubes and tested for albumin by salicylsulphonic acid. Two 
3" x 2" slides are divided into 8 sections by a diamond marker. 
One drop of each urine deposit is added to the slide and the 
eight specimens are examined at a time without coverslips under 
16 mm. objective. The absence of coverslips saves time and gives 
a greater depth of deposit with more cells per field. The number 
of cells present are recorded using + to ++++ as an indication of 
quantity.
Original stained smear method (after Crabbe 1952)
An equal volume of 95^ ethanol is added to the urine and 
40 ml. are centrifuged for 15 minutes at 2,000 r.p.m. The super­
natant fluid is removed. The smear is made by spreading a drop 
of the urine deposit on slides which have been smeared with 
glycerine albumen. When the smear begins to cloud round the edges 
or in its thinner parts, it is fixed in equal parts of 95$^  alcohol 
and ether. It must not be allowed to dry at any time.
The smears are then stained using Papanicolaou's technique
(1954).
Concentration technique now in use
1 Adjust the urine to pH. 6.0 with a few drops of 0#5Na0H or
0.5HC1. (This avoids the precipitation of phosphates).
2 Centrifuge at 2,000 r.p.m. for 10 minutes in a 50 ml. conical 
tube.
3 Slowly draw off the supernatant fluid by suction.
4 Add 10 to 15 ml. of absolute alcohol, shake and leave for 5
minutes.
5 Pill up with distilled water and shake gently*
6 Centrifuge as before for 10 minutes*
7 Slowly draw off the supernatant fluid*
8 Add 3 — 4 drops of glycerine albumen diluted with an equal 
volume of distilled water*
9 Centrifuge as before for 5 minutes*
10 Carefully draw off the few drops of supernatant fluid*
11 Mix the deposit by gentle shaking and with a clean capillary 
pipette of 0*5 bbu internal diameter remove the deposit and 
expel on to a clean marked slide* Spread the deposit on the 
slide with the tip of the pipette so that the resultant smear 
can be covered by a square coverslip. While the smear is 
still wet examine under a lo mm* objective for even distribu­
tion of cells*
12 Allow the slide to dry (usually 1 to 5 minutes) and immediately 
place it in the ether/alcohol fixative* After 5 minutes the 
smear is ready for staining but it may be preserved in the 
fixative indefinitely*
13 The smear is  stained by Papanicolaou * s method (1954) but the  
E.A.65 counterstain is  adjusted to pH 5*5*
THE INCIDENCE OF BLADDER TUMOURS 
IN A DYESTUFFS FACTORY
BY
T. S .  S C O T T
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Volume 9, page 127, 1952
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THE INCIDENCE OF BLADDER TUMOURS 
IN A DYESTUFFS FACTORY*
BY
T . S. S C O T T
From the Clayton Aniline Company Ltd., Manchester
Ilk incidence of bladder tumours in workers in 
industry was first described by Rehn 
1906. Leuenberger reported 41 cases in 
II, and by the third decade o f this century in 
exposure to beta naphthylamine and to 
te had been accepted as a cause o f bladder 
burs by Kennaway (1924), Berenblum and 
per (1937), Goldblatt (1949), and M uller (1951). 
U.S.A. Gehrmann, Foulger, and Fleming 
, are less certain o f the carcinogenicity o f 
pidine than the European investigators and have 
sled that it cannot be accepted as a bladder 
, Jogen until it is known that benzidine workers 
pout an y  exposure to beta naphthylamine have 
led tumours of the bladder, 
paper describes 23 cases o f papilloma and 
linoma of the bladder among workers exposed 
Ho benzidine, and reviews in  all 6 6  cases not 
Wusly reported o f confirmed bladder tumours 
®gin  a  dyestuffs factory. Fifty-eight cases were 
®lin the section where intermediates are manu- 
and eight in the colour factory where the 
iates are handled. N o cross transfers have 
place and the populations have remained 
t  Only the men fo r whom data are complete 
p.been included in this series. In  addition there 
former employees believed to have died o f 
r tumour whose histories are not yet fu lly 
, and two men reported to  have developed 
P irs  with whom contact has been temporarily 
A. voluntary system o f compensation, by 
Ww payments, should help to ensure that the 
tones of men who develop tumours after leaving 
f  act°ry will be known.
Manufacture o f Intermediates
p Table 1 it w ill be seen that o f the 58 patients 
. A ll except three o f these 58 patients 
[been employed in the manufacture o f benzidine,
(   was read at the Tenth International
M edicine, L isb on , Septem ber, 1951.
T a b l e  1
CASES OF TUMOUR OF THE BLADDER IN  THE MANUFACTURE  
OF INTERMEDIATES
Type of Exposure Total Alive Dead
Benzidine .. 23 15 8
(3 Naphthylamine 15 9 6
a Naphthylamine 1 1 0
Mixed benzidine a &  (3 
naphthylamine 16 1 1 5
Other 3 3 0
Total 58 39 19
TOofia? of.tllis paper
Industrial i
alpha naphthylamine, o r beta naphthylamine, or 
in various combinations o f the three. Twenty- 
three had worked solely on benzidine in  a 
separate building and had never had contact with 
naphthylamines. Fifteen had worked solely on 
beta naphthylamine and had not had contact w ith 
benzidine. The 16 mixed exposures arose either in  
the still house, where benzidine and naphthylamines 
were sent to be distilled, or in  the sulphonation 
building where alpha and beta naphthylamine were 
sulphonated. The percentage o f beta isomer in  the 
alpha naphthylamine was about 4. There have 
been no transfers between these departments. Three 
cases arose in men with other exposures.
Benzidine.—Benzidine manufacture by the zinc 
reduction method was started in  1918. I t  was first 
produced as the sulphate which was then converted 
to the base, and until 1944 either the sulphate, the 
base, o r both have been isolated. Since 1944 the 
hydrochloride has been made. These and other 
changes in the process are shown diagrammatically 
in  Fig. 1. Ortho-dichlorbenzene was used as a 
diluent until 1926 when i t  was replaced by a solvent, 
paraffin oil. In  1947 solvent naphtha was substituted
127
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ar many 
a third, 
, with a 
men, the 
es were
iges and 
in Fig, 2, 
laphthyl- 
sulphite 
s, varied 
g. The 
paration 
lutoclave 
m time 
1933 the 
distilled, 
up by 
1933 to 
and a
frtwas flaked without distillation. A fter 
the amine was then sulphonated in
i  manufacture of beta naphthylamine and its 
fain the colour factory ceased in 1950 because 
stealth hazard involved. The normal working 
fbnent was about 55 men, and the total 
ier exposed for six months or more since 1920 
I. Fifteen cases of tumour have occurred in 
nip since 1934.
947 the
) -1950,
Naphthylamine.—Alpha naphthylamine was 
ictured in this factory fo r four years only, 
to 1930, by the nitration o f naphthalene 
subsequent iron reduction o f alpha-nitro- 
. The usual number o f men employed 
|Sis process was three, and the total number who 
led on it for six months or more was four. None 
tee men has developed bladder tumour, 
jkcase, which might be attributed to alpha 
and "the i ^ am*ne *n manufacture o f intermediates, 
hen the ^  a tumour a t^er being employed fo r 18 
washing p ® manufacture o f naphthionate o f soda 
n closed f 3^  naPhthylamine. During this process a 
i naph- P'on residue containing about 17% o f beta 
he still jWam’ne (from the 4% beta impurity) was 
wed as a molten product, set in trays, broken 
1? hand, and transferred to casks. I t  has 
wly been suggested by other investigators 
Hblatt, 1949; Muller, 1951) that the beta 
iylamine impurity in alpha naphthylamine is 
c^ausative factor in tumour production, and this 
(was, owing to the nature o f the process, more 
®ly exposed to the residue w ith a high beta 
iylamine content than to technical alpha 
hhylamine.
line.—The manufacture o f aniline by the iron 
ktion process started before 1900 and has always 
51 carried on in separate buildings. The total 
exposed over six months since 1920 is 76. 
records are not dependable. The normal 
complement is 11. No cases o f bladder 
have been found among men in this process 
some men have worked since the early 
p °f primitive plant and bad conditions, and 
■ up to 45 years are substantiated. In  
tumours attributed to aniline have been 
Gross (1940) 33 cases, Goldblatt (1949) 
®s, and Muller (1951) 22 cases, but Gehr- 
s^nd others (1949) reported that they had found 
s in men from an aniline plant w ith a 
number of employees who had worked 
Exposed up to 25 years.
^er Exposures.—One man was employed on 
manufacture of beta naphthylamine for three
CLOSED
VESSELS
FLAKED
f^Scasi
1950.
months, and fo r the next 27 years worked as a boiler 
fireman in the factory, an occupation which did 
not bring him into contact w ith intermediates. 
M uller (1951) reports the case o f a stoker who 
developed bladder carcinoma after three years’ 
exposure to firing anthracene vapours, and quotes 
Rosner, Young, Russell, and O’Donovan as 
reporting bladder carcinoma in addition to skin 
and scrotal carcinoma in tar and fuel operatives. 
The observations o f Henry, Kennaway, and Kenna- 
way (1931) do not show any increased incidence 
fo r this class fo r the 1921-28 period in England and 
Wales. As no other exposure under four years is 
known to have occurred in this series, he has not 
been included w ith the beta naphthylamine cases, 
although exposures as short as six months have 
been accepted by Gross (1940).
Another, a process worker, developed a papilloma 
after 28 years on the manufacture o f ortho-toluidine 
and chlor-toluidines. He had no contact w ith benzi­
dine. The nearest process to him in this building, 
however, was one in which alpha naphthylamine 
sulphate, which contained about 4% beta naphthyl­
amine sulphate, was baked to make naphthionic 
acid. N o other cases have arisen in this shed.
The third, a process worker, developed carcinoma 
o f the bladder after working fo r five years on the 
manufacture o f amino salicylic acid. In  the next 
unit in  the same building dianisidine was made. 
Neither o f these substances has been reported 
previously as causing bladder tumours, although 
Perlman and Staehler (1933) included dianisidine in a 
list o f substances which they mentioned as possible 
causes.
Exposure and Latent Periods.—The shortest 
period o f exposure, excluding the one doubtful case
A
-------BEN
------"A N A
:iD INE.‘  (, 
3HTHYLA)
3 c a s e s ;
AWE = 
LSXASESi
/\
■------ OTH ERS. = O CASES)
\
/  \/  \
/  \
/
' r-
\
-
3 1C3 1 2 0  2b Jl0  35
F i g .
LATENT PERIOD (YEARS)
3.— G raph o f  tim e from  starting work to  diagnosis o f  tum ours.
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M  the better fireman, was four years and the longest 
32 years, w ith an average o f 16 years for alt the 
mmufa&uringgreup. The latent period (Fig, 3), that 
is the time from  starting work to diagnosis o f tumour, 
showed no appreciable difference between the 23 
benzidine eases w ith a range of eight to 32 years 
(average 15-9 years) and the beta napthylamlne 
cases w ith a range o f five to 27 years (average 15*5 
years). The 20 mixed and other exposures with a 
range o f seven to 2 2  years tended on the whole to 
appear earlier but their average latent period 
was 16 years (Fig. 3).
I t  is worth noting that, o f the men exposed to 
beta naphthylamine who developed tumour, the 
one w ith the longest latent period (27 years’ 
exposure) was the only chemist in the series. As a 
chemist he would have had considerably less exposure 
than a process worker.
Handling o f Intermediates
All of the eight cases reported in the colour 
factory have arisen among men who have worked 
on diazotization processes in colour synthesis. 
Seven have handled benzidine, and one both benzi­
dine and alpha naphthylamine with the former as 
the major exposure. There have been no deaths 
among these men (Table 3). This factory, which 
opened in  1919, has used benzidine in one building 
and small amounts o f alpha naphthylamine in 
another. The amount o f benzidine used has increased 
eightfold over the past 31 years and has utilized 
practically the whole output from the intermediates 
section. Special precautions were extended in this 
factory at about the same time that cases arose 
among men manufacturing intermediates, but the 
first case did not arise in the colour factory until 
1941. Since then only one man at a time has been
jjown
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T a b l e  2
TYPES OF TUM OUR ENCOUNTERED IN THE M ANUFACTURE OF INTERMEDIATES
:,ther
Type of Exposure Total Cases Papilloma Carcinoma PapillomaCarcinoma
B e n z id in e ........................................................ 23 14* 74 2
P N aphthylam ine............................................. 15 8 1 75 —
« Naphthylam ine............................................. 1 — 1 -
Mixed benzidine and a 8c (3 naphthylamine 16 5- 9 3 2
Other................................................................... 3 2 1 -
Total ............................................. 58 297 2512 4
aining
ie 66 a
it after
The index figures relate to deaths.
Eight men left the firm  and subsequently devel­
oped tumours. The period o f exposure was from 
four to 11 years with an average o f seven years. The 
average latent period ranging from nine to 2 0  years 
was 15 years, which is similar to the latent period fo r 
those who had not left the firm  before developing 
tumours.
Types of Tumour.—Of the 58 cases, 29 had papil­
loma, 25 had carcinoma, and four had papilloma 
which recurred as carcinoma (Table 2). There is 
no striking difference in the incidence o f benign and 
malignant tumours in  the varying types o f exposure 
in  these small numbers, except that the men with 
mixed exposures had a higher proportion o f car­
cinomata than other groups.*
handling and charging benzidine. The three men so 
employed consecutively have been volunteers. The 
first, who had 14 years’ previous exposure to benzi-
T a b l e  3
CASES OF TUM OUR OF THE BLADDER IN HANDLING OF
death o 
jsdof nei 
Has 67-5
Type of Exposure Total Alive Dead
Benzidine 7 7 0
Benzidine +  a naphthyl­
amine 1 1 0
Total 8 8 0
fWAGNOl
* The pathology and treatm ent o f  these tum ours will be the subject 
o f  another paper n collaboration with M r. P oole-W ilson .
2 1  years)
Normal working strength 
Total numbers exposed 
No. cases
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a tumour a year later and was taken 
own request; the second was promoted 
n after six years; and the present one 
and charged all the benzidine fo r three 
The latter two men have not developed
om a
lom a
nenso 
:. The 
benzi-
[NG OF
Dead
tors.
[lenoraial working complement on the benzidine 
is is 14 and the total number who have worked 
lionths or more since 1919 is 8 6 .
•e and Latent Periods.—A ll the men in
factory who developed tumours were still 
ayed at the time o f diagnosis and therefore the 
Jitand exposure periods are the same. The short­
ly 15 years and the longest 27 years w ith an 
$ of 21 years. The cases among the men 
ling benzidine in the colour factory had a 
r average exposure ( 2 1  years) than those 
jaiifacturing (16 years), and the first case among 
idlers arose seven years later. I t  is reasonable 
ime, therefore, that the intensity or the nature 
Jlie exposure in the manufacturing process was 
jfermming factor in producing tumours earlier 
pin handling.
;e at Diagnosis o f Bladder Tumours
I the 6 6  cases, 40 entered the industry before 
■i§ of 30, 17 between the ages o f 30 and 40, 
tlnine after the age o f 40. I t  w ill be seen from 
44 that of those under 30 the average age o f 
|d of tumour was 42 and o f death was 44 ; o f 
s between 30 and 40 the average age o f onset 
51 and of death 54 ; and in  those over 40 the 
age of onset was 58 and o f death 6 6 . From 
Mstrar General’s figures fo r 1947 the average 
death of 1,417 males in  England and Wales 
1W of neoplasms o f the bladder, urethra, and 
ttnvas 67-5 years. Stocks (1950) took records o f 
s of cancer of the bladder and ureter from 275 
Ah in England and Wales in 1945. He found 
'fe average age o f a ll cases at first attendance 
•^3years and at death 66-3 years. These figures
T a b le  4
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30 3 0 -4 0 Over 40
0
0
:% of cases ..
™nber of deaths) "
40
(10)
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9
(4 )
iverage : 3 2  at
^(Range)
42
(2 5 -5 2 )
51
(4 1 -6 2 )
58
(4 7 -6 6 )
_ —
%  at death 
^(Range) ’ 44(3 4 -5 1 )
54
(5 1 -6 0 )
66
(6 1 -6 9 )
emphasize the shortened expectation o f life o f men 
who are exposed to carcinogens before the age o f 
40 and develop bladder tumour. Thus, there is a 
strong argument in favour o f excluding young 
entrants from  processes where the hazard o f bladder 
carcinogens can even be suspected. I t  has been the 
policy in  recent years in  this factory to debar men 
under 30 from such plants and to prefer healthy 
men over 40.
Future Prevention
Methods o f prevention at first followed the usual 
lines. Technical improvements in the plants and 
processes, some o f which have been indicated, have 
been applied. Men are carefully selected by pre­
employment examination w ith consideration given 
to age, fam ily history, and previous health ; strict 
hygienic measures such as special working clothing 
and daily bathing are obligatory ; regular medical 
supervision is carried o u t ; and although routine 
periodic cystoscopy o f all workers is not yet applied, 
routine examination o f the urine fo r red and white 
blood cells is done on all workers monthly. But with 
the possibility o f such a high morbidity and early 
mortality arising from these processes more radical 
measures were deemed to be essential. Delayed by 
the war w ith its greater priorities, a new benzidine 
plant in  which all possible precautions are taken 
to obviate contact between the operator and the 
carcinogens has now been built on a new site and 
w ill be in production this year. The old plant w ill 
be pulled down. Apart from a small number o f 
key men, whose experience is needed and who w ill 
be selected from those who have had tumours and 
are cured, new men from the older age groups, w ith 
no previous exposure, w ill be selected and trained 
fo r this job. Thus, should any o f these new men 
develop tumours it w ill be possible to attribute them 
solely to exposure on this plant when assessing the 
incidence. '
Beta naphthylamine manufacture ceased a year 
and a half ago, as soon after the war as technical 
exigencies permitted, and sulphonation o f beta 
naphthol followed by amidation is now the method 
used fo r preparing beta naphthylamine sulphonic 
acids in the synthesis o f the colours for which beta 
naphthylamine was previously used as an inter­
mediate.
In  the future it  should be possible to know 
whether or not these hazards have been controlled, 
but the time necessary fo r the development o f 
tumours may be so long that we cannot be sure that 
the problem has been mastered until a whole genera­
tion has been unaffected. A  list has been compiled, 
and is kept up to date, o f all men who are known to 
have worked more than six months with carcinogens
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since 1918. As even shorter exposures may come to 
be accepted as sufficient to initiate a tumour, careful 
records are now kept o f any exposure, however 
short, and no cross transfers are permitted between 
departments where carcinogens are manufactured 
or used.
Summary
Sixty-six cases o f bladder tumours in a dyestuffs 
factory are reported.
The methods and history o f manufacture and 
handling are described.
O f the 6 6  cases there were 30 (23 in the manufac­
turing section and seven in the handling section) 
whose exposure was to benzidine, and which had 
never been exposed to beta naphthylamine. Benzi­
dine is therefore considered to be as dangerous a 
carcinogen, industrially, as beta naphthylamine.
The role o f beta naphthylamine as a bladder 
carcinogen in manufacture and experimentally has 
previously been accepted, and 15 cases are attributed 
to it alone and others to mixed exposures. Beta 
naphthylamine as an impurity cannot be eliminated 
as a cause o f bladder tumours in men who worked 
on alpha naphthylamine.
No cases have been traced which can be attributed 
to aniline, despite the longer time o f manufacture 
and periods o f exposure, and the similar numbers
engaged on it  compared with benzidine and beta ' 
naphthylamine.
Three other exposures are described in which the1 
cause o f tumour was doubtful or unknown.
Exposure, latent periods, and ages at diagnosis =■ 
and death are discussed.
Men under the age o f 30 should not be employed 
in the manufacture or handling o f substances knowi '$■ 
or suspected to be bladder carcinogens and, whei |  
possible, healthy men over 40 should be employed I  
on these processes.
This paper would not be complete without an expres •' 
sion of gratitude to Mr. J. B. Macalpine and his successoi! 
Mr. D. S. Poole-Wilson, the urologists who have had ‘ 
these cases under their care.
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The Control o f Occupational Cancer of the Bladder*
By T. S. SCOTT 
From The Clayton Aniline Company, Ltd.
IUPATIONAL tumours o f the bladder were 
ist described by Rehn in  1895, and many 
'have accumulated since then. In  this 
| Goldblatt reported a notable series in 
id Table 1 shows my own cases reported 
r. The heaviest incidence occurs in 
engaged in both the manufacture and 
three aromatic amines, namely benzidine,
phthylamine
(ha-naphthylamine
was a local carcinogen by implanting i t  in the 
bladders o f mice. In  dogs given betanaphthyla- 
mine the concentration o f 2 -amino-1 -naphthol 
in the urine was 2 0 0  times that in the blood 
plasma. I t  is important and significant that 
man excretes beta-naphthylamine as 2 -amino-1 - 
naphthol to  a comparatively high degree. I t  is 
reasonable therefore to conclude that beta- 
naphthylamine and not an im purity is responsible 
fo r the industrial tumours attributed to it  and 
that this metabolite o f it  is active in their 
production.
Benzidine
Benzidine as a cause o f bladder tumours in  
workmen had been suggested in  this country since 
the nineteen thirties but i t  was not un til 1950 
that Spitz (1950) and her co-workers induced 
tumours w ith  it  in  animals. These were multiple, 
but no bladder tumours occurred. Baker, in  my 
own department, showed that 3:3'dihydroxy- 
benzidine
[Other compounds, such as auramine and 
|$l naphthylamines come under suspicion 
n’s original cases were in  workers manu- 
rfuchsin (or magenta). Aniline was at 
o blamed but recent evidence has 
tonpletely exonerated i t  as an industrial 
en.
ablish the best methods of prevention 
*n necessary to answer several questions, 
processes and w ith  what substances 
danger lie ? Is the active carcinogen 
jatice suspected or is i t  present as an 
|  Is the hazard present a ll the time or 
pine stage o f the process ? How  is the 
attacked in  the human ?
Ijhylamine
?er of manufacturing beta-naphthy- 
recognised from  industrial experience 
production o f experimental tumours 
peuper, Wiley, Wolfe, 1938). Bonser 
STeeds excluded impurities as the cause 
tupiours in  dogs w ith  a highly puri- 
pund. In  1951 she and her co-workers 
p  one of its metabolites, 2 -am ino-l-
NH,
I'
Cases of Tumours of the Bladder
Type of exposure Total Alive Dead
Benzidine 30 22 8
Beta-naphthylamine 15 9 6
Alpha-naphthylamin 1 1 0
Mixed. Bz.,/on ., OC — n., 17 12 5
Other 3 3 0
Total 66 47 19
Table 1
* R ead at a m eeting o f  the Association on  30th October, 1953.
was a metabolite in the human and w ith i t  we 
have induced tumours, sim ilar to those o f Spitz, 
in rats. Bladder and local tumours also appeared.
There is a striking resemblance between these 
tumours and those induced by 2 -acetylamino- 
fluorene and the latest investigations were on 
acetyl benzidine, as acetylation is important in 
the metabolism and carcinogenic property of 
benzidine.
Alpha-naphthylamine
This has not been shown experimentally to be 
a carcinogen. Bladder tumours in  workmen who 
have been exposed to it  have been reported.
In  its commercial form  it  always contains a 
small proportion o f beta-naphthylamine as an 
im purity and larger amounts occur in residues 
but it m ight be premature to conclude that this 
is the only carcinogenic factor. I t  cannot be 
presumed that alpha-naphthylamine is not itself 
carcinogenic.
Aniline
A niline is made from  the same raw material 
as benzidine. Occupational bladder tumours were 
at one time known as “  aniline cancers ” — a 
misnomer which stuck fo r many years. N o cases 
o f tumour from  aniline have arisen in any o f our 
workmen who have been engaged in its manu­
facture, which has always been done in a separate 
building w ith  no exposure to the other amines. 
M any o f these men have had long exposure, some 
o f well over 40 years, and in the earlier decades 
working conditions were bad and contact was 
heavy. Moreover, experimental tumours have 
not been induced w ith  aniline. Last year Walpole, 
W illiams and Roberts (1952) drew attention to 
the fact that naphthylamines and 4-aminodiphenyl
n h 2
and 3:2'dimethyl 4:aminodiphenyl
c h 3 ch 3
-NH,
were present as impurities in  aniline in  the early 
days o f manufacture at the end o f the last 
century, and they have induced tumours in  rats 
w ith  the two latter compounds. This goes a long 
way to explain the undoubted occurrence o f the 
tumours in  aniline workers in Europe which have 
been reported by earlier writers.
Description o f Disease
Occupational tumours o f the bladder occur as 
benign papilloma and carcinoma. Once they 
have arisen they do not differ from  those o f non- 
occupational origin. Recurrences or fresh tumours
are frequent and are not always of the same tyj 
as the original growth. J
Exposure and Latent Periods
Tumours appear after a latent period, that 
the time between entry to the industry and oni • 
o f the disease ; this ranges in my own sec ^  * 
(.Figure I )  between 4 and 32 years with an averaj 
o f 16 years and a mode between 15 and 20 yeti itperi 
but shorter and longer periods have been 
ported. This latent period is not necessarily i 
same as the exposure period and tumours it lofTui
develop years after a man has left the indus [__
(Table 2). The average latent period is much 1 
same as in  those who stay on, so that given sii 
cient exposure, the process of tumour develi 
ment is not arrested by removal from contact., forke
■ [the c<
Prevention ; on tl
A t first these three amines—benzidine, be16 chei 
naphthylamine and alpha-naphthylamine— J 
peared to be harmless. No acute toxic effe pem ]! 
resulted from  heavy industrial exposure. Tl P5 can 
did not cause cyanosis from methaemog |t° ca 
binaemia as do aniline and many other amir 1 
and they were not even irritant to the skin.? inufacf 
was not un til after an unusually high incidej bee 
o f tumours o f the bladder was recognised; jpontry 
workmen that the hazard became evident, i acce
The industry itself had to deal with this ri ®cult i 
problem. A lthough i t  may at first appear to | 
a comparatively localized hazard confined tofORY 0 
small section o f only one industry, yet the pi [ 
ciples and methods of control are simply „ 
application o f industrial medicine and hygii | 
and they could be applied to the prevention r  
many other hazards in other industries. «oclave«
The measures which have been adopted o 
sist o f medical, chemical and engineering. It
also essential fo r a precise assessment of STc
hazard that comprehensive technical reccj is-broke 
should be kept as well as personal and medi r 
ones. These must include the plants and p
(DINE.-
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on the technical side, which comprises 
chemical and engineering aspects, that 
itest hope o f effective control lies, and 
ilem is prim arily a technical one, in  that, 
can be found to prevent the exposure 
to carcinogens, i t  is solved. The most 
iway to achieve this would be to cease 
inufacture altogether. 
incidefj08 ^een done voluntarily  by the industry 
)gnised ?untry in the case o f beta-naphthylamine, 
ent jjn account o f the hazard, and a much 
i this i Pcu^  and costly method now omits beta- 
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Table 2
naphthylamine in  the manufacture o f dyestuffs. 
A  sim ilar eradication is not technically possible 
w ith benzidinS or alpha-naphthylamine and they 
are still manufactured and used. A ll  operations 
which carry the risk o f absorption, which in  in ­
dustry is usually by inhalation or through the
skin, must be made as safe as possible. Old
plant, the design and layout o f which cannot be
adapted fo r safe working, should be scrapped. 
Our old benzidine plant orig inally bu ilt fo r T.N .T. 
manufacture in 1915 and changed over to benzi­
dine in  1918 has been replaced by a new building
basically planned and equipped fo r safe working
under the strictest modern conditions.
Other plant has been 
modified to keep the 
carcinogens contained in 
enclosed systems and, 
wherever their was ex­
posure o f the compounds 
as in open pans or filters, 
adequate arrangements 
were made fo r their 
complete enclosure and 
fo r s a f e  maintenance. 
For distribution, handling 
has been replaced by 
mechanization, transmis­
sion through pipelines, o r 
by using enclosed con­
tainers. Physical and 
chemical forms o f the 
compounds have been 
modified to avoid those 
which would vaporize 
readily or get into the 
atmosphere as dust. Sol­
uble salts have been made 
instead o f the dusty bases; 
solutions or slurries are 
distributed through pipe­
lines, o r wet pastes are 
used to avoid dusting. 
Heat processes such as 
distilling, melting, stoving 
and heat drying which in ­
crease the risk from  vola­
tilization have been re­
CLOSED VESSELS : PIPE LINES
FLAKED
3
vised and, where possible, cold methods o f manu­
facture substituted, but sometimes the risk can be 
lessened by distributing molten amine by enclosed 
pipelines. H arm fu l impurities in  the form  of 
unreacted free amines in  the finished colour are 
closely guarded against. Ventilation o f working 
places and local draughting at points where ex­
posure was likeliest to occur were carefully tested 
and improved. Tests fo r the determination 
o f infinitesimal amounts o f amines in the atmos­
phere, and on the clothing o f workmen have 
been devised. Although safe o r permissible con­
centrations cannot be la id down, a check can 
thus be kept on the efficiency o f the precautions 
taken, and measures are taken to improve them 
i f  necessary.
The application o f some o f these principles can 
be seen in  the history o f the manufacture o f beta- 
naphthylamine which started here in  1920 (Figure 
2 ). From then u n til 1933 the charge was filtered 
in open filters, dried in hot stoves which men 
entered w ithout precautions, distilled, set in  open 
trays, broken up by hand and fina lly ground 
to a fine powder. Exposure was thus extremely 
heavy but the hazard was not realised then, 
although in 1933, when an odd case o r so had 
arisen, stoving was omitted and the trays and 
grinding were replaced by a flaker. In  1938, 
when the hazard became apparent, a ll washing 
and drying was carried on in closed vessels, and 
molten beta-naphthylamine was piped to the still, 
distilled and flaked. In  1947, at the end o f the 
war, further refinements became possible and 
distilling was omitted. F inally, manufacture o f 
beta-naphthylamine ceased in 1950, and it  was 
replaced by the safer alternative method o f 
sulphonation o f beta-naphthol and subsequent 
amidation in the synthesis o f those intermediates 
fo r which beta-naphthylamine was used. These 
later developments'would have been much earlier 
but fo r the war.
Medical
Despite the strictest technical precautions a 
medical officer, fu ll time or part time, is indispen­
sable in the control o f this hazard. Selection o f 
workers, supervision o f their health, the early 
diagnosis o f tumours, liaison w ith  the fam ily doc­
tor, urologists and hospital, regular review, reha­
bilita tion and replacement o f those who have had 
tumours, are matters fo r the doctor alone. For. 
maintenance and investigation o f records, super­
vision o f the general conditions and places o f 
work, and o f the measures taken to protect the 
workmen from  exposure, he requires the appro­
priate technical help and advice but they come 
w ith in  his province and he is frequently the co­
ordinator o f the various specialists in these fields.
Selection
Men to be employed must have a high standard 
o f personal hygiene to keep down absorption by 
the skin and mouth, and must be mentally capable 
o f co-operating in  the hygienic protective measures 
prescribed ; men w ith a history o f exposure to
other industrial carcinogens and those wit 
previous or existing genito-urinary disease^  
neoplasm in any organ or tissue, are exclude 
because o f the risk o f subsequent confusion j 
the assessment o f the hazard. For the sail 
reason all applicants have microscopic exaraii 
ation o f urine and those w ith red blood cells < 
abnormal cells are rejected, even i f  otherwise, 
healthy. Incidentally, I  do not reject on a fami f J  
history o f cancer as there is no evidence that t'-* 
predisposes to occupational bladder tumour,
O f the published industrial cases in this counl 
where the age at death is given, about 60 per cei 
died before the age of 55 whereas from tl 
Registrar General’s figures o f male deaths in 19< 
the average age at death from  neoplasm of ti 
bladder and ureter in the United Kingdom wl 
67-5 years. M y  own series of cases (Table 
shows how the age o f onset o f tumours in thoj 
who develop them is almost entirely depende!^^ 
on the age at which they entered the industry*^ a 
since tumours occur after a latent period 
usually 15 to 20 years. This results in a corn 
pondingly earlier death. I t  w ill be seen that 
those who entered the industry below the 
30, onset and death occurred at a much earlii 
age than in those who entered after the 
40. I t  is not suggested that older people are h 
susceptible, but only that the older a man is 
entry, the older he is like ly to be at onset if 
develops a tumour and that younger entrants mi 
have their lives shortened i f  tumour develops, 
selecting men fo r this type o f work I  therefo] 
exclude those under 30 and where the physj 
effprt required and the available labour alio 
accept men over 40 fo r preference. The averaj 
age at entry o f the present labour force in 
new benzidine factory is 41 years. None 
worked in chemicals before, except the forei 
who had to have previous experience.
A part from  these special considerations, 
physical standard required w ill depend on 
type o f work to be done. Good health and stro; ^  j  
physique have no relation to a man’s resistati 
to bladder carcinogens.
Age at entry, onset, and death
r
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;casua 
,nl 
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|D 0tl
|txpo
Age at entry Under30
Number of cases 
(Number of deaths)
40
(10)
Average age 
at onset of tumour 42
Average age at death 44
Average latent period 18
Table 3
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,tion and training may not be strictly a
:matter, but I  th ink i t  is ethically right
[worker should be to ld  what the hazard
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>n 1 for his protection can be used to the best
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am*! seldom asked to do this, 
itth s
ion of R iskir.
mnti 
cei 
ti tl 
ll9‘ 
)f t! 
n wi 
hie 
thoi 
mdei 
stry- 
od 
mrri 
hat
earlii 
age 
re I 
i is 
t if 
ts mi 
ips, 
erefoj 
hysici 
alio1 
iverai 
in 
ne
sremi
ns, t! 
on 
I stroi 
sistari
Over
40
levent amines remaining on the skin and 
orbed after work, fu ll working clothing 
to each man and must be changed 
id of each shift and a bath must be taken. 
|e applies on accidental contamination, 
’i.' clothing such as gloves, aprons, 
irs and other devices, are supplied 
to the nature o f the job. 
r to. keep down the time o f possible 
to a minimum the hours o f w ork are 
nd no' overtime is permitted except in  
|emergencies. 
bers who are exposed to risk are re- 
the minimum necessary to do the work 
[casual or temporary workers are allowed 
plants; only men who have been passed 
ledical officer are permitted, and selected 
are appointed to cover the absence o f 
len; cross-transfers from  one hazardous 
[another are not allowed so that workmen 
to more than one carcinogen, 
all works I  th ink it  m ight be better to 
man or one small team to do all the 
f  there is risk, rather than to increase 
irs exposed.
|ployment of men fo r short periods has 
located on the ground that this would 
duration o f exposure and hence the 
Ipmour induction. Comparatively short 
| exposure o f a few months have, how- 
reported as causing tum our and even 
?s may come to be accepted, so that 
i period o f exposure does not obviate 
$id certainly increases greatly the num- 
Therefore, as fa r as possible, we 
|on the same jobs, i f  they are w illing, 
multiply the numbers at risk by 
[replacements.
pi-so far, been discussing some o f the 
[ [prevention o f the hazard, but however 
J ! the measures we have applied may 
P, tumours are still like ly  to arise, fo r 
I  entry, in those who have already been 
®o offer real hope o f successful treat- 
1  l f UrS must '3e diagnosed as early as 
j pore the growth is inoperable. Ordinary 
^ na^ on is useless in  the early diag- 
f li r  der tumours ; only advanced 
poly to be detected, and may at times 
3  this means, Haematuria is some- 
®t in advanced malignant disease,
although i t  may sometimes be severe in small 
benign papilloma ; i t  may be a symptom o f some 
other disease or in jury or may, in  workmen in 
this industry, result from  a transient haemorrhagic 
cystitis caused by an apparently non-carcinogenic 
bladder irritan t such as 5-chlor-orthotoluidine.
The diagnosis can be made w ith  certainty only 
by cystoscopy. Workmen who have had no 
symptoms or complaints naturally do not relish 
the prospect o f undergoing this operation and it  
cannot be applied as easily as some routine 
methods o f screening, such as blood counts or 
X-rays, which are used fo r other occupational 
hazards.
In  America and some continental countries all 
workmen are said to be cystoscoped at regular 
intervals o f a year as a routine. In  one clinic 
abroad, which I  visited only this year, I  was told 
that although most workmen accept i t  once a 
year, i t  could not be applied more often as they 
would certainly refuse. There are several other 
objections to routine annual cystoscopy. A  
tumour can arise and become inoperable in  less 
than a year; its application m ight lead to refusal 
to undergo i t  at the very time when i t  has become 
most necessary; in  this country many men would 
leave after one or two cystoscopies rather than 
continue in  work where it  was a condition o f 
employment and the numbers e^osed  would be 
increased by their replacement ; the psycho­
logical effect on men i f  cystoscopy were to be 
made a condition o f employment, would almost 
certainly be bad. A ll  investigators in  B rita in  have 
agreed that routine cystoscopy would not be 
accepted by British workmen and attempts to 
institute i t  have had to be abandoned.
I f  the chance o f h itting upon an early tumour 
by a routine annual cystoscopy is not acceptable, 
then some other methods o f deciding when cysto­
scopy should be done must be applied. In  my 
works, microscopic examination o f a wet smear 
o f the urine o f a ll workers is done at monthly 
intervals. The presence o f large numbers or the 
persistence o f small numbers o f red blood cells 
in a man who has been sufficiently exposed" is 
almost invariably regarded as an indication fo r  
cystoscopy. Examination o f stained smears o f 
urinary deposit fo r tumour cells by the 
Papanicolau technique has been done on our 
men fo r the past two years and we have been 
fortunate that D r. Crabbe has examined and 
interpreted these fo r us. The appearance of 
tumour cells is obviously an indication fo r cysto­
scopy. I f  doubtful or suspicious cells are noted, 
frequent re-examination or cystoscopic investi­
gation is called fo r depending on other factors 
such as the wet smear or the exposure history. 
A  negative finding, as w ith the wet smear, is not
(e c y t o l o g ic a l  d ia g n o s is  o f  b l a d d e r  t u m o u r s  
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Tumours o f the urinary bladder occurring amongst 
the general population usually disclose their presence 
by the onset o f symptoms such as haematuria, 
dysuria, frequency, or pain. In  some cases haema­
turia may develop from a small benign papilloma 
which offers a good chance o f successful treatment, 
whilst in others the tumour may have reached large 
proportions and even metastasized before its 
discovery.
In  1920 Oppenheimer in Germany recommended 
regular microscopical examination o f the urine for 
the presence o f red blood cells as a means for the 
earlier detection o f occupational bladder tumours. 
For similar reasons in 1934, Cresdee, Guest, and 
Wignall (unpublished) instituted such regular 
examinations in two British dyestuffs factories and 
shortly afterwards Hope and Scott (unpublished) 
applied them in a third factory. They hoped that 
red blood cells or other abnormal constituents in 
the urine might give an indication fo r cystoscopy 
before the onset o f symptoms due to a tumour so 
that earlier diagnosis might afford a chance o f more 
effective treatment. During the next 15 years Cresdee, 
Goldblatt, Scott, and Williams (unpublished) in 
Great Britain extended these examinations o f wet 
unstained smears o f urinary sediments to include 
more men at more frequent intervals. Many cases 
diagnosed by this means were included amongst 
those described by Goldblatt (1949) and by Scott 
(1952) and all o f them were included in the figures 
used by Case, Hosker, McDonald, and Pearson 
(1954), and Case and Pearson (1954) in their survey 
o f the incidence of the disease in Great Britain. They 
confirmed statistically that there was a significantly 
higher incidence of bladder tumours amongst men 
exposed to a- and ^-naphthylamine and benzidine 
than in the general population and revealed an 
occupational hazard o f bladder tumours amongst 
men engaged in the manufacture o f magenta and 
auramine.
work
jiexfol
Similar examinations o f wet smears of urinaU mj 
sediment have been used as an indication for cyst ?ll|atj( 
scopy in Germany for a number of years (Gros ro]a0l 
1940). In  Switzerland, however, the urine w jroduc 
examined fo r occult blood in 1932 but by 1937, aft p aj 
consultation with American colleagues, routii : 
cystoscopy was chosen as the most efficient 
o f achieving early diagnosis (Muller, 1951). Routii resuj( 
annual cystoscopy o f exposed workers was fir|( ^
instituted in the United States of America in 19;; iolaoi
and has continued until recently with concurre (^  
examinations o f wet smears (Gehrmann, 193)  ^
Gehrmann, Foulger, and Fleming, 1949). Theyevi^  
advocate the cystoscopy o f all men before startii 
work. Similarly this procedure was adopted ear 
in Italy and still continues to be applied (di Mai tin o 
1937 and 1949). Many tumours have been diagnosi bnly 
in this way, but there is no indication of wh^ wevf 
proportion o f unaffected men have continued ; 
undergo cystoscopy annually for up to 2 0  
I t  is claimed by the above authors that regul ^  
annual cystoscopy can be achieved. In Fran,^ 
Billiard-Duchesne (1949) published the results of! ^  
cystoscopies, but Aboulker, Gaultier, Benguigi j y  
and Smagghe (1949) record the successful use oft; dcarc 
wet smear technique which suggests that routii mples 
cystoscopy was not acceptable to them. j* san"
In  Great Britain it is admitted that, although ,® ot 
substantial proportion of healthy men who ha o 
been at high risk might undergo cystoscopy on.^ f. 
demand, with repetition the numbers would quic ^  
dwindle to levels which would invalidate any o i ^  . 
alleged advantages. Cystoscopy may be accor. 
panied by some discomfort and is an opera i<|r(j 
which must be performed with great care i 
sequelae are to be avoided. In Great Britain l 
been the practice to restrict it to the neecss is 
minimum. Furthermore, in practice, routine cy ^ 
scopy cannot be extended effectively to those pe 
w ith a relatively small exposure to carcinogen
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have a remote chance o f developing a 
it tumour. Some tumours may grow to 
able proportions in a year, so that an annual 
jopic examination does not afford complete 
even i f  there were no defaulters and no 
JRjations.
the reasons given above, routine cystoscopy
jnsidered to be quite unsuitable fo r intro-
i into British factories. Since their inception
[ the examinations o f wet unstained smears
nary deposits have resulted in many pre-
Jjmatic diagnoses, but despite these successes,
cases were only discovered when inoperable.
:work of Papanicolaou and Marshall (1945)
(Papanicolaou (1947) suggested that a study
|exfoliated from the bladder epithelium into
urinal iue might offer another method o f screening
r cystc |uiation at risk. Accordingly in 1951 the
(Gros jjoiaou smear technique o f urine examination
ne w‘ traduced into the three factories alongside
17, afti ipnai wet, unstained smear technique. A
routii jjary report on the results o f the first year
met^ ° ipplication has been given by Crabbe (1952).
Etoutii iesuits were sufficiently encouraging to
as ^ ! the continuation and extension o f the
m colaou technique during subsequent years
icurr®' t subject of this paper is the evaluation of
I the two techniques against the symptoms
iey eve top ic findings, startrn
:d earf Methods
li Maiafion of Samples.—At first, urine samples were 
agnosef only from men working on suspect processes, 
af whPweveri some successes had been achieved, the 
nued i r  laminations were extended to cover men 
0  v e a f l P 1 hazardous processes and were employed
’ WlUArlr 1*1 {V. .
reguUpork in the factory.
F and Kcent^ ’ ’n two the factories, the working
, i of all persons employed have been examined
Its o employment cards of all persons who have at
:nguigt (had the possibility of contact with known or
seoftl 1 carcinogens are marked for the collection of
routii mples. No difficulty has been experienced in
S samples and their regular collection is now
hough !JS °ne of the routines of factory life. A large
ho hai81 °f men exposed to carcinogens in the past
! on fir ™ployed in a multitude of unrelated jobs else-
1 quick f  Tories, and must be specially sought out
of i re^ u'ar samples. The bottles are delivered
nn 891 ’n phe afternoon and collected full next accon i
(peratiQ t^hird factory it has been possible to examine the 
re 1 , ; J* men. For geographical reasons it is 
lin it ni ® tor them to attend at the surgery to void their 
tecessai at is preferable to collect the urine in two jars 
ne cyst< W tlie first containing contamination from the 
j persoi ^ Prepuce, but this was only possible in the 
igens hi ^.where the men attend at the surgery, or 
jwial sample is demanded.
Wet Smear Technique.—About 10 to 15 ml. of fresh 
urine is centrifuged at approximately 2 , 0 0 0  r.p.m. for 
15 minutes. A drop of the sediment is placed on a micro­
scope slide. A  cover slip can be applied, but this is not 
necessary for low- or medium-power examination and 
much time can be saved by dispensing with it.
The presence of red blood cells, leucocytes, and 
epithelial cells is noted, and a rough count of red cells is 
made. An experienced technician very quickly develops 
the ability to assess the number of cells present at a glance.
The decision to advise cystoscopy on wet smear 
examination alone always rests on the results of repeated 
examinations unless the urine contains sufficient blood 
to be visible to the naked eye, when cystoscopy becomes 
imperative. One of us (T. S. S.) examined the urine of 
2 , 0 0 0  consecutive male applicants for employment, none 
of whom had previously been exposed to chemicals, 
and 124 (6-2%) were rejected because of considerable 
numbers of red blood cells in the urine although there 
was no other factor which on physical examination would 
have been cause for rejection. Apart from this presence 
of red cells in the urine of a proportion of apparently 
healthy men, such cells may appear in the urine from 
other causes such as calculi, infection, or renal or pros­
tatic disease; the problem is further intensified by the 
fact that certain aromatic amines, such as ortho-toluidine 
and 5-chlor-2-toluidine, can cause acute chemical cystitis 
with haematuria so that i f  a man with microscopic 
haematuria has a history of recent contact with such 
amines further urine examinations after his removal 
from exposure are necessary. Thus microscopic haema­
turia in a single sample cannot be taken as an absolute 
indication for cystoscopy.
The wet smear technique has diagnosed many tumours 
but is not specific. Where no tumour was detected other 
conditions of the urinary tract were occasionally found. 
Sometimes, however, a man with no detectable cause for 
the microscopic haematuria would undergo a negative 
cystoscopy on two or three occasions and then refuse 
at the very moment when cystoscopy was vital.
Although the presence of an abnormal number of red 
blood cells has been the usual criterion for cystoscopy, 
as pointed out by Nassauer (1920) the presence of pus 
cells in the urine of men previously exposed to carcinogens 
is also an indication for further investigation.
Each man’s case has to be considered individually, 
taking into account the intensity and duration of exposure, 
the nature of the carcinogen and the time that has 
elapsed since first exposure, together with the severity 
and duration of the urinary abnormalities. For instance, 
inconclusive wet smears combined with a history of long 
and severe exposure would lead the medical officer to 
advise cystoscopy more readily than i f  the exposure had 
been moderate or negligible.
Papanicolaou Smear Technique.—About 40 ml. of 
urine is centrifuged at approximately 2 , 0 0 0  r.p.m. for 
15 minutes and a portion of the sediment is smeared on 
to an albuminized slide. Without letting the smear dry, 
it is immediately placed in a fixative solution consisting 
of equal parts of 95 % ethanol and ether for a minimum 
time of 10 minutes. I t  is then stained with haematoxylin,
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counterstained, and mounted. The preparations are 
permanent and can be kept indefinitely. A detailed 
description of this technique has been given by Papani­
colaou and Marshall (1945).
Although it is preferable to use freshly voided urine 
when possible, this is not absolutely necessary. It has 
been stated by Sawaya, Sandin, and de Almeida (1954) 
that specimens of urine must be processed within one 
hour of micturition as the cells may be so altered as to 
render interpretation impossible. We have found that 
even in unfixed urine, cellular degeneration does not 
proceed so rapidly and the addition of absolute alcohol 
serves to fix and preserve the cells for as long as 96 hours 
at room temperature. I t  was, therefore, possible to collect 
the specimens at convenient points in two of the factories 
and to deliver them to the laboratories for processing 
later.
Sediments from the majority of both fresh and fixed 
normal urines contain so few cells that they appear to be 
almost acellular, and in order to reduce the time spent 
on the examination of the slides various methods have 
been devised to concentrate more cells into each smear. 
Chute and Williams (1948) and Ruth Graham (1950) 
advocate making smears from the pooled deposit of the 
whole urine samples. Deden (1954), on the other hand, 
allows 200-400 ml. of urine to stand for six hours in a 
separating funnel and then centrifuges the sediment, 
while Rofe (1955) removes the non-cellular elements by 
differential centrifugation and the mucus by solution in 
water after fixation of the cells. Though these methods 
are too prolonged for a busy laboratory where many 
urines per day are being processed, a modified form of 
differential centrifugation is being used successfully in 
one of our laboratories.
The interpretation of the smears is difficult and requires 
a thorough knowledge not only of the criteria of malig­
nancy as laid down by Papanicolaou in his atlas (1954) 
but also of the numerous variations from the normal due 
to non-neoplastic conditions. While anyone can be 
trained in a matter of weeks to identify and record blood 
and epithelial cells in wet smears, it takes many months 
of instruction and practice before a technician can make 
a reliable assessment of the cytological characteristics of 
exfoliated cells. The results are interpreted as follows:—
Class I  ........................  Normal 1 x,
Class I I  ........................  Atypical j Negatlve
Class I I I ........................................... Suspicious
Class I V ......... Probably malignant \  p
Class V .........Definitely malignant] osl lve
A positive result is considered an indication fdR.Bd 
cystoscopy. Suspicious smears are regarded as positive an 
if  exposure has been heavy or i f  blood is also preseifnot - 
but in other cases repeated samples are examined uni 
a decision can be reached. The cases presented belo 
will serve to illustrate the application of the Papanici 
laou technique:—
Case 1.—This man was aged 51 when the tumour wi 
found. He had been exposed to the manufacture 
benzidine for seven years from 1933.
Routine wet smears of urine had been done from 19 
but had never suggested the presence of a tumor 
Papanicolaou tests since 1951 were negative until . 
1955, when a suspicious result (Class III) was notefmi 
Early in June the smear was Class II  but on June 30 ®e‘ 
became positive (Class IV). Cystoscopy on July'Mn v 
revealed a papilloma and this was confirmed as a benpaddi
tumour on biopsy. i {a) 
eR.B.i 
and ht 
two ca 
looma c
Case 2.—This workman was aged 49 when the tumo 
was found. He had been exposed to benzidine for 
years, from 1931.
His urine had been tested for R.B.C.s from 19] 
onwards and showed no significant quantity of bioKn 
cells. Papanicolaou smears made on two separator 
occasions in December, 1953, were definitely positi py (ff 
Because of this he was cystoscoped on January 25,19; iufficif 
and a small area of malignant tumour was reveal | 
which was confirmed as transitional cell carcinoma 
biopsy.
lowed 
a me 
tumo 
w cy 
icie 
seven h 
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Results
During the five years 1951 to 1956 the urines 
approximately 1,800 men were screened by 
Papanicolaou smear technique and also, except 
three cases, by the wet smear technique.
O f these 1,800 men, 91 were cystoscoped as 
result o f the two tests or on account of developi | the 1 
symptoms and 62 new cases of bladder tunw i 1 men 
were discovered. The results are shown in Tabl< on firs 
(The examination o f the urines of those men will j} out 
previous history o f treated bladder tumour w ’ anc 
have been under regular cystoscopic review , 
considered separately.)
Fifty-one men w ith positive Papanicolaou smj Wned 1 
showed bladder tumours on first cystoscopy (wan 
positives), (a) Twenty-six had symptoms andiatjn
f t  early
T a b le  1 ]^ > suj
S M E A R  R E S U L T S  A N D  F IN D IN G S  I N  91 M E N  C Y S T O SC O P E D   J ^ itW i
Sm ear R esu lts and Findings in 91 M en Cystoscoped
C y stoscop ic  F indings True
Positives
Probably
True
Positives
False
N egatives T ota l
False
Positives
True
Negatives
Sym ptom s and/or R .B .C .s 26 4 6 36 4 18
N o  sym p tom s 26* 1 - 27* 6
T otal 52 5 6 63* 10 18
* O ne case o f  carcinom a o f  the prostate.
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ion fjlLB.C.s on microscopy sufficient in them-
positijbean indication fo r cystoscopy, (b) Twenty-
presepot at any time had R.B.C.s or any other
ied u%i that a tumour was present. One man had
^ ^e!|apanicolaou smears but no bladder tumour
apam<kopy, although a carcinoma o f the prostate
jovered on clinical examination.
lourvpn with positive Papanicolaou smears,
cturei showing no tumours on first cystoscopy,
jd bladder tumours from five months to
ora later (probably true positives), (a) Four
tumo|ptoms or R.B.C.s sufficient to warrant
lti* in any case. (6 ) One showed no R.B.C.s s not|\
with negative Papanicolaou smears 
abenlWder tumours on first cystoscopy (false 
s), {a) Four were cystoscoped because o f 
; R.B.C.s. (b) Two showed only occasional 
s tum( and had symptoms .
ie *'or two cases o f bladder tumour and one case 
om j, ®na of the prostate were detected.
0f yc ffl had positive Papanicolaou smears, but 
separ; tumours have so far been discovered on 
positi py (false positives), (a) Three showed 
25,19 afficient in themselves to be an indication 
revea jscopy. (6 ) One had slight symptoms, 
lowed only occasional R.B.C.s.
:o men had negative Papanicolaou smears 
tumour on cystoscopy (true negatives), 
ie cystoscoped because (a) 1 1  showed 
arinesMcient to be an indication fo r cystoscopy, 
wen had both R.B.C.s and symptoms.
W men were cystoscoped.
T a b l e  2  
W E T  S M E A R  R E S U L T S
noma
by
icept
oed as Discussion
:velopi [the five years under review, 51 ( 7 6 -1 % )  
tumt 1 men with positive smears had bladder 
. Table mi first cystoscopy and the figure becomes 
;n witl () out of 67 when the five “  probably true 
our w" and the carcinoma o f prostate are 
eview
ft negative Papanicolaou and wet smears 
iu sme mned to be clear o f tumours in the absence 
jpy (t »sand were not submitted fo r cystoscopy, 
s and tat in the five years all the tumours found 
I1 early stage in their development on first 
^suggests that this view is reasonable.
   i® h was found that a tumour was present
ppanicolaou smear was negative but all 
an excess o f red blood cells or had
|^ nd 3 show the results o f the application 
®ear technique and the Papanicolaou 
- the urine o f the 91 men who were
3 show that in applying the wet smear
R ed  B lo o d  C ells or Sym ptom s
C ystoscop y T o ta l
P ositive N eg a tiv e
T u m ou r present 34 25 59
N o  tum ou r foun d 20 9 29
T ota l 54 34 88*
* In three cases n o  w et sm ear tests w ere d one.
T a b l e  3
P A P A N IC O L A O U  S M E A R  R E S U L T S
C ystoscopy
P ap an ico laou  T est
T o ta l
P ositive N eg a tiv e
T u m ou r present  
N o  tum ou r found
57*
10
6
18
63
28
T o ta l . . 67 24 91
* O ne case o f  carcinom a o f  prostate.
technique to the urine o f 8 8  o f the men there were 
2 5  (2 8 -4 % )  false negatives and 2 0  ( 2 2 -7 % )  false 
positive results whereas the Papanicolaou technique 
in  91 cases yielded only six (6 * 6 % )  false negative 
and 10 ( 1 1 -0 % )  false positive results. From these 
data it can be concluded that the latter technique 
is superior as a diagnostic measure. In  fact, as a 
result o f the Papanicolaou technique 25  men were 
sent fo r investigation and a tumour detected before 
the onset o f microscopic haematuria or any other 
indication that a tumour was present.
False Positive Results.—When cells w ith malig­
nant characteristics are present in the urine and no 
growth is found anywhere in  the urinary tract, the 
result is regarded as a false positive. A t their first 
cystoscopy 15 men gave false positive results but 
five o f them showed visible tumours on cystoscopic 
follow-up after five, 10, 11, 2 9 , and 4 6  months 
respectively.
The following case is given as an example:—
Case 3.—This man was aged 58 when the tumour was 
found. He had been exposed to ^-naphthylamine for 
eight years.
His urine was tested for R.B.Cs from 1936 onwards; 
occasional R.B.C.s had been apparent since 1950 but 
never of such significant number as to warrant cystoscopy. 
The Papanicolaou test showed malignant cells from 
March, 1953, onwards. He was investigated because of 
this in September, 1953, but no abnormality was seen 
except that on cystoscopy there was a little redness in a 
tiny area at the apex near the air bubble. Five weeks 
later, in October, 1953, the bladder looked more normal 
than previously and there was no change again in 
February, 1954. However, five months after this (July, 
1954) and 10 months after the first cystoscopy a sessile 
tumour was found high up in the apex and a smaller 
tumour was seen near to the right ureteric orifice,
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Clinically they appeared to be papillomata, but biopsy 
revealed them to be carcinomata.
The finding o f apparently malignant cells in the 
urine before a tumour actually becomes visible is 
comparable to the finding by von Haam and 
Menzies (1953) o f malignant cells in vaginal smears 
from laboratory animals some time before the gross 
appearance o f experimentally induced carcinoma 
o f the cervix uteri.
Chute and Williams (loc. cit.) in their series o f 
cases were surprised at the number o f carcinomata 
o f the prostate that gave rise to positive smears in 
the sediment from ordinary voided urine, as distinct 
from that passed following prostatic massage. 
Amongst our cases one man w ith positive Papani­
colaou smears was found to have a carcinoma o f the 
prostate.
However, amongst our 10 false positive cases 
there are four men who have repeatedly shown 
malignant cells in  the smear during the past two 
years and a further three who have shown similar 
findings recently. In  none o f these cases so far has 
a tumour been found on cystoscopy. The following 
case is a typical example:—
Case 4.—A man aged 44 had had slight exposure to 
bladder carcinogens, but had occasional attacks of 
cystitis with pain and dysuria.
He has had a few red blood cells persistently in the 
urine since 1949. The first Papanicolaou smears in April, 
1952, were strongly positive, and all subsequent smears 
have remained so. He was cystoscoped in September, 
1952, and again in February, 1954, but no abnormality 
was found either in the bladder or elsewhere in the 
urinary tract.
Masina (1952) in this country and Melicow (1952) 
and Melicow and Hollowell (1952) in America have 
noted that normal-looking epithelium taken from 
tumour-bearing bladders removed at total cystec­
tomy when examined microscopically showed foci 
o f cellular activity which closely resembled areas 
o f tumour formation and other areas which they 
thought might in time develop into obvious growths. 
These observations may help to explain the con­
tinuous false positive smears from men w ith 
apparently normal bladders. I t  remains to be seen 
whether these men w ill develop tumours o f the 
renal pelvis, ureter, bladder, or prostate later.
The remaining three false positive cases had renal 
calculus, urethral stricture, and haematuria following 
extensive burns. Ferguson (1949) points out that 
there are certain non-neoplastic conditions which 
produce cells almost identical to malignant ones 
and give rise to misinterpretation.
False Negative Results.—When a growth is found 
in  the urinary tract o f a man whose urinary sediment
rere see 
j!y beni 
by I 
an
never shows the presence o f tumour cells, the resui 
is a false negative. There were six false negatii 
results in our series, o f which the following case 
an example.
t-seven
Case 5.—This man was aged 52 when the tumour Jonfaroec 
found. He had been exposed to a-naphthylamine f i 26 ou 
19 years from 1935. His urine had been tested fmata ha 
R.B.C.s from 1936, and by the Papanicolaou techniq ret only 
from 1951. Although occasional R.B.C.s were not (0 be m 
they never reached sufficient numbers to warra 
cystoscopy and the Papanicolaou results were alwa 3gf r. • 
negative until he developed acute haematuria in Si. ® 
tember, 1954. Cystoscopy revealed a benign papilloiltlon wc 
which was confirmed by biopsy. ® of mi
explan;
In  five o f these cases the growth was clinicalceUs ' 
o f a simple papillary type. On section, four w<1 tlie ur 
histologically benign, whilst in the fifth the biof15 conta 
material was unsatisfactory. In the sixth case **a he 
solid type o f carcinoma covered with slough a Dature c 
calcareous deposit was present. exfoliate
iat, cont
“ Benign”  Papillomata.—Benign papillomi tehniqui 
appear to vary very much in the cells which t l :m of bs 
shed, and in some cases as Dean (1948) and Let ^  papar 
better (1955) point out, the exfoliated cells sh cases _ 
no recognizable difference from the normal. Papa ^  turnc 
colaou (loc. cit.) says such growths may be reci a(e(j for 
nized by the presence o f cuboidal and columi ^  reyi-( 
cells often arranged in groups and clusters, s o i^  wj 
times showing a palisade formation, and he p ^  ^  t 
them in the category o f Class II, reporting them 
atypical but suggestive o f benign papillon 
However, he says, “  their occasional presencej^k ^  
cases in which there is no evidence of such a grov 
lim its their diagnostic significance” , and also 4 ^
“  intermediate cell types from the prostate are afowra 
seen, some with a cuboidal or columnar f(| 
reminding one o f cells exfoliated from a ben 
papillary growth ” . McDonald (1954) says that 
is exceedingly difficult to distinguish benign pap| 
mata unless fronds o f tissue are exfoliated, w| 
Osborn (1953) observes that such fragments of tis 
show little  cellular variation. Other authors (Ch 
and Williams loc. cit.; Schmidlapp and Marsh 
1950; Deden, loc. cit.) have come to the conc |  , 
that cells from benign papillomata do not usu| e res 
deviate from the normal sufficiently to PermXiajDrev 
diagnosis and that amongst their cases their |  vi uals 
negative results were mostly such tumours. w lie
Our experience o f these benign tu™our:\ T  Se 
considerable interest. Fifty-six men had aa r mve 
tumours in association with the exfobaUonlfc stau 
abnormal cells. In  53 of them these t^a.t
apparently malignant characteristics an f  ®her 
other three only clumps of “  benign pap , ie sij
Nega
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he resi
nnour
imine
;ested
wari 
re ah 
a in 
papillc
ere seen.
:h ca 
ough
Yet, o f these 56 men, 29 had 
benign papillomata; 15 o f these were 
ne^ at|ed by biopsy, four proved to be malignant 
6 casCc„ and 1 0  were treated without biopsy, 
■seven men had clinical carcinomata; 2 2  
lafirmed by biopsy.
26 out o f 29 men w ith clinically benign 
ata had apparently malignant cells in the 
techniktonly four out o f 19 o f these tumours were 
ere nc jo be malignant on biopsy. Although it is 
; to suggest that malignant changes were 
taking place in these tumours, such an 
lion would lead to an abnormally high 
ie of malignancy amongst them. No satis- 
explanation is available to explain the 
cUnicjof cells with apparently malignant character- 
tour v i the urine from such a high proportion of 
he bio5 contain ing benign tumours. In  our 
it has not been possible to predict the 
nature of the tumours from the appearance 
exfoliated cells. Nevertheless, these results 
at, contrary to many opinions, the Papani- 
ipillon Unique is capable o f detecting a significant 
fhich I ®n °f benign papillomata.
ind L< J Papanicolaou Technique in Follow-up of 
'ells si Cases.—As there is a continuing liab ility  
1- PaP ter tumours to appear in persons who have 
be reiy for a bladder tumour, it is essential that 
colui%c reviews should be continued fo r life, 
ers, so |jped5 when the Papanicolaou technique was 
d he : dj, that it could be substituted fo r at least 
ig thei ||,ese review cystoscopies. We have applied 
papilh i()agroUp Qf  4 2  men who have had tumours 
iresenQ|able4). 
h a grd
4 i
POF 225 REVIEW  CYSTOSCOPIES OF 42 M EN
ite are «ed w it h  r e s u l t s  o f  s m e a r s  b e f o r e  e a c h  
nnar f  c y s t o s c o p y
i a be 
says th| 
ignpaf 
ated,
nts of ti 
lors 0 
i  Man 
, concli 
not us
C ystoscop y
T otal
Negative S uspicious P ositive
83 10 20 113
19 20 4 43
27 27 15 69
129 57 39 225
it appears that dependence cannot be 
e result o f Papanicolaou smears from 
o pen# 4 previous history o f a treated tumour, 
foiduals showed complete agreement all 
'While others continually showed false
* false negative results. A t the present 
(»r investigation it can therefore only be 
foliatio Hit stained smear technique is unreliable 
;e cellspg established cases. I t  is too early yet 
and inpether these false positive smears have 
papillofKtic significance.
s their 
ars. 
nours 
iad bli
Conclusions
Our experience over the past five years has shown 
that the Papanicolaou technique can be successfully 
used as a method o f screening the urine o f an 
industrial population. This confirms the suggestions 
o f Case (unpublished, 1949) and o f Cromwell and 
Papanicolaou (1952) that cytological examination o f 
the urine would be o f value in detecting industrial 
bladder tumours. The most important advantage 
o f the method is its ability to indicate the presence 
o f a tumour at a very early stage o f its development, 
often before any presenting symptoms or other 
urinary abnormalities have given an indication o f its 
presence. Poole-Wilson (1953) observes that on 
account o f routine medical examination in industry 
occupational bladder tumours tend to be seen in 
an earlier stage than those arising spontaneously.
To obtain the best results both the Papanicolaou 
and the wet smear technique should be employed 
together. On the other hand, wet smears o f con­
centrated deposit can be examined fo r epithelial 
cells, and a Papanicolaou smear only made and 
examined i f  such cells are seen. I f  the urine is 
acellular much time and trouble can be saved in this 
way without a significant loss o f efficiency. By this 
means it  is possible to maintain a much more 
comprehensive and frequent check on large industrial 
populations than can be achieved by the use o f 
routine cystoscopy. I t  is also possible to include 
considerable groups o f workers whose chance o f 
tumour development may only be remote.
Routine annual cystoscopy o f persons w ith high 
risk is claimed to be practicable abroad. I f  i t  had 
been used as a screening method on this population 
it would have involved at least 8 , 0 0 0  cystoscopies 
in five years compared with the 91 carried out fo r us. 
The fact that early diagnosis was achieved in our 
cases leads us to believe that the techniques we have 
described offer very considerable advantages. We 
consider that they are indispensable, i f  all necessary 
care is to be given to workers in any factory where a 
hazard o f industrial bladder tumours exists.
Summary
A  description is given o f cytological methods of 
achieving early diagnosis o f occupational bladder 
tumours. The results obtained by examining the 
urine o f some 1,800 workers fo r the presence o f 
microscopic haematuria and by the Papanicolaou 
technique are reported together w ith the cystoscopic 
findings amongst 91 men.
The advantages and disadvantages o f the two 
techniques are discussed.
I t  is concluded that the Papanicolaou technique 
offers considerable advantages in the diagnosis o f 
benign and malignant tumours o f the bladder, and
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that this, coupled w ith the examination o f urine for 
red blood cells, is the method o f choice fo r screening 
an industrial population w ith a high risk o f such 
tumours.
We should like to thank Dr. Alexander Munn for his 
assistance in this work, and Miss M. Grice, Miss D. 
Jackson, Miss L. North (Imperial Chemical Industries, 
Dyestuffs Division), and Mr. E. Booth (The Clayton 
Aniline Company Ltd.) for processing and examining 
the slides by both techniques.
We are indebted to Mr. M. L. Kennedy, Huddersfield 
Royal Infirmary, and Mr. D. S. Poole-Wilson, Salford 
Royal Hospital and Christie Hospital and Holt Radium 
Institute, Manchester, the urologists under whose care 
the majority of our patients were treated. Mr. Poole- 
Wilson gave us much valuable advice in the preparation 
of this paper.
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and Use o f Products Causing Tumours of the Bladder JThat
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From the Papilloma Committee o f the Association of British Chemical Manufacturers 
( r e c e i v e d  f o r  p u b l i c a t i o n  m a r c h  2 5 ,  1 9 5 7 )
Bladder tumours have been recognized as an 
occupational hazard amongst dyestuffs workers for 
over 60 years. The news o f this hazard reached 
Great B rita in  in  1912 following the visit o f Thomas 
Legge, then H .M . Senior Medical Inspector o f 
Factories, to Frankfurt-am -Main in 1911 (Legge, 
1912, 1913), but i t  was not un til 1926 that the first 
cases in  England were described by members o f the 
factory medical inspectorate (Bridge, 1927). The 
first contribution from  the industry itself came from  
W ignall in 1929. By 1933 Bridge, H .M . Senior 
Medical Inspector o f Factories, reported that 28 
deaths from  occupational bladder tumours had come 
to his notice. Goldblatt (1949) described 101 cases 
from  a group o f British factories and Scott (1952) 
recorded 6 6  cases from yet another works.
In  1947 the Dyestuffs Group o f the Association 
o f B ritish Chemical Manufacturers (A.B.C.M.) set 
up and financed a major research project on in­
dustrial papilloma o f the bladder. This has been 
described in a booklet which was circulated to 
managements, trades unions, and workmen (1953). 
A  scientific committee was appointed under the 
chairmanship o f Professor A. Haddow to guide 
research work in to the cause, consider diagnostic 
methods, and examine preventive techniques. A  
sub-committee was invited, under the chairmanship 
o f M r. N. Strafford, to provide accurate methods 
fo r the analysis o f suspected compounds under 
industrial conditions (Butt and Strafford, 1956). In  
1948 a research fellow, D r. R. A. M . Case, was 
appointed at the Chester Beatty Institute to conduct 
an investigation into the industrial data. This 
enquiry covered the records o f over 30 years o f 
the manufacture o f dyestuffs and their intermediates 
in  Great Britain. The results and the statistical 
analysis were published in  1954 (Case, Hosker, 
McDonald, and Pearson, 1954).
Case and his co-workers were able to produce
periot 
entry 
lumoi 
years 
most 
betwe 
necesi 
expos
statistical proof that contact with alpha-naphthyla- . m  
mine, beta-naphthylamine and benzidine, three ; accep 
compounds which had previously been suspected, ; ium0| 
caused a significant incidence o f bladder tumour 
amongst the men engaged in their manufacture or * 
use. No evidence was found to inculpate aniline : Mce 
and it  is now considered that under the conditions ; arres* 
o f its manufacture and use in this country it is not a . e 
significant cause o f bladder tumour, and that the : 
name aniline cancer o f the bladder is an unfortunate ■ ^  
misnomer. Suspicion, however, fell on the manu- . ^,en( 
facture o f magenta and auramine and further data . ^  
collected and analysed confirmed that the risk also : c^an! 
existed in connexion with their manufacture. The j °^ tre 
results o f the study were at once given to the Ministry 
o f Pensions and National Insurance, and in 1953 
papilloma o f the bladder was prescribed as an 
industrial disease in occupations involving contact 
w ith alpha-naphthylamine, beta-naphthylamine, or 
benzidine, and the manufacture of auramine or 
magenta.
Progress had already been made in many direc­
tions to improve the methods of protection from the 
compounds now proved to be carcinogenic, but it 
was obviously necessary not only to devise the safest 
possible method o f working but also to be able to 
assess the efficacy of those measures in eradicating 
the tumours. We were, therefore, invited by the : 
A.B.C.M. to draw up a “  code of industrial practice 
to cover the manufacture and use of known or : 
suspected bladder carcinogens and the present paper . fact 
is based on the recommendations made to the : ^  
member firms o f the Association in 1953 now brought ^
up to date. Many o f these recom m endations have ,j
been made before but it  is felt that repetition is not ^  
without virtue in this context.
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This report is based on the following premises 
which are now generally accepted in Great Britain 
and which have been confirmed by the report on the
highi
tw o !
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ild survey, by other published reports, and by the 
iustrial experience o f the authors:—
(a) That the high incidence o f bladder 
tumours has occurred in men working on 
the manufacture or handling o f beta- 
naphthylamine, benzidine, and to a lesser 
extent, alpha-naphthylamine.
(b) That there is a widely variable latent 
period (or induction period) between 
entry to the industry and onset o f the 
tumours. This may range from one to 45 
years with an average o f 18 years and the 
most common time o f development is 
between 15 and 20 years. This does not 
necessarily coincide with the period of 
exposure, which also varies widely. Ex­
posure periods of a few months are 
accepted as being sufficient to cause a 
tumour.
(c) That the process of tumour development, 
once initiated, is irreversible and is not 
arrested by cessation of exposure. Thus 
the exposure period may, in those who 
leave the industry and subsequently 
develop a tumour, be shorter than the 
latent period. During this time it is not 
possible to demonstrate any pre-tumour 
changes in the bladder, nor is any method 
of treatment known which would prevent 
the development o f a tumour.
id) That the onset of tumour and death 
occurs at much earlier ages in those who 
enter the industry before the age o f 30 
than in the general population or in 
entrants over 40. This may be applied 
as a rough test for occupational hazard,
i.e., death from bladder tumours in 
younger age groups would give rise to 
the suspicion that the tumours were of 
occupational origin. I t  is not thought 
that younger people are more susceptible 
to the disease but only that the younger 
the age at entry into the industry, the 
younger w ill be the victim at onset should 
a tumour develop. Older people are in 
fact more likely to develop spontaneous 
tumours o f nearly every type including 
bladder tumours.
(e) That the proportion o f exposed persons 
who will be affected is influenced by the 
intensity and duration o f exposure. The 
higher the “  dose ”  as determined by these 
two factors, the greater w ill be the number 
affected.
( / )  That the mean latent period is influenced 
by the type o f carcinogen. I t  had pre­
viously been thought that the severity or 
length o f exposure might influence the 
latent period and this is the case in a 
number of recorded animal experiments. 
The statistical analysis, however, did not 
confirm this view.
(g) That the cancer-producing potency of 
these substances in industry varies, 
technical beta-naphthylamine being about 
twice as potent as benzidine and four 
times as potent as technical alpha- 
naphthylamine. I t  is strongly recom­
mended that all compounds which are 
known or suspected to be cancer- 
producing should, where manufacture is 
necessary, be manufactured and handled 
with equally stringent precautions as far 
as is technically possible.
(A) That alpha-naphthylamine may be a 
carcinogen itself apart from its beta- 
isomer impurity. Therefore even if  alpha- 
naphthylamine can be manufactured free 
of its beta-isomer impurity it should still 
be regarded as dangerous, unless over­
whelming proof to the contrary could be 
adduced.
(/) That aniline does not cause occupational 
tumours of the bladder in men engaged 
in its manufacture or use.
(j) That there is an occupational hazard of 
bladder tumour in the manufacture o f 
auramine and magenta with a latent 
period of the same order as the other 
occupational cases. This does not neces­
sarily mean that the finished products, 
auramine and magenta, are themselves 
the causal agents and the statistical 
analysis could not elucidate this point.
Case and others (1954) give a statistical estimate 
of the number of cases that may be expected in the 
future from the people who have already been 
exposed. Case (1953) has also set out a method by 
which it is possible for a firm in Britain to estimate 
the number of deaths that might arise by the non- 
occupational risk of the disease. A  comparison of 
this with the observed number can be used to detect 
dangers associated with unsuspected processes and 
eventually to test the efficacy of new precautions. 
Case and Lea (1955) have described a more general 
and simpler method of achieving this object, and, 
in conjunction with Case and Pearson’s tables 
(Registrar General’s office, in the press), the method 
can be applied to other forms of cancer as well.
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Description of the Disease
O ccupational tum ours o f the b ladder present all 
clinical and  histological stages between benign 
p ap illom ata  an d  infiltrating carcinom ata. A  papil­
lom a m ay undergo m alignant change. T he tum ours 
occasionally occur in  th e  u re ter o r th e  pelvis o f the 
kidney (M acalpine, 1947). There is no  dem onstrable 
difference betw een those contracted  by chemical 
w orkers and  those arising in the general population .
R ecurrences are  frequent and  tum ours m ay recur 
as pap illom ata  o r as carcinom ata irrespective o f  the 
n a tu re  o f the original lesion. I t  is thought tha t 
m any  o f  these so-called recurrences are  fresh 
tum ours arising in  an  already activated bladder 
m ucosa. T he usual com plications, such as haem or­
rhage an d  infections, occur w ith either type of 
tum our.
T he onset is insidious and  the disease m ay be 
advanced o r  even incurable before any sym ptom s 
o r  signs appear, bu t, o n  th e  o ther hand , it  is com m on 
fo r severe sym ptom s to  occur in the early stages 
w hen trea tm en t is likely to  effect a  cure. Usually, 
the  first sign is haem aturia, bu t bleeding m ay not 
be visible even in advanced disease. A nother sign is 
p yu ria  caused by the  tum our surface ulcerating or 
becom ing infected. O ther signs o r sym ptom s such 
as dysuria o r  frequency m ay arise, depending on 
th e  stage to  w hich the  tum our o r its complications 
has advanced. I t  will be obvious from  this th a t any 
haem atu ria , even in  m icroscopic am ounts, m ust be 
regarded  w ith suspicion and this is extremely im ­
p o rta n t in  early diagnosis.
Because o f the  tendency to  recurrence, it follows 
th a t once a  tum our has been treated  it is necessary 
to  have regular follow -up exam inations and review 
o f each case a t suitable intervals. Even when 
ap p aren t cure has been m aintained over m any years 
a t least annual re-exam ination should be continued. 
In  view o f  the  long la ten t period, in  som e cases over 
30 years, it also follows th a t once a  m an has been 
exposed fo r a  sufficient tim e to  chemicals which can 
cause b ladder cancer he rem ains a t risk fo r the rest 
o f his life, w hether he continues to  w ork w ith them  
o r no t. W e consider th a t a period o f six m onths’ 
exposure can be sufficiently long bu t even shorter 
periods m ay com e to  be accepted as sufficient to  
induce a tum our.
PART I 
Medical Recommendations
This section deals w ith the m edical contro l o f the 
hazard , w ith selection and education o f w orkers, the 
m ethods o f p rotection , and  th e  keeping o f records. 
O ur recom m endations fo r ensuring the early diag­
nosis o f tum ours in industrial w orkers a t risk are 
the  subject o f a  separate paper (Crabbe, Cresdee,
Scott, and Williams, 1956), which should be studiedlPrev 
in conjunction with these recommendations. (Worl
Medical Control.—Medical control is essential tc 
ensure (1) proper selection and adequate medical 
supervision of workers; (2) early diagnosis of bladdei"®™ 
tum ours; (3) liaison with the family doctor, th |for; 
urologist, and the hospital; (4) the follow-up of mec®' ^  
w ith established tumours from the point of vie#®00 
o f their treatm ent, regular reviews, and workingPartil 
capacity; (5) general supervision of the health oj^d 
workers, supervision of plant hygiene, investigationno 
o f the records to determine the incidence of sicknesiW 
due to bladder disease. ?»the
I t  is recommended, therefore, that where there is ?! and ] 
hazard there should be a medical officer, either fullWs 
time or part-time, depending on the amount of workH. fie 
involved. I t is desirable that all investigation ano*din 
treatm ent should be undertaken with the cooperation be ct 
of the w orkm an’s family doctor and that, if possible/, the r 
all the cases in one area should be treated by thdjlheo 
same surgeon or unit, who would thus gain valuablesma 
experience of industrial tumours. To this end thefeand 
works doctor should approach the man’s familynJam 
doctor to arrange through him the necessary iffl have 
vestigation or treatment by the surgeon with whonaade fc 
he would also be in touch. in th
I t  is an im portant part of the treatment and®of] 
rehabilitation o f these cases that they should be 
enabled to continue at work and not become chronic™1-- 
invalids; here again it is essential to have skilleff roc 
medical advice on their capacity for work antPjc 
placement in a job. g j
Records.—The following records should be 
m aintained in relation to each suspected carcino^^ 
genic substance: j n ^
1. (a) Plant and processes. Chemical and physicCal 
form o f products during process an ^ 
isolation {e.g., base, sulphate or hy ro ^  .
chloride, etc.) Ud m
0b) Quantities manufactured and handled * q. 
(c) Methods of manufacture and handling 
with dates of changes .
{d) Type and design of plant used with daft* a e
of changes _ J
(e) Plant hygiene precautions 
( / )  D uration and types of shift worke 1
2. The following records should be main 
in relation to each man working wi ^  ^
pounds:— >3dmo
(a) Name and address ^
(b) N ational Insurance number iecom
(c) Date of birth 'absoi
(d) D ate of entry into the indus j, wj
(e) D ate of starting hazardous occ p idas,
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(/) Previous significant occupational history
(f) Works history
(h) Any significant accidental contam ination
(i) Particulars of death certificate
The information compiled from  these records is 
initial for a precise assessment o f the hazard in 
fefuture. They need not necessarily be kept by the 
■edical officer but should be available to him. Many 
/these particulars will already be recorded by the 
kdinical and labour departments.
Where no records have existed previously a 
ijister should be compiled with these particulars, 
5 far as they can be ascertained, in respect of 
lesent and past workers. This is similar to the 
minal rolls supplied by the mem ber firms for the 
IB.C.M. field survey. This register should be 
mtinued in the future and kept up to date. From  
l may be calculated, by the methods mentioned 
iriier, the number of cases of tum our likely to 
rise by the ordinary risk of the disease. The actual 
xidence may, now or in the future, be compared 
A this and hence may indicate the existence of 
i hazard and whether the measures applied for 
wtrol have been effective. Arrangem ents have 
ffli made for the appropriate records to be main- 
wd in the future by H .M . Senior Medical 
Aector of Factories.
Selection.—New entrants to jobs which involve 
of tumour, either in m anufacture or use of 
Winogenic substances, should be selected by the 
*As medical officer, bearing in mind the following 
^derations:—
The age of onset o f bladder tum ours in 
®ewho develop them is alm ost entirely depen- 
upon the age of entry into the industry, occur- 
J8 after a latent period of usually 15 to 20 years. 
01 over the age of 30 should be chosen when 
•Wicable in order to reduce the likelihood of 
^t and mortality from these tum ours at early 
^ en °ver 40 should be given preference.
Hygiene.—A high standard of personal 
Wne is essential to reduce the absorption of 
, lcal by the skin and m outh to the minimum. 
Orally speaking, those whose standard o f hygiene 
jPoor will be unlikely to cooperate in the personal
J entive measures such as clean working, bathing,
c anging. The dirty should obviously be rejected; 
^ding increases the risk of ingestion; septic 
'oiilrn? m°uths suggest poor hygiene; the bearded 
Srd he exc'uc^ ed because of the possibility of the 
 ^ becoming contam inated and so increasing the 
o absorption by the m outh and nose; m outh 
W'^  nasal obstruction should, also be 
e as they may tend to remove masks.
Intelligence.—A sufficient standard o f intelligence 
is necessary to understand the hazard, to profit by 
training in methods of prevention, and to apply the 
self-discipline necessary to cooperate in the measures 
prescribed for personal hygiene and protection.
Previous Health.—Special attention must be paid 
to any previous disease o f the genito-urinary system 
and to any previous history o f cancer of any type 
or o f any organ. An applicant with such a history 
must be rejected because o f the risk o f non- 
occupational disease which would confuse the 
assessment of the hazard and the diagnosis o f indus­
trial tumour. There is no evidence that a  family 
history of cancer predisposes to bladder tum our and 
we do not recommend rejection merely on this 
ground.
Present Health.—Men selected should be free 
from gross disease, especially of the genito-urinary 
system, and from cancer or any pre-cancerous 
lesions of any organ or of the skin. The urine should 
be examined for albumin and blood and pus cells, 
partly to assist in excluding genito-urinary disease 
and partly to avoid confusion in the interpretation 
of urine tests after the applicant has started work.
Occupational History.—It is most im portant to 
ascertain whether there has been any previous 
exposure to carcinogens. Men who have previously 
worked in occupations in which they have been 
exposed to other carcinogens should be excluded 
from starting work with these compounds. This 
would also entail the rejection of men with a previous 
industrial history of work in tar products, gas works, 
rubber works, coke ovens, and in other chemical 
plants carrying a carcinogenic risk. On a plant 
where the hazard is suspected but no t proved it is 
undesirable to employ men who have had previous 
exposure to carcinogens.
A part from the above considerations, the standard 
of fitness required will be determined by the type 
of work to be done. The physique or strength of a 
man or the general state of his health is no indication 
of his resistance to bladder tumour.
Education and Training.—The worker selected 
should have explained to him clearly and simply 
(a) what the hazard is, (b) where and how it arises,
(c) the measures which are taken on the plant to 
prevent risk, (d) how he should use the measures 
provided for his personal protection.
We consider that it is not possible to justify the 
concealment of such a risk from men who are being 
exposed to it. Better cooperation can be expected 
if they understand what is being done to attain safe 
working conditions and why it is being done. A 
simple explanation of the situation, including refer­
ence to medical care, engenders confidence in the
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w o rk er’s m ind. P articu lar care should  be attached  
to  supervision an d  train ing  during  the first few 
weeks o f  a m an ’s em ploym ent on  such a  p lant.
Protective Measures.— In  industry  these com ­
pounds en ter the body by tw o m ain  rou tes— inhala­
tio n  an d  ab so rp tio n  th ro u g h  the  skin—b u t it should 
be b o rne  in  m ind  th a t they can also be ingested. Thus 
th e  a im  o f  all preventive m easures m ust be to  reduce 
to  the  m inim um , and  w here possible to  elim inate, 
all con tac ts betw een o pera to r and  carcinogens. The 
first an d  basic m ethod  o f  ensuring  this end m ust 
be by p lan t design and  operation . The second line 
o f  defence is th e  provision  o f personal p ro tection  
fo r the  w orkm en b u t the hygiene o f the p lan t and 
o f  the  w orking environm ent is m ore im portan t than  
any m easure which depends fo r its efficiency on the 
co o pera tion  o r discipline o f the opera to r o r on  any 
m easure w hich is u nder his con tro l (Legge, 1934).
W orking Clothing .— N o m an  should  w ear any of 
his ow n clo th ing  while exposed to  carcinogens. A  
com plete set o f w orking clo th ing should  be supplied 
an d  should  include underw ear, footw ear, socks, and 
outer-w ear. They should  be changed im m ediately 
on  accidental con tam ination , and  should  be changed 
an d  w ashed a t regular intervals depending on the 
p lan t conditions an d  on  the  degree o f exposure b u t 
n o t less th a n  once a  week in  any circum stances. A  
daily  change will avoid the absorp tion  o f am ine 
w hich has im pregnated  the  clo th ing on  the previous 
day. F o r  laundering  a  slightly acid synthetic 
de tergent is preferab le  to  alkaline soap as the la tter 
leads to  th e  fo rm ation  o f  the insoluble base which 
m ay dry  in  th e  clothes. T he clo th ing should be 
tested  a t frequen t intervals fo r the  presence of 
am ines by the  m ethods w hich have been described 
by  B u tt and  S trafford  (1956). This form s a useful 
check o n  the  efficacy o f the m easures taken  to 
p reven t ab so rp tion  o f the noxious substances. The 
w ork ing  clo th ing  supplied should  be taken  off at 
th e  end  o f  each shift and  m ust be left a t the factory. 
O n  n o  accoun t shou ld  it be taken  hom e. Separate 
lockers should  be provided  fo r hom e and  w orking 
clo thes so th a t no  cross con tam ination  takes place. 
A  clean sm ock o r coa t can  be w orn  during meals so 
th a t tables an d  food  are  n o t contam inated  from  
w ork ing  clothes.
Protective Clothing .— T he protective clothing, 
w hich shou ld  be  supplied and  w orn  in add ition  to  
th e  w ork ing  clo th ing  described above, will vary 
accord ing  to  the  process and  the  type o f p lan t and 
th e  resu ltan t po ten tia l exposure, b u t will generally 
consist o f  overalls o f  closely woven co tton  o r wool 
(o r b louse an d  trousers o f sim ilar m aterial), rubber 
boo ts , ru b b er o r p lastic  gloves w ith gauntlet fitting
or long sleeves attached, and a cap which can 
washed.
lediaiG loves.— PVC and rubber withstand the amimIfrnnt, 
bu t if  new carcmogens are discovered care must I  • 
taken to  ensure that protective materials are resist* I T  
to  them . Gloves contaminated on the inside mP u, 
be destroyed. The outside of gloves should I 
washed by the operative during and after work r°' 
the  laundering o f gloves for re-issue is not recoi 
m ended because of the danger of accidental re-i 
and  incom plete decontamination. Cotton glol 
are inadequate and may result in longer absorpticlw1' 
th an  brief contact with bare hands followed ill Work- 
im m ediate washing. This latter practice may }is. to lin 
necessary where delicate manual operations $ (a) N 
carried ou t by fitters. Impervious armlets can p emerge 
w orn w ith gloves in dealing with molten carcinogek being 
or solutions. icontinuo
A prons.—Light impervious aprons for handlipsforpi 
m olten carcinogens or solutions should extend xlchange b 
to  the neck and below the tops of the rubber boofteir shift
F ootwear.— Rubber safety boots are preferabta 0f 
to  clogs as they are more impervious and they qfien exj 
be w orn to  knee length if liquids are being handles! ^  ]jn 
Turning down the tops of boots is wrong, particty men v 
larly when aprons are worn, as liquid is apt to n f c  ^  
inside the boots. ?or hand
Masks.— Should vapour or dust give rise to heainporary i 
atmospheric contamination, hoods with cleifculdbe 
compressed air supplies should be used. DUt 
respirators are not always dependable because $ transfe 
the unreliability of individual fit and the risk of skJlould nc 
absorption from the face and neck. Cotton wot  ^to th 
pads are not adequate protection against these du^ jy ^ 
or vapours. J better t
Baths.— Suitable changing and bathing facilititfmen, to 
w ith adequate ho t water, soap, and towels must lather than 
available at the factory. Shower baths are the nwilarly, th< 
satisfactory and are usually preferred, but soritjhould b 
w orkers, especially the older ones, prefer a shpwscale of 
bath. The m ain objection to the slipper bath o{ 
tha t in cases of contamination some amine nujje ajy | 
rem ain on the skin from the bath water; there J^linethoc 
also be some danger of inhaling amine vo ati izticted depi 
by the ho t water while lying in the bath. to f regi
(1) A  bath  or shower must be taken at the ejdtodotl] 
o f each shift so tha t small quantities of amine engage 
m ay be present on the skin will be remove . fon a vc 
m ust be obligatory and the bathing tune sh™ ^should 1 
paid  for. Twenty minutes is regarded as adequa^ ^
time. . . j  jrect? w^ere
(2) These compounds can be absorbed Wor in
through the skin in any physical form as sa j ^  t 
base, m olten liquid or solution, ° r a* suitat
perature,' so tha t if  there is accidental contamin ^  to (
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re must be 
re resistant
r  work lot 
lot n a n -  
ntal rente
itions are
ch can be  ^contamina-tion occurs during p lan t main- 
laice or cleaning, it is essential th a t the workm an 
:d immediately and his clothing completely 
i. If contamination is very heavy and a 
tter bath is used, a  second bath  is advisable as 
■rater in the first becomes heavily charged with 
lie. A scrubbing brush will help to remove 
pical from rough skin or fissures and care 
mild be taken to ensure tha t the nails are cleaned, 
te hair should also be washed and it should be 
ed that spectacles, if worn, m ay be 
l^aminated.
of Work.—Process operation should be so 
as to limit the time of exposure to a 
i®mum. (a) N o  overtime should be worked 
in an emergency and an emergency should be 
ad as being an occasional isolated incident 
[ulnot a continuous period. (b) I f  men work with 
amines for part of a day or shift they should 
i  and change before going on to  other work to 
mplete their shift.
limitation of Numbers Exposed.—The total 
mber of men exposed regularly to  these carcino- 
»should be limited as far as conditions allow. 
,s) Only men who have been selected by the 
*fal officer should be allowed to w ork on 
fusing or handling operations.
I  Temporary or casual process workers and 
J®Hers should be kept to a minim um and avoided
skofsfo
facility 
just I* 
the most
flit
asfifl#
■ hath is
Cross transfers from one hazardous plant to 
Jwlier should not normally be allowed so that 
as to the relative risks of each p lant or 
may be avoided. But, in small factories, 
be better to employ one m an, or a  small 
of men, to operate all the plants where there 
Jriskrather than to increase the numbers exposed. 
^ Similarly, the handling o f these substances in 
Mant should be confined if possible to one man 
^  the scale of work is too large for this, to a 
d number of men who would handle, weigh, 
line iW)  ^ charge all the dangerous m aterial where 
here®*! %iical methods cannot be installed. 
olatiP !) Selected deputies should be appointed to  cover 
1 absence of regular men. N o other men should 
the'flowed to do the job.
men engaged on these processes should be 
& on a voluntary basis and no industrial
should be applied to  persuade m en to 
id# ; flake this work or to rem ain on it.
Plants where radical improvements have been
oiITh °Ut 0r *n new plan*- which has been built 
L regard to safe working, we recommend 
' men of suitable age who have no t previously 
e*posed to carcinogens should be employed
whenever possible, although it m ay be necessary to 
employ certain key m en who have previous ex­
perience and possibly previous exposure.
Cases o f tum our developing after a  few m onths of 
heavy exposure to benzidine and beta-naphthyla­
mine have been reported. Safe working should be 
achieved by appropriate p lan t design and m ethods 
o f working and no reliance should be placed on the 
practice o f employing m en for short periods, as 
advocated by earlier writers, as this would only 
increase the numbers o f men a t risk. «
PART II 
Plant and Operating Precautions
This section will deal with the industrial and 
technical measures recommended in the m anufacture 
and use of alpha-naphthylamine, beta-naphthyla­
mine, benzidine and its homologues, and a num ber 
o f other processes. Before discussing the details 
peculiar to  each process it is proposed to  lay down 
the basic principles which must lie behind all efforts 
to eradicate this hazard completely from  the 
industry.
Buildings.—In the design o f new plants the ceiling 
should be sufficiently high to allow adequate ventila­
tion. W here possible, pressure vessels containing 
m olten carcinogen should be isolated in the open air. 
The walls should be made of a material which cannot 
become impregnated with chemicals. The floors 
should have an adequate slope to drain and be 
constructed of a m aterial which will withstand both 
physical and chemical damage. I f  wear and te a r 
occurs so tha t pools form, these m ust be filled in 
since they can form a constant source o f atmospheric 
contam ination as well as a cause of splashes. Where 
a  high level of exposure is liable to occur no wood 
should be used in the construction of stairs, platform 
floors, or hand-rails, all of which should be made 
of metal. F loor grids m ust be easily removable and 
drains should have a sufficient gradient to ensure 
quick flow. A lthough it may be difficult to  alter old 
sheds, these recommendations represent the standard 
to be aimed at.
Ventilation.—Forced ventilation will be desirable 
for all buildings where carcinogens are regularly 
handled in a m anner where there is any possibility, 
however remote, tha t the general atmosphere may 
become contam inated with vapour or dust. In  order 
to achieve adequate air changes in the lower floors 
of some buildings, it may be necessary to provide 
air suction trunks from  the roof to  each floor in 
order to achieve the desired effect. I t must be made 
clear tha t the need for forced ventilation o f the 
general working space is much more necessary
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w here volatile h o t carcinogens are  being handled 
th a n  w here the  hazard  is in  the  form  o f  dust. L ike­
wise, fo rced  ven tila tion  is least necessary w here there 
is n o  h o t process an d  th e  final p roduc t is handled
multiple holes can be fitted so that the floor can \ 1 
kept constantly wet. '
as a  
so th a t 
m an.
paste . A ll general airflow  should  be arranged 
th e  a ir  cu rren t moves away from  the
N o  p lan t item  contain ing h o t m olten  carcinogen 
shou ld  be vented w ithin the w orking space and if a 
n um ber o f  such vent pipes are  necessary a  com m on 
scrubber system  should be provided so th a t con­
tam ina ted  a ir does n o t en ter o ther sheds nearby or 
re-en ter the  shed from  w hich th e  contam ination 
orig inated . I f  no  such scrubber system is installed 
th e  vent pipes m ust be carried  well above any point 
w here a ir  is entering the w orking space, such as 
w indow s o r  ventilators.
P lan t.— T he object in all p lan t design m ust be to 
co n ta in  the  carcinogens w ithin an  enclosed system 
w herever possible w hether they are  present as dust, 
vapour, o r  liquid. Every p lan t item  should be 
considered  w ith  regard  to  its enclosure and  ventila­
tio n  outside the w orking space. Lagging liable to be 
con tam inated  should be encased in an impervious 
m aterial, so  th a t spillages can  be effectively removed. 
H o t con tam inated  lagging is a  danger and care 
should  be tak en  during its repair. Catwalks should 
be provided where necessary to  avoid dam age to 
lagging. A ll operations involving m anual handling 
o f  carcinogens w hether in  concentrated  form  or 
w hen they are  present only as an im purity should 
be studied  w ith a view to  the establishm ent o f 
au tom atic  enclosed types o f p lant. A ll such p lan t 
should  be designed so th a t decontam ination can be 
carried  o u t before it  is handled  by fitters. Sharp 
angles o f  pipes should be avoided to minimize the 
chance o f blockages, and  in  pipe design special 
a tten tio n  should  be paid  to  ease o f  replacement.
W hen these im provem ents have been carried out 
there rem ains the risk o f  these carcinogens being in 
con tac t w ith the w orkroom  atm osphere during final 
packaging in  m anufacture, o r in charging if these 
in term ediates are  being used. B ulk handling o f 
m ateria l in  enclosed pipelines as m olten liquid, 
slurry, o r so lu tion  will often close this last loophole.
I f  m anual handling is inevitable in charging or 
iso lating  the m aterial, adequate draughting and full 
pro tective clothing m ust be relied upon. I t  is 
realized th a t bulk handling will only be possible 
w here considerable quantities o f carcinogens are 
being handled . Evidence available suggests th a t by 
fa r the  greatest risk exists on  plants which handle 
carcinogens consistently every day. W here dust is 
likely to  occur floors should be kept wet to prevent 
it from  rising in to  the atm osphere. A  pipe with
Sampling of Product.-W here sampling of hildren 
carcinogens within an enclosed system is necessaP int£ 
for process control, a device can be installed ljcessary 
carry out a melting point determination wither^ m 
opening up the plant. Where samples have to W  
withdrawn this should be done in a small vent 
cabmet The use of dip pans for sampling is u 
satisfactory because hot amine is given off to tl 
atm osphere during withdrawal and transport. T^1 
use o f dip sticks to determine the depth of l iq u id * ^ 1 
vessels containing carcinogens is dangerous ai?tnotb 
autom atic depth recorders should be installed, ^limi
Batch Weighing.—Tumours have occurred among!,!™™ 
weighmen. Adequate draughting should be pro™, 0f 
vided where any batch weights of intermediates ajj>(0nrO( 
m ade up and suitable protective clothing should t^ the d< 
w orn by the operator. ^
Isolation of Solids.—Filter presses and ope?1^ 0 
nutsches are unsatisfactory for the isolation small 
carcinogens or of materials where the carcinogen kint 
are present as impurities, unless a completely iijle provid 
pervious one-piece suit with compressed air suppedsb 
is worn by the operator. When the operation ^ enclos 
completed the clothing must be scrupulousW conta 
decontam inated before the man emerges from tff kequer 
suit. R otary  filters, pressure filters, vacuur®ted c 
nutsches, and automatically discharging whizzed 
all totally enclosed, are more suitable. The emptyingself-d 
o f  closed nutsches by shovel easily leads to coi&piately 
tam ination o f skin and clothes and re-slurrying ifcmom< 
the only satisfactory method of discharge. AttentioMed 
should be paid to the possibility of pastes drying ot$ durin 
and giving rise to dust hazards. Flakers should biflation sj 
totally enclosed and their discharge points draughtec^^
Disposal of Still Residues.—Tar or pitch must ncf contaii 
be allowed to set hard on the inside of stills. On n<tr since 
account m ust a  man enter a still to chip out suclfcs so 
pitch unless he is protected by a completely imMdow 
pervious suit with a fresh-air feed hood. This latte^ pient i 
practice should only be an emergency measure. Thi1 prefen 
risk can be eliminated entirely if molten still r e s i d u e s  aei 
are fed directly to a furnace which must destroy th?*nd that 
carcinogen and not distil it to the outside atm ospherq^^
Drying.—The hazard to workmen on driers in thj^°nca 
dyestuffs industry is real and may arise in thrPpar 
drying either of concentrated carcinogens or P^ cat 
products derived from them which contain 
reacted carcinogenic amines. It is recommendec* II 
tha t where complete dryness is not essential, tr\ i  ,,^ rci 
drying should be avoided and the materials shou orr 
be isolated as pastes from enclosed filters or ron^
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'CM<* tad high-speed autom atically discharging 
iizzers. Where possible no unreacted carcinogenic 
a e  should remain in the products derived from 
lKes5aiy Kinogenic intermediates and routine analyses 
ailed to i)' he necessary to check this, 
without ®ere these measures are technically impossible 
vetulu M e a t  drying has to be used, the m ost dangerous 
] vented d undesirable of the methods o f drying is tha t in 
p m .  licit a  man has to enter the drying space where he 
If to tie »y breathe or be in contact with any vapourized 
jrt, ifc fete which is in the atm osphere. Hence tunnel 
liquid in ites are quite unsuitable. Stoves with forced air 
ohs and w m u s t  not be vented into the working space, 
ed, tot a n d  sublimed m aterial tend to  blow from ill- 
and to collect in the flues, so tha t this 
iod of drying is not w ithout hazard, apart from 
s defraying of a dusty product. Vacuum stoves 
s liable to produce high atm ospheric contam ina- 
mwhen the doors are first opened. All forms o f 
iy drying carry a heavy risk because o f the dusting 
fthe material on discharge from the trays. If tray 
of small amounts of m aterial containing 
•iinogens is inevitable, special exhaust ventilation 
dd be provided and protective clothing with a 
i-air hood should be worn. D rum  driers which 
^ to ta l l y  enclosed produce a large am ount of dust 
1 may contaminate the operator because o f the 
f o r  frequent blade adjustm ent and overhaul 
1 an enclosed draughted “ venuleth ” drier may be
iatesare
ition of 
anog®  
,tely iffl-
'rom the 
vacuum
to  COO- 
trying is
Onm
out sod1 
i t e l f t  
b is laP  
ure. 1^
Enclosed self-discharging driers with the discharge 
W adequately draughted are the best type avail- 
**t the moment. I t m ust be rem embered tha t if 
unreacted bases are present, some will be 
ilized during drying and will be deposited in 
v^entilation system.
s  o r
.tray
—If possible grinding o f carcinogens or 
. r,a|s containing carcinogens should be avoided 
‘Wner since even the best enclosed draughted 
produces some dust. If it is possible to whizz 
material down to a sufficiently low water content 
‘ subsequent use, this should be the method of 
IQn preferred. Checks should be made to 
rc that aerosols are n o t produced by the 
r and that maintenance is efficient.
t^aintenance.—However effective plant design 
(i operation can be made, it is eventually necessary 
»Lpcn Up Plant for inspection or repair. Unless 
«nn  precaut*ons are taken there is a high 
to o  i ^  to m a’ntenance and engineering 
tored f ^  P ^ n t items should, therefore, be 
tona ti carc'no8en where possible before being 
^ r b ^  ^°r mafntenance. This may be achieved 
y steaming out an  enclosed system ensuring 
eam laden with amine is no t sent to atm o­
sphere, or by washing with cold water followed by 
chemical inactivation o f any carcinogen remaining. 
Where the carcinogen is an amine, inactivation may 
be carried out with hypochlorite o r formaldehyde 
o r by diazotization and destruction o f the amine. 
In  the event of maintenance of a contam inated plant 
item being inevitable, as in the setting of flaker 
blades, complete impervious protective clothing is 
necessary together with the use o f a fresh-air feed 
hood. Changes of clothing and washing facilities 
are as necessary for fitters on these processes as for 
processmen. Where contam ination is likely to 
occur, protective clothing and plant decontamina­
tion must likewise be provided for other tradesmen, 
such as electricians, instrument fitters, and con­
struction engineers.
Transport and Packaging.—Where dry flaked 
carcinogens are being packaged, drums with tight- 
fitting lids are advocated as the best method of 
transport. Damaged drums which do not fit 
standard draughted devices should not be used as 
dust may escape due to the setting up of uneven air 
currents.
W ooden casks must be avoided if possible. Where 
acid pastes are being handled, however, casks may 
have to be used but specially lined drums are 
preferred. Individual casks should have the lids 
fitted immediately after filling so that the paste 
does not have time to form a dust on the surface. 
The use of a handle in the centre of the lid may help 
to avoid contam ination of the lid with the contents 
o f the cask during heading up. If  a  cask used in the 
transfer of carcinogenic materials becomes unusable, 
it should be burned rather than sent for repair since 
it is impossible to remove dust from the cracks 
in a broken cask. Casks which have contained a 
carcinogen must be washed with cold water since 
tum ours have occurred amongst cask washers who 
inhaled steam vaporized carcinogens from hot 
washing. Remote control hot water washing can be 
used if cold water fails to clean the vessel but care 
should be taken to ensure that the steam is ade­
quately removed and does not drift towards the 
operator.
In the event of transfer of hot or molten material, 
special drums with indwelling dip legs can be used.
In the event of such a drum containing a solid 
this will have to be melted in a draughted compart­
m ent before emptying. Drums requiring welding 
should be specially cleaned before repair so as to 
avoid vaporization of carcinogen during this work.
Where bulk handling is used special devices will 
be necessary to catch drips and ensure clean 
coupling of charging and discharging pipes. Local 
draughting will ensure that vapour does not arise
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from  the open  ends o f  pipes after use. B ulk transport 
lorries should be supplied w ith w arnings and  full 
in structions fo r safe handling o f  m aterial spilt after 
accidents, together w ith the necessary protective 
clothing. I f  such solid m aterial sets on  the road, 
its cold  chipping with full protective clothing will 
be necessary after the police have been inform ed.
DETAILED CONSIDERATION OF 
MANUFACTURE AND USE 
H aving discussed the basic principles to  be 
ad o p ted  in  considering the  elim ination o f this 
hazard  from  the dyestuffs industry, it  is now  p ro ­
posed  to  devote a  section to  each relevant process. 
These sections m ay repeat som e o f  the  general 
principles b u t it is in tended to  po in t ou t to the 
m anu fac tu re r th e  m ain  and  also the subtle dangers 
associated w ith the operation  o f  each process. 
E xplanations based on experience o f factory con­
ditions are  included where necessary as well as any 
relevant results o f anim al experiments.
Beta-naphthylamine
T he m anufacture  o f beta-naphthylam ine has 
p roved  to  be by far the m ost hazardous occupation 
in  the dyestuffs industry. I t  was felt th a t no  p lan t 
could  be econom ically devised which could be 
operated  w ith any degree o f certainty th a t tum ours 
w ould  n o t occur. T he cessation o f its m anufacture 
and  use in  1952 in G reat B ritain is considered to  be 
one o f the  m ost im portan t m easures in  the prevention 
o f industrial b ladder tum ours.
Its  m ain  use was in colour m anufacture for which 
beta-naphthylam ine was sulphonated. T he sul- 
p h o n a ted  com pounds, which are n o t considered to 
be carcinogenic, can  be m ade effectively by the 
am ination  o f  the appropriate  sulphonated  beta- 
naphthols.
The use o f  beta-naphthylam ine to  m ake rubber 
chem icals and  colours has also been abandoned in 
G rea t B ritain. In  the case o f the rubber chemicals 
and  small co lour m anufacturers, alternative products 
w ith sim ilar or im proved technical effects have been 
developed using non-carcinogenic interm ediates.
Tobias Acid (2 Naphthylamine-l-SuIphonic Acid)
Since crude and  technical T obias acid contain  a 
trace  o f  beta-naphthylam ine as an  im purity, this 
com pound m ust be treated  w ith certain precautions. 
This im purity  can be reduced to  a m inim um  by 
app rop ria te  contro l o f process conditions. The 
beta-naphthylam ine is present as the sulphate so 
th a t no  free am ine is volatilized during drying. 
H ow ever, the  final dry pow der m ay constitute a  
po ten tia l hazard , bo th  in m anufacture and use. 
Efficient draughting should be provided a t the
packaging point and a type of enclosed drier isllowev 
recom mended as opposed to any form of tray^of va 
drying. The product is very apt to “ fly ” and it is**®11 
doubtful if  tray drying can be achieved with com-*1'011 
plete safety. fa  ]
Full protective clothing for the workman with®- 
dust masks or fresh-air hoods should be adequate1"^ 1 
for charging this powder for use in subsequent®1°PPC 
processes, but pneumatic handling is preferable ifJcond> 
large am ounts are regularly used. Anti-dusting®^ 
treatm ent o f the powder should not be relied upom»l,llzzir
N o tum ours have been attributed to Tobias acidi^0™ 
m anufacture in any country to date, but in view ofk P« 
the vast increase in manufacture accompanying thd” Mdi 
cessation o f beta-naphthylamine manufacture, ex^ bisol 
posure to it will certainly be increased greatly and*edi 
the recom mended precautions must be taken. is the {
Benzidine 1
The findings of Case et al. (1954) removed any® ha 
doubt previously held as to the hazard associatedmfact 
w ith the m anufacture of this chemical. No alterna-ffistin; 
tive has been found, however, to the use of benzi-ie azo 
dine in  colour manufacture as has been the casepic 
w ith beta-naphthylamine. The hazard is believedmt thi 
to  exist after the conversion of hydrazobenzenSazo p 
to  benzidine. In  some factories, where thelure o 
reduction o f nitrobenzene to hydrazobenzene andould r 
the subsequent conversion to benzidine have beepiconsic 
entirely separated, no tumours have been recorderiseemp 
am ongst m en carrying out the reduction process# work 
whilst m any tum ours have occurred amongst thosaszidinc 
w orking on the conversion and isolation of benzitthen t 
dine itself. However, in many cases reduction andanine 
conversion are carried on in the same building andtf to f 
therefore, full-scale precautions are recommendeogapac 
for both. W hether the reduction is effected by zincno doi 
dust, sodium amalgam, or electrolytic meanstd j 
enclosure of all plant items should be aimed at^n^ jjr 
I f  it is necessary to isolate the hydrazo compound^ (jev 
enclosed types of filter should be used. The com benz 
version vessel should be totally enclosed and dip pot! cold 
sam pling should be avoided. The material shou %(^  
be handled in an enclosed system as a slurry befo r^^  
isolation in an enclosed filter. The distillation o$ctive 
benzidine base and the isolation of the product lijy  ^
solid form as base is liable to result in contamination ^  
o f the atm osphere with vapour which can be entire 
avoided by final isolation as a salt. The na(j$e 0 
product m ust be packed with all necessary PreH«ithi 
cautions against dust and skin contact. The sa s % jn f 
benzidine can be absorbed easily throug t e s for ass
« i i. * j.'U s t o n r r r r P C t i n n  Lll2lzhw-.>
□ e i l Z I U I I I C  Cell I L/C C lU d U L  u v u    _
and no refuge must be sought in the suggestion 
the salts are less dangerous. Tumours have occurre#^ 
amongst men handling all the salts and the base 
various factories in the world. Isolation of benzidin^^
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salt, however, avoids alm ost completely the 
ability of vapour contam ination but a potential 
jand skin hazard still exists, 
le isolation of this com pound from  an open 
jshe filter press or any open filter device is 
aerous. In the event o f the p roduct being 
pictured as base, the grinding o f the final 
pet as opposed to flaking is strongly deprecated, 
pbest conditions are m ost likely to be attained 
pthe isolation of the final product as a salt paste 
fllhe whizzing of base in an  enclosed centrifuge 
pbe performed safely. Special attention  m ust be 
}ilto the provision o f protective clothing to the 
;:xbnan lidding drums in this m anufacture. If  
tmpts to isolate a very dry paste are m ade, a dust 
ard immediately arises and a user hazard is also 
ated as the packages are difficult to empty safely.
e me 
le and 
e been 
corded 
rocess, 
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Benzidine Azo Colours
;(j any Tumours have occurred am ongst a  num ber of 
dated 31 manufacturing azo colours from  benzidine. 
Item- “ interesting and im portant to  note tha t these 
benii- ®dine azo colours are the only ones using 
e case ®ogenic intermediates m ade continuously 
elieved j:®ghout the year. The incidence of tum ours 
enzene j*»gst azo process men is largely confined to the 
ifacture of these large-scale benzidine colours, 
is would result in these particular workmen 
fea considerably higher total dose of carcinogen 
juthose employed for short and occasional periods 
other work using carcinogens as intermediates, 
f benzidine itself is m anufactured in a user 
benzi- %, then there is no doubt tha t bulk handling 
an and ® amine slurry or tetrazo solution is to be 
:gand, %ed to filling and emptying containers. In 
iended ?tying a package with a  shovel in azo manufacture 
jyzinc ,®is no doubt that the clothing will become con- 
neans, pfflated. In the case of smaller manufactures 
icd af N handling drums or casks is inevitable an 
»fflid, Natic device can be installed which will wash 
e con- 1 the benzidine from the container by high 
Up pot j®ire cold water. This can be operated quite 
should ly and the water is used to m ake the solution 
before Uhe subsequent tetrazo reaction. I t may prove 
ion o' ® effective to charge all the benzidine used in 
luctin joshed to one well-protected point using such 
nation vice. Subsequently, slurry or tetrazo solution 
nti^ *1 Pumped to different units as is advocated 
; final Mease of factories where benzidine is manu- 
f re^  within the same works. G reat care will be 
altso ary in obtaining samples from such a central 
e skm rce f0r assessment of the strength of the slurry. 
n , autornatic enclosed device should be installed
mired tobtain'
; in tch llr"ng such samples w ithout using a dip tin  
• * Wou^  drip on the surrounding floor and 
a’dwe ps splash the m an taking the sample. I t is not
recom mended that batch weights o f benzidine should 
be m ade up but if this has to be done, full-scale 
impervious clothing m ust be worn together with a 
fresh-air hood.
Tests for residual benzidine in the final product 
should be made to  avoid atmospheric contam ination 
during its drying or grinding.
o-Tolidine, Dianisidine, and Djchlorbenzidine
A lthough animal experiments on the ra t suggest 
that the homologues and derivatives of benzidine 
are considerably less carcinogenic than the parent 
amine, it is felt that in industrial practice the hom o­
logues should be treated in a similar fashion to 
benzidine itself if large amounts are handled. 
Whereas there are records of men developing tum ours 
who have been exposed to benzidine w ithout its 
homologues, no population is known which has 
been exposed to the homologues of benzidine with­
out the parent amine also being manufactured in 
the same plant.
Thus, in the m anufacture o f azo colours from 
o-tolidine, dianisidine, dichlorbenzidine, or benzi­
dine disulphonic acid, an emptying device employing 
high-pressure water jets should be used for charging 
these intermediates to the azo vats. Benzidine 
disulphonic acid is not believed to be a carcinogen.
The final colour should be analyzed to ensure 
that no free amine is volatilized during drying.
Alpha-naphthylamine
The m anufacture of alpha-naphthylamine has 
been associated with an incidence of tum ours 
of the bladder amongst workers employed on 
it under poor conditions where very heavy ex­
posure was encountered. Even under these con­
ditions, exposure of five years or more was necessary 
for a tum our to develop. Statistical evidence 
suggests that it is of considerably lower potency 
than benzidine or beta-naphthylamine as a car­
cinogen in man. The commercial product usually 
contains about 4%  beta-isomer but this level may 
be higher in some cases. Hazards exist during 
reduction of alphanitro-naphthalene and distillation 
and isolation of the final product. Completely 
enclosed plant should be used for the reduction with 
special attention paid to the gland of the agitator 
shaft. Any residue should be transferred through 
an enclosed system to a vessel where the amine 
can be completely destroyed. Special devices should 
be used for obtaining samples in order to ascertain 
the state of the reduction and the use of a dip po t 
for obtaining such samples is strongly deprecated. 
W here large quantities of material are to be handled 
by the user the final product should be transferred 
m olten in tankers but some flaking will be necessary
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fo r the sm aller user. T he flaker should be totally 
enclosed and  draughted . A tten tion  to  the flaking 
cond itions can  increase the size o f flake and  reduce 
the am o u n t o f  fine dust in the final product.
Alpha-naphthylamine Sulphate
This m anufacture  carries w ith it no t only the risk 
in the charging o f the initial am ine, bu t also the 
risk o f handling  the  final p roduct. Thus, the 
charging po in t should be adequately ventilated to  
avoid  con tam ination  o f  the general atm osphere w ith 
dust o r the  m ateria l can be handled  m olten in an 
enclosed system  to  avoid this hazard  completely. 
T he hazard  in  the  filtration  and  drying o f this 
p roduc t is one o f skin contac t and inspiration of 
dust. D u ring  the drying, vapour will n o t be given 
off bu t dust will collect in  the vents from  the drying 
space. A  continuous enclosed drier is recom m ended 
and  the  use o f any form  o f tray  drying is strongly 
deprecated.
Alpha-naphthol
A lthough  this chemical is m ade from  alpha- 
naphthylam ine it is n o t believed to  be carcinogenic. 
B ulk use o f m olten  alpha-naphthylam ine in a 
to tally  enclosed system to  avoid atm ospheric 
con tam ination  is recom m ended. A nalytical estim a­
tions o f  a lpha-naphthylam ine in  the final product 
should be m ain tained  to  ensure its safety.
Naphthionic Acid
T here is no  evidence to  suggest th a t naphthionic 
acid  itself is carcinogenic bu t its m anufacture 
involves the handling  o f alpha-naphthylam ine. 
The am ine charging po in t is the first hazard. In  
the event o f a  bulk supply o f m olten alpha- 
naphthylam ine being available, heated enclosed 
m easure vessels and  weigh-scales can be used so 
th a t no  problem  o f charging solid a lpha-naphthyla­
m ine arises. I f  alpha-naphthylam ine flake or 
alpha-naphthylam ine sulphate is used efficient 
d raughting  and  full protective clothing will be 
necessary. A lpha-naphthylam ine flake packs in  the 
d rum  on  standing so th a t no  au tom atic emptying 
device is suitable, and  for the sam e reason it is no t 
su itable for pneum atic handling.
The sulphonation  is never quite com plete so tha t 
the naph th ion ic  acid dust is contam inated with 
am ine. F urther, the sulphonation  is preferential to 
the  alpha-isom er so th a t the unsulphonated  amine 
will con ta in  m ore o f the beta-isom er than  the original 
am ine charged to  the su lphonator. This high pro­
p o rtio n  o f  beta-isom er constitutes a  very real 
hazard . D uring  the  washing o f the acid these 
am ines are  present in the liquors together with tar. 
T his ta r , contam inated  w ith beta-naphthylam ine,
should not be removed in an open vessel or filtejta is 
press. An enclosed filter with automatic dischargee has) 
is the m ost suitable means of purifying naphthionhofthe ha 
acid liquors. The recovered amine must be collecte«potential 
in a drum  or vessel and either destroyed chemicallj due to 
o r disposed of at sea. It is unsafe to use regular (Case 
am ounts o f this recovered amine for any othdisolvent ] 
process in the industry. y amjne
If a solvent bake process is used, a major problei^ the haz; 
o f distillation of the solvent for use again arises^ the car 
The recovered amines have to be removed from thi 
still as well as tar. Leakages will contaminate th^ -naphth 
atm osphere with beta-naphthylamine. A direct ruicon(jens. 
o f ta r  and amines from the still to a muffle furnace me£ 
for destruction appears to be the most satisfactory carcjj 
m ethod o f disposal of these waste products. F u l^ g  j 
protective clothing is adequate for the subsequent ^  
use o f naphthionic acid in the dyestuffs industry.
Sodium Naphthionate . ffropri
This chemical is not thought to be carcinogenu^  ^
but precautions must be taken to enclose all plan  ^^  
items which contain even a small trace of unjtnine s 
sulphonated amine, particularly when they are hotj, ^  
Equally, all residues from the plant should bi^  
handled molten in an enclosed system before dis
posal or destruction.
ffofcou:
■ .  . Alpha-nPhenyl-alpha-naphthylamme ^
This secondary amine can be made from alpha^®a'
naphthylam ine but this involves charging a
cinogen to the phenylation vessel. Furthermore,
condensation with aniline is not complete and fre^
carcinogen in the final product constitutes a hazarc^
in isolation and its subsequent use. All thestj > ■
hazards can be easily eliminated by making pheny ^
alpha-naphthylamine from alpha-naphthol. Atteni ‘
tion should be paid to the purity of the ap  at
naphthol used, as this is made from alpha-naphthy i
amine and can contain this carcinogen as at
im purity. Phenyl-alpha-naphthylam ine is n0
believed to be carcinogenic.
Ethyl-alpha-naphthylamine dr
This secondary amine can also be made ro^  11 in 
alpha-naphthylamine, but again this 
ing a carcinogen and also the removal c tv x v a * *  ^
starting m aterial. C om plete safety can mono^  ^
by making it from aIPha' naj J  ® • is noNour 
ethylamine. Ethyl-alpha-napht y :#cupatj
believed to be carcinogenic. ^  Qf
Rubber Chemical Manufacture from J o n ,  c
Alpha-naphthylamine 
condensates o f alpha-naph.hylamme » d  * £ ,  « 
hydes have been made as rubber chemicats. «
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lensation is never quite complete and their 
afacture has been discontinued in G reat Britain 
aise of the hazard in m anufacture and isolation 
potential hazard of their use in the rubber 
due to the presence o f uncondensed 
jen (Case and Hosker, 1954). Only by the 
of a solvent process is it possible to  reduce the 
acted amine to negligible quantities, but this 
lives the hazard of redistilling the solvent and 
loving the carcinogen therefrom .
Alpha-naphthylamine Condensation Colours
tee condensations do not go to  completion so 
t special measures m ust be taken to  remove 
leaded carcinogens from the final product, 
ietwise these impurities m ay constitute a  hazard 
iso lation , drying, and grinding o f the final colour.
Phenyl-beta-naphthylamine
i is appropriate here to  m ention phenyl-beta- 
iithylamine because it is sometimes suspected 
hg to its name. It is not m ade from beta- 
ihthylamine and is not considered to be car­
bonic. No tumours have been reported amongst 
;men engaged in its large-scale m anufacture in 
uber of countries for m any years.
Alpha-naphthylamine Azo Colours
fere large amounts of alpha-naphthylam ine are 
bused for azo m anufacture the bulk handling of 
ton amine is recommended. W ith the use of 
teed heated measure vessels, contact with the 
fefel is entirely avoided. W here small amounts 
•handled, efficient exhaust ventilation m ust be 
teled at the point where batch weighings are 
tel out and adequate ventilation provided at the 
n^g point to the azo vat. Some azo reactions 
Ml complete and analytical tests should be 
tel out to ensure tha t no free amine is left in the 
'product. Tumours have occurred amongst a 
fer of persons carrying out colour drying and 
1 attributed to the vaporization of uncoupled 
during drying. Such a hazard will be passed 
•he grinding and standardizing of these colours 
amine is not controlled.
m o n o - 
is  n o t
id aide- 
Is.
Auramine Manufacture
A lthough  Muller (1933) attributed two cases of 
tekf tumour to auram ine, it was no t recognized 
atl occupational hazard was associated with the 
tefacture of this substance until the statistical 
legations ° f  Case and Pearson (1954) were 
, ed. As yet it is impossible to indict any 
cular part of the process bu t it is recommended 
a review should be made of the handling of all 
te'ediates and the final product in this process;
a generally higher standard of housekeeping and 
working practice should be instituted. The object 
should be to  cut down contact with all chemicals in 
the process to a minimum until m ore specific data 
on the exact cause of these tum ours are available. 
The possibility must not be overlooked tha t these 
tum ours may have been due to  other chemicals 
handled in the auram ine sheds in the factories where 
tum ours have occurred. Further examination o f this 
possibility would seem to be necessary before carry­
ing out any drastic alterations.
Magenta Manufacture
The finding by Case and Pearson (1954) tha t a 
hazard has existed in G reat Britain in magenta 
manufacture falls into line with the G erm an ex­
perience in the early days of the chemical industry 
in that country.
In  considering the appropriate protective measures 
to be taken it must be remembered tha t no tum ours 
have been attributed to  magenta in Germany 
amongst men starting work later than 1910. A 
general improvement of working conditions, together 
with a high standard of chemical handling, have 
apparently completely eliminated the hazard o f  this 
process in German factories without the installation 
o f special totally enclosed plant such as is recom­
mended for the manufacture of benzidine and alpha- 
naphthylamine. It is not possible to say a t this 
m om ent whether the cause o f the tumours in England 
is due to intermediates, to impurities in the magenta 
process, or to  the final product itself. I t  would 
appear that a general review of working conditions 
in the m anufacture o f magenta, with special care to 
avoid atmospheric contam ination and skin contact 
with chemicals employed in the processes, should 
result in the complete elimination o f this hazard. 
In  view o f German experience it is no t suggested 
that the building o f special totally enclosed plant is 
necessary. A high standard of handling o f chemicals 
should be sufficient to  produce a  result similar to 
that prevailing in Germany to-day.
Xenylamine (4-Aminodiphenyl)
4-Aminodiphenyl (referred to as xenylamine in the 
U.S.A.) has never been manufactured in G reat 
Britain because experiments in rats and dogs demon­
strated its carcinogenicity before its proposed m anu­
facture (Walpole, Williams, and Roberts, 1952, 
1954). Subsequently, Melick Escue,.Naryka, Mezera, 
and Wheeler (1955) confirmed the existence of an 
industrial hazard in a report of tumours in men 
engaged in its manufacture in the U.S.A. Its m anu­
facture has been discontinued there and it is recom­
m ended that manufacture should not be started in 
G reat Britain. There is also the possibility that a
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hazard  m ay also have been associated w ith the 
m anufactu re  o f 4-nitrodiphenyl due to the reduction  
in the body o f the n itro  com pound to  the correspond­
ing am ine.
ASSESSMENT OF RESULTS ACHIEVED BY 
IMPROVEMENTS
I t is m ost im portan t to  ensure th a t the im prove­
m ents in  p lan t and  w orking which have been in tro ­
duced are  effective. I t  m ust be borne in  m ind tha t 
the chem ical industry  is always changing and som e 
so-called im provem ents m ay open up new  sources 
o f  contam ination .
B u tt and  S trafford (loc. cit.) have established 
m ethods o f analysis o f air, clothing, and liquors for 
the  presence o f  benzidine and  beta-naphthylam ine. 
By the ir m ethod  rou tine sam pling o f  atm osphere can 
be achieved a t specific po in ts by the use o f 24-hour 
bubblers and  spo t sam ples can also be taken  where 
an  u nusua l p ractice carry ing a  risk  o f atm ospheric 
con tam ination  is being carried  out. Similarly, 
atm ospheric  sam pling is recom m ended for any other 
com pounds w hich are  though t to  be suspect in  any 
o f the processes considered in  this repoi t. Analysis 
o f  clo th ing fo r con tam ination  w ith carcinogens can 
also be used as an  additional check on safe working 
as well as a  m eans o f  ensuring the efficacy o f 
laundering. The m axim um  concentration o f car­
cinogen allow able in  the a ir o r on clothing which 
can be regarded as com pletely safe is n o t know n and 
these tests are recom m ended as a  m eans o f assessing 
the efficiency o f preventive m easures o r o f giving 
w arning o f a  process defect which is n o t otherwise 
obvious.
A n  additional check is afforded by the exam ination 
o f the u rine o f w orkers fo r the presence o f excess 
am ines. M ethods have been described by Kuchen- 
becker (1920) and  by G lassm an and Meigs (1951). 
H igh am ine conten t in  urine m ay indicate absorption 
due to  unsatisfactory  operating  technique, accidental 
contam ination , or dirty working.
CONCLUSIONS
T he above recom m endations have been m ade in 
the belief th a t if  they are  im plem ented the incidence 
o f b ladder tum ours in w orkers in these processes 
will be reduced to  a  level no greater than  th a t which 
prevails in the general population . A lthough this 
repo rt incorporates the precautions which are 
though t to be necessary in the light o f present-day 
know ledge, it m ust be realized that, as our know ­
ledge o f this hazard  increases, further am endm ents 
and  additions m ay become necessary as, for instance, 
when new chemicals o r processes come into use 
o r w hen o ther sources o f hazard  h itherto  undetected 
becom e apparent.
I t is hoped that the recommendations contained in, 
this report will be carried out by the industry as P°S! 
soon as is practicable, but it must be remembered®of ‘ 
tha t the benefits to be reaped will not necessarily'®!110 
be visible for many years to come. :^ lomi
xidary
SUMMARY i the r
Safe methods o f working practice recommended^^y1 
to the Association of British Chemical Manufacturer#of b 
fo r the m anufacture and use of chemical compounds115 ha 
likely to induce tumours of the bladder are described.^1S 
The present position of knowledge of industrials™^ 
bladder tum ours in Great Britain is given and the%. a: 
data from  which the recommendations have been®s tl 
derived are detailed. i and th
M edical supervision is essential to ensure properfc d£ 
control o f the hazard. Desiderata for selection and?Und n 
education o f the workers and for their personal"'source 
protection are laid down. The need for maintaining 
accurate medical and industrial records is stressed.^  ^  
L im itation o f exposure and of the number of m en^^ 
a t risk should lessen the possible incidence. Thetta(j’j( 
early diagnosis, treatment, and follow-up of estab-^ iy to 
lished cases o f tum our are imperative.
Design and ventilation of buildings and plant 
are o f prim ary importance. Completely enclosed 
p lan t with the carcinogens totally contained in the 
system is the ideal. The isolation, sampling, weigh-: 
ing, distilling, drying, grinding, or packaging of 
products and the disposal of residues can all be 
dangerous and measures to prevent contamination 
o f the operators are recommended. Maintenance; 
and cleaning o f buildings, plant, and plant items: 
can lead to serious exposure and men engaged in 
these operations m ust also be protected.
D etailed consideration of the manufacture and: 
use o f each relevant compound is presented. The: 
dangers associated with each are pointed out and: 
specific precautionary measures are given in detail: 
in each case.
Beta - naphthylamine a n d  4 - aminodiphenyl 
(xenylamine) should not be manufactured as no safe; 
economical method can be devised. Safer alterna-; 
tives which have been developed should be apphe ..
Benzidine should be manufactured in a close , 
system. The base and the salts are all dangerous an e 
bulk handling as a slurry or as tetrazo solution is:
preferred in user factories.
The homologues and derivatives of benzidine arc 
considered to be less carcinogenic than the ParejV 
am ine but if large amounts are involved, they s ou 
be treated with equal care. , .
A lpha-naphthylam ine should be manufac ur _ 
a closed system and bulk handling of mo en 
in enclosed containers or tankers is the sa es 
for the large user.
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I n le possible hazards associated w ith the m anu- 
a je of certain other com pounds, n o t themselves 
1 efM aed to be carcinogenic, such as alpha-naphthol, 
bionic acid, sodium naph th ionate , several 
jitdary amines, and som e condensation  colours 
3 the naphthylamines are considered. A niline 
lendedP^yl'beta-naphthylamine are  n o t accepted as 
:turers^ bladder tumours.
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n and! and new compounds o r processes m ay create 
-sonal*sources of risk in the future, 
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Hubert Wyers p rac tised  fo r many years in  the chemical 
industry . This has a lso  been my own speeial f ie ld  of work. In  
honouring h is memory today I  wish p a rticu la rly  to  discuss the 
moral a tt i tu d e  of the employer and the doctor in  industry towards 
the manufacture and use of dangerous substances. I  sha ll examine 
the  re sp o n sib ility  of each in  the recognition, control and 
prevention of in d u s tr ia l diseases and serious toxic hazards, from 
the adm in istrative, technical and e th ica l aspects.
I  am g ra te fu l fo r many reasons fo r the in v ita tio n  to  
deliver th is  le c tu re . Hubert Wyers and I  were life -lo n g  friends. 
We were fellow  students in  the same year in  medicine a t Glasgow 
U niversity. A fter graduating we spent some years as hosp ital 
residen ts and then we both entered general p rac tice, he in  Essex 
and I  in  Manchester. Neither of us had had any p a rticu la r bent 
fo r , or tra in in g  in , in d u s tr ia l medicine or organic chemistry, 
yet a f te r  a period as appointed factory surgeon and part time 
fac to ry  doctors, each of us eventually became a f u l l  time 
in d u s tr ia l medical o ffice r, and each of us was engaged in  the 
chemical industry . Thus a friendship which had s ta rted  in  the 
days of our youth matured and deepened throughout the years, 
cemented by common in te re s ts  and problems, by a great mutual 
lik in g  and by a liv e ly  sense of pleasure and enjoyment in  each 
other* s company.
Wyers had serious problems to  concern and to  challenge 
him in  h is in d u s tr ia l p rac tice  -  problems as serious as 
asbestosis and b e ry llio s is . On my side my g rea test preoccupation 
was with an equally grave in d u s tr ia l disease -  cancer of the 
bladder. Again our work, our in te re s ts  and our problems ran on 
p a ra lle l  l in e s . How then did we, who had entered these highly 
techn ica l industries from general p rac tice, come to  command and 
use the e so te ric  s k i l ls  fo r  which we had no special tra in in g  but 
which were so v i ta l  to  the so lu tion  of our problems?
D iff ic u ltie s  to  be resolved b.v the doctor.
Much of the chemistry and engineering in  the industry 
i s  incomprehensible to  those outside i t  or to  those entering i t  
and i t  would be id le  to  pretend tha t even a f te r  many years* 
experience the in d u s tria l medical o ffice r can be expected to  
have expert knowledge or s k i l l  in  any of the many d if f ic u lt  
sciences and technologies which comprise the daily  working of 
th is  modern industry.
As doctors we are concerned with human beings, with 
the preservation of th e ir  liv es  and with the protection and 
promotion of th e ir  bodily health  and mental happiness. The fac t 
th a t we work in  industry makes no difference to  the fundamental 
p rincip les of our vocation.
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Some of us often speak of ourselves as simple doctors, 
meaning th a t we have an a r t  and science of our own, but i t  may 
a lso  imply th a t we disclaim any s k il l  or resp o n sib ility  outside 
th a t narrow f ie ld .  How can the doctor in  industry  approach a 
serious tox ic  hazard and advise on adequate prevention measures 
i f  he i s  going to  disclaim such s k i l l  and responsib ility?  I t  
i s  true  th a t he cannot by himself lay  down and implement a l l  
the necessary ehemical and engineering precautions which are 
inseparable from the complete control of dangerous substances in  
modern industry . I t  is  true  th a t he must depend on others fo r 
much techn ical advice and supervision, but a t the same time he 
must shoulder a great deal of responsib ility  fo r matters usually  
outside the orb it of a simple doctor.
Recognition of in d u stria l disease.
In  la s t  year* s memorial lec tu re  Andrew Meiklejohn 
reminded us of two important tenets propounded by Hubert Wyers, 
f i r s t  th a t experience in  general practice i s  a valuable tra in ing  
fo r in d u s tr ia l medical o ffice rs  and secondly, and th is  might 
well be my tex t today, th a t medical work in  the factory should 
be based on the sound practice  of c lin ic a l medicine directed 
to  the care of the individual workman. is  as essen tia l to
the doctor in  industry as i t  is  to  the doctor in  general or 
consultant p rac tice .
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I t  i s  the individual who su ffers from in d u s tr ia l 
diseases and in toxications and i t  i s  in  him or her th a t th e i r  
m anifestations are to  be found even when s ta t i s t i c s  or elaborate 
investigations are necessary to  prove th a t the orig in  of these 
diseases i s  occupational. In  many cases considerable c lin ic a l 
acumen is  needed to  detect them a t stages su ff ic ie n tly  early  
fo r  treatm ent to  be e ffe c tiv e . Their recognition as in d u s tr ia l 
diseases depends on th e ir  being id en tified  with specific  
occupations. In  some cases strange or unusual diseases can 
read ily  be proved to  be of occupational o rig in . In  other 
instances i t  has not been easy to  detect the connection of an 
apparently ordinary disease, such as occurs in  the general 
population, with a p a rticu la r in d u stria l operation or group of 
workpeople. When the same occupational disease subsequently 
appears elsewhere i t  should usually  be easily  recognized but 
unfortunately  th is  is  not always the case and in  some instances 
the whole sorry  experience has been repeated.
This i s  not an o rig ina l observation -  in  1832 Thackrah 
wrote f,to  repeat and urge what is  forgotten is  sometimes as 
important as to  s ta te  what is  unknown.tt
This happened in  the chemical industry in  the case of 
occupational cancer of the bladder. I t  was f i r s t  recognized in
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Sw itzerland a t the end of la s t  century. I t  was not u n t i l  the 
1914-18 war th a t the a l l ie d  countries s ta r te d  to  make the 
chemicals which were responsible fo r i t  but the experience of 
the e a r l ie r  manufacturers was forgotten i f ,  indeed, i t  had ever 
been heard of or seriously  believed and so the chain of events 
was repeated. I t  is  fo r us one of the more g ratify ing  features 
of th is  sad sto ry  th a t in  B rita in  the existence of the hazard 
was urged by a medical o ffice r inside the industry and th a t from 
him came the impetus which was the driving force in  the post-war 
e ffo r ts  towards i t s  control here and abroad. I  re fe r  to  the work 
of Maurice Goldblatt which is  so well-known to  us in  th is  
Association.
RESPONSIBILITY OF EMPLOYER 
I t  has often been in ferred  th a t employers in  many 
instances remained in d iffe ren t to  the existence of a hazard or 
to  i t s  e ffe c ts  u n til  forced to  do something by the pressure of 
public opinion or by a heroic medical o ffice r. That public 
opinion or the enactment of leg is la tio n  forced many backward 
employers to  take action is  a matter of h isto ry , but the role 
of the heroic medical o ffice r is  less  authentic . At f i r s t  only 
those employers with advanced ideas and a reasonable degree of 
altru ism  employed medical o ffice rs  and these were the very
employers who would be most conscious of th e ir  duty to  th e ir  
employees and most ready to  take action to  pro tect them. Where 
no doctor was vo lun tarily  employed the Inspectors of Factories 
could take ac tion  to  m itigate bad conditions but th is  was 
rendered possible only by the leg is la tio n  which had resu lted  
la rg e ly  from  the  campaigns of the social reformers and the lead 
given by the  good employers. I t  was not from any concern on the 
part of thb le ss  progressive employers, nor from any heroics on 
the part of the doctors.
U n til about f i f t y  years ago factory  owners with 
advanced and l ib e ra l  ideas lik e  those of Robert Owen were ra re , 
i f  not unique. A great change of sentiment and opinion has 
since occurred. In  th is  century the duty of the employer to  
h is employees has increasingly become directed towards th e ir  
well-being, welfare and safety  u n til  now the employer, in  th is  
country a t any ra te , must take the ultim ate responsib ility  fo r 
safeguarding h is workpeople.
There can be l i t t l e  doubt th a t i t  was the employers1 
growing re a lis a tio n  of th e ir  responsib ility  which paved the way 
for the en try  of the doctor in to  industry* I t  i s  not d if f ic u lt  
to  imagine the ho stile  reception the in d u stria l physician would 
have had a hundred years ago before industry was ready fo r him.
When industry  did  begin to  accept him, i t  was merely because in  
the ea rly  days the g rav ity  of a hazard had produced a re a l need 
fo r  h is services or because some degree of medical supervision
was required  by s ta tu te . More ver we cannot blink the fac t th a t
many fac to ry  doctors were o rig in a lly  engaged to  p ro tect the 
employer against compensation claims.
In d u s tr ia l  medicine has come a long way since then.
I t s  standing has been estab lished  and i t  has now become 
indispensable in  many industries  not only beeause of the high 
p o ten tia l r isk s  attached to  them, but a lso  because of the 
improvements in  health , morale and production which re su lt from 
the pursu it of good in d u s tr ia l health  programmes. The increase 
in  the number of our members in  recent years to  a to ta l  surely  
undreamed of by the handful of men who founded th is  Association 
is  i t s e l f  evidence of the change in  in d u stria l philosophy, which 
the development of public opinion and the enlightenment of 
socie ty  has made possible.
At the same time we must remember th a t, whether in  
p rivate  en terp rise  or nationalised  industry, the employer has 
to  pay fo r  the medical and an c illa ry  services in  his industry. 
Even a nationalised  in d u s tr ia l health service would have to  be 
paid fo r , by the S tate  or by whatever form of corporation might
-  8 -
be se t up to  administer i t .  Therefore, apart from s ta tu to ry  
requirements, the standard of the in d u s tr ia l medical services may 
la rg e ly  be d ic ta ted  by how much the employer can afford , or i s  
w illin g , to  pay. This may be a decisive fac to r in  determining 
and lim iting  the scope and value of the work of the doctor in  
industry  both now and in  the fu ture.
D iff ic u lt problems have to  be resolved by the employer as 
the awareness of a serious hazard dawns and as i t s  extent and 
g rav ity  i s  rea lised . The e ffec t of a hazard as serious as, fo r 
example, cancer of the bladder -  of which men and management began 
to  be aware simultaneously -  can be disastrous on the men18 morale 
unless there  i s  mutual good f a i th  and t r u s t .
To keep f a i th  the employers have to  show not only 
th a t they are w illing  to  in s t i tu te  investigations in to  the 
cause of the disease and support the e ffo rts  to  a t ta in  early  
diagnosis and effective  treatment but also  th a t they are 
prepared to  go to  any necessary lengths to  protect the men from 
the danger. This en ta ils  the safe control of the physical 
environment, which is  obviously of supreme importance.
C h e rn ia te  a n d  e n g in e e r s .
Nothing frap yet been sa id  of those who have made the 
g rea test contribution to  the medical officer*s understanding of
the  environmental fac to rs in  the hazard and th e i r  contro l.
The chemists and chemical engineers have l i t e r a l ly  taught me, 
as I  have no doubt they taught Wyers, the l i t t l e  I  know of 
chemistry and of the workings of the chemical industry . In  tu rn  
I  have endeavoured, and I  hop© I  have succeeded, to  give them 
some appreciation  of the medical side of the problem. The 
intim ate knowledge and experience of th e ir  own works which they 
possess are of inestimable value in  the investigation , 
adm inistration and so lu tion  of many d if f ic u lt  in d u s tria l 
medical problems.
Safety O fficers and in d u s tr ia l hvgien ists.
The place of the sa fe ty  o ffice r or sa fe ty  engineer 
w ill depend on his tra in in g , qua lifica tion  and experience. I f  
he has a tta in ed  a high standard of knowledge and s k i l l  he w ill 
obviously be of the greatest value in  ass is tin g  to  supervise 
dangerous tox ic  processes. While some of us have been fortunate 
to  have had as associates sa fe ty  o fficers of the highest ca lib re , 
i t  must be admitted th a t u n til  a minimum standard of qua lifica tion  
is  imposed some w ill be inadequately f i t te d  fo r the duties they 
should be able to  perform. I t  is  only f a i r  to  say th a t in  the 
chemical industry , th e ir  standards have usually  been high and 
th a t many of them are widely experienced sp ec ia lis ts  in  th e ir  
own r ig h t.
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In d u s tr ia l  hygienists have not so f a r  become a fea tu re  
of industry  in  th is  country. As with sa fe ty  o ff ic e rs , a  
su ff ic ie n t standard of attainm ent i s  e sse n tia l fo r  them to  
function s a tis fa c to r i ly . I f  the  medical o ff ic e r  and the  sa fe ty  
o ff ic e r , with a l l  the techn ical advice availab le  to  them, 
function as they should, the  in troduction of in d u s tr ia l  
hygienists in to  any but the la rg e s t of our organisations would 
re su lt in  much overlapping. I t  is  d if f ic u lt  to  see how i t  could 
be ju s t if ie d  or useful as a working part of any but a few of our 
fac to r ie s . On the other hand the creation  of in d u s tr ia l  hygiene 
or toxico log ical in s t itu te s  in  B rita in  i s  widely canvassed «nd 
the need fo r  them is  widely agreed. While separate in d u s tr ia l 
organisations may have in su ffic ien t work fo r  highly tra in ed  and 
qu a lified  hygienists there w ill be a need fo r them in  these 
in s t i tu te s  not only fo r teaching and research but a lso  fo r  the 
provision of a service to  supply f a c i l i t ie s  to  firms whieh are 
not equipped or s ta ffed  to  carry out the necessary procedures 
fo r  themselves.
RESPONSIBILITY OF THE DOCTOR 
So f a r  I  have not mentioned the part played by the 
two p a rtie s  who, in  the context we are discussing are the most 
concerned, the workman and the doctor. The problem of the 
e ffec ts  of toxic substances in  industry is  not prim arily a
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problem of s t a t i s t i c s ,  te s t- tu b e s , animal experiments or even of 
toxicology. I t  i s  a human problem, but while we in  industry  are 
prim arily  concerned w ith the preservation of the  workman* s 
health  we have a lso  to  look beyond the indiv idual human being.
Thackrah wrote “A study of medicine which disregards 
the prevention of disease lim its  i t s  u t i l i t y  and i t s  honour. I t
would s t r ip  the profession of i t s  noblest a t t r ib u te  ..**
In  industry we have a g rea ter duty, and a g rea ter opportunity, 
in  the f ie ld  of prevention than is  possible in  most other 
branches of medicine. This duty na tu ra lly  devolves on the 
in d u s tr ia l medical o ffice r. He has had a basic tra in in g  in  the 
e ssen tia ls  of science as well as in  the a r t  of medicine so th a t 
he can undertake the task  of co-ordinating the work of a l l  the 
experts necessary to  the control of serious hazards. He is  the 
best possible lin k  in  co-ordinating many sp ec ia ltie s  -  as diverse 
as, fo r example, as chemistry, engineering, v en tila tio n , or 
work study.
I t  i s  the doctor to  whom managements and men natu ra lly  
tu rn  when the health and safety  of workmen are a t r isk  and they 
have the righ t to  expect from him a balanced, and d iscrete 
judgment given without fea r, favour, or sectional in te re s t. One 
e sse n tia l requ is ite  must be stressed  -  men and management must
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have complete confidence in  his in te g r ity  and honesty as an 
in d u s tr ia l physician and these can only be preserved by the 
observance of a s t r i c t  standard of professional and in d u str ia l 
e th ic s .
ETHICS OF PROHIBITION OF DANGEROUS MANUFACTURES
In  the  preventive f ie ld  i f  the doctor in  industry, 
faced w ith a serious toxic hazard, is  to  liv e  up to  the highest 
standard of e th ics i t  might be held th a t he should advise th a t 
the  manufacture and use of any very dangerous substance or the 
continuation of any very dangerous process be banned a ltogether. 
At f i r s t  sigh t th is  seems a simple and a ttra c tiv e  solution and 
fo r the doctor i t  would ce rta in ly  be an easy way out. I t  i s ,  
however, not always so easy, or even so reasonable, as i t  
appears on the surface.
Hazards vary in  th e ir  degree of severity  so th a t there 
i s  the obvious d iff ic u lty  of knowing where to  draw the lin e  
between manufactures carrying unacceptable toxic hazards and 
those with a permissible degree of r isk . While the doctor can 
point out the existence of a hazard and indicate i t s  extent and 
g rav ity , i t  may not be possible to  define i t s  exact cause or 
even to  determine i f  the cause is  chemical, physical or 
psychological. No specific  substance or precise physical agent
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can be blamed fo r the rheumatism, bronchitis or nystagmus of 
coal miners; should we seriously  suggest th a t the correct 
prophylactic measure is  to  close the mines? Should we have 
shut down the cottorn industry before the long and patien t 
research of Richard Sch illing  and his co-workers demonstrated 
the  cause of byssinosis and before i t s  control was made 
possible by the system of draughting designed a t the Shirley  
In s ti tu te ?  Such po lic ies would be stupid; but even when the 
exact cause of a grave hazard is  c lear, the consequences of 
abandoning manufacture may give pause to  those who would 
advocate prohibition of the compounds or cessation of the 
process. In  some of the cases with the highest po ten tia l 
danger, i t  would be morally as well as m ateria lly  wrong to  use 
proh ib ition  as a prophylactic measure.
P rinc ip les of allowing or prohibiting dangerous manufactures.
The industry carrying the highest po ten tia l danger to  
i t s  workmen is  the atomic industry. Much p o li t ic a l  and 
emotional controversy rages over the question of giving up 
atomic weapons because of the danger to  humanity a t large -  not 
because of the hazard to  the workmen engaged in  the industry. 
The prospective benefits of nuclear power fo r peaceful purposes 
are too great fo r us to  contemplate prohibition. Instead 
b r i l l ia n t ly  designed plant and meticulous•prophylactic measures
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have been devised and have rendered th is  industry  sa fe r than 
many with much le ss  p o ten tia l r isk .
This may be an extreme example but the same precepts 
apply on a more mundane plane. We do not forego the f a c i l i t i e s  
afforded us by having lead b a tte r ie s  in  our cars because lead  
i s  dangerously toxic nor do we deprive the farmer and the 
consumer of the advantages of c e rta in  in sectic ides because 
organic phosphorus compounds are highly poisonous. In  these and 
many other instances prohib ition  has never been effected . The 
work of Ronald Lane showed th a t the lead worker can be protected  
and the incidence of lead poisoning in  a vigorous growing 
industry  is  now v ir tu a lly  absent. S im ilarly  in  many other 
industries i t  has been shown th a t the assau lt on the health  of 
the  workmen can be prevented by the application of adequate 
prophylactic measures.
Nevertheless, some dangerous compounds have been 
banned from our fac to ries and from our environment. Why some 
and not others? I t  is  sign ifican t th a t those which were f i r s t  
prohibited  were those for which sa fer and economically feasib le  
su b s titu tes  were availab le. The f i r s t  to  be banned, and i t  
was by in te rnational agreement, was yellow phosphorus in  1906.
I t  i s  invariably  claimed, and with considerable unction, th a t
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tM s  was done because of the  dreadful disease of th e  jaw it 
caused and one i s  l e f t  to  in fe r  th a t th is  a l t r u i s t i c  yyfciegu 
was taken by the  manufacturers regardless o f any other 
consideration* There was another consideration i t  was a 
decisive one -  i t  was the fac t th a t a safe a lte rn a tiv e  could 
be used to  replace i t .
That th is  contention is  true  can be i l lu s t r a te d  by 
considering the two major uses of benzene in  industry* This 
insid ious poison was widely used both as a solvent and as a 
chemical without much concern, except fo r the high f i r e  risk it 
carried , u n til  i t  was rea lised  th a t i t s  chronic e ffe c ts  on tb s  
bone marrow were l ik e ly  to  be f a ta l .  Many le ss  tox ic  solvents 
can be used in  i t s  stead and benzene as a solvent has v ir tu a lly  
disappeared from our fac to rie s , due large ly  to  the e ffo r ts  o f 
the medical branch of H.M.Factory Inspectorate and especially  
to  the work of Dr. E thel Browning.
Benzene would almost certa in ly  be used as a solvent 
today i f  we did not have le ss  toxic compounds as sa tis fac to ry  
a lte rn a tiv e s . The rubber industry alone could hardly have 
survived without i t ,  and undoubtedly would have used i t  on a 
large  sca le . Extensive precautions and s t r i c t  supervision would, 
in  view of our present knowledge and enlightened sentiment, have
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been attached to  i t s  use, but i t  would s t i l l  have been used*
On the other hand, there  i s  no su b stitu te  and no a lte rn a tiv e  
to  benzene as a chemical. I t  is  one of the most important basic 
raw m aterials in  the organic chemical industry and i t  i s  the 
s ta r tin g  point in  the synthesis of many substances which we 
r ig h tly  regard as indispensable in  our modem c iv ilis a tio n . 
Without i t  we would not be able to  obtain many pharmaceuticals, 
dyestuffs, organic pigments, pa in ts, in sectic ides and rubber 
chemicals. For these reasons, i t  is  s t i l l  used in  large amounts 
and i t  has never been seriously  suggested th a t benzene should be 
given up except as a solvent. Because the danger i s  known, 
modern chemical engineering methods are u til iz e d  to  make i t s  use 
as a chemical safe.
From th is  i t  may be thought th a t v ir tu a lly  anything, however 
dangerous, can be made safely , provided the danger is  known but 
two important considerations lim it th is  optim istic generalisa tion . 
In  some instances, the cost would be proh ib itive . In  others, 
and herein l ie s  a very specia l and important princip le  of 
in d u s tr ia l medicine in  the chemical industry, users of dangerous 
compounds even in  very small quantities may undergo much greater 
r isk s  than those manufacturing them on a large scale . The users 
may be working in  small fac to ries sometimes under prim itive
conditions, and may have little idea of the danger they are 
running, and even less idea of preventive techniques, unless 
specific warnings and clear instructions are communicated to 
them. When the toxicity of an industrial product and the 
prophylactic measures which have to be prescribed are being 
considered, its ultimate distribution may be the decisive factor 
in determining whether or not it should be made*
When highly toxic substances are to be made and when 
potentially dangerous processes are to be carried on, the medical 
officer has a heavy responsibility in that he has to advise on 
the degree of danger to be anticipated and the extent of the 
precautions which have to be applied to satisfy the required 
standard of safe working.
It is important for us to remember that, except where 
complete prohibition has to be effected, the primary function 
of industry is to produce and it is no part of our function to 
impede production by overloading it with precautions or 
strangling it by regulations which are not necessary*
This does not mean that we cannot resolve the difficulty 
in which we may find ourselves in having to choose between the 
rival claims of economics and safety. It may seem that we have
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conflicting loyalties to reconcile if we are to retain ©or 
ethical integrity and satisfy our professional conscience in 
the industrial setting but certain principles can be formulated 
by which we may regulate our actions and reach our decisions.
If they are to be made, substances or processes which 
promote grave industrial diseases such as radiation sickness- 
or occupational cancer call for the maximum necessary 
precautions at whatever cost may be involved. If the 
achievement of the required standard is not practicable, complete 
prohibition must be insisted upon and industrial or public 
opinion would surely make this effective. Lesser hazards require 
less drastic measures. It would not be necessary to apply the 
same sanctions to work where the possible danger is slight and 
its effects trivial.
Between such extremes there are all gradations so that we, 
the industrial physicians, have to determine how far the well­
being of the workpeople is being prejudiced or is likely to be 
prejudiced and we have a responsibility to state the nature and 
extent of danger to health. Chemists, engineers, safety officers 
and production managers will co-operate with us to circumvent 
that danger with the lease possible interference with production.
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But we as doctors must be satisfied that the men and women who 
may be at risk are adequately protected and we must insist that 
no person is wittingly or wilfully exposed to danger which can 
be avoided.
Application of the principles in chemical industry.
The principles I have discussed are applicable throughout 
the chemical industry and the way in which they have been 
applied can be illustrated by considering the industrial bladder 
carcinogens. Here is yet another instance in which the simplest 
solution would appear to be an absolute prohibition of the 
manufacture and use of all the carcinogenic agents. The gravity 
of the malady can leave no room for doubt that unless safe 
methods can be adopted this extreme measure would have to be 
applied.
By 1950 betanaphthylamine appeared to be so highly 
dangerous that its manufacture was voluntarily given up because 
it was impossible to devise and operate, at an economic cost, 
plant which could afford any degree of certainty that tumours 
would not occur. Its proposed abandonment was going to leave a 
serious gap in the dyestuffs and rubber industry. There was a 
subtle change of attitude and sentiment here.
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In the past it is probable that, as we have seen, the 
manufacture would have been continued in the absence of a safer 
alternative but now the climate of industrial, commercial and 
public opinion made prohibition inevitable. This stimulated 
the chemists to contrive alternative methods of synthesising 
the dyestuffs for which it had been used and to develop 
alternative non-carcinogenic products for the rubber industry.
If no such alternatives had been developed the British industry 
could hardly have avoided giving up betanaphthylamine as the 
high cost of making and using it safely would have resulted in 
a prohibitively fantastic price for the ultimate products.
Benzidine and alphanaphthylamine are the other two most 
common and most widely used of the known bladder carcinogens; 
but they are less potent than betanaphthylamine, and so afford the 
prospect that safe methods of manufacture can be applied to them. 
No alternatives to them have been devised for the purposes for 
which they are so widely used. They are, however, essential 
intermediate compounds for the manufacture of a very large range 
of the colours for wool, cotton, paper and many other fabrics* 
Banning of their manufacture would cause a widespread slump and 
unemployment not only in the chemical industry but in the textile, 
paper, paint, rubber and many other industries. Without
international agreement, and this would be more difficult to 
obtain than it was in the case of yellow phosphorus in 1906, 
the adverse effect on these industries and on our economic 
position would be serious. As we have seen, other compounds 
and processes more dangerous are accepted as necessary 
manufactures.
For these reasons manufacture and handling of the products 
therefore continue. They are carefully safeguarded and close 
medical supervision of plant and personnel is maintained. 
Careful instructions as to their toxicity and methods of 
prevention are communicated to users in other factories and a 
code of safe working practice in their manufacture and handling 
has been issued to them.
Much has been said of giving up compounds because safer 
alternatives could be used or because they were found to be too 
dangerous after their toxicity to workmen had been proved by 
tragic experience. A few have been found to be so dangerous 
that their contemplated manufacture was not started. The 
insecticidal properties of 2-acetylaminofluorene made it an 
attractive social and industrial proposition until toxicologioal 
studies fortunately revealed its high potential as a carcinogen 
before it was made on a commercial scale.
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Walpole, Williams and Roberts, (one of them, Michael Williams, 
is an industrial medical officer), working with experimental 
animals, demonstrated in 1952 that xenylaraine was at least as 
potent a carcinogen as betanaphthylamine. It was being made and 
used in the U.S.A. as a rubber chemical. They warned of the 
danger of tumours arising in men exposed to it and recommended 
that its manufacture should not be contemplated in this country. 
Three years later in 1955, they were dramatically justified when 
a report was published of a series of cases of bladder tumour 
which had arisen in the men who had worked with it in the U.S.A. 
where it had been manufactured since 1938. It has now been 
given up there but many years must elapse before the final toll 
of tumours in these workmen is known. We are fortunate that it 
has never been manufactured industrially in this country.
Standards of safety.
Even with modern safe plant and processes assurance oust 
be made doubly sure and a high margin of safety must be sought 
to make absolutely certain that the plant and operating 
precautions are completely safe. Contamination can still oocur 
during maintenance operations and through accidental breakage or 
failure of equipment. The human element may fail if supervision 
allows men to relax from the strict standards laid down in 
operating the plant and handling the material. The minimum dose
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of a carcinogen required to produce a tumour in man under 
industrial conditions is not known and it is not always possible 
to measure the amount of a toxic agent in the atmosphere or in 
body fluids* In such cases standards far more stringent than 
are usually required must be imposed.
Monitoring of the atmosphere is desirable but is not always 
possible. Keith Moore at the last meeting of this Association 
described the effects of hexoestrol in men working with it. He 
pointed out that it was impossible to find satisfactory methods 
of estimating it in the atmosphere or in the body. In this 
instance the effects of contamination appear in a relatively 
short time, days or weeks. With carcinogens many years may 
elapse before they are manifest.
Again we must not lose our sense of proportion. Moore 
found that simple local draughting general ventilation and 
enclosure of the process have stopped the occurrence of the 
hexoestrol syndrome in his men. The work of A.J.Amor has already 
reduced the incidence of carcinoma of the lung and nasal sinuses 
in workers in the Mond nickel process to the level of that in the 
ordinary population. This has been achieved by non-specific 
prevention consisting of suppression of dust and other similar 
empirical measures put in 20 years ago.
Scope of the doctor in the chemical industry.
In the case of the carcinogens removal from exposure 
does not eliminate the possibility of developing the disease.
In several industries many men have in the past been exposed to 
conditions we now know to be eapable of causing tumours of lung, 
skin, or bladder after latent periods of up to 4-0 years. Some 
of these men have already developed tumours, a proportion of 
the other will eventually develop them and some will escape.
To ensure the adequacy and the effectiveness of any 
prophylactic programme, medical supervision must, therefore, be 
continued indefinitely in the case of the carcinogens and many 
serious toxic hazards. The industrial medical officer must do 
more than figure simply as a general practitioner inside the 
factory. He must be able to utilize and co-ordinate the skill 
and experience of scientists and technologists in many different 
specialties and he must continue to function as a doctor in his 
own right.
After the Windscale incident, the Fleck report this year 
recommended that codes of practice for dangerous processes should 
be compiled by experts. This is not a new idea. It was done 
for the chemical industry in 1953 to cover the manufacture and 
use of certain carcinogens and two industrial medical officers
were called upon, to do it.
These two doctors were invited by the Association of 
British Chemical Manufacturers to recommend a code of working 
practice for the Manufacture and use of products causing tumours 
of the Madder. They drew up & document which was accepted fey 
the industry in 1953 as the recommended standard and a  shortened 
version was published in 1957. Their reconend&tions first deal 
with the selection of workers, the .general supervision of 
their health and working conditions, and much More work of a 
predominantly medical nature.
The second part of the report, however, is devoted 
entirely to questions of plant hygiene, operating methods and 
the precautions recommended therein. In this section they lay 
down principles for the construction and design of buildings, 
general and local ventilation of the working place, the design 
of plant and its working, the sampling, weighing, handling, 
isolation and drying of products, the maintenance of plant and 
even packaging and transport of materials. They then proceed 
to a detailed consideration of the methods of manufacture and 
handling of some twenty compounds known or suspected to be 
carcinogenic and the chemical and engineering precautions 
necessary for each one. None of these subjects appears in the
Curriculum of the medical student and the doctor does not start 
in industry with any knowledge of them. He can hardly expect 
to be expert even after years of experience.
It is not surprising, therefore, that at the end these two 
doctors thank their technical and medical colleagues ”too numerous 
to mention individually” whose advice, criticism and help had 
contributed so greatly to their work. In fact it was not only 
their own knowledge and experience but also the ability it gave 
them to utilize the knowledge and experience of colleagues with 
a different professional and technical training and a different 
expertise that enabled them to produce a comprehensive document 
of work in such a difficult sphere.
THE FUTURE
So much for the past and the present, but what of the future? 
Countless new compounds will certainly be synthesized and many 
will be produced commercially. Even with the largest toxicological 
laboratories, big enough and numerous enough to satisfy the dreams 
of the most optimistic planners, it will still be impossible to 
test every new chemical for chronic toxicity and carcinogenicity 
even if in vitro and animal experiments could be extrapolated to 
assess the vulnerability of the human industrial worker. Until 
we can be certain that it is harmless we must regard each now
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compound as potentially toxic. We shall, therefore, still have 
to be ready to detect in our workpeople the first signs of any 
adverse effects of the new compounds which will be introduced 
into our factories. Some compounds which already have been in use 
on a comparatively small scale and which now appear safe may be 
in greater demand in the future. Their manufacture and use on a 
large scale may reveal long term noxious properties hitherto 
unsuspected. In the future, too, we must not forget the lessons 
of the past and allow substances we already know to be dangerous 
to cause a repetition of previous trouble. Nor must we allow 
precautions which may be inadequate to lull us into a false 
sense of security by' any short term success that they may yield.
Conclusions.
In view of all the considerations I have examined, it will 
surely be conceded that while the value of our work depends on 
our being doctors we must use other sciences as well. Let us 
cease, therefore, to think of ourselves as simple doctors. We 
have to acquire something from many other specialities, 
professions and technologies, we have to have some understanding 
of difficult and sometimes abstruse technical matters and we 
have to be able to co-ordinate work which does not usually lie 
within the compass of the simple doctor.
I have chosen these lines of thought because Hubert Wyers 
was so closely concerned with toxic substances and hazards, 
because he applied himself so successfully to the solution of 
many of the most serious problems they presented and because I 
am in the same industry and have similar problems. He stood 
for the very best of what we mean to convey when we describe 
ourselves in terms of pride and humility as simple doctors. He 
was, if you like, a simple doctor but he was more that that. He 
was a man of many talents and many interests and he had a 
burning compulsion to do his work to the best of his not 
inconsiderable ability. He also had such a depth of learning - 
in the arts as well as in medicine - such a knowledge and 
experience of industry and such a wide sympathetic understanding 
of human nature as to make the word •simple1 a paradox where he 
was concerned.
Thackrah, Legge and the more recent pioneers of industrial 
medicine, some of them here today, laid the foundations and 
started the development of the situation he inherited. His gift 
to posterity was to foster this growth and to make easier the 
path of the men who came after him. Industrial medicine like 
other social advances can but reflect the philosophy of the hour. 
It is given to some few to influence that philosophy and the
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doctor in industry is in a specially favourable position to do 
so, to lead those who manage it and those who work in it to a 
more acute realisation of their responsibilities and to a more 
effective discharge of their material and moral duties.
At the same time, we must never forget that we are doctors 
and that we have the ultimate responsibility for the lives, 
bodily health and mental happiness of the men and women who 
make our industry so prosperous and our standard of living so 
abundant.
Like Hubert Wyers we will keep faith.
